data_2ku7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ku7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 81.3 mtm-85 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.53 0.205 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.5 t -104.02 134.94 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.65 154.36 39.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.803 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.4 t80 -94.48 134.44 37.01 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.652 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.27 114.75 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.614 0.571 . . . . 0.0 109.687 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.83 146.98 18.75 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.556 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.18 23.34 6.12 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 123.881 0.4 . . . . 0.0 112.425 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -93.42 165.12 12.92 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.548 0.339 . . . . 0.0 110.262 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.445 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -81.09 151.75 28.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.044 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.58 -29.97 70.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.714 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.77 9.13 6.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 72' ' ' ALA . 3.5 m -90.55 136.93 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 120.635 0.255 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -107.79 174.72 5.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -61.42 -28.05 68.98 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.619 0.368 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.5 -39.03 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.0 -47.81 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.086 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.4 -38.27 84.4 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.354 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.531 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 9.8 t60 -68.09 -49.07 63.56 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.566 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.453 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.44 -20.49 62.89 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.26 -33.62 24.0 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 111.271 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.33 1.88 33.35 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.437 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -69.75 -31.97 2.77 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.25 -0.881 . . . . 0.0 113.339 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.6 Cg_exo -59.8 -23.3 71.6 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.861 1.707 . . . . 0.0 113.955 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 47.8 m-85 -80.04 -31.27 39.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.89 -168.56 41.44 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.804 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.18 134.06 34.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.468 0.307 . . . . 0.0 110.97 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 111' ' ' GLU . 9.6 mt -113.54 140.86 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.851 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 -64.99 1.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.226 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -145.34 153.84 41.68 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.2 mm -117.84 128.73 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 63.7 mt-30 -115.52 133.87 55.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.875 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.62 104.19 24.35 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.06 96.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.471 2.114 . . . . 0.0 112.387 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -111.56 133.63 53.69 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -85.03 141.71 30.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -64.67 -34.55 78.56 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -73.05 -49.12 30.49 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.517 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 31.3 p -93.89 -28.79 15.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 49.71 30.81 3.91 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.394 0.678 . . . . 0.0 111.823 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 101' ' ' THR . 42.8 mttt -112.24 153.41 27.17 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.346 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -101.21 143.78 30.88 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.617 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -99.12 1.62 45.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.559 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 92.28 20.82 34.26 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 120.336 -0.935 . . . . 0.0 114.904 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.82 146.73 31.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.863 0.832 . . . . 0.0 111.458 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 94' ' ' GLN . . . -159.66 173.02 16.72 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.66 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.452 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 76.7 m-85 -118.08 150.64 39.0 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -119.41 136.17 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 123.47 0.481 . . . . 0.0 111.027 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.611 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -106.46 121.17 43.74 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.213 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 9.1 m-85 -105.84 133.07 51.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.076 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.66 -34.73 78.89 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.794 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.81 135.9 49.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.92 61.6 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.642 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.93 -40.95 75.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.59 -31.75 71.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.425 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.44 -45.66 92.08 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.267 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.62 -28.98 67.39 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.267 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.27 -40.25 71.07 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.27 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.1 89.84 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.653 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.603 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 11.4 mt -71.21 -34.21 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.512 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.9 p30 -83.01 -16.77 45.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -100.02 -42.05 6.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.539 ' O ' HG12 ' A' ' 137' ' ' VAL . 86.5 mtp -128.82 45.05 2.85 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.8 t-20 -63.72 -38.54 91.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.676 0.274 . . . . 0.0 111.238 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 39.3 mt-10 -142.09 78.13 1.61 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.729 0.776 . . . . 0.0 109.656 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.538 ' OG ' ' HE3' ' A' ' 125' ' ' MET . 68.0 p -125.13 162.68 24.08 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.454 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -91.99 118.73 31.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.035 0.445 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.29 130.78 48.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.675 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.36 15.02 8.36 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.25 5.28 59.4 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.164 -0.471 . . . . 0.0 113.344 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -127.86 156.87 41.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.56 0.344 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.94 134.1 35.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.0 pt -120.23 154.85 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 123.37 0.419 . . . . 0.0 112.075 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 52.9 mtt180 -125.83 134.68 51.58 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.466 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.803 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.8 134.02 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.044 0.45 . . . . 0.0 110.834 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 13.4 p-10 -151.14 171.47 17.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.498 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 14.3 mt -71.06 130.72 42.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.533 0.206 . . . . 0.0 111.168 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.51 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG23 ' OE1' ' A' ' 111' ' ' GLU . 17.1 t -106.4 128.67 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.539 0.209 . . . . 0.0 110.575 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.14 159.73 29.38 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.66 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.749 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.7 OUTLIER -112.66 117.4 32.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.952 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 136' ' ' ARG . 0.8 OUTLIER -108.71 115.32 49.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 178.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -127.86 148.8 17.83 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.027 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.8 41.27 3.15 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 106' ' ' GLY . 3.7 mp -91.33 159.82 15.81 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.106 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -82.16 174.54 11.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.358 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -69.03 -32.51 72.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.841 0.456 . . . . 0.0 111.519 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -98.83 63.26 1.38 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.405 0.621 . . . . 0.0 111.527 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 72' ' ' ALA . 12.2 p -139.05 137.59 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.705 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.803 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.0 m-20 -140.94 -175.9 4.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.486 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.76 -37.06 86.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.85 0.46 . . . . 0.0 112.203 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -66.25 -43.52 86.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.982 0.513 . . . . 0.0 112.186 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.803 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 16.8 m -73.34 -39.53 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 123.322 0.389 . . . . 0.0 111.769 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.67 -35.75 82.04 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.53 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 6.8 t60 -68.31 -46.2 70.91 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.556 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.12 -20.73 63.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.91 -35.12 22.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' C ' HD13 ' A' ' 90' ' ' ILE . 56.7 m-85 -97.38 -0.9 45.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.021 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 82' ' ' ALA . 4.1 tp -70.39 -31.67 2.35 Favored Pre-proline 0 CA--C 1.565 1.548 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.4 Cg_exo -59.73 -24.14 74.52 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.917 1.744 . . . . 0.0 113.798 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -78.05 -31.28 50.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.89 -159.14 32.13 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.458 0.474 . . . . 0.0 112.612 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -85.94 137.91 32.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.636 0.374 . . . . 0.0 111.456 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.53 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 5.4 mt -118.4 144.33 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.809 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 1.4 p -91.2 -67.33 0.86 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.896 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -148.63 158.04 43.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.8 mm -116.94 129.4 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -126.61 127.02 44.57 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.2 mp -127.83 118.1 20.99 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.795 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.54 126.11 20.35 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.304 2.003 . . . . 0.0 112.642 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -128.02 134.67 49.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -89.55 143.38 26.86 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.278 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -64.58 -34.65 78.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.11 -48.71 41.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.8 p -94.72 -28.33 15.36 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 55.35 24.7 6.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.21 0.604 . . . . 0.0 111.513 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -120.31 156.83 30.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.1 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -92.77 158.58 15.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.973 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -88.52 0.54 56.21 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.017 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.583 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.85 19.46 29.05 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 119.453 -0.637 . . . . 0.0 114.305 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 95' ' ' ILE . 55.1 p90 -144.55 151.15 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.464 0.632 . . . . 0.0 111.191 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.44 164.73 36.1 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.954 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -115.31 138.64 50.75 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.32 133.78 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.93 0.395 . . . . 0.0 111.393 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.517 ' OE1' HG23 ' A' ' 65' ' ' VAL . 1.1 mm-40 -109.0 137.62 46.64 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -117.65 147.32 43.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.21 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.87 -39.52 90.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.07 141.74 39.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.705 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.23 -22.13 63.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.071 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.76 -42.17 95.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.177 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.96 -33.05 71.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.74 92.65 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.207 0.317 . . . . 0.0 111.028 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.51 -28.9 64.22 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.12 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.63 -45.24 59.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.426 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.26 90.17 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.583 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 46.8 mt -70.65 -39.98 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.67 -28.3 60.79 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.8 -49.7 10.09 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.541 ' O ' HG12 ' A' ' 137' ' ' VAL . 85.4 mtp -135.24 61.33 1.67 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.091 0.472 . . . . 0.0 111.993 -177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 11.3 t-20 -69.21 -41.68 76.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.482 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.6 mt-10 -140.61 79.18 1.69 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.678 0.751 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 p -126.68 164.57 21.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.366 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -87.15 116.14 25.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.02 0.438 . . . . 0.0 110.513 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -133.31 130.49 38.97 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.136 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 64.92 17.05 10.87 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.089 0.955 . . . . 0.0 112.168 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.55 -0.19 61.24 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.735 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.97 156.8 43.2 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.353 0.261 . . . . 0.0 111.099 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -77.97 128.69 34.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 3.0 pt -112.58 148.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 112.158 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 13.0 ttp180 -121.77 128.95 52.29 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.749 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -127.74 133.18 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 110.342 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -157.16 170.87 21.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.828 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.3 tt -71.87 130.88 42.1 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.073 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.165 -179.758 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 62.8 mtt180 . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 4.5 t -95.66 129.31 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.02 154.52 39.75 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.524 0.515 . . . . 0.0 110.818 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.5 t80 -98.97 122.45 42.25 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.929 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 m -117.54 116.9 53.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.965 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.54 151.09 18.8 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.876 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.26 5.24 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.7 mp -91.56 165.45 13.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.61 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -88.59 161.84 16.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.412 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.15 -31.45 70.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.59 3.02 26.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.036 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 72' ' ' ALA . 2.3 p -86.42 138.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 120.542 0.211 . . . . 0.0 110.923 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -124.83 176.38 6.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.354 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -61.36 -31.87 71.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.196 0.598 . . . . 0.0 112.079 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -67.74 -40.91 84.1 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.57 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.33 -42.3 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.024 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.402 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.2 tt -68.41 -37.79 80.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.396 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.52 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.2 t60 -68.48 -48.59 64.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.329 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.542 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.7 -20.52 62.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -35.38 23.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.851 0.358 . . . . 0.0 111.298 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.428 ' C ' HD13 ' A' ' 90' ' ' ILE . 71.2 m-85 -97.83 -2.26 41.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 82' ' ' ALA . 3.9 tp -68.28 -31.11 2.95 Favored Pre-proline 0 CA--C 1.567 1.599 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.57 -24.12 60.32 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 121.922 1.748 . . . . 0.0 113.691 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.69 -31.2 46.48 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.367 0.417 . . . . 0.0 111.692 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.96 33.8 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.262 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.23 134.23 34.74 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.4 mt -109.87 141.99 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.855 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -89.21 -64.29 1.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.673 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -145.75 153.44 40.95 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.2 mm -119.42 123.69 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -123.46 129.34 51.1 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 107' ' ' PHE . 0.9 OUTLIER -128.0 124.1 23.0 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.724 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.7 119.95 7.46 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.111 1.874 . . . . 0.0 112.191 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.57 135.66 50.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.362 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.18 144.31 25.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.312 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -64.81 -34.32 78.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.54 -46.82 62.86 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.2 p -101.43 -27.66 13.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.07 25.45 8.93 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.25 0.62 . . . . 0.0 111.709 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -121.87 154.99 36.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.648 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -106.78 164.39 12.14 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.415 0.447 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -88.02 -1.49 58.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 100.3 25.87 8.59 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.479 -0.623 . . . . 0.0 114.57 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 95' ' ' ILE . 28.9 p90 -145.07 147.11 32.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.445 0.622 . . . . 0.0 111.108 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.91 167.31 27.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.264 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.473 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 75.9 m-85 -111.65 137.49 49.47 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 7.1 p -112.55 132.09 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 O-C-N 123.243 0.34 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.632 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.9 tt0 -103.81 130.73 51.39 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.762 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 52.3 m-85 -117.12 146.99 42.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.66 -36.07 65.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.04 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.57 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -105.72 141.05 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.503 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.55 -19.99 58.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.559 0.695 . . . . 0.0 109.162 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.92 -49.96 33.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.431 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.7 p30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.52 84.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.795 0.438 . . . . 0.0 111.135 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.39 69.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.049 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.4 72.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.143 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.03 82.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.586 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 14.2 mt -70.48 -34.12 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.271 0.357 . . . . 0.0 111.473 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.96 -16.84 49.07 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -101.52 -43.71 5.82 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.549 ' O ' HG13 ' A' ' 137' ' ' VAL . 61.8 mtt -124.79 44.48 2.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.3 t30 -63.22 -37.95 89.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.618 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.3 mt-10 -142.85 77.57 1.58 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.667 0.746 . . . . 0.0 109.809 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.6 p -123.09 165.03 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.301 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -91.99 120.38 32.58 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.624 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -125.54 129.13 49.11 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.098 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 56.56 20.45 4.91 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.905 0.882 . . . . 0.0 112.814 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.67 3.85 59.39 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.848 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -126.9 153.2 46.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.86 0.33 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.2 m -78.57 132.28 37.09 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -119.54 156.46 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 14.1 ptt-85 -129.39 136.13 49.58 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.001 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -127.17 140.73 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 14.9 p-10 -150.78 171.63 16.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.805 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 mt -69.34 133.2 47.55 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.529 0.332 . . . . 0.0 111.146 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.137 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.095 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 50.9 mtm180 . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.9 132.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.15 152.56 41.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.674 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.3 t80 -100.68 116.33 32.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.583 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.33 117.7 56.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.976 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.05 153.08 19.91 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.074 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.91 26.06 5.94 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.9 0.412 . . . . 0.0 112.502 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -94.27 163.47 13.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.54 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.476 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -91.0 157.35 17.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.902 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 45.7 mt-10 -63.66 -26.9 68.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.64 0.376 . . . . 0.0 111.744 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.7 -4.05 35.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.801 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.0 m -86.71 141.1 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.671 0.272 . . . . 0.0 110.855 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.467 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -122.08 179.1 4.64 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 23.5 m-20 -59.87 -30.44 68.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.845 0.458 . . . . 0.0 111.669 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.57 -40.91 80.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.721 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.467 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.1 t -66.66 -46.74 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.292 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 2.2 tt -67.02 -39.38 87.04 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.594 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.501 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 25.6 t-80 -68.01 -48.42 65.77 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.78 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.6 62.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.16 -32.7 24.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.98 0.419 . . . . 0.0 111.268 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -103.78 1.76 32.03 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.416 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -70.23 -33.12 3.14 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 19.8 Cg_endo -59.7 -23.5 71.93 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.867 1.711 . . . . 0.0 114.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -80.76 -31.26 35.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.84 -170.28 43.18 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.773 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -84.01 133.55 34.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.53 0.332 . . . . 0.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 111' ' ' GLU . 6.9 mt -113.0 139.4 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.854 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -90.19 -62.59 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.174 -179.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.5 155.21 42.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.413 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 20.6 mm -116.64 124.98 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -120.13 126.23 50.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.88 117.45 20.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.961 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.68 126.64 21.85 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.313 2.009 . . . . 0.0 112.519 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -125.36 134.36 52.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.143 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.13 142.25 27.9 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.22 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -64.64 -33.46 75.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -71.05 -48.28 53.69 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.7 p -98.69 -27.75 13.84 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 97' ' ' LEU . 47.0 mt-10 57.92 22.59 8.89 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.178 0.591 . . . . 0.0 111.506 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -123.07 156.34 35.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.212 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.54 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 13.5 p80 -99.89 160.15 14.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 24.2 mtp180 -88.5 0.08 56.67 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.584 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 98.95 29.3 7.32 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.15 -0.548 . . . . 0.0 114.269 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.464 ' O ' HG21 ' A' ' 95' ' ' ILE . 36.5 p90 -145.09 145.47 31.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.155 0.477 . . . . 0.0 111.028 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.14 165.91 34.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.105 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -111.96 143.5 42.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -116.78 135.94 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.821 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -107.62 125.77 51.75 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.86 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 28.4 m-85 -111.12 136.08 50.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -64.66 -36.58 84.73 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.664 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.26 132.51 52.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.58 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.68 -24.54 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.206 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.74 -44.57 81.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.808 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -68.89 -32.7 72.53 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.397 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.41 -48.51 81.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.375 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.56 69.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.207 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.549 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.66 -37.41 70.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.299 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.39 88.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.828 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.598 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 14.3 mt -70.4 -38.91 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.6 p30 -76.34 -25.88 55.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.36 -50.05 9.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 137' ' ' VAL . 63.5 mtt -132.73 58.97 1.74 Allowed 'General case' 0 C--N 1.347 0.482 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.6 t30 -67.36 -37.82 83.81 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 33.9 mt-10 -140.7 79.48 1.7 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.915 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.2 t -122.15 160.97 24.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.187 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -90.77 118.24 30.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -129.35 129.78 45.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.993 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 62.54 15.31 7.79 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.671 0.788 . . . . 0.0 112.389 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.83 3.95 59.13 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.222 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -126.02 154.22 43.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.533 0.333 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 133.74 35.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -117.81 152.91 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 1.8 tpt180 -125.54 131.43 52.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.237 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -126.95 135.68 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 123.196 0.31 . . . . 0.0 110.319 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -147.24 171.75 14.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.368 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.61 129.67 38.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.227 0.211 . . . . 0.0 110.894 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.47 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.0 mtt85 . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.446 HG22 ' OE2' ' A' ' 111' ' ' GLU . 14.4 t -103.49 129.42 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.92 157.81 33.42 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.501 0.501 . . . . 0.0 111.324 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 37.0 t80 -99.6 136.21 39.87 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.321 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.42 115.33 19.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 123.546 0.529 . . . . 0.0 109.927 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.95 149.28 19.12 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.631 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.83 19.22 9.29 Favored Glycine 0 C--N 1.331 0.298 0 O-C-N 123.914 0.42 . . . . 0.0 112.271 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -90.94 166.24 13.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 122.604 0.361 . . . . 0.0 110.438 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -90.7 156.97 17.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.44 -27.52 68.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.36 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.1 -4.75 40.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.849 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 72' ' ' ALA . 2.3 m -82.52 138.12 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 120.606 0.241 . . . . 0.0 110.664 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.47 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 77.3 m-20 -119.01 178.9 4.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.48 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 22.9 m-20 -59.19 -30.93 68.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.904 0.482 . . . . 0.0 111.64 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -68.56 -40.51 80.57 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.764 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.47 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.2 t -67.32 -47.33 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.522 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.479 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.5 tt -68.14 -39.74 82.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.714 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.538 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 21.3 t-80 -68.32 -47.76 66.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.495 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.46 -20.62 62.87 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.11 -33.19 24.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.912 0.387 . . . . 0.0 111.156 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -102.31 0.79 34.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.381 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.571 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 tp -69.95 -32.75 3.08 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 14.9 Cg_endo -58.48 -23.23 63.21 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.941 1.761 . . . . 0.0 113.931 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -78.85 -31.17 45.57 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.345 0.403 . . . . 0.0 112.085 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.75 -163.74 37.45 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.898 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -82.9 135.27 34.97 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.775 0.43 . . . . 0.0 111.823 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 111' ' ' GLU . 7.2 mt -116.85 140.34 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.389 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 9.1 p -88.47 -64.23 1.18 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.85 157.04 43.55 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 12.7 mm -119.38 128.75 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.428 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 65.4 mt-30 -114.96 131.81 56.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.692 0.282 . . . . 0.0 111.683 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.457 HG22 ' CD2' ' A' ' 104' ' ' HIS . 4.1 mp -126.6 102.75 25.55 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.824 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.36 121.42 9.87 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.533 2.156 . . . . 0.0 112.546 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tp -129.52 134.9 48.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.939 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -87.74 140.83 29.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -64.42 -34.31 77.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.14 -48.75 32.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.892 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.4 p -93.03 -29.22 15.93 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 50.65 32.27 6.69 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.247 0.619 . . . . 0.0 111.018 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 101' ' ' THR . 51.6 mttt -118.03 154.82 31.38 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.359 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.457 ' CD2' HG22 ' A' ' 95' ' ' ILE . 12.3 t-80 -97.32 142.45 29.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.594 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -93.95 -1.68 54.28 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.46 20.42 38.01 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 120.393 -0.908 . . . . 0.0 114.669 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -145.6 148.1 32.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.708 0.754 . . . . 0.0 111.192 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 94' ' ' GLN . . . -157.49 172.78 17.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.857 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -117.94 149.32 41.1 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.89 136.46 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 123.257 0.348 . . . . 0.0 111.214 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 90' ' ' ILE . 1.1 tm-20 -109.9 130.0 55.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.082 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 15.9 m-85 -109.42 143.2 39.31 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.974 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.26 -37.07 82.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.376 0.422 . . . . 0.0 110.624 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.568 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -105.7 141.44 37.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.898 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.01 56.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.763 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -72.25 -48.61 41.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.347 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 23.2 p30 -66.58 -32.36 73.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.974 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.48 83.38 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.49 0.494 . . . . 0.0 111.131 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.89 69.83 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.352 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.43 75.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.13 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.98 86.35 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.781 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 35.4 mt -70.71 -33.49 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.63 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -32.75 69.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -104.32 -35.68 7.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.611 ' O ' HG11 ' A' ' 137' ' ' VAL . 77.8 mtp -103.37 14.83 30.61 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.615 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.1 t-20 -57.2 -36.69 71.15 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.691 0.281 . . . . 0.0 111.253 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.9 74.25 1.44 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.742 0.782 . . . . 0.0 109.765 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.3 p -124.09 161.25 25.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.333 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -94.31 120.59 34.78 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -128.35 128.8 45.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.808 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.22 15.82 7.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.728 0.811 . . . . 0.0 112.364 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.06 5.27 58.37 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.475 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mtp85 -127.22 154.81 44.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.427 0.291 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -81.12 132.97 35.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.1 pt -119.41 154.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 55.5 mtt85 -123.04 133.58 54.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.186 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.99 136.08 59.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.531 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -149.82 171.86 16.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.74 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.98 128.85 37.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.606 0.241 . . . . 0.0 110.898 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.309 -179.448 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 120.581 0.229 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.54 HG23 ' OE2' ' A' ' 111' ' ' GLU . 14.6 t -104.74 135.88 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.21 155.31 37.37 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.358 0.411 . . . . 0.0 111.473 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.767 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.3 t80 -96.32 135.1 38.62 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.171 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 m -134.37 115.65 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.333 0.396 . . . . 0.0 110.006 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.42 154.41 21.04 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.94 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.87 26.49 6.71 Favored Glycine 0 C--N 1.332 0.352 0 O-C-N 123.935 0.432 . . . . 0.0 112.309 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.591 HD11 ' O ' ' A' ' 106' ' ' GLY . 0.7 OUTLIER -92.9 159.88 15.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.955 0.407 . . . . 0.0 110.652 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -83.62 154.08 23.94 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.027 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 24.1 tp10 -60.03 -30.89 69.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.678 0.391 . . . . 0.0 111.454 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -72.17 -18.7 61.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 72' ' ' ALA . 1.5 m -68.58 139.03 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.686 0.279 . . . . 0.0 111.487 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -117.63 179.03 4.18 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.31 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -61.96 -28.95 69.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.972 0.415 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.05 -40.53 78.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.6 t -64.86 -46.48 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.084 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.483 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.7 tt -65.77 -39.57 91.13 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.908 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.603 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 23.7 t-80 -68.49 -47.97 65.65 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.944 0.498 . . . . 0.0 111.82 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.533 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.31 -20.59 63.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.42 23.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.483 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 75.0 m-85 -102.38 1.39 35.37 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.239 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 82' ' ' ALA . 4.0 tp -70.79 -31.62 2.16 Favored Pre-proline 0 CA--C 1.565 1.553 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.3 Cg_exo -59.5 -23.9 72.68 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.954 1.769 . . . . 0.0 113.859 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.567 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 60.1 m-85 -78.89 -31.31 45.36 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.95 -163.28 36.69 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.032 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -83.85 134.34 34.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.868 0.467 . . . . 0.0 111.97 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.603 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 6.2 mt -116.67 139.81 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.426 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 6.4 p -86.97 -61.23 1.77 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.817 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -152.53 159.67 43.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.948 0.404 . . . . 0.0 111.949 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.7 mm -115.23 124.58 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -117.76 127.45 53.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.233 0.333 . . . . 0.0 111.818 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.62 121.12 22.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.665 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.77 96.69 0.31 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 121.937 1.758 . . . . 0.0 112.082 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.33 135.87 48.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.234 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -87.37 141.18 28.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.67 -34.18 77.69 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -70.85 -48.8 52.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 29.9 p -95.85 -28.31 14.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 54.36 24.76 5.38 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.256 0.622 . . . . 0.0 111.672 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 101' ' ' THR . 61.5 mttt -117.13 152.27 35.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.178 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.52 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.4 p80 -103.76 157.64 16.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.227 0.329 . . . . 0.0 110.692 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -88.05 0.81 55.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.186 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.591 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 96.22 24.73 13.86 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.199 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.66 150.38 34.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 117.216 0.508 . . . . 0.0 111.037 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.36 171.09 18.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -115.73 140.2 49.43 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.3 p -116.09 134.17 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.155 0.284 . . . . 0.0 111.192 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.547 ' O ' HG21 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -106.45 126.83 52.74 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.414 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 21.8 m-85 -111.07 139.35 46.51 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.755 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.48 -37.92 89.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.78 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.573 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.3 mp -103.87 136.47 43.48 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.958 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.45 60.6 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.441 0.639 . . . . 0.0 109.374 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.4 -50.45 31.84 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.371 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.573 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 19.2 p30 -69.72 -32.13 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.878 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.48 91.87 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.96 69.01 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.943 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.45 74.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.114 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.51 84.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.93 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.588 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 21.2 mt -70.56 -34.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.301 0.375 . . . . 0.0 111.944 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.76 -17.07 45.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -99.48 -44.48 6.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.574 ' O ' HG13 ' A' ' 137' ' ' VAL . 61.4 mtt -130.18 50.55 2.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.6 t-20 -64.08 -37.1 86.22 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.962 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.8 tt0 -143.77 76.65 1.52 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.068 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.8 t -119.4 162.73 18.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.85 118.15 29.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.015 0.436 . . . . 0.0 110.796 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.35 131.77 42.24 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 t80 62.93 14.66 7.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.771 0.828 . . . . 0.0 112.307 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.9 2.31 59.59 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.204 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -126.96 156.39 41.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.559 0.344 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.22 133.71 35.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -115.66 154.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.425 0.453 . . . . 0.0 112.046 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 6.0 tpt180 -124.42 132.23 53.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.03 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -131.39 133.62 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.421 178.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -147.38 171.44 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.21 129.78 39.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.517 0.199 . . . . 0.0 111.123 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.204 -179.518 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.453 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 52.9 mtm180 . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.551 HG21 ' OE1' ' A' ' 111' ' ' GLU . 5.4 t -107.49 126.63 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.56 156.16 36.26 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.363 0.414 . . . . 0.0 111.008 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.818 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 50.9 t80 -95.22 133.64 38.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.706 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.77 115.27 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 123.378 0.424 . . . . 0.0 109.974 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -134.73 153.01 20.89 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.891 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.06 32.78 4.86 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 106' ' ' GLY . 1.1 mp -94.0 164.0 13.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.451 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -80.59 153.0 28.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.977 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -61.84 -26.6 68.22 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.842 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.69 9.05 22.77 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 72' ' ' ALA . 2.7 m -90.63 142.24 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.383 -0.198 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.485 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.6 p30 -126.01 -175.8 3.46 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 17.3 m-20 -58.87 -33.34 70.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.725 0.41 . . . . 0.0 111.786 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -69.4 -36.27 76.59 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.914 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.485 HG23 ' OD1' ' A' ' 76' ' ' ASP . 55.9 t -69.48 -48.57 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.797 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tt -66.55 -38.82 87.92 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.625 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 27.0 t-80 -68.38 -47.96 65.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.79 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.72 62.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.21 -33.07 24.21 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 111.126 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.53 1.24 34.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.37 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.04 -32.02 2.67 Favored Pre-proline 0 CA--C 1.565 1.519 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 32.4 Cg_exo -60.39 -23.9 76.11 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 121.982 1.788 . . . . 0.0 113.922 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 44.1 m-85 -81.46 -31.53 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.69 -170.0 42.62 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.89 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.9 134.67 34.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.598 0.359 . . . . 0.0 110.894 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.7 mt -115.6 140.12 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.005 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 3.8 p -89.15 -62.47 1.47 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.892 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -148.09 158.42 44.06 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.038 0.447 . . . . 0.0 112.11 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.516 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 mm -118.02 125.59 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.438 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -116.11 121.98 43.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.543 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.65 118.83 21.34 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.822 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.36 114.88 2.17 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.24 1.96 . . . . 0.0 112.222 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.19 135.5 51.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.193 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -89.61 144.2 26.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.415 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.64 -35.07 79.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.22 -49.06 29.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.8 p -93.72 -28.54 15.88 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 53.55 24.64 4.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.355 0.662 . . . . 0.0 111.615 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 101' ' ' THR . 79.1 mttt -114.15 156.12 24.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.371 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -106.47 158.34 16.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.718 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -88.57 -0.13 56.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.21 25.55 13.99 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 119.56 -0.578 . . . . 0.0 114.488 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.483 ' O ' HG23 ' A' ' 95' ' ' ILE . 53.1 p90 -146.51 150.0 34.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.337 0.569 . . . . 0.0 111.034 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.47 169.48 24.54 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.39 143.72 45.2 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.48 134.95 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.717 0.294 . . . . 0.0 111.415 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.551 ' OE1' HG21 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -108.08 125.51 51.67 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.958 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 16.3 m-85 -106.49 138.86 41.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.981 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.94 -36.65 85.07 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.73 132.96 53.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.742 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.9 64.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -42.99 84.68 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.756 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.27 -32.82 72.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.251 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.53 90.26 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.304 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.94 67.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.141 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.85 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.344 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.24 92.34 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.086 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.599 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 17.6 mt -70.94 -34.24 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.278 0.361 . . . . 0.0 111.74 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.87 -17.12 44.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -94.7 -48.68 5.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.568 ' O ' HG13 ' A' ' 137' ' ' VAL . 64.3 mtt -133.51 59.03 1.75 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.035 0.445 . . . . 0.0 112.156 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 15.8 p30 -69.4 -36.73 77.05 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.432 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.34 79.62 1.67 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.652 0.739 . . . . 0.0 109.728 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -124.96 163.25 22.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.46 119.44 32.54 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 110.619 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -128.53 130.1 46.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.903 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.57 15.23 7.74 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.04 4.34 58.72 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 116.261 -0.427 . . . . 0.0 113.22 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -126.34 155.07 42.61 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.455 0.302 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.05 131.98 35.14 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.4 pt -117.17 149.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 123.359 0.412 . . . . 0.0 111.873 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 76.9 mtt180 -123.2 133.74 54.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.593 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.818 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.12 134.02 63.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.874 0.368 . . . . 0.0 110.421 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -150.15 172.78 14.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.668 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mt -68.95 129.66 40.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.953 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.113 -179.518 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.644 0.259 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.552 HG22 ' OE2' ' A' ' 111' ' ' GLU . 26.0 t -101.86 134.97 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.686 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.06 147.23 48.02 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.381 0.426 . . . . 0.0 110.582 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.725 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.1 t80 -99.93 125.13 45.89 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.924 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.71 118.92 59.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 123.547 0.529 . . . . 0.0 110.028 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.49 149.08 18.19 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.544 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.39 23.93 7.75 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.1 mp -90.02 168.61 11.87 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.968 0.507 . . . . 0.0 110.824 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -96.4 161.82 13.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.337 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.62 -32.2 71.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.657 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -75.7 -7.65 54.86 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.917 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 72' ' ' ALA . 1.7 p -78.44 131.08 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 120.66 0.267 . . . . 0.0 110.577 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -114.84 175.47 5.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.952 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.505 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.3 m-20 -60.69 -33.65 73.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.459 0.704 . . . . 0.0 112.131 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -67.19 -40.32 86.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.584 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.56 -45.09 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tt -69.55 -37.66 77.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.428 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.549 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 30.3 t60 -68.14 -48.78 64.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.75 -21.25 62.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -34.32 23.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.266 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.433 ' C ' HD12 ' A' ' 90' ' ' ILE . 61.7 m-85 -98.09 -2.36 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 82' ' ' ALA . 3.7 tp -69.44 -31.31 2.54 Favored Pre-proline 0 CA--C 1.566 1.596 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.97 -24.18 71.87 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.93 1.753 . . . . 0.0 113.637 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -79.64 -31.22 41.53 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.563 0.345 . . . . 0.0 111.693 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.03 37.0 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.247 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.23 132.61 36.0 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.594 0.235 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 111' ' ' GLU . 4.4 mt -109.34 142.04 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.956 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.2 p -85.73 -61.59 1.72 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.901 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -151.48 158.04 43.11 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.505 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 15.1 mm -117.73 129.8 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.545 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 18.7 tp60 -115.57 127.89 55.57 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.417 HG21 ' CD2' ' A' ' 104' ' ' HIS . 4.3 mp -124.75 100.66 33.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.12 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.25 119.8 6.87 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.042 1.828 . . . . 0.0 112.904 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -125.23 132.59 52.95 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.598 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -83.37 140.88 32.15 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.429 0.455 . . . . 0.0 110.676 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.62 -34.09 77.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -72.66 -48.83 35.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.068 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.7 p -95.16 -28.94 14.81 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 50.3 32.02 5.84 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.391 0.676 . . . . 0.0 111.76 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 101' ' ' THR . 85.1 mttt -115.23 150.64 35.83 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.437 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.417 ' CD2' HG21 ' A' ' 95' ' ' ILE . 13.0 t-80 -101.53 138.31 38.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.64 1.8 57.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.591 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 90.04 22.62 35.0 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.175 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -142.83 151.13 40.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.111 0.956 . . . . 0.0 111.326 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 94' ' ' GLN . . . -158.67 166.92 30.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.194 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.471 ' CE2' ' HD2' ' A' ' 67' ' ' TYR . 72.8 m-85 -111.33 139.55 46.64 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.6 p -118.84 132.38 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 123.307 0.379 . . . . 0.0 110.334 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -105.74 133.1 51.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.184 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.433 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 20.4 m-85 -115.32 140.14 49.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.315 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.31 -37.03 85.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.562 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.7 mp -106.2 141.17 37.99 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.47 -19.68 59.27 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.949 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -73.92 -49.94 22.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.263 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.562 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.3 p30 -68.95 -32.43 72.02 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.88 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.9 -43.57 83.02 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.471 0.482 . . . . 0.0 111.016 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.77 69.38 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.051 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.72 -34.94 74.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.154 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.25 82.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.803 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 15.3 mt -69.59 -33.53 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.357 0.41 . . . . 0.0 111.596 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -16.71 46.61 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -100.62 -44.17 5.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.57 ' O ' HG12 ' A' ' 137' ' ' VAL . 62.1 mtt -126.26 45.51 2.63 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.4 t-20 -63.13 -36.61 84.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.611 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 40.8 mt-10 -141.78 79.47 1.68 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.659 0.742 . . . . 0.0 109.625 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 82.0 p -125.07 166.11 16.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.274 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -91.84 120.17 32.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -127.57 129.53 47.49 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.809 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 t80 59.23 18.85 6.93 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.921 0.888 . . . . 0.0 112.31 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.51 -9.63 64.67 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -114.98 152.68 31.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.66 0.384 . . . . 0.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -76.88 137.32 39.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -121.21 156.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.52 0.513 . . . . 0.0 112.299 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 12.8 ptt85 -129.17 132.38 47.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.567 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -125.83 136.49 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.102 0.477 . . . . 0.0 111.212 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -148.41 171.15 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.29 131.04 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.507 0.194 . . . . 0.0 111.171 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.154 -179.624 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 79.0 mtt180 . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 19.3 t -101.63 129.43 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.83 155.34 38.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.015 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.0 t80 -92.67 130.39 38.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.89 116.6 34.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.345 0.403 . . . . 0.0 110.146 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.76 157.9 22.59 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.769 -0.651 . . . . 0.0 113.026 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.69 26.72 7.9 Favored Glycine 0 C--N 1.333 0.361 0 O-C-N 123.943 0.437 . . . . 0.0 112.158 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 106' ' ' GLY . 1.6 mp -89.83 160.88 16.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.991 0.424 . . . . 0.0 110.729 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -80.66 157.49 25.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 104' ' ' HIS . 44.3 mt-10 -65.94 -27.54 68.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -84.27 7.91 17.69 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.4 m -90.39 142.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -128.21 -176.24 3.74 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.344 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.04 -31.55 68.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.912 0.387 . . . . 0.0 111.523 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -68.46 -40.99 80.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.58 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.8 -47.39 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.911 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.9 tt -66.55 -38.19 86.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.683 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.52 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.8 t60 -68.17 -49.22 62.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.648 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.39 -20.33 62.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -33.86 23.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.972 0.415 . . . . 0.0 111.342 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 83.6 m-85 -102.56 1.36 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.389 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.3 tp -69.5 -31.73 2.75 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.8 Cg_exo -59.03 -23.46 68.79 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.979 1.786 . . . . 0.0 113.907 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.632 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 64.8 m-85 -77.34 -31.5 54.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.53 -160.27 33.71 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.696 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.58 134.63 34.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.71 0.404 . . . . 0.0 111.81 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.566 HG21 ' O ' ' A' ' 111' ' ' GLU . 13.0 mt -115.76 137.23 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -92.38 -59.35 2.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.285 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.42 154.69 41.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.2 mm -116.85 120.13 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.21 125.24 53.94 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.262 0.351 . . . . 0.0 111.354 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.32 109.42 21.26 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.573 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.34 126.23 18.05 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.274 1.983 . . . . 0.0 112.147 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 136.69 53.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.255 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -91.68 143.33 26.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -64.66 -34.96 79.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.14 -48.79 32.52 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.0 p -93.84 -28.48 15.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.21 24.38 2.78 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.386 0.675 . . . . 0.0 111.9 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 101' ' ' THR . 70.1 mttt -109.15 149.44 29.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.461 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 11.9 p80 -84.94 -14.36 47.86 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 67.75 -7.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.266 1.026 . . . . 0.0 113.502 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.625 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 99.25 23.73 11.01 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.29 -0.728 . . . . 0.0 114.755 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.03 152.25 40.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.794 0.797 . . . . 0.0 111.44 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.62 170.75 20.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.894 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -113.51 145.22 41.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 15.0 p -117.56 131.47 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 90' ' ' ILE . 26.4 tt0 -104.11 125.02 50.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.771 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 21.0 m-85 -112.27 143.07 43.97 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.053 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -69.38 -36.79 77.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.923 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.56 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.8 mp -105.62 139.95 39.44 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.057 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.34 -22.28 57.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.361 0.601 . . . . 0.0 109.896 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -70.02 -49.35 52.25 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.602 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.56 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -67.3 -31.92 72.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.868 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.73 90.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.85 -28.72 69.18 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.025 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.1 -35.81 71.95 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.355 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.6 85.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.062 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.58 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 25.2 mt -70.87 -37.61 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 -18.71 39.85 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -97.25 -43.57 7.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.632 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 83.1 mtp -132.09 52.02 2.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.7 t30 -63.91 -40.2 95.94 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.5 mt-10 -141.25 78.26 1.63 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.402 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.543 ' OG ' ' HE3' ' A' ' 125' ' ' MET . 51.9 p -122.04 164.03 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.642 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -91.44 118.96 31.01 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.1 tp -131.12 130.87 43.67 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.053 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 t80 62.42 15.11 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.694 0.798 . . . . 0.0 112.285 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.52 60.1 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -126.08 154.48 43.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.548 0.339 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.22 133.23 35.24 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.3 pt -116.43 153.78 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.095 0.474 . . . . 0.0 112.265 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -125.83 130.63 51.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.531 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.84 137.2 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.291 0.369 . . . . 0.0 110.483 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -148.94 171.91 15.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.59 126.29 29.28 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.448 0.299 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.139 -179.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 . . . . . 0 CA--C 1.543 0.684 0 CA-C-O 120.586 0.232 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.86 134.29 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.364 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.87 155.49 37.96 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.655 0.597 . . . . 0.0 111.024 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 67.1 t80 -102.32 130.85 49.15 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 108' ' ' ALA . 12.6 m -126.22 124.57 66.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 O-C-N 123.533 0.52 . . . . 0.0 110.074 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 154.58 22.16 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.1 20.68 10.21 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 123.888 0.405 . . . . 0.0 112.424 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -89.6 160.44 16.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 110.664 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -89.08 155.54 19.39 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.978 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 43.5 mt-10 -61.69 -26.21 67.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.892 0.477 . . . . 0.0 111.933 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.44 -4.34 33.06 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.1 m -90.43 142.49 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.541 0.21 . . . . 0.0 110.786 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.508 ' OD1' HG22 ' A' ' 79' ' ' VAL . 3.8 p30 -127.71 -173.84 3.03 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.744 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.18 -32.94 71.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.764 0.425 . . . . 0.0 111.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 90.8 mttt -68.9 -40.25 79.28 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.782 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.508 HG22 ' OD1' ' A' ' 76' ' ' ASP . 44.1 t -66.25 -47.91 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.191 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.449 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -67.22 -38.41 85.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 11.2 t60 -68.26 -48.7 64.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.54 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.55 -20.51 62.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.41 -34.39 23.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.934 0.397 . . . . 0.0 111.473 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.449 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.9 m-85 -100.79 -0.63 36.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.189 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.6 -31.92 2.81 Favored Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.95 -22.82 65.15 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 121.93 1.753 . . . . 0.0 113.867 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.44 -31.18 47.95 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.08 -162.69 36.43 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.656 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -82.53 134.21 35.2 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.604 0.362 . . . . 0.0 111.72 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 111' ' ' GLU . 12.1 mt -114.67 139.73 39.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.365 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -90.36 -62.9 1.36 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -146.95 153.01 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.5 mm -117.94 123.3 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -120.27 121.67 39.19 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.84 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mp -127.7 116.57 20.97 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.979 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.88 124.57 16.0 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.254 1.97 . . . . 0.0 112.514 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.87 134.71 49.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.036 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.18 143.31 26.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.459 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -64.59 -34.6 78.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -71.65 -48.73 45.78 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.1 p -96.04 -28.02 14.83 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 56.27 24.67 8.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.221 0.608 . . . . 0.0 111.562 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -122.21 154.71 37.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.457 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 25.0 p80 -99.49 161.62 13.51 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.293 0.371 . . . . 0.0 110.802 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -86.01 -4.8 59.25 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.487 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.25 27.96 7.04 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.311 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -148.71 149.68 31.85 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.215 0.507 . . . . 0.0 110.887 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 68' ' ' VAL . . . -155.35 163.66 39.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.345 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.466 ' CE1' ' HD1' ' A' ' 67' ' ' TYR . 90.2 m-85 -109.57 134.35 52.02 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.01 132.93 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.327 0.392 . . . . 0.0 110.54 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.55 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -107.14 128.8 54.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.615 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -114.14 145.11 42.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.928 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.76 -37.08 76.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.589 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.9 mp -105.38 137.68 42.79 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.058 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.07 -19.75 59.85 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.172 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -71.15 -49.98 38.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.152 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.576 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.7 p30 -69.29 -31.77 70.49 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.73 90.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.99 0.516 . . . . 0.0 111.334 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.84 69.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.073 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.59 -35.16 75.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.962 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.53 -38.73 81.09 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.718 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 72.5 mt -69.78 -33.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 123.096 0.247 . . . . 0.0 111.195 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.33 -35.71 73.8 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -102.53 -36.01 8.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.465 1.284 . . . . 0.0 114.465 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.532 ' O ' HG13 ' A' ' 137' ' ' VAL . 90.9 mmm -90.74 0.43 57.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.646 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.9 t-20 -56.68 -37.01 70.26 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.747 0.248 . . . . 0.0 111.602 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -140.78 71.89 1.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.371 0.605 . . . . 0.0 109.516 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m -121.13 154.03 36.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.295 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -92.01 119.17 31.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.427 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -127.9 127.42 43.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.925 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 61.89 15.91 7.57 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.736 0.814 . . . . 0.0 112.399 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.45 -9.09 62.57 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.01 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -113.45 149.52 34.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.811 0.444 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.46 138.45 36.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.671 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.11 156.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.843 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 10.2 ptp180 -128.32 134.06 48.82 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.181 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.12 143.64 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.384 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -141.8 171.1 14.52 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.976 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tt -81.51 125.55 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.14 -179.764 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 120.622 0.249 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.21 134.72 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.429 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.35 155.46 37.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.866 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 76.8 t80 -93.56 137.46 32.81 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.417 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 108' ' ' ALA . 6.7 m -132.64 123.42 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 123.598 0.561 . . . . 0.0 110.226 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.98 151.57 20.48 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.135 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.79 15.71 12.81 Favored Glycine 0 C--N 1.334 0.423 0 O-C-N 123.996 0.468 . . . . 0.0 112.57 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -88.48 164.64 15.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.766 0.317 . . . . 0.0 110.637 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -89.47 154.36 20.09 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.57 -30.34 69.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.556 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.53 1.8 13.29 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.978 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 72' ' ' ALA . 2.9 m -88.95 137.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.598 0.237 . . . . 0.0 110.769 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.561 ' OD1' HG22 ' A' ' 79' ' ' VAL . 3.4 p30 -117.49 -175.77 2.88 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -61.98 -31.16 71.49 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.693 0.397 . . . . 0.0 112.042 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -35.62 76.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.879 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.561 HG22 ' OD1' ' A' ' 76' ' ' ASP . 61.8 t -69.75 -49.03 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.437 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -66.96 -38.64 86.47 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.74 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.502 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 31.2 t-80 -68.62 -47.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.742 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.527 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.27 -20.89 63.02 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.3 -33.98 23.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.009 0.433 . . . . 0.0 111.178 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 70.0 m-85 -100.39 0.04 39.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.254 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.527 HG21 ' O ' ' A' ' 82' ' ' ALA . 4.0 tp -69.36 -31.89 2.9 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 44.8 Cg_exo -59.27 -22.93 67.48 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.879 1.719 . . . . 0.0 113.822 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.63 -31.63 36.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.92 35.49 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.798 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -83.18 137.49 34.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.718 0.407 . . . . 0.0 112.027 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 111' ' ' GLU . 6.8 mt -117.53 138.21 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.519 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.48 -62.1 1.51 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -145.09 153.13 41.09 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.1 mm -119.58 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.454 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 5.8 tp60 -114.38 135.06 54.5 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.263 0.352 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mm -121.81 101.09 42.88 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.91 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.69 124.41 14.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.214 1.943 . . . . 0.0 112.382 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.54 132.12 53.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.961 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.93 141.73 28.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -64.74 -33.56 76.26 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.97 -48.8 51.29 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.1 p -100.59 -28.62 12.77 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 53.08 29.99 8.93 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.253 0.621 . . . . 0.0 111.673 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 101' ' ' THR . 34.1 mttt -121.18 156.89 31.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.193 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -89.42 139.22 30.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.69 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -99.01 3.31 46.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.574 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 93.84 21.77 27.54 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 114.741 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -146.05 150.82 36.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.655 0.728 . . . . 0.0 111.13 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -162.33 -179.83 7.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.875 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.464 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 85.3 m-85 -119.51 151.8 37.99 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.71 132.97 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 123.325 0.391 . . . . 0.0 110.495 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.628 ' O ' HG22 ' A' ' 90' ' ' ILE . 21.1 tt0 -106.04 130.18 54.0 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.287 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.02 147.39 42.38 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.46 -37.94 71.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.456 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.594 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.6 mp -106.7 137.3 44.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.024 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.19 -19.62 60.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.253 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -70.8 -50.03 40.04 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.235 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 13.3 p30 -68.99 -31.71 70.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.7 -44.46 93.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.298 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -30.34 70.3 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.08 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.32 -34.72 75.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.845 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.25 -38.14 81.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.6 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.668 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 74.6 mt -68.79 -35.56 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.129 0.268 . . . . 0.0 111.124 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.17 -37.15 78.04 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -101.14 -35.44 9.31 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.539 ' O ' HG11 ' A' ' 137' ' ' VAL . 92.6 mmm -91.95 1.17 57.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.8 t-20 -57.16 -37.48 72.13 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -140.04 70.28 1.36 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.398 0.618 . . . . 0.0 109.523 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -122.24 157.42 31.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.217 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.88 122.32 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.04 129.46 42.03 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.879 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 62.25 15.43 7.55 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.675 0.79 . . . . 0.0 112.393 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 5.28 59.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.273 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -126.91 154.17 44.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 122.446 0.298 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.25 134.78 35.3 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.88 158.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 O-C-N 123.4 0.438 . . . . 0.0 111.92 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 4.0 ptp180 -128.24 134.31 48.96 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.401 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.566 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.28 143.57 40.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 123.198 0.311 . . . . 0.0 111.128 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -141.75 171.25 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.152 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.14 124.42 28.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.716 0.293 . . . . 0.0 110.532 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.216 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 74.8 mtt85 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.79 129.18 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.32 156.87 34.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.811 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.768 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 38.8 t80 -92.91 131.48 37.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.791 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 108' ' ' ALA . 1.5 m -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.643 0.589 . . . . 0.0 109.565 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -137.24 162.06 25.3 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.595 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.0 32.92 6.85 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.3 mp -91.08 164.86 13.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.051 0.54 . . . . 0.0 111.501 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.579 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -84.73 163.3 19.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.643 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.94 -36.35 77.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.803 0.441 . . . . 0.0 112.093 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.66 -10.77 59.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.205 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -74.31 140.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.703 0.287 . . . . 0.0 111.632 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.548 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -126.78 179.09 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.314 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.583 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 2.1 t70 -62.5 -35.72 80.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 112.675 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -65.26 -35.32 80.66 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.106 0.479 . . . . 0.0 111.013 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.548 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -66.69 -39.65 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.707 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -67.84 -37.49 81.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.283 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.536 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 17.4 t60 -68.36 -49.65 58.73 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.342 0.401 . . . . 0.0 111.492 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.535 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.76 -20.93 62.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.05 -34.44 22.28 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.909 0.385 . . . . 0.0 111.351 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' C ' HD12 ' A' ' 90' ' ' ILE . 70.9 m-85 -98.61 -1.38 41.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.163 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.04 -31.89 3.05 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.0 Cg_exo -59.48 -23.86 72.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.953 1.769 . . . . 0.0 113.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -78.28 -31.39 48.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.5 -162.45 36.22 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.501 0.501 . . . . 0.0 112.761 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -81.77 136.91 35.41 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.684 0.393 . . . . 0.0 111.723 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 111' ' ' GLU . 11.1 mt -115.79 139.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.703 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -92.94 -60.76 1.73 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.462 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -145.96 153.1 40.42 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.583 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 16.6 mm -120.01 119.33 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -118.57 129.28 55.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.44 HG21 ' O ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -127.92 114.61 20.51 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.729 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.78 116.49 3.29 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.216 1.944 . . . . 0.0 112.449 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.03 135.82 51.35 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.48 ' HB2' ' OG1' ' A' ' 101' ' ' THR . 9.9 m-20 -92.91 146.41 23.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.298 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.51 -36.24 83.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -77.03 -49.06 16.23 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.932 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 98' ' ' ASP . 33.5 p -88.95 -28.58 20.17 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 49.81 25.3 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.607 0.763 . . . . 0.0 112.242 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 101' ' ' THR . 65.4 mttt -103.8 146.08 29.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.734 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -87.89 -15.84 35.59 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.407 0.442 . . . . 0.0 112.104 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 70.42 -6.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.251 1.02 . . . . 0.0 112.991 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.601 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 95.13 20.28 28.39 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-O 119.138 -0.812 . . . . 0.0 114.98 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.44 ' O ' HG21 ' A' ' 95' ' ' ILE . 53.6 p90 -144.44 150.02 36.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.044 0.922 . . . . 0.0 111.68 178.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 68' ' ' VAL . . . -156.53 174.0 16.09 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.793 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.0 151.12 41.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.57 134.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 111.188 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 90' ' ' ILE . 21.8 tt0 -108.5 131.0 55.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.937 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 62.8 m-85 -116.59 149.16 40.13 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.417 0.448 . . . . 0.0 111.441 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.58 -38.05 70.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.562 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.572 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.7 mp -104.58 139.27 39.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.179 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.05 59.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.527 0.68 . . . . 0.0 109.186 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.94 -50.02 39.15 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.63 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.572 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -68.76 -31.96 71.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.999 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.32 -45.41 88.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.755 0.422 . . . . 0.0 111.02 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.34 70.03 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.48 68.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.015 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -38.75 84.62 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.85 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.605 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 9.6 mt -70.27 -40.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.242 0.339 . . . . 0.0 111.692 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.41 -44.57 11.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.593 ' O ' HG12 ' A' ' 137' ' ' VAL . 87.7 mtp -129.27 50.02 2.19 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 8.8 t-20 -64.36 -37.86 89.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.736 0.303 . . . . 0.0 110.887 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.1 77.63 1.59 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.712 0.767 . . . . 0.0 109.705 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.3 m -122.81 162.73 21.57 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.211 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -89.68 118.33 29.21 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.979 0.418 . . . . 0.0 110.74 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -122.14 128.44 51.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.897 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 56.81 20.51 5.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.073 0.949 . . . . 0.0 112.754 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.03 4.78 58.58 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.875 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -127.75 154.0 45.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.77 0.285 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.96 132.14 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.8 pt -119.55 153.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 68.8 mtt180 -124.08 134.82 53.3 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.24 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -129.1 135.56 61.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.191 0.52 . . . . 0.0 110.96 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -149.72 174.59 12.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 130.39 40.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.631 0.253 . . . . 0.0 111.245 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.042 -179.541 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG23 ' OE2' ' A' ' 111' ' ' GLU . 9.4 t -103.59 125.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.29 158.42 32.59 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.078 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.878 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 36.7 t80 -96.66 123.75 40.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.88 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.47 114.56 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -133.78 160.19 23.96 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.556 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.3 33.5 6.22 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.633 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.7 mp -92.13 165.78 12.98 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 124.016 0.48 . . . . 0.0 111.374 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -87.9 161.16 17.63 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.06 -33.11 73.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 0.0 111.949 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.78 4.45 25.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.804 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -86.16 139.26 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.859 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -124.68 174.28 7.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' OD2' HD11 ' A' ' 95' ' ' ILE . 7.0 m-20 -61.26 -33.19 73.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.234 0.613 . . . . 0.0 112.23 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -66.0 -39.5 90.33 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.84 -42.28 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.729 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.1 tt -67.98 -37.38 81.45 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.665 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.52 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 7.0 t60 -68.6 -47.86 65.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.476 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.557 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.49 -21.36 62.77 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.08 22.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.147 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 62.3 m-85 -98.14 -1.03 43.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.135 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 82' ' ' ALA . 3.9 tp -70.16 -31.78 2.5 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.3 Cg_exo -59.56 -24.11 73.8 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.942 1.761 . . . . 0.0 113.785 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.514 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 52.1 m-85 -79.05 -31.24 44.46 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.244 0.34 . . . . 0.0 111.902 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.29 -164.83 38.33 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.455 0.472 . . . . 0.0 112.764 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -82.38 136.09 35.04 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.671 0.388 . . . . 0.0 111.638 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.52 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 4.8 mt -116.1 141.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.558 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 4.9 p -88.85 -64.15 1.19 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 123.521 0.513 . . . . 0.0 112.11 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -149.48 157.4 43.26 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.8 mm -116.56 122.85 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.74 132.14 54.89 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 107' ' ' PHE . 1.3 mp -128.13 118.09 20.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.456 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.05 117.13 4.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.938 1.759 . . . . 0.0 112.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.7 mt -117.39 147.29 42.79 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.545 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -86.69 143.81 27.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.523 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -64.82 -32.0 73.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.1 -44.57 68.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.8 p -112.83 -26.47 8.54 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 56.5 21.99 6.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.648 0.779 . . . . 0.0 112.253 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -108.22 147.73 30.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.392 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -86.9 152.38 22.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -89.32 2.32 54.53 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.791 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.633 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 99.39 21.45 14.93 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.466 -0.63 . . . . 0.0 114.165 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 95' ' ' ILE . 44.7 p90 -143.11 149.3 37.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.454 0.627 . . . . 0.0 111.481 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.42 172.09 18.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.65 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -120.01 149.08 42.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.74 135.5 62.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.224 0.328 . . . . 0.0 111.216 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.514 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -109.42 130.79 55.48 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.438 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.449 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 64.9 m-85 -112.26 142.37 44.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.77 -37.78 85.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.677 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.574 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.1 mp -103.58 136.02 44.09 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.597 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.4 -23.63 61.91 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.3 0.571 . . . . 0.0 110.399 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.07 -49.58 49.59 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.283 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.574 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.4 p30 -68.35 -32.64 72.88 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.96 -44.88 79.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.521 0.328 . . . . 0.0 111.199 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.5 -30.19 71.35 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.821 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.549 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -70.44 -32.83 70.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.623 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.41 -38.69 88.03 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.376 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 41.3 mt -70.74 -36.6 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.354 0.409 . . . . 0.0 111.749 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.3 p30 -82.82 -16.08 49.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -98.27 -45.23 6.26 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.548 ' O ' HG11 ' A' ' 137' ' ' VAL . 88.9 mtp -130.6 51.87 2.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 16.7 p30 -67.03 -36.14 81.43 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.502 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.93 80.16 1.7 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.777 0.799 . . . . 0.0 109.468 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.0 p -126.4 165.61 18.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.398 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.33 120.62 33.04 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -125.82 128.97 48.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD2' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER 55.84 21.69 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.06 0.944 . . . . 0.0 112.813 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.66 4.45 59.2 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 116.186 -0.461 . . . . 0.0 114.059 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -128.63 154.7 45.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.885 0.343 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.5 m -79.33 132.08 36.32 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -118.4 153.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.433 0.458 . . . . 0.0 112.132 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 86.7 mtt180 -125.47 134.25 52.13 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.493 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.878 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -127.42 133.36 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 110.361 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -147.38 172.75 13.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 tt -67.85 125.52 26.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.693 0.397 . . . . 0.0 110.476 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.114 -179.751 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 45.9 t -99.38 135.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.08 151.25 44.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 110.909 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.665 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 66.0 t80 -94.45 129.46 41.2 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 m -126.21 121.46 59.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 123.468 0.48 . . . . 0.0 110.202 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.35 153.0 20.59 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.645 0.591 . . . . 0.0 112.961 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.8 10.38 Favored Glycine 0 C--N 1.334 0.441 0 O-C-N 124.015 0.479 . . . . 0.0 112.442 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -87.74 161.44 17.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.798 0.333 . . . . 0.0 110.672 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -89.5 158.22 17.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.228 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 44.6 mt-10 -64.32 -27.76 69.25 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.648 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.92 -2.54 34.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.887 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 72' ' ' ALA . 1.7 m -86.11 138.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 120.689 0.28 . . . . 0.0 110.738 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.3 m-20 -117.94 178.56 4.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.598 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.89 -28.82 69.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.566 0.346 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.82 -40.71 79.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.49 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.429 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 5.2 t -65.88 -45.81 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.087 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -65.91 -39.21 90.38 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.549 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 26.9 t-80 -68.31 -48.49 64.78 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.763 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.28 62.99 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.42 -35.41 23.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 82.2 m-85 -100.25 -0.43 38.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.159 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.8 tp -68.07 -32.59 4.17 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.69 -22.87 69.34 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.773 1.649 . . . . 0.0 113.89 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -81.18 -31.46 34.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.35 -167.86 40.05 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.098 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.06 131.79 34.77 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.684 0.394 . . . . 0.0 111.183 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 111' ' ' GLU . 9.2 mt -112.98 135.88 51.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.388 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -91.3 -58.73 2.35 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.544 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -146.57 152.97 39.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.4 mm -118.23 115.14 47.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -114.53 122.77 47.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.035 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.43 123.23 23.11 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.602 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.15 127.6 18.73 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.226 1.951 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.64 135.6 47.06 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -94.01 146.33 24.02 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -64.6 -36.03 82.91 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.55 -49.2 19.35 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.5 p -92.57 -28.58 16.66 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 52.46 22.99 2.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.265 0.626 . . . . 0.0 111.885 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 101' ' ' THR . 66.2 mttt -107.44 148.48 29.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.67 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.557 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 21.8 p80 -93.0 -9.39 39.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.016 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 71.61 -18.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.359 1.063 . . . . 0.0 113.063 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 111.9 26.07 4.56 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 119.507 -0.607 . . . . 0.0 114.551 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -147.5 145.58 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.604 0.702 . . . . 0.0 111.213 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.58 168.26 26.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.949 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -113.29 140.93 47.58 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 7.8 p -116.22 135.22 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 90' ' ' ILE . 19.0 tt0 -104.79 125.59 51.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.261 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -111.52 138.38 48.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.088 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -66.35 -37.0 84.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.65 134.19 52.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.94 63.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.45 -49.54 63.2 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.08 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -68.67 -32.47 72.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.09 97.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.534 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.07 68.82 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.252 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.94 73.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.243 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.82 -37.95 87.62 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.717 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.659 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 64.8 mt -69.99 -33.89 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.022 0.201 . . . . 0.0 111.125 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.44 -35.9 80.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -102.58 -35.03 8.87 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.565 ' O ' HG13 ' A' ' 137' ' ' VAL . 95.6 mmm -92.07 0.57 57.47 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.659 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.4 t-20 -56.49 -37.37 70.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.827 0.285 . . . . 0.0 111.728 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -141.9 73.49 1.41 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.345 0.593 . . . . 0.0 109.504 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.2 p -125.41 157.2 37.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.25 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -94.99 120.05 34.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.612 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.11 129.83 44.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.985 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.9 t80 62.64 15.1 7.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.747 0.819 . . . . 0.0 112.366 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.62 4.61 58.04 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.402 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -127.58 154.11 45.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.741 0.271 . . . . 0.0 110.999 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -83.0 134.62 35.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 pt -119.8 156.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 123.421 0.451 . . . . 0.0 112.113 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 31.7 ptt180 -126.06 132.94 51.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.211 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -128.98 140.19 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.062 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -144.31 170.26 16.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 119.81 15.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.153 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.086 -179.726 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 76.1 mtt85 . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.551 HG21 ' OE1' ' A' ' 111' ' ' GLU . 6.0 t -106.5 131.3 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.45 156.95 34.55 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.459 0.475 . . . . 0.0 110.837 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.841 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 48.0 t80 -98.71 134.8 41.12 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.704 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.11 114.82 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.9 150.52 19.37 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.656 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.62 36.77 3.67 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.3 mp -94.4 164.73 12.89 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.004 0.431 . . . . 0.0 111.227 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.624 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -88.7 164.44 15.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.499 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.38 -32.79 72.04 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.14 5.73 21.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.24 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.624 HG11 ' O ' ' A' ' 72' ' ' ALA . 3.9 p -86.41 136.07 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 120.648 0.261 . . . . 0.0 110.854 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -122.35 174.58 6.92 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.467 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.0 m-20 -61.65 -32.53 72.69 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.146 0.578 . . . . 0.0 112.045 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -67.37 -40.25 85.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.684 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.2 -43.08 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.967 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.425 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -68.46 -36.47 79.05 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.809 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.517 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 6.4 t60 -68.56 -49.51 58.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.595 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -71.0 -20.91 62.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.64 -34.35 23.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.209 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 64.9 m-85 -98.14 -2.46 39.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.102 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.548 HG21 ' O ' ' A' ' 82' ' ' ALA . 3.4 tp -67.13 -32.35 4.66 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.5 -23.54 71.21 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 121.782 1.655 . . . . 0.0 113.795 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.505 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 45.0 m-85 -80.3 -31.62 38.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.23 -168.05 40.94 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 123.467 0.48 . . . . 0.0 112.738 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -84.88 133.19 34.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.566 0.347 . . . . 0.0 111.148 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.3 mt -114.08 138.9 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.643 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.1 p -89.89 -60.31 1.97 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.951 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -149.06 159.22 44.43 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.45 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 17.7 mm -117.93 126.98 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -121.01 126.96 51.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -128.13 115.88 20.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.698 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.45 126.87 22.67 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.284 1.989 . . . . 0.0 112.623 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -127.53 135.09 49.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.173 -179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -91.32 144.17 25.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -34.9 79.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -71.21 -48.63 50.33 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 p -98.7 -27.69 13.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' O ' HD11 ' A' ' 97' ' ' LEU . 51.4 mt-10 57.18 22.84 7.96 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.29 0.636 . . . . 0.0 111.674 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -121.32 155.44 34.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.292 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -101.32 160.85 14.07 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.236 0.335 . . . . 0.0 110.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 77.9 mtt180 -88.55 2.95 52.03 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.197 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.638 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 96.34 27.13 10.23 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.326 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.4 p90 -143.6 148.98 36.68 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.372 0.586 . . . . 0.0 111.127 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.54 169.5 22.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -117.3 144.08 45.25 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.99 134.53 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.211 0.319 . . . . 0.0 111.01 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.551 ' OE1' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -106.53 128.49 54.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.32 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 13.6 m-85 -109.25 137.16 47.55 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.04 -35.82 82.39 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.54 134.26 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.82 -26.42 65.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.31 -44.1 84.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.873 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -68.49 -33.06 73.5 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.58 -46.16 91.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.28 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.29 -28.79 66.59 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.314 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.88 72.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.507 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.01 88.78 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.223 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.597 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 12.8 mt -70.73 -33.65 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 123.252 0.345 . . . . 0.0 111.875 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.13 -17.31 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -101.22 -43.03 6.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.598 ' O ' HG13 ' A' ' 137' ' ' VAL . 84.7 mtp -126.24 47.41 2.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 19.0 p-10 -66.29 -33.92 76.83 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.328 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.1 mt-10 -143.06 77.47 1.57 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.733 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.6 m -123.56 162.57 22.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.179 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.32 119.7 30.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.87 0.367 . . . . 0.0 110.77 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.8 129.63 48.7 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.003 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 57.22 20.59 5.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 112.693 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.99 3.99 60.3 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.893 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -127.66 155.08 44.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.686 0.243 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.0 131.25 35.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -116.83 151.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 74.6 mtt180 -122.72 134.3 54.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -128.16 133.78 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.459 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -147.13 172.67 13.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.665 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.506 ' N ' HD21 ' A' ' 139' ' ' LEU . 1.9 mm? -67.9 127.42 32.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.704 0.402 . . . . 0.0 110.66 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.128 -179.651 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 72.5 mtt85 . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.663 0.268 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.95 136.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.632 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.88 155.97 37.11 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.554 0.533 . . . . 0.0 111.386 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.753 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.0 t80 -92.71 134.79 34.69 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.437 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.64 115.18 19.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 O-C-N 123.654 0.596 . . . . 0.0 109.663 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.22 152.31 20.35 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.989 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.89 8.03 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.99 0.465 . . . . 0.0 112.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.3 OUTLIER -92.01 164.76 13.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.573 0.349 . . . . 0.0 110.592 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -91.09 155.52 18.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.739 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.08 -26.16 68.7 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.67 0.388 . . . . 0.0 111.749 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.79 -3.03 32.72 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.689 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -86.3 135.51 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.907 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -109.49 174.86 5.68 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.547 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -60.52 -29.63 69.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.567 0.347 . . . . 0.0 111.57 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -68.81 -35.39 76.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.42 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.79 -47.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.792 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.62 -38.88 84.56 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.614 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.522 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 7.7 t60 -67.67 -48.94 65.2 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.446 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.59 -20.36 62.78 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.84 -34.04 24.73 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 111.456 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -102.34 0.2 33.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.433 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.569 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -68.83 -32.81 3.75 Favored Pre-proline 0 CA--C 1.565 1.525 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 15.1 Cg_endo -58.61 -23.42 65.22 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 121.94 1.76 . . . . 0.0 113.941 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -78.34 -31.39 48.64 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.87 -161.94 34.81 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.998 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.71 134.79 34.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.689 0.396 . . . . 0.0 111.833 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 111' ' ' GLU . 15.2 mt -116.63 138.67 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -94.21 -60.8 1.65 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -143.86 153.19 42.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.8 mm -119.46 124.64 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.59 127.56 54.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.71 114.37 20.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.935 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.28 130.88 37.99 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.399 2.066 . . . . 0.0 112.734 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.09 132.53 50.61 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.131 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -94.25 142.76 27.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.355 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -64.69 -34.28 77.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.8 -42.58 81.35 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 19.1 p -112.65 -26.71 8.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 60.82 19.61 9.81 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.347 0.659 . . . . 0.0 111.397 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -122.43 155.34 36.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.343 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -107.03 157.88 17.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.645 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -82.75 -1.39 51.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.326 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.569 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.57 41.64 2.49 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-O 119.807 -0.44 . . . . 0.0 113.836 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -147.28 147.47 30.43 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.85 0.357 . . . . 0.0 110.961 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.27 172.76 17.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -115.57 142.33 46.87 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.05 134.51 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 123.213 0.321 . . . . 0.0 110.599 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.601 ' O ' HG21 ' A' ' 90' ' ' ILE . 17.0 tt0 -108.26 125.64 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.618 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 30.0 m-85 -112.42 137.61 50.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.56 -36.71 84.58 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.571 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.6 mp -105.74 140.23 39.1 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.38 -22.51 57.44 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.924 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -72.8 -49.55 29.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 21.3 p30 -67.03 -32.3 73.41 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.653 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.73 91.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.01 0.524 . . . . 0.0 111.036 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.1 69.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.209 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.18 -37.31 78.11 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.934 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.05 -38.08 87.47 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.454 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 44.2 mt -70.16 -33.0 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 123.234 0.334 . . . . 0.0 111.281 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.83 -36.18 77.87 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -105.56 -33.04 8.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.584 ' O ' HG13 ' A' ' 137' ' ' VAL . 98.0 mmm -95.85 3.98 53.21 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.6 t-20 -56.57 -37.52 70.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.845 0.293 . . . . 0.0 111.764 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.06 72.85 1.4 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.695 0.76 . . . . 0.0 109.94 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.1 t -124.71 157.33 35.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -93.8 120.85 34.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.6 tp -128.48 128.21 43.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.806 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.98 7.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.658 0.783 . . . . 0.0 112.437 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.92 58.25 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.447 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -127.51 153.81 45.89 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.428 0.291 . . . . 0.0 110.778 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -82.08 134.17 35.32 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.27 154.36 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 73.7 mtt180 -122.26 134.3 54.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.359 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -130.95 138.38 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.896 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -151.67 172.18 16.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.7 mt -70.29 129.9 40.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.553 0.216 . . . . 0.0 111.118 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.459 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.556 ' NH2' HD11 ' A' ' 139' ' ' LEU . 67.0 ttt180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.614 0.245 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.9 t -106.63 136.38 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.403 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.0 157.58 34.08 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.457 0.473 . . . . 0.0 111.709 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.812 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 42.8 t80 -96.38 136.16 37.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.302 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.39 115.09 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 109.718 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.04 142.52 13.75 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.821 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.8 29.52 2.61 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.946 0.439 . . . . 0.0 112.616 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER -97.11 163.31 12.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.929 0.395 . . . . 0.0 110.549 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.486 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -84.61 155.79 21.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.13 -27.64 68.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.64 0.376 . . . . 0.0 111.608 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.61 -0.28 29.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.951 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -84.7 140.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.127 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.81 178.71 4.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -59.31 -31.22 68.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.742 0.417 . . . . 0.0 111.482 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.42 -39.97 81.39 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.07 -47.51 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.894 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.458 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.7 tt -67.62 -38.96 84.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.541 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 24.0 t-80 -68.69 -47.64 65.93 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.657 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.503 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.33 -20.69 62.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -32.96 23.65 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 74.9 m-85 -102.32 1.16 35.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.319 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.503 HG21 ' O ' ' A' ' 82' ' ' ALA . 3.9 tp -70.22 -31.64 2.41 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.362 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.6 Cg_exo -59.21 -24.01 72.06 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 121.967 1.778 . . . . 0.0 113.861 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.551 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 55.2 m-85 -79.91 -31.45 40.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.18 -161.51 35.11 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.95 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.16 136.56 33.93 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.793 0.437 . . . . 0.0 111.864 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 111' ' ' GLU . 5.8 mt -116.66 139.24 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.595 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -93.71 -61.27 1.58 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.656 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -143.26 153.51 42.86 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.3 mm -119.84 125.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.81 125.99 50.81 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.23 0.331 . . . . 0.0 111.721 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.35 110.81 21.22 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.04 128.44 27.81 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.43 2.087 . . . . 0.0 112.565 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 102' ' ' GLU . 1.1 tp -124.01 134.24 53.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.165 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.23 139.64 30.41 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.504 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -64.76 -31.98 73.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.09 -41.89 94.59 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 p -117.28 -22.84 8.09 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.505 ' O ' HD11 ' A' ' 97' ' ' LEU . 46.7 mt-10 59.99 22.66 11.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.231 0.613 . . . . 0.0 111.444 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -124.84 154.5 40.92 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.348 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -110.21 154.93 22.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -79.57 -11.1 59.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.025 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.59 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.77 41.47 1.11 Allowed Glycine 0 C--N 1.341 0.847 0 C-N-CA 121.095 -0.574 . . . . 0.0 114.019 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -145.12 145.13 31.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.195 0.497 . . . . 0.0 111.103 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.99 173.09 17.05 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.966 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.94 144.5 43.98 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.2 p -116.17 131.03 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 110.692 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.558 ' O ' HG22 ' A' ' 90' ' ' ILE . 20.3 tt0 -106.37 126.89 52.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.259 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.416 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 47.7 m-85 -111.51 141.94 44.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.05 -36.89 85.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.63 125.1 52.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.758 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.68 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -68.25 -47.87 66.61 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.586 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.416 ' OD1' ' HB3' ' A' ' 112' ' ' PHE . 8.0 p30 -69.03 -32.43 71.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.378 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 64' ' ' ARG . . . -66.58 -42.2 87.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.685 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.17 71.29 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.699 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.657 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -68.48 -33.66 74.54 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.692 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.83 82.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.602 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 48.0 mt -70.33 -37.76 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.657 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.7 p30 -82.94 -16.72 46.27 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -93.89 -47.86 6.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.551 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 62.7 mtt -130.87 53.49 1.97 Allowed 'General case' 0 C--N 1.346 0.434 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.1 t-20 -64.73 -37.71 88.53 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.9 mt-10 -143.18 77.22 1.56 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.728 0.775 . . . . 0.0 109.834 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.0 m -119.77 160.72 22.05 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.31 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -90.28 118.25 29.64 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.955 0.407 . . . . 0.0 110.679 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.3 tp -129.17 130.55 46.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.911 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.3 t80 62.86 15.07 7.94 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.727 0.811 . . . . 0.0 112.232 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.19 4.69 59.74 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.209 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -126.93 155.48 43.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.572 0.349 . . . . 0.0 110.817 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.15 133.32 35.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.2 pt -118.05 151.77 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 57.7 mtt180 -122.81 134.71 54.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.424 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.812 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.73 134.99 61.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.89 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -154.2 172.13 18.09 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.494 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.556 HD11 ' NH2' ' A' ' 64' ' ' ARG . 5.4 tt -69.21 129.69 40.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.578 0.228 . . . . 0.0 110.628 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.136 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 133.13 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.11 156.99 33.87 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.535 0.522 . . . . 0.0 111.411 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.0 t80 -101.04 134.61 43.78 Favored 'General case' 0 N--CA 1.458 -0.042 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.98 116.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 O-C-N 123.548 0.53 . . . . 0.0 109.769 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.2 152.96 18.88 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.762 -0.733 . . . . 0.0 113.384 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.02 23.72 7.6 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.985 0.462 . . . . 0.0 112.588 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 106' ' ' GLY . 0.3 OUTLIER -92.0 163.09 14.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -90.61 157.86 17.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.869 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 38.8 mt-10 -64.71 -26.67 68.47 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.722 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -77.41 -1.53 30.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.766 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -86.53 139.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 120.572 0.225 . . . . 0.0 110.66 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.1 m-20 -121.71 179.02 4.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.803 0.441 . . . . 0.0 111.54 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.54 -40.77 80.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.702 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.447 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.3 t -67.06 -46.98 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.212 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.449 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -67.04 -39.42 86.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.644 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.551 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 9.1 t60 -68.07 -48.68 64.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.023 0.529 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.41 -20.62 62.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.43 -34.03 23.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 111.402 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.449 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.8 m-85 -101.54 0.21 36.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.285 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -70.25 -31.85 2.49 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.5 Cg_exo -59.01 -23.4 68.42 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.007 1.805 . . . . 0.0 113.882 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -78.02 -31.29 50.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.43 -162.67 36.26 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.827 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.88 134.0 35.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.72 0.408 . . . . 0.0 111.769 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' GLU . 12.7 mt -114.41 139.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.267 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -62.63 1.42 Allowed 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.668 0.605 . . . . 0.0 112.303 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.9 154.91 41.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.5 mm -117.2 125.51 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.07 128.22 52.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 107' ' ' PHE . 1.4 mp -127.73 116.72 20.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.706 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.37 121.74 10.39 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.209 1.939 . . . . 0.0 112.413 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 134.57 49.74 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.175 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.81 143.07 26.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.73 -33.47 76.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.66 -48.57 54.22 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.2 p -100.46 -27.85 13.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.82 23.88 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.235 0.614 . . . . 0.0 111.569 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -121.37 156.83 31.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.522 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.585 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 9.5 p80 -110.18 159.36 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.928 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 85.5 mtt-85 -87.77 3.6 47.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.015 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.536 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 94.51 35.02 6.07 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.594 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' HG21 ' A' ' 95' ' ' ILE . 1.3 p90 -143.73 147.12 33.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.65 0.262 . . . . 0.0 110.941 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.0 169.52 23.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.639 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -116.19 144.42 44.21 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.84 133.15 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.425 0.453 . . . . 0.0 110.434 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.538 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -108.05 127.33 53.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.521 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.417 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 32.2 m-85 -113.8 141.69 46.99 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.271 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -67.47 -37.23 82.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.606 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.506 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -102.77 138.95 38.99 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -19.54 59.37 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.483 0.658 . . . . 0.0 109.267 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.19 -50.99 23.29 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.754 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 24.0 p30 -69.33 -31.86 70.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.15 -45.02 86.71 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.931 0.492 . . . . 0.0 111.423 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.66 -30.51 71.22 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.6 77.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.101 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -67.29 -39.52 85.98 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.8 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.629 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 52.7 mt -69.16 -33.82 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.862 -0.154 . . . . 0.0 111.32 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -68.72 -36.4 78.37 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.36 -34.46 8.28 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.52 ' O ' HG12 ' A' ' 137' ' ' VAL . 94.0 mmm -91.68 0.54 57.49 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.629 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 10.1 t-20 -56.64 -36.95 70.09 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.847 0.294 . . . . 0.0 111.678 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.74 70.96 1.36 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.619 0.723 . . . . 0.0 110.061 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 55.0 m -121.81 154.7 36.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.336 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.7 119.4 32.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.471 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tp -129.94 130.18 44.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.013 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 61.99 15.68 7.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.658 0.783 . . . . 0.0 112.443 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 4.92 59.22 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.298 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -127.0 154.39 44.68 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.514 0.326 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.53 134.35 34.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.02 154.79 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.024 0.44 . . . . 0.0 112.135 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 22.8 ttp-105 -124.24 131.78 53.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.785 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.27 139.49 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.316 0.385 . . . . 0.0 110.738 179.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -145.25 171.94 13.85 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.95 133.33 48.05 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.24 0.216 . . . . 0.0 110.921 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.34 -179.438 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.2 mtt85 . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 t -107.54 128.94 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.33 155.64 36.88 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.678 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.798 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 52.5 t80 -92.29 136.02 33.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.834 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' ARG . 2.9 m -134.54 115.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.43 142.23 13.5 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.563 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.26 24.9 4.3 Favored Glycine 0 C--N 1.332 0.315 0 O-C-N 123.954 0.444 . . . . 0.0 112.429 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -95.53 164.6 12.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.264 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -79.58 151.79 30.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.72 -30.42 71.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.652 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -83.88 13.61 4.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.883 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 72' ' ' ALA . 5.6 m -88.8 133.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.707 0.289 . . . . 0.0 110.856 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -102.42 173.52 6.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.457 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -59.34 -30.1 68.14 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.697 0.399 . . . . 0.0 111.248 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.44 -38.36 81.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.431 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.81 -48.32 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.017 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.8 tt -68.74 -37.25 79.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.471 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.3 t60 -68.52 -49.32 60.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.634 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.28 -20.75 63.02 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.62 -32.53 23.66 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 73.1 m-85 -103.0 2.5 35.03 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.465 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 82' ' ' ALA . 4.5 tp -71.31 -31.46 1.93 Allowed Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.206 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.9 Cg_exo -59.7 -23.54 72.08 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.901 1.734 . . . . 0.0 114.033 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.67 -31.43 46.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.52 -158.41 30.71 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.49 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -85.73 139.66 31.15 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.672 0.389 . . . . 0.0 111.426 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 111' ' ' GLU . 8.3 mt -117.09 140.54 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 p -93.86 -62.49 1.34 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.308 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -144.89 152.52 40.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.4 mm -121.04 130.59 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.617 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.562 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 86.4 mm-40 -120.51 137.1 54.55 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.222 0.326 . . . . 0.0 111.583 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.405 HG23 ' CD2' ' A' ' 104' ' ' HIS . 4.4 mp -126.73 100.39 28.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.787 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.52 128.09 23.71 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.543 2.162 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -128.07 133.76 49.09 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.774 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.24 138.51 31.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.422 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -64.53 -33.69 76.48 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.17 -44.68 75.42 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.979 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.516 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.5 p -102.42 -29.04 11.86 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 52.86 32.56 12.64 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.19 0.596 . . . . 0.0 110.785 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 101' ' ' THR . 58.4 mttt -124.33 154.22 40.63 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.062 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.405 ' CD2' HG23 ' A' ' 95' ' ' ILE . 18.2 t-80 -94.77 134.8 36.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.63 4.65 53.62 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.561 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.04 25.91 23.21 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.43 -0.891 . . . . 0.0 114.695 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -143.7 148.3 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 117.668 0.734 . . . . 0.0 111.378 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.09 176.34 12.39 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.539 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.05 150.45 39.96 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -121.63 134.56 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.989 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 90' ' ' ILE . 20.1 tt0 -111.03 133.15 53.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.093 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 80.7 m-85 -117.19 150.62 38.43 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.42 0.45 . . . . 0.0 111.261 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -69.07 -39.04 79.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.038 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mp -111.27 141.13 45.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -21.21 62.67 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.613 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.18 -42.99 99.79 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.131 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.89 -32.05 68.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.051 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.418 ' O ' HD11 ' A' ' 122' ' ' ILE . . . -57.64 -46.88 83.6 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.374 0.421 . . . . 0.0 111.057 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.51 63.29 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.383 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.28 63.25 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.582 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.72 91.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.607 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 16.2 mt -70.83 -43.42 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.28 -32.49 68.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -79.42 -49.6 12.1 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.568 ' O ' HG12 ' A' ' 137' ' ' VAL . 64.0 mtt -135.17 63.69 1.61 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.098 0.475 . . . . 0.0 112.227 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 17.6 p30 -69.82 -35.17 74.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.044 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.7 mt-10 -142.99 78.65 1.62 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.698 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.9 m -120.58 161.23 21.68 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.282 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -90.36 117.19 28.89 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.019 0.437 . . . . 0.0 110.752 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -129.06 131.78 47.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.88 14.49 8.39 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.765 0.826 . . . . 0.0 112.189 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.16 60.28 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.237 -0.438 . . . . 0.0 113.085 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -127.66 157.19 40.94 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.612 0.365 . . . . 0.0 110.721 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.55 133.89 34.85 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.6 pt -118.19 152.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 58.6 mtt-85 -122.81 134.55 54.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.259 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.798 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.46 133.31 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 110.766 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -151.01 172.31 15.91 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.986 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.28 131.29 42.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.662 0.268 . . . . 0.0 111.369 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.158 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.112 -179.69 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 84.4 mtt180 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 20.5 t -102.44 129.29 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.79 158.85 30.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.304 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 31.3 t80 -93.84 132.88 37.82 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.013 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -132.51 115.49 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.91 156.45 21.73 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.355 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.14 20.82 9.39 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.146 -0.527 . . . . 0.0 112.448 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.553 HD11 ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -89.32 163.11 15.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.49 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -89.71 156.62 18.42 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.946 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.03 -26.66 68.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.654 0.382 . . . . 0.0 111.678 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -76.95 -2.2 32.54 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.676 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -87.41 139.57 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 120.577 0.227 . . . . 0.0 110.747 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 78' ' ' LYS . 4.3 p30 -120.64 -176.64 3.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.5 -31.11 71.09 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.879 0.472 . . . . 0.0 111.788 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 91.5 mttt -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.714 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.5 t -65.42 -47.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.056 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.4 tt -67.38 -39.14 85.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.411 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.505 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.8 t60 -68.15 -47.85 66.94 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.572 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.82 -20.22 62.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.86 -34.81 24.53 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-O 120.845 0.355 . . . . 0.0 111.38 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 76.3 m-85 -99.87 -2.05 35.85 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.391 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 4.9 tp -68.51 -32.48 3.78 Favored Pre-proline 0 CA--C 1.566 1.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 11.4 Cg_endo -56.66 -24.81 56.47 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.035 1.823 . . . . 0.0 113.874 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -79.43 -31.32 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.287 0.367 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.9 -169.71 42.85 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.308 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -86.03 130.77 34.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.314 0.246 . . . . 0.0 110.748 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.5 mt -105.89 141.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.919 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 p -88.37 -60.5 1.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.757 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -146.29 153.21 40.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.0 mm -120.53 122.26 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.9 125.85 48.52 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.522 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mp -127.15 117.37 21.83 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.811 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.89 121.86 8.94 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.994 1.796 . . . . 0.0 112.521 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.93 136.56 54.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.076 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -86.87 139.42 30.67 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.6 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 87.4 m-85 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.06 -42.72 89.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -108.58 -27.02 10.11 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' OE2' ' HA ' ' A' ' 99' ' ' TYR . 73.2 mm-40 57.7 24.84 11.07 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.231 0.612 . . . . 0.0 111.474 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -124.48 154.88 39.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.269 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.421 ' HD1' ' N ' ' A' ' 106' ' ' GLY . 26.3 p80 -115.34 148.71 38.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.344 0.402 . . . . 0.0 110.81 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.293 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 110.71 39.19 1.47 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.918 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.09 149.23 36.26 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 117.084 0.442 . . . . 0.0 110.823 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.58 170.96 21.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.092 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -118.02 145.55 44.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 10.4 p -118.69 137.87 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.068 0.461 . . . . 0.0 111.43 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 90' ' ' ILE . 23.1 tt0 -107.23 128.99 54.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.23 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 45.4 m-85 -116.87 146.0 43.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -70.75 -37.4 73.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.862 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.599 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -107.37 143.19 36.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -25.87 58.85 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.745 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.13 -47.24 59.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.599 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.7 p30 -67.23 -32.02 72.78 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.962 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.04 -45.18 82.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.079 0.552 . . . . 0.0 111.343 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.68 70.52 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.23 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.62 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -69.67 -33.92 73.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.59 78.67 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.723 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.609 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 74.3 mt -66.65 -47.68 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.62 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 4.3 p30 -67.47 -34.31 76.91 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -88.36 -35.04 17.39 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.476 ' O ' HG11 ' A' ' 137' ' ' VAL . 83.6 mtp -110.73 14.39 22.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.5 t-20 -57.47 -37.26 72.6 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.813 0.278 . . . . 0.0 111.572 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -142.71 77.14 1.56 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.624 0.726 . . . . 0.0 109.908 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.5 t -127.17 157.0 40.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.118 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -93.21 118.99 31.89 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.6 tp -131.0 130.41 43.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.982 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.6 15.52 8.03 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.573 0.749 . . . . 0.0 112.361 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.39 60.08 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.301 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -126.55 153.96 44.5 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.502 0.321 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.97 133.36 34.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 pt -116.1 152.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 5.0 tpt180 -124.66 128.45 48.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.599 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.43 139.18 51.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.38 0.425 . . . . 0.0 110.764 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 28.5 p30 -145.27 173.76 11.68 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.496 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.0 tt -69.79 123.67 22.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.321 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.339 0.114 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.1 mtt -101.74 136.93 40.74 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.349 0.406 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.3 mtp -101.21 141.74 33.65 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.703 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -117.5 153.45 33.14 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.121 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.0 t -122.62 143.87 49.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.744 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.77 -65.15 1.19 Allowed Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.936 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -93.72 134.76 35.71 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.364 0.265 . . . . 0.0 111.03 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 t -130.47 121.55 26.02 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.621 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -70.85 -38.36 73.17 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.559 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -126.73 154.32 44.31 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.348 0.405 . . . . 0.0 111.241 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -96.82 134.4 40.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.71 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -86.17 -39.9 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.386 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -64.97 -43.54 92.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 t -66.32 -39.13 89.08 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -69.74 -39.93 76.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.907 0.483 . . . . 0.0 111.88 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -76.71 -42.91 39.6 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.67 140.72 49.09 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.23 0.331 . . . . 0.0 111.298 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -139.73 156.79 46.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.055 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.9 tp -108.06 147.4 31.23 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.262 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -68.05 149.23 49.94 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.722 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -63.12 -35.33 79.92 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.805 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -65.6 -47.32 76.1 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.297 0.373 . . . . 0.0 111.599 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.601 ' HE1' ' NE2' ' A' ' 94' ' ' GLN . 91.7 mmm -70.19 -37.98 75.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -66.72 -41.88 87.2 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.072 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 44.5 mt-10 -70.06 -40.83 74.84 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.7 mt -70.57 -47.34 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.0 mt -69.62 -41.42 75.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 m -77.88 -38.06 46.75 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 85.5 m-20 -93.74 10.03 34.64 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 2.2 pp -73.27 146.08 86.34 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-N 118.487 0.585 . . . . 0.0 111.865 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.3 129.84 14.43 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.732 2.288 . . . . 0.0 112.003 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -51.66 -33.23 32.77 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 81.7 p -84.32 -39.31 19.31 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.13 -28.69 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.167 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.55 -29.05 70.37 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.931 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -154.8 126.01 7.27 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.328 0.393 . . . . 0.0 110.87 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -123.3 135.44 54.21 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.491 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 89.8 m -98.76 -38.66 8.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.49 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.86 139.34 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 123.372 0.42 . . . . 0.0 110.065 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -95.02 133.76 38.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.488 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.2 t -111.47 139.02 47.23 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.919 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.1 p -78.24 -16.54 57.72 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.436 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.33 -36.8 79.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.79 0.436 . . . . 0.0 112.165 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -69.14 -40.03 78.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.755 0.422 . . . . 0.0 112.073 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -133.12 128.24 35.67 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.479 0.487 . . . . 0.0 110.299 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.79 142.32 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.782 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -87.72 136.84 32.78 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.132 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.02 -122.74 1.65 Allowed Glycine 0 C--N 1.336 0.566 0 O-C-N 123.628 0.58 . . . . 0.0 112.542 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.75 -175.97 46.93 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.616 -0.326 . . . . 0.0 112.977 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.0 p -69.95 -26.17 63.99 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.76 -177.79 46.56 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.448 0.468 . . . . 0.0 113.03 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.77 -77.18 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.434 -0.413 . . . . 0.0 112.437 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.0 m -63.82 -35.33 80.27 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.18 -169.88 33.77 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 116.178 -0.464 . . . . 0.0 112.999 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.81 -38.56 89.53 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 113.801 0.28 . . . . 0.0 113.801 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.4 p -123.75 151.79 42.86 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.571 0.225 . . . . 0.0 111.201 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.33 -167.43 35.72 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.001 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.9 -56.5 1.31 Allowed Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.652 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.0 m -122.25 146.93 46.81 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.667 0.275 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' O ' HD11 ' A' ' 139' ' ' LEU . . . -105.51 143.07 34.19 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.0 t -115.74 -1.13 12.73 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.7 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.8 p -76.81 -24.37 52.78 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.08 134.45 39.11 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.345 0.403 . . . . 0.0 110.987 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 81.3 mtm-85 -105.98 1.9 26.95 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.322 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.415 HG22 ' SD ' ' A' ' 23' ' ' MET . 8.5 t -104.02 134.94 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.65 154.36 39.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.803 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.4 t80 -94.48 134.44 37.01 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.652 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.27 114.75 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.614 0.571 . . . . 0.0 109.687 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.83 146.98 18.75 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.556 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.18 23.34 6.12 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 123.881 0.4 . . . . 0.0 112.425 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -93.42 165.12 12.92 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.548 0.339 . . . . 0.0 110.262 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.445 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -81.09 151.75 28.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.044 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.58 -29.97 70.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.714 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.77 9.13 6.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 72' ' ' ALA . 3.5 m -90.55 136.93 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 120.635 0.255 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -107.79 174.72 5.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -61.42 -28.05 68.98 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.619 0.368 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.5 -39.03 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.0 -47.81 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.086 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.4 -38.27 84.4 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.354 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.531 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 9.8 t60 -68.09 -49.07 63.56 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.566 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.453 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.44 -20.49 62.89 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.26 -33.62 24.0 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 111.271 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.33 1.88 33.35 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.437 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -69.75 -31.97 2.77 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.25 -0.881 . . . . 0.0 113.339 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.6 Cg_exo -59.8 -23.3 71.6 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.861 1.707 . . . . 0.0 113.955 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 47.8 m-85 -80.04 -31.27 39.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.89 -168.56 41.44 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.804 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.18 134.06 34.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.468 0.307 . . . . 0.0 110.97 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 111' ' ' GLU . 9.6 mt -113.54 140.86 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.851 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 -64.99 1.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.226 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -145.34 153.84 41.68 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.2 mm -117.84 128.73 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.601 ' NE2' ' HE1' ' A' ' 23' ' ' MET . 63.7 mt-30 -115.52 133.87 55.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.875 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.62 104.19 24.35 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.06 96.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.471 2.114 . . . . 0.0 112.387 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -111.56 133.63 53.69 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -85.03 141.71 30.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -64.67 -34.55 78.56 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -73.05 -49.12 30.49 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.517 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 31.3 p -93.89 -28.79 15.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 49.71 30.81 3.91 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.394 0.678 . . . . 0.0 111.823 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 101' ' ' THR . 42.8 mttt -112.24 153.41 27.17 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.346 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -101.21 143.78 30.88 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.617 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -99.12 1.62 45.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.559 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 92.28 20.82 34.26 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 120.336 -0.935 . . . . 0.0 114.904 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.82 146.73 31.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.863 0.832 . . . . 0.0 111.458 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 94' ' ' GLN . . . -159.66 173.02 16.72 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.66 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.452 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 76.7 m-85 -118.08 150.64 39.0 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.0 p -119.41 136.17 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 123.47 0.481 . . . . 0.0 111.027 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.611 ' O ' HG22 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -106.46 121.17 43.74 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.213 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 9.1 m-85 -105.84 133.07 51.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.076 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.66 -34.73 78.89 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.794 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.81 135.9 49.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.92 61.6 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.642 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.93 -40.95 75.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.59 -31.75 71.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.425 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.44 -45.66 92.08 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.267 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.62 -28.98 67.39 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.267 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.27 -40.25 71.07 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.27 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.1 89.84 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.653 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.603 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 11.4 mt -71.21 -34.21 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.512 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.9 p30 -83.01 -16.77 45.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -100.02 -42.05 6.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.539 ' O ' HG12 ' A' ' 137' ' ' VAL . 86.5 mtp -128.82 45.05 2.85 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.62 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.8 t-20 -63.72 -38.54 91.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.676 0.274 . . . . 0.0 111.238 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 39.3 mt-10 -142.09 78.13 1.61 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.729 0.776 . . . . 0.0 109.656 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.538 ' OG ' ' HE3' ' A' ' 125' ' ' MET . 68.0 p -125.13 162.68 24.08 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.454 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -91.99 118.73 31.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.035 0.445 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.29 130.78 48.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.675 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.36 15.02 8.36 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.25 5.28 59.4 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.164 -0.471 . . . . 0.0 113.344 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -127.86 156.87 41.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.56 0.344 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.94 134.1 35.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.0 pt -120.23 154.85 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 123.37 0.419 . . . . 0.0 112.075 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 52.9 mtt180 -125.83 134.68 51.58 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.466 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.803 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.8 134.02 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.044 0.45 . . . . 0.0 110.834 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 13.4 p-10 -151.14 171.47 17.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.498 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.437 HD11 ' O ' ' A' ' 60' ' ' ALA . 14.3 mt -71.06 130.72 42.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.533 0.206 . . . . 0.0 111.168 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.51 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 111.305 0.113 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.0 mtp -99.09 122.7 42.67 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.343 0.402 . . . . 0.0 110.833 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.4 mmm -90.72 -40.33 11.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.595 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -124.56 153.48 42.07 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.487 0.492 . . . . 0.0 111.025 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.9 t -126.34 131.44 51.81 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.656 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.77 -108.11 0.72 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.636 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.78 149.0 21.6 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.467 0.307 . . . . 0.0 111.19 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -124.46 131.46 53.5 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.648 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -87.01 133.12 33.61 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.525 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtt-85 -125.88 151.28 47.1 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.579 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -94.12 111.44 23.16 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.435 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -129.74 145.66 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.562 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -57.15 -38.1 73.05 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 m -64.63 -37.2 86.77 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -64.3 -29.9 70.97 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.2 m -58.4 -39.06 78.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -108.87 123.69 49.46 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -133.26 124.74 27.89 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.068 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.71 140.54 43.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.88 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 m -62.81 153.54 32.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.735 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -61.57 -38.16 86.47 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.72 -42.51 70.49 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.497 ' O ' HD13 ' A' ' 27' ' ' LEU . 78.1 mmm -64.69 -38.45 91.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -68.82 -46.52 68.4 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.948 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -71.64 -43.77 65.54 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.8 mt -66.84 -45.83 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 23' ' ' MET . 10.6 mt -69.3 -40.46 77.67 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -74.46 -36.29 63.34 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.661 0.267 . . . . 0.0 111.186 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -115.0 90.65 3.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.436 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 mt -104.18 113.8 64.91 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.651 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.31 126.16 12.03 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.737 2.292 . . . . 0.0 111.391 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -45.29 -35.3 3.36 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.006 0.922 . . . . 0.0 113.449 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.1 m -85.62 -43.7 13.23 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.01 -32.94 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.363 0.265 . . . . 0.0 111.349 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.94 -30.27 70.36 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -159.73 143.68 14.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.761 0.315 . . . . 0.0 111.494 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.7 p -115.19 34.06 5.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.8 m -78.11 167.88 20.74 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.761 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -122.18 151.86 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.694 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -57.4 -32.02 66.42 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 43' ' ' GLU . 35.1 t -89.63 123.9 34.1 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.279 0.362 . . . . 0.0 111.418 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.7 p -96.66 2.83 52.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.662 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 45.7 mt-10 -65.94 -30.3 70.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.045 0.538 . . . . 0.0 112.429 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -105.23 134.48 48.27 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.402 0.439 . . . . 0.0 110.847 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -98.31 -6.94 29.91 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.823 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.93 134.55 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -98.86 152.8 19.34 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.28 -130.45 3.9 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.784 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.12 -179.47 47.08 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.577 -0.345 . . . . 0.0 113.144 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.2 p -126.63 154.62 43.76 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.325 0.25 . . . . 0.0 111.07 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.37 -177.23 47.24 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.978 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.82 -115.06 1.93 Allowed Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.525 -0.369 . . . . 0.0 112.486 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.7 p -116.94 151.14 37.3 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.279 0.232 . . . . 0.0 111.038 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -109.67 -126.75 5.26 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.486 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.37 -35.42 91.43 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 113.784 0.274 . . . . 0.0 113.784 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.5 p -119.19 151.92 37.5 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.365 0.266 . . . . 0.0 111.017 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.46 -174.35 41.97 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.746 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.03 -177.15 40.7 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.467 -0.396 . . . . 0.0 112.716 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.8 p -126.94 153.56 45.66 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.624 0.249 . . . . 0.0 111.157 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.61 145.02 30.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.969 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.94 -49.35 7.43 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.299 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.9 p -125.72 156.51 39.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 89.2 mttt -110.09 112.28 24.17 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.768 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -141.18 -27.98 0.68 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG23 ' OE1' ' A' ' 111' ' ' GLU . 17.1 t -106.4 128.67 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.539 0.209 . . . . 0.0 110.575 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.14 159.73 29.38 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.66 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.749 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.7 OUTLIER -112.66 117.4 32.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.952 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 136' ' ' ARG . 0.8 OUTLIER -108.71 115.32 49.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 178.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -127.86 148.8 17.83 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.027 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.8 41.27 3.15 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 106' ' ' GLY . 3.7 mp -91.33 159.82 15.81 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.106 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -82.16 174.54 11.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.358 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -69.03 -32.51 72.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.841 0.456 . . . . 0.0 111.519 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -98.83 63.26 1.38 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.405 0.621 . . . . 0.0 111.527 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 72' ' ' ALA . 12.2 p -139.05 137.59 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.705 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.803 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.0 m-20 -140.94 -175.9 4.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.486 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.76 -37.06 86.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.85 0.46 . . . . 0.0 112.203 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -66.25 -43.52 86.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.982 0.513 . . . . 0.0 112.186 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.803 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 16.8 m -73.34 -39.53 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 123.322 0.389 . . . . 0.0 111.769 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.67 -35.75 82.04 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.53 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 6.8 t60 -68.31 -46.2 70.91 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.556 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.12 -20.73 63.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.91 -35.12 22.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' C ' HD13 ' A' ' 90' ' ' ILE . 56.7 m-85 -97.38 -0.9 45.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.021 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 82' ' ' ALA . 4.1 tp -70.39 -31.67 2.35 Favored Pre-proline 0 CA--C 1.565 1.548 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.4 Cg_exo -59.73 -24.14 74.52 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.917 1.744 . . . . 0.0 113.798 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -78.05 -31.28 50.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.89 -159.14 32.13 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.458 0.474 . . . . 0.0 112.612 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -85.94 137.91 32.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.636 0.374 . . . . 0.0 111.456 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.53 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 5.4 mt -118.4 144.33 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.809 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 1.4 p -91.2 -67.33 0.86 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.896 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -148.63 158.04 43.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.8 mm -116.94 129.4 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -126.61 127.02 44.57 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.2 mp -127.83 118.1 20.99 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.795 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.54 126.11 20.35 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.304 2.003 . . . . 0.0 112.642 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -128.02 134.67 49.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -89.55 143.38 26.86 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.278 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -64.58 -34.65 78.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.11 -48.71 41.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.8 p -94.72 -28.33 15.36 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 55.35 24.7 6.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.21 0.604 . . . . 0.0 111.513 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -120.31 156.83 30.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.1 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -92.77 158.58 15.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.973 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -88.52 0.54 56.21 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.017 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.583 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.85 19.46 29.05 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 119.453 -0.637 . . . . 0.0 114.305 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 95' ' ' ILE . 55.1 p90 -144.55 151.15 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.464 0.632 . . . . 0.0 111.191 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.44 164.73 36.1 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.954 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -115.31 138.64 50.75 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.2 p -118.32 133.78 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.93 0.395 . . . . 0.0 111.393 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.517 ' OE1' HG23 ' A' ' 65' ' ' VAL . 1.1 mm-40 -109.0 137.62 46.64 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -117.65 147.32 43.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.21 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.87 -39.52 90.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.07 141.74 39.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.705 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -69.23 -22.13 63.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.071 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.76 -42.17 95.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.177 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.96 -33.05 71.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.73 -45.74 92.65 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.207 0.317 . . . . 0.0 111.028 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.51 -28.9 64.22 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.12 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.63 -45.24 59.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.426 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.26 90.17 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.583 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 46.8 mt -70.65 -39.98 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.67 -28.3 60.79 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.8 -49.7 10.09 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.541 ' O ' HG12 ' A' ' 137' ' ' VAL . 85.4 mtp -135.24 61.33 1.67 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.091 0.472 . . . . 0.0 111.993 -177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 11.3 t-20 -69.21 -41.68 76.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.482 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.6 mt-10 -140.61 79.18 1.69 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.678 0.751 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 p -126.68 164.57 21.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.366 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -87.15 116.14 25.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.02 0.438 . . . . 0.0 110.513 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -133.31 130.49 38.97 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.136 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 64.92 17.05 10.87 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.089 0.955 . . . . 0.0 112.168 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.55 -0.19 61.24 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.735 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.97 156.8 43.2 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.353 0.261 . . . . 0.0 111.099 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -77.97 128.69 34.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 3.0 pt -112.58 148.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 112.158 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 13.0 ttp180 -121.77 128.95 52.29 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.749 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -127.74 133.18 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 110.342 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -157.16 170.87 21.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.828 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.3 tt -71.87 130.88 42.1 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.073 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.165 -179.758 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.611 0.243 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.2 mtp -101.15 137.18 39.85 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.801 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.1 mtt -95.93 129.4 43.19 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.036 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -69.51 -35.5 75.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.919 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.8 t -111.5 139.24 47.09 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.167 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.52 120.87 3.36 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.332 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -97.76 129.9 44.75 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.27 0.228 . . . . 0.0 110.924 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.6 t -133.67 131.13 39.15 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.84 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -93.55 129.42 39.8 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.924 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.88 -37.67 82.06 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.187 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -116.67 151.35 36.5 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.506 0.504 . . . . 0.0 111.079 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 m -123.87 153.32 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.293 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -64.99 -31.59 72.91 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 m -65.27 -38.34 90.0 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -69.97 -43.29 71.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -84.4 -42.15 15.98 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -108.15 151.81 25.4 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.338 0.399 . . . . 0.0 111.108 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -104.63 140.44 38.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.932 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tp -97.53 148.59 23.09 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.355 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.5 p -67.32 157.28 34.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.005 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -64.97 -36.16 83.51 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.546 ' OE2' HG21 ' A' ' 65' ' ' VAL . 29.6 tt0 -67.81 -47.38 69.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.548 0.339 . . . . 0.0 111.539 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.644 ' SD ' HG23 ' A' ' 65' ' ' VAL . 90.8 mmm -68.71 -36.94 79.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -66.95 -44.18 81.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.006 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.01 -39.31 79.37 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.3 mt -70.01 -47.66 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.208 0.203 . . . . 0.0 111.269 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 23' ' ' MET . 6.9 mt -69.77 -37.23 76.32 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.3 p -76.22 -27.48 56.82 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -111.44 80.61 1.33 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.325 0.584 . . . . 0.0 110.117 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.71 158.95 33.53 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.397 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.494 ' O ' HG11 ' A' ' 34' ' ' VAL . 6.3 Cg_exo -79.92 162.18 23.76 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.892 2.395 . . . . 0.0 113.264 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.47 -25.04 66.98 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.033 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.2 p -84.14 24.2 0.97 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.066 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.494 HG11 ' O ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -56.01 -12.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.65 -43.92 71.62 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 54.42 24.98 5.62 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.908 0.883 . . . . 0.0 112.913 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -126.59 33.05 5.05 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.942 0.401 . . . . 0.0 111.548 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.9 p -127.19 151.96 48.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.98 142.16 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.719 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -68.85 -37.86 79.39 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.045 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.505 ' SG ' ' HB ' ' A' ' 46' ' ' VAL . 35.9 t -126.99 131.15 51.1 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 123.363 0.415 . . . . 0.0 111.044 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.8 p -92.61 -10.17 38.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.277 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -110.82 140.18 45.48 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.163 0.289 . . . . 0.0 111.223 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 mtp-105 -72.68 -32.83 66.1 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.211 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -72.86 -20.89 61.03 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.505 ' HB ' ' SG ' ' A' ' 41' ' ' CYS . 12.0 t -103.61 131.48 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -98.36 144.92 27.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.078 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.93 166.84 26.51 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.46 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.93 48.0 5.97 Favored Glycine 0 C--N 1.342 0.88 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.083 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.6 m -115.45 149.86 37.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 122.343 0.257 . . . . 0.0 111.138 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.17 38.32 7.34 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.822 -0.627 . . . . 0.0 113.262 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.54 175.13 43.8 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 121.473 -0.394 . . . . 0.0 113.039 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t -135.21 149.15 49.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.328 0.251 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.57 67.22 0.85 Allowed Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.922 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.26 -55.4 2.49 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.536 -0.364 . . . . 0.0 112.398 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.4 t -70.43 -35.47 73.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.867 0.467 . . . . 0.0 111.683 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.01 -173.62 40.25 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.454 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.13 -149.59 5.88 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.43 -0.415 . . . . 0.0 112.421 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -66.65 -25.29 66.51 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.74 138.89 37.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.64 -61.24 1.54 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.8 p -145.91 119.55 9.16 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.983 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mttt -130.88 137.5 49.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.14 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 62.8 mtt180 -71.92 -24.48 61.64 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.576 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.644 HG23 ' SD ' ' A' ' 23' ' ' MET . 4.5 t -95.66 129.31 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.02 154.52 39.75 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.524 0.515 . . . . 0.0 110.818 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.5 t80 -98.97 122.45 42.25 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.929 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 m -117.54 116.9 53.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.965 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.54 151.09 18.8 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.876 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.26 5.24 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.7 mp -91.56 165.45 13.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.61 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -88.59 161.84 16.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.412 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.15 -31.45 70.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.59 3.02 26.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.036 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 72' ' ' ALA . 2.3 p -86.42 138.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 120.542 0.211 . . . . 0.0 110.923 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -124.83 176.38 6.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.354 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -61.36 -31.87 71.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.196 0.598 . . . . 0.0 112.079 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -67.74 -40.91 84.1 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.57 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.33 -42.3 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.024 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.2 tt -68.41 -37.79 80.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.396 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.52 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.2 t60 -68.48 -48.59 64.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.329 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.542 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.7 -20.52 62.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -35.38 23.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.851 0.358 . . . . 0.0 111.298 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' C ' HD13 ' A' ' 90' ' ' ILE . 71.2 m-85 -97.83 -2.26 41.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.542 HG21 ' O ' ' A' ' 82' ' ' ALA . 3.9 tp -68.28 -31.11 2.95 Favored Pre-proline 0 CA--C 1.567 1.599 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.57 -24.12 60.32 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 121.922 1.748 . . . . 0.0 113.691 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.69 -31.2 46.48 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.367 0.417 . . . . 0.0 111.692 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.96 33.8 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.262 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.23 134.23 34.74 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.4 mt -109.87 141.99 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.855 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -89.21 -64.29 1.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.673 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -145.75 153.44 40.95 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.2 mm -119.42 123.69 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -123.46 129.34 51.1 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 107' ' ' PHE . 0.9 OUTLIER -128.0 124.1 23.0 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.724 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.7 119.95 7.46 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.111 1.874 . . . . 0.0 112.191 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.57 135.66 50.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.362 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.18 144.31 25.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.312 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -64.81 -34.32 78.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.54 -46.82 62.86 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.2 p -101.43 -27.66 13.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.07 25.45 8.93 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.25 0.62 . . . . 0.0 111.709 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -121.87 154.99 36.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.648 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -106.78 164.39 12.14 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.415 0.447 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -88.02 -1.49 58.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 100.3 25.87 8.59 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.479 -0.623 . . . . 0.0 114.57 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' O ' HG22 ' A' ' 95' ' ' ILE . 28.9 p90 -145.07 147.11 32.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.445 0.622 . . . . 0.0 111.108 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.91 167.31 27.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.264 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.473 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 75.9 m-85 -111.65 137.49 49.47 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 7.1 p -112.55 132.09 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 O-C-N 123.243 0.34 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.632 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.9 tt0 -103.81 130.73 51.39 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.762 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 52.3 m-85 -117.12 146.99 42.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.66 -36.07 65.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.04 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.57 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -105.72 141.05 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.503 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.55 -19.99 58.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.559 0.695 . . . . 0.0 109.162 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.92 -49.96 33.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.431 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.57 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.7 p30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.52 84.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.795 0.438 . . . . 0.0 111.135 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.39 69.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.049 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.4 72.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.143 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.03 82.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.586 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 14.2 mt -70.48 -34.12 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.271 0.357 . . . . 0.0 111.473 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.96 -16.84 49.07 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -101.52 -43.71 5.82 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.549 ' O ' HG13 ' A' ' 137' ' ' VAL . 61.8 mtt -124.79 44.48 2.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.3 t30 -63.22 -37.95 89.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.618 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.3 mt-10 -142.85 77.57 1.58 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.667 0.746 . . . . 0.0 109.809 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.6 p -123.09 165.03 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.301 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -91.99 120.38 32.58 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.624 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -125.54 129.13 49.11 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.098 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 56.56 20.45 4.91 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.905 0.882 . . . . 0.0 112.814 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.67 3.85 59.39 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.848 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -126.9 153.2 46.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.86 0.33 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.2 m -78.57 132.28 37.09 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -119.54 156.46 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 14.1 ptt-85 -129.39 136.13 49.58 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.001 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -127.17 140.73 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 14.9 p-10 -150.78 171.63 16.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.805 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 mt -69.34 133.2 47.55 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.529 0.332 . . . . 0.0 111.146 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.137 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.095 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 111.319 0.118 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.5 mtp -99.21 132.0 44.83 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.365 0.416 . . . . 0.0 110.837 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.8 mtp -68.8 -37.27 79.15 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.253 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -118.59 148.43 42.69 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.395 0.435 . . . . 0.0 111.164 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.2 t -130.31 133.53 46.52 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.498 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.28 -112.16 0.45 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.948 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -92.73 152.42 19.51 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.57 0.348 . . . . 0.0 111.316 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.4 t -122.25 131.04 53.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.61 150.08 20.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.21 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -119.51 141.2 49.41 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.646 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -70.47 -38.63 74.46 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -100.86 86.61 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.16 0.505 . . . . 0.0 111.454 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.35 -40.66 89.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.662 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -63.56 -38.68 92.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -69.03 -35.99 77.24 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.476 0.546 . . . . 0.0 112.476 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.2 m -85.7 -40.29 16.29 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -100.45 146.21 27.32 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.278 0.361 . . . . 0.0 111.186 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -110.17 150.57 28.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.922 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 tp -95.31 142.81 27.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.4 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.3 p -70.69 159.28 34.74 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.779 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -62.73 -35.05 78.49 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -68.12 -46.48 70.78 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.324 0.39 . . . . 0.0 111.824 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.512 ' O ' HD13 ' A' ' 27' ' ' LEU . 91.1 mmm -67.39 -39.13 85.58 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -63.67 -42.05 98.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.69 0.396 . . . . 0.0 111.772 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -70.44 -38.66 74.57 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mt -68.2 -45.78 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 122.162 0.185 . . . . 0.0 111.169 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.512 HD13 ' O ' ' A' ' 23' ' ' MET . 5.4 mt -69.45 -40.96 76.87 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.0 p -76.58 -29.98 56.81 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.268 0.355 . . . . 0.0 111.812 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -123.33 88.88 3.0 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.472 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 pp -123.12 152.76 64.06 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.109 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.39 125.8 9.9 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.495 2.13 . . . . 0.0 111.824 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -50.93 -32.91 22.23 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.552 ' O ' ' HB ' ' A' ' 37' ' ' THR . 80.9 p -82.61 -41.73 19.13 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.314 0.384 . . . . 0.0 111.89 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.94 -27.0 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.595 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.28 -31.43 71.74 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.753 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' O ' HG23 ' A' ' 37' ' ' THR . 13.8 p90 -166.32 -47.13 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.552 ' HB ' ' O ' ' A' ' 33' ' ' SER . 10.9 t 47.73 24.23 0.53 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.49 1.116 . . . . 0.0 113.704 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.5 m -96.18 -42.14 8.35 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.573 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.25 133.28 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 123.374 0.421 . . . . 0.0 110.099 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -113.58 130.21 56.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.135 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.5 t -120.73 116.45 25.29 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.013 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 p -97.17 -18.17 19.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.626 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.67 -33.08 73.38 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.933 0.493 . . . . 0.0 112.207 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -119.0 138.15 53.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -130.52 152.01 50.37 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.79 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.9 139.66 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.77 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -96.22 131.28 42.86 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.599 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.87 8.56 55.5 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.4 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.41 1.62 84.33 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 121.592 -0.337 . . . . 0.0 113.318 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -122.16 142.01 50.85 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.45 0.3 . . . . 0.0 110.675 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.1 -173.74 42.02 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.568 0.543 . . . . 0.0 112.767 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.58 129.39 6.65 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.588 -0.339 . . . . 0.0 112.431 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -64.21 -36.73 85.01 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.56 3.96 64.28 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.509 0.505 . . . . 0.0 113.342 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.94 -40.81 62.72 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 113.687 0.235 . . . . 0.0 113.687 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.6 p -126.13 152.58 45.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.574 0.226 . . . . 0.0 111.21 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.54 -172.87 45.53 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.676 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.64 -93.32 1.04 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.459 -0.401 . . . . 0.0 112.727 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 t -115.71 145.37 42.82 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.598 0.237 . . . . 0.0 111.071 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.96 146.24 28.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.002 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.1 p -124.54 157.66 34.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.463 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p 48.06 38.57 9.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.284 1.034 . . . . 0.0 113.202 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -101.78 137.23 40.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.999 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 50.9 mtm180 -104.75 -2.47 24.84 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.632 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.9 132.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.15 152.56 41.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.674 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.3 t80 -100.68 116.33 32.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.583 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.33 117.7 56.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.976 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.05 153.08 19.91 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.074 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.91 26.06 5.94 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.9 0.412 . . . . 0.0 112.502 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -94.27 163.47 13.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.54 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.476 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -91.0 157.35 17.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.902 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 45.7 mt-10 -63.66 -26.9 68.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.64 0.376 . . . . 0.0 111.744 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.7 -4.05 35.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.801 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.0 m -86.71 141.1 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.671 0.272 . . . . 0.0 110.855 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.467 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -122.08 179.1 4.64 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 23.5 m-20 -59.87 -30.44 68.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.845 0.458 . . . . 0.0 111.669 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.57 -40.91 80.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.721 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.467 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.1 t -66.66 -46.74 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.292 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 2.2 tt -67.02 -39.38 87.04 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.594 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.501 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 25.6 t-80 -68.01 -48.42 65.77 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.78 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.478 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.6 62.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.16 -32.7 24.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.98 0.419 . . . . 0.0 111.268 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -103.78 1.76 32.03 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.416 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -70.23 -33.12 3.14 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 19.8 Cg_endo -59.7 -23.5 71.93 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.867 1.711 . . . . 0.0 114.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -80.76 -31.26 35.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.84 -170.28 43.18 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.773 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -84.01 133.55 34.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.53 0.332 . . . . 0.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 111' ' ' GLU . 6.9 mt -113.0 139.4 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.854 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -90.19 -62.59 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.174 -179.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.5 155.21 42.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.413 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 20.6 mm -116.64 124.98 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -120.13 126.23 50.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.464 HG21 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.88 117.45 20.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.961 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.68 126.64 21.85 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.313 2.009 . . . . 0.0 112.519 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -125.36 134.36 52.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.143 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.13 142.25 27.9 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.22 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -64.64 -33.46 75.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -71.05 -48.28 53.69 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.7 p -98.69 -27.75 13.84 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 97' ' ' LEU . 47.0 mt-10 57.92 22.59 8.89 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.178 0.591 . . . . 0.0 111.506 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -123.07 156.34 35.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.212 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.54 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 13.5 p80 -99.89 160.15 14.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 24.2 mtp180 -88.5 0.08 56.67 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.584 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 98.95 29.3 7.32 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.15 -0.548 . . . . 0.0 114.269 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.464 ' O ' HG21 ' A' ' 95' ' ' ILE . 36.5 p90 -145.09 145.47 31.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.155 0.477 . . . . 0.0 111.028 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.14 165.91 34.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.105 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -111.96 143.5 42.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -116.78 135.94 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.821 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -107.62 125.77 51.75 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.86 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 28.4 m-85 -111.12 136.08 50.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -64.66 -36.58 84.73 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.664 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.26 132.51 52.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.58 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.68 -24.54 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.206 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.74 -44.57 81.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.808 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -68.89 -32.7 72.53 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.397 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.41 -48.51 81.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.375 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.56 69.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.207 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.549 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.66 -37.41 70.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.299 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.39 88.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.828 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.598 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 14.3 mt -70.4 -38.91 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.6 p30 -76.34 -25.88 55.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.36 -50.05 9.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 137' ' ' VAL . 63.5 mtt -132.73 58.97 1.74 Allowed 'General case' 0 C--N 1.347 0.482 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.6 t30 -67.36 -37.82 83.81 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 33.9 mt-10 -140.7 79.48 1.7 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.915 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.2 t -122.15 160.97 24.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.187 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -90.77 118.24 30.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -129.35 129.78 45.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.993 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 62.54 15.31 7.79 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.671 0.788 . . . . 0.0 112.389 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.83 3.95 59.13 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.222 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -126.02 154.22 43.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.533 0.333 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 133.74 35.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -117.81 152.91 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 1.8 tpt180 -125.54 131.43 52.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.237 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -126.95 135.68 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 123.196 0.31 . . . . 0.0 110.319 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -147.24 171.75 14.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.368 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.61 129.67 38.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.227 0.211 . . . . 0.0 110.894 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.442 0.163 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 86.0 mtp -104.38 137.15 42.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.83 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.4 mtt -120.99 156.34 32.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -103.18 152.28 21.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.1 t -119.9 134.16 55.33 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.92 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.65 -30.07 12.46 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.468 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -94.32 134.93 36.29 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.603 0.239 . . . . 0.0 111.212 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -133.37 134.24 43.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.69 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -91.33 117.96 30.1 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -71.87 -41.74 67.69 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -125.72 137.11 53.81 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.188 0.305 . . . . 0.0 111.804 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.97 131.72 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.336 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -65.84 -41.64 91.51 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 m -65.25 -38.61 90.89 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.3 -35.34 80.13 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.9 m -75.89 -41.85 50.89 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.62 -39.07 70.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -131.93 151.98 51.37 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.316 0.385 . . . . 0.0 111.252 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.48 HD22 ' SD ' ' A' ' 23' ' ' MET . 0.4 OUTLIER -93.21 161.62 14.34 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.701 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.416 ' H ' HD21 ' A' ' 19' ' ' LEU . 99.9 p -65.19 158.93 24.75 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.87 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.04 -33.7 76.34 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.09 -46.06 75.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.48 ' SD ' HD22 ' A' ' 19' ' ' LEU . 23.8 mtt -73.66 -38.12 65.05 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -68.31 -45.66 72.38 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -71.31 -42.7 68.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 56.7 mt -70.34 -48.57 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 23' ' ' MET . 9.5 mt -68.95 -41.49 77.97 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 m -73.1 -34.88 66.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.551 0.215 . . . . 0.0 111.256 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -116.26 91.42 3.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.79 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 7.2 mt -109.55 107.14 59.25 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.752 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.74 129.62 19.05 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 123.022 2.481 . . . . 0.0 111.336 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -44.36 -33.55 1.68 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m -93.56 -40.62 10.2 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.637 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 54.4 t -68.15 -30.12 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.84 71.9 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.53 125.32 11.19 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.232 0.332 . . . . 0.0 110.819 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 54.65 100.54 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.946 0.898 . . . . 0.0 112.198 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 34' ' ' VAL . 83.6 m -105.84 -49.05 3.48 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.344 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 t -124.9 136.22 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 123.44 0.462 . . . . 0.0 110.175 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -118.36 137.88 52.8 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.964 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.1 t -129.5 130.73 46.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.954 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.8 p -79.46 -27.57 41.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.409 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -111.74 153.22 26.81 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.297 0.373 . . . . 0.0 111.078 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -120.48 149.11 42.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.771 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -111.28 137.28 49.21 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.904 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -129.68 143.52 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.586 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.05 121.28 29.3 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.684 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.79 -114.42 2.77 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.25 48.22 1.57 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.874 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 m -63.48 -36.64 84.43 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.34 36.36 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 123.498 0.499 . . . . 0.0 113.232 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.48 -134.75 3.74 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.618 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.7 m -117.42 150.48 38.82 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.438 0.295 . . . . 0.0 110.899 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.94 -169.97 46.6 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.773 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.23 67.61 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 113.664 0.226 . . . . 0.0 113.664 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.3 p -115.32 150.64 35.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.401 0.281 . . . . 0.0 110.74 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.8 172.99 24.23 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.768 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.52 105.41 1.13 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.417 -0.421 . . . . 0.0 112.65 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.6 m -123.08 144.06 49.56 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.306 0.242 . . . . 0.0 110.793 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.42 140.13 44.96 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.237 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.0 p -130.65 158.23 40.6 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.563 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.6 p 56.46 -0.71 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -102.66 122.75 45.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.71 0.291 . . . . 0.0 110.945 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.47 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.0 mtt85 -122.36 -1.02 9.2 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.359 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.446 HG22 ' OE2' ' A' ' 111' ' ' GLU . 14.4 t -103.49 129.42 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.92 157.81 33.42 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.501 0.501 . . . . 0.0 111.324 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 37.0 t80 -99.6 136.21 39.87 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.321 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.42 115.33 19.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 123.546 0.529 . . . . 0.0 109.927 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.95 149.28 19.12 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.631 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.83 19.22 9.29 Favored Glycine 0 C--N 1.331 0.298 0 O-C-N 123.914 0.42 . . . . 0.0 112.271 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -90.94 166.24 13.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 122.604 0.361 . . . . 0.0 110.438 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -90.7 156.97 17.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.44 -27.52 68.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.36 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.1 -4.75 40.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.849 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 72' ' ' ALA . 2.3 m -82.52 138.12 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 120.606 0.241 . . . . 0.0 110.664 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.47 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 77.3 m-20 -119.01 178.9 4.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.48 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 22.9 m-20 -59.19 -30.93 68.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.904 0.482 . . . . 0.0 111.64 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -68.56 -40.51 80.57 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.764 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.47 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.2 t -67.32 -47.33 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.522 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.479 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.5 tt -68.14 -39.74 82.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.714 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.538 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 21.3 t-80 -68.32 -47.76 66.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.495 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.46 -20.62 62.87 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.11 -33.19 24.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.912 0.387 . . . . 0.0 111.156 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -102.31 0.79 34.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.381 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.571 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 tp -69.95 -32.75 3.08 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 14.9 Cg_endo -58.48 -23.23 63.21 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.941 1.761 . . . . 0.0 113.931 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -78.85 -31.17 45.57 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.345 0.403 . . . . 0.0 112.085 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.75 -163.74 37.45 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.898 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -82.9 135.27 34.97 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.775 0.43 . . . . 0.0 111.823 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 111' ' ' GLU . 7.2 mt -116.85 140.34 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.389 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 9.1 p -88.47 -64.23 1.18 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.85 157.04 43.55 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 12.7 mm -119.38 128.75 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.428 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 65.4 mt-30 -114.96 131.81 56.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.692 0.282 . . . . 0.0 111.683 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.457 HG22 ' CD2' ' A' ' 104' ' ' HIS . 4.1 mp -126.6 102.75 25.55 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.824 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.36 121.42 9.87 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.533 2.156 . . . . 0.0 112.546 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tp -129.52 134.9 48.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.939 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -87.74 140.83 29.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -64.42 -34.31 77.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.14 -48.75 32.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.892 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.4 p -93.03 -29.22 15.93 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 50.65 32.27 6.69 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.247 0.619 . . . . 0.0 111.018 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 101' ' ' THR . 51.6 mttt -118.03 154.82 31.38 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.359 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.457 ' CD2' HG22 ' A' ' 95' ' ' ILE . 12.3 t-80 -97.32 142.45 29.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.594 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -93.95 -1.68 54.28 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.587 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.46 20.42 38.01 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 120.393 -0.908 . . . . 0.0 114.669 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -145.6 148.1 32.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.708 0.754 . . . . 0.0 111.192 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 94' ' ' GLN . . . -157.49 172.78 17.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.857 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -117.94 149.32 41.1 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 p -125.89 136.46 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 123.257 0.348 . . . . 0.0 111.214 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.599 ' O ' HG23 ' A' ' 90' ' ' ILE . 1.1 tm-20 -109.9 130.0 55.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.082 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.47 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 15.9 m-85 -109.42 143.2 39.31 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.974 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.26 -37.07 82.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.376 0.422 . . . . 0.0 110.624 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.568 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -105.7 141.44 37.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.898 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.01 56.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.763 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -72.25 -48.61 41.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.347 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 23.2 p30 -66.58 -32.36 73.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.974 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.48 83.38 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.49 0.494 . . . . 0.0 111.131 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.89 69.83 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.352 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.43 75.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.13 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.98 86.35 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.781 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.615 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 35.4 mt -70.71 -33.49 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.63 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -32.75 69.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -104.32 -35.68 7.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.611 ' O ' HG11 ' A' ' 137' ' ' VAL . 77.8 mtp -103.37 14.83 30.61 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.615 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.1 t-20 -57.2 -36.69 71.15 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.691 0.281 . . . . 0.0 111.253 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.9 74.25 1.44 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.742 0.782 . . . . 0.0 109.765 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.3 p -124.09 161.25 25.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.333 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -94.31 120.59 34.78 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -128.35 128.8 45.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.808 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.22 15.82 7.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.728 0.811 . . . . 0.0 112.364 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.06 5.27 58.37 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.475 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mtp85 -127.22 154.81 44.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.427 0.291 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -81.12 132.97 35.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.1 pt -119.41 154.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 55.5 mtt85 -123.04 133.58 54.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.186 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.99 136.08 59.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.531 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -149.82 171.86 16.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.74 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.98 128.85 37.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.606 0.241 . . . . 0.0 110.898 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.309 -179.448 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 111.286 0.106 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 86.8 mtp -106.42 136.97 45.25 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.43 0.456 . . . . 0.0 110.71 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.9 mtt -111.8 142.56 44.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.57 -34.12 77.2 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.4 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.5 t -108.35 131.94 54.24 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.384 0.427 . . . . 0.0 111.062 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.55 -41.27 2.76 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 123.735 0.647 . . . . 0.0 112.953 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -92.62 151.02 20.35 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.458 0.303 . . . . 0.0 111.198 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.0 t -101.78 141.41 34.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.932 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -89.67 7.7 35.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.172 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -118.87 141.3 48.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -131.26 -1.88 3.97 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.992 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.07 141.56 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -65.62 -28.44 69.12 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.979 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 m -58.1 -37.01 73.72 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.61 -36.9 83.71 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.0 m -86.5 -44.03 12.28 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.301 0.375 . . . . 0.0 112.005 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -115.01 142.36 46.74 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.395 0.435 . . . . 0.0 110.7 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.34 -44.05 22.33 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.149 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 tp -133.37 150.45 51.83 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.328 0.393 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.2 p -80.6 160.55 25.07 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.249 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.93 -39.45 92.12 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.11 -40.87 78.07 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.566 ' SD ' ' HG3' ' A' ' 111' ' ' GLU . 10.1 mtt -67.68 -39.04 84.5 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -65.33 -42.01 93.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.612 0.365 . . . . 0.0 111.687 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.81 -47.72 57.98 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 24.3 mt -67.59 -45.4 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mt -68.88 -33.86 74.48 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.0 p -69.35 -35.9 76.33 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -131.65 101.45 5.49 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 123.363 0.414 . . . . 0.0 111.026 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 4.6 mt -114.69 124.75 30.03 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.149 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.04 128.51 17.78 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.427 2.084 . . . . 0.0 111.561 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -46.14 -34.4 4.23 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.9 p -89.24 -41.11 12.39 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.35 -32.62 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.248 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.09 69.5 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -156.92 130.34 8.03 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.208 0.318 . . . . 0.0 111.348 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.0 p -128.44 157.64 40.53 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.8 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 94.2 m -92.76 -50.9 5.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.308 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.45 133.27 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -116.24 -50.72 2.64 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.189 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.6 t -136.29 128.74 30.33 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.325 0.39 . . . . 0.0 110.949 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.8 p -85.23 -24.76 27.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.115 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -110.27 152.68 25.85 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 123.395 0.435 . . . . 0.0 110.425 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -110.73 142.58 42.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.65 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -91.66 -20.32 21.73 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.808 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 t -72.7 -42.24 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.708 0.403 . . . . 0.0 111.343 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -84.99 131.31 34.49 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.44 0.462 . . . . 0.0 111.294 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.11 -31.15 7.62 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.844 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.12 -166.36 39.46 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 121.766 -0.254 . . . . 0.0 112.773 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.7 p -107.72 151.4 25.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.595 0.236 . . . . 0.0 111.037 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.97 -172.0 46.05 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.074 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.43 172.31 33.62 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 121.601 -0.333 . . . . 0.0 112.822 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 m -64.75 -33.97 77.23 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.37 175.62 34.34 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.691 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.43 -50.73 3.71 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.715 -0.279 . . . . 0.0 113.284 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.8 m -121.9 149.36 43.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.607 0.242 . . . . 0.0 111.47 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.66 178.21 37.63 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.374 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.65 157.0 27.11 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.952 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.0 p -133.92 153.63 51.63 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.52 0.328 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.36 131.01 49.26 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -108.53 -12.65 14.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.963 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.2 p -84.78 -29.32 25.54 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -118.65 126.19 51.39 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.223 0.327 . . . . 0.0 111.311 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -115.39 1.83 13.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.183 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG23 ' OE2' ' A' ' 111' ' ' GLU . 14.6 t -104.74 135.88 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.21 155.31 37.37 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.358 0.411 . . . . 0.0 111.473 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.767 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.3 t80 -96.32 135.1 38.62 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.171 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 m -134.37 115.65 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.333 0.396 . . . . 0.0 110.006 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.42 154.41 21.04 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.94 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.87 26.49 6.71 Favored Glycine 0 C--N 1.332 0.352 0 O-C-N 123.935 0.432 . . . . 0.0 112.309 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.591 HD11 ' O ' ' A' ' 106' ' ' GLY . 0.7 OUTLIER -92.9 159.88 15.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.955 0.407 . . . . 0.0 110.652 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -83.62 154.08 23.94 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.027 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 24.1 tp10 -60.03 -30.89 69.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.678 0.391 . . . . 0.0 111.454 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -72.17 -18.7 61.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 72' ' ' ALA . 1.5 m -68.58 139.03 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.686 0.279 . . . . 0.0 111.487 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -117.63 179.03 4.18 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.31 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -61.96 -28.95 69.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.972 0.415 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.05 -40.53 78.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.6 t -64.86 -46.48 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.084 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.483 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.7 tt -65.77 -39.57 91.13 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.908 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.603 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 23.7 t-80 -68.49 -47.97 65.65 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.944 0.498 . . . . 0.0 111.82 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.533 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.31 -20.59 63.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.42 23.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.483 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 75.0 m-85 -102.38 1.39 35.37 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.239 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.533 HG21 ' O ' ' A' ' 82' ' ' ALA . 4.0 tp -70.79 -31.62 2.16 Favored Pre-proline 0 CA--C 1.565 1.553 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.3 Cg_exo -59.5 -23.9 72.68 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.954 1.769 . . . . 0.0 113.859 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.567 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 60.1 m-85 -78.89 -31.31 45.36 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.95 -163.28 36.69 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.032 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -83.85 134.34 34.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.868 0.467 . . . . 0.0 111.97 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.603 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 6.2 mt -116.67 139.81 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.426 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 6.4 p -86.97 -61.23 1.77 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.817 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -152.53 159.67 43.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.948 0.404 . . . . 0.0 111.949 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.7 mm -115.23 124.58 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -117.76 127.45 53.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.233 0.333 . . . . 0.0 111.818 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.62 121.12 22.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.665 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.77 96.69 0.31 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 121.937 1.758 . . . . 0.0 112.082 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.33 135.87 48.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.234 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -87.37 141.18 28.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.67 -34.18 77.69 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -70.85 -48.8 52.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 29.9 p -95.85 -28.31 14.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 54.36 24.76 5.38 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.256 0.622 . . . . 0.0 111.672 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 101' ' ' THR . 61.5 mttt -117.13 152.27 35.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.178 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.52 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.4 p80 -103.76 157.64 16.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.227 0.329 . . . . 0.0 110.692 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -88.05 0.81 55.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.186 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.591 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 96.22 24.73 13.86 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.199 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.66 150.38 34.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 117.216 0.508 . . . . 0.0 111.037 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.36 171.09 18.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -115.73 140.2 49.43 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.3 p -116.09 134.17 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.155 0.284 . . . . 0.0 111.192 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.566 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -106.45 126.83 52.74 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.414 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 21.8 m-85 -111.07 139.35 46.51 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.755 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.48 -37.92 89.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.78 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.573 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.3 mp -103.87 136.47 43.48 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.958 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.45 60.6 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.441 0.639 . . . . 0.0 109.374 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.4 -50.45 31.84 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.371 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.573 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 19.2 p30 -69.72 -32.13 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.878 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.48 91.87 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.96 69.01 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.943 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.45 74.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.114 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.51 84.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.93 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.588 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 21.2 mt -70.56 -34.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.301 0.375 . . . . 0.0 111.944 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.76 -17.07 45.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -99.48 -44.48 6.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.574 ' O ' HG13 ' A' ' 137' ' ' VAL . 61.4 mtt -130.18 50.55 2.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.6 t-20 -64.08 -37.1 86.22 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.962 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.8 tt0 -143.77 76.65 1.52 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.068 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.8 t -119.4 162.73 18.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.85 118.15 29.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.015 0.436 . . . . 0.0 110.796 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.35 131.77 42.24 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 t80 62.93 14.66 7.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.771 0.828 . . . . 0.0 112.307 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.9 2.31 59.59 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.204 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -126.96 156.39 41.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.559 0.344 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.22 133.71 35.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -115.66 154.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.425 0.453 . . . . 0.0 112.046 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 6.0 tpt180 -124.42 132.23 53.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.03 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -131.39 133.62 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.421 178.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -147.38 171.44 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.21 129.78 39.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.517 0.199 . . . . 0.0 111.123 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.204 -179.518 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.531 0.205 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.0 mtp -101.1 137.1 39.91 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.859 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.5 mtt -102.08 144.5 30.58 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -65.31 -35.85 82.25 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.529 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.1 t -127.72 135.44 50.17 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.387 0.429 . . . . 0.0 111.196 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.55 132.01 3.67 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.244 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -98.85 139.75 34.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.613 0.244 . . . . 0.0 111.069 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 76.3 m -85.83 -37.1 19.57 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.753 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.21 136.84 35.88 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.444 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -98.01 0.01 45.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.704 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -100.46 140.8 34.2 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.09 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.09 -30.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.584 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -63.63 -30.81 71.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.103 0.561 . . . . 0.0 112.402 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.9 m -60.84 -36.3 78.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.075 0.55 . . . . 0.0 112.467 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -60.38 -38.1 82.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.034 0.533 . . . . 0.0 111.768 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.3 m -72.69 -34.64 67.31 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.136 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.93 -26.95 67.1 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.16 0.584 . . . . 0.0 112.424 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.86 160.36 29.3 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.761 0.424 . . . . 0.0 111.729 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.14 165.49 20.5 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.082 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.9 p -62.93 159.7 16.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.953 0.501 . . . . 0.0 112.014 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.46 -31.0 72.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' O ' HD13 ' A' ' 26' ' ' ILE . 75.4 mm-40 -64.65 -49.31 71.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.509 ' O ' HD13 ' A' ' 27' ' ' LEU . 74.2 mmm -73.19 -39.08 65.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -69.04 -44.99 71.56 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.66 -41.21 72.38 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.436 HD13 ' O ' ' A' ' 22' ' ' GLU . 53.8 mt -70.14 -47.32 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 23' ' ' MET . 8.7 mt -69.56 -41.72 75.52 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.6 m -74.43 -35.31 63.37 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -111.3 84.28 1.91 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.214 0.53 . . . . 0.0 110.266 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 4.1 mt -90.81 133.67 31.92 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.972 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 2.8 Cg_exo -76.03 29.99 0.39 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.664 2.243 . . . . 0.0 113.342 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 50.64 -80.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.77 1.228 . . . . 0.0 113.869 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 m -62.25 -40.08 95.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.86 -34.42 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-O 120.472 0.177 . . . . 0.0 111.071 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.63 -32.58 71.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -151.88 144.58 24.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.674 0.273 . . . . 0.0 111.701 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.2 p -87.84 1.96 52.61 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.249 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.0 m -64.77 -27.45 68.9 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 p -123.59 150.81 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 123.365 0.416 . . . . 0.0 110.618 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -97.44 160.98 14.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.234 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.0 t -94.67 127.86 40.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.84 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.6 p -76.96 -26.38 53.9 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -104.19 130.36 51.95 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.345 0.403 . . . . 0.0 110.901 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -77.26 -37.09 53.71 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.169 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -119.87 142.53 48.58 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.418 0.448 . . . . 0.0 111.169 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 m -130.04 156.8 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.239 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -89.33 129.37 35.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.386 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 179.1 -128.74 1.28 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.31 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.02 -179.75 45.65 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.531 -0.366 . . . . 0.0 112.857 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.4 p -126.5 150.79 48.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.578 0.228 . . . . 0.0 111.235 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.49 174.61 19.67 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.689 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.34 175.09 37.42 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.86 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.0 m -67.83 -37.43 81.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.23 -178.75 41.47 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.982 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.28 -43.3 6.29 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.684 -0.293 . . . . 0.0 113.043 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 t -118.67 145.29 45.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.308 0.243 . . . . 0.0 110.772 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.41 55.87 0.11 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.567 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.46 9.08 59.29 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.539 -0.362 . . . . 0.0 113.444 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 m -64.06 -37.41 87.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.7 148.31 41.18 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.457 0.473 . . . . 0.0 111.125 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.45 155.25 16.84 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.439 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.0 p -74.47 112.71 10.91 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.443 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -131.37 143.06 50.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.884 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.453 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 52.9 mtm180 -93.09 -0.47 57.05 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.603 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.551 HG21 ' OE1' ' A' ' 111' ' ' GLU . 5.4 t -107.49 126.63 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.56 156.16 36.26 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.363 0.414 . . . . 0.0 111.008 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.818 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 50.9 t80 -95.22 133.64 38.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.706 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.77 115.27 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 123.378 0.424 . . . . 0.0 109.974 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -134.73 153.01 20.89 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.891 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.06 32.78 4.86 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 106' ' ' GLY . 1.1 mp -94.0 164.0 13.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -80.59 153.0 28.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.977 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -61.84 -26.6 68.22 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.842 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.69 9.05 22.77 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.451 HG11 ' O ' ' A' ' 72' ' ' ALA . 2.7 m -90.63 142.24 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.383 -0.198 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.485 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.6 p30 -126.01 -175.8 3.46 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 17.3 m-20 -58.87 -33.34 70.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.725 0.41 . . . . 0.0 111.786 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -69.4 -36.27 76.59 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.914 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.485 HG23 ' OD1' ' A' ' 76' ' ' ASP . 55.9 t -69.48 -48.57 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.797 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tt -66.55 -38.82 87.92 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.625 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.503 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 27.0 t-80 -68.38 -47.96 65.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.79 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.72 62.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.21 -33.07 24.21 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 111.126 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.53 1.24 34.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.37 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.04 -32.02 2.67 Favored Pre-proline 0 CA--C 1.565 1.519 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 32.4 Cg_exo -60.39 -23.9 76.11 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 121.982 1.788 . . . . 0.0 113.922 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 44.1 m-85 -81.46 -31.53 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.69 -170.0 42.62 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.89 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.9 134.67 34.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.598 0.359 . . . . 0.0 110.894 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.7 mt -115.6 140.12 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.005 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 3.8 p -89.15 -62.47 1.47 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.892 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -148.09 158.42 44.06 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.038 0.447 . . . . 0.0 112.11 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.516 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 mm -118.02 125.59 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.438 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -116.11 121.98 43.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.543 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.65 118.83 21.34 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.822 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.36 114.88 2.17 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.24 1.96 . . . . 0.0 112.222 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.19 135.5 51.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.193 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -89.61 144.2 26.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.415 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.64 -35.07 79.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.22 -49.06 29.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.8 p -93.72 -28.54 15.88 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 53.55 24.64 4.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.355 0.662 . . . . 0.0 111.615 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 101' ' ' THR . 79.1 mttt -114.15 156.12 24.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.371 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -106.47 158.34 16.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.718 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -88.57 -0.13 56.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.556 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.21 25.55 13.99 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 119.56 -0.578 . . . . 0.0 114.488 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.483 ' O ' HG23 ' A' ' 95' ' ' ILE . 53.1 p90 -146.51 150.0 34.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.337 0.569 . . . . 0.0 111.034 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.47 169.48 24.54 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.39 143.72 45.2 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.48 134.95 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.717 0.294 . . . . 0.0 111.415 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.551 ' OE1' HG21 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -108.08 125.51 51.67 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.958 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 16.3 m-85 -106.49 138.86 41.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.981 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.94 -36.65 85.07 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.73 132.96 53.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.742 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.9 64.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -42.99 84.68 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.756 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.27 -32.82 72.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.251 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.53 90.26 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.304 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.94 67.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.141 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.85 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.344 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.24 92.34 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.086 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.599 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 17.6 mt -70.94 -34.24 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.278 0.361 . . . . 0.0 111.74 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.87 -17.12 44.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -94.7 -48.68 5.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.568 ' O ' HG13 ' A' ' 137' ' ' VAL . 64.3 mtt -133.51 59.03 1.75 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.035 0.445 . . . . 0.0 112.156 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 15.8 p30 -69.4 -36.73 77.05 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.432 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.34 79.62 1.67 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.652 0.739 . . . . 0.0 109.728 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -124.96 163.25 22.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.46 119.44 32.54 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 110.619 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -128.53 130.1 46.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.903 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.57 15.23 7.74 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.04 4.34 58.72 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 116.261 -0.427 . . . . 0.0 113.22 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -126.34 155.07 42.61 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.455 0.302 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.05 131.98 35.14 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.4 pt -117.17 149.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 123.359 0.412 . . . . 0.0 111.873 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 76.9 mtt180 -123.2 133.74 54.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.593 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.818 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.12 134.02 63.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.874 0.368 . . . . 0.0 110.421 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -150.15 172.78 14.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.668 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mt -68.95 129.66 40.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.953 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.113 -179.518 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.506 0.193 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -104.37 136.52 43.79 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.5 mtp -71.82 -36.99 70.41 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.247 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.47 -36.91 85.28 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.0 t -127.74 131.62 49.67 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.352 0.407 . . . . 0.0 111.232 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.35 -179.93 38.1 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.734 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -105.36 150.88 24.83 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.388 0.275 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -123.24 128.01 49.39 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -95.54 3.39 54.18 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.757 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -115.49 132.73 56.53 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -115.41 136.88 52.63 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.803 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -85.78 -36.74 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.21 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.53 ' HA ' ' SG ' ' A' ' 16' ' ' CYS . 90.2 m-70 -64.93 -40.02 94.4 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.0 m -65.38 -39.92 92.85 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -68.69 -36.31 78.31 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 13' ' ' HIS . 26.0 p -82.79 -31.95 27.98 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.433 0.458 . . . . 0.0 112.181 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.19 140.74 29.32 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.278 0.361 . . . . 0.0 111.053 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -89.85 -45.47 9.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.207 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 tp -112.19 144.17 42.03 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.36 0.412 . . . . 0.0 110.307 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -75.42 152.95 37.91 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.465 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.54 -35.71 76.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.387 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -66.0 -41.88 90.47 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.455 0.472 . . . . 0.0 111.399 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.712 ' SD ' HG23 ' A' ' 65' ' ' VAL . 74.0 mmm -71.93 -39.88 69.13 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.916 0.486 . . . . 0.0 112.075 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -68.23 -41.27 81.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.068 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -70.18 -49.5 49.74 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.4 mt -65.13 -47.2 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.45 -31.79 70.33 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.9 p -66.19 -38.8 88.87 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.473 0.178 . . . . 0.0 111.351 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -117.64 98.62 6.47 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.447 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.61 79.08 55.5 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.324 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.01 133.12 39.72 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.007 2.471 . . . . 0.0 111.867 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -47.17 -36.16 8.26 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.869 0.868 . . . . 0.0 113.286 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 m -84.57 -41.38 16.51 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.51 -19.89 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.134 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.88 69.6 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.912 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -141.98 130.56 22.63 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.38 0.425 . . . . 0.0 111.16 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.8 t -138.96 158.49 44.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.068 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.2 m -72.96 -40.79 65.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.985 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.58 145.18 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 123.424 0.452 . . . . 0.0 110.847 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -108.64 128.24 54.67 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.934 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 t -123.09 119.32 29.95 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.497 0.498 . . . . 0.0 111.179 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.6 p -139.76 -6.71 1.29 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.485 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.19 -31.77 71.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.0 mtm105 -92.46 142.74 27.09 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.308 0.38 . . . . 0.0 111.121 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -122.74 140.76 52.54 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -42.65 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.399 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -88.3 152.49 21.91 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.324 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.55 -160.95 23.76 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.928 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.64 -32.87 7.08 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.596 -0.335 . . . . 0.0 112.824 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.2 m -67.52 -35.39 79.02 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.816 0.446 . . . . 0.0 112.178 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.3 147.84 4.78 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.366 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.89 64.31 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.5 -0.381 . . . . 0.0 113.369 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.0 t -119.85 143.64 47.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.253 0.221 . . . . 0.0 110.762 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.66 6.18 Favored Glycine 0 C--N 1.34 0.789 0 O-C-N 123.656 0.598 . . . . 0.0 113.077 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.02 -54.39 2.76 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.619 -0.324 . . . . 0.0 113.179 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.7 t -126.4 140.52 52.42 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.584 0.23 . . . . 0.0 111.143 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.38 -168.33 37.16 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.738 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.25 54.03 0.98 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.77 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.9 p -71.79 -24.14 61.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.56 -30.64 69.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.2 p -79.63 -8.28 59.1 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.455 0.472 . . . . 0.0 112.223 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.49 -42.7 15.3 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.642 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.15 134.64 38.98 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.37 0.419 . . . . 0.0 111.446 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -110.33 2.42 19.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.16 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.712 HG23 ' SD ' ' A' ' 23' ' ' MET . 26.0 t -101.86 134.97 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.686 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.06 147.23 48.02 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.381 0.426 . . . . 0.0 110.582 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.725 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.1 t80 -99.93 125.13 45.89 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.924 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.71 118.92 59.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 123.547 0.529 . . . . 0.0 110.028 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.49 149.08 18.19 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.544 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.39 23.93 7.75 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.1 mp -90.02 168.61 11.87 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.968 0.507 . . . . 0.0 110.824 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -96.4 161.82 13.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.337 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.62 -32.2 71.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.657 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -75.7 -7.65 54.86 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.917 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 72' ' ' ALA . 1.7 p -78.44 131.08 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 120.66 0.267 . . . . 0.0 110.577 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -114.84 175.47 5.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.952 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.505 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.3 m-20 -60.69 -33.65 73.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.459 0.704 . . . . 0.0 112.131 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -67.19 -40.32 86.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.584 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.56 -45.09 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tt -69.55 -37.66 77.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.428 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.549 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 30.3 t60 -68.14 -48.78 64.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.75 -21.25 62.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -34.32 23.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.266 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.433 ' C ' HD12 ' A' ' 90' ' ' ILE . 61.7 m-85 -98.09 -2.36 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 82' ' ' ALA . 3.7 tp -69.44 -31.31 2.54 Favored Pre-proline 0 CA--C 1.566 1.596 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.97 -24.18 71.87 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.93 1.753 . . . . 0.0 113.637 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -79.64 -31.22 41.53 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.563 0.345 . . . . 0.0 111.693 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.03 37.0 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.247 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.23 132.61 36.0 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.594 0.235 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 111' ' ' GLU . 4.4 mt -109.34 142.04 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.956 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.2 p -85.73 -61.59 1.72 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.901 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -151.48 158.04 43.11 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.505 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 15.1 mm -117.73 129.8 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.545 ' O ' ' HB2' ' A' ' 108' ' ' ALA . 18.7 tp60 -115.57 127.89 55.57 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.417 HG21 ' CD2' ' A' ' 104' ' ' HIS . 4.3 mp -124.75 100.66 33.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.12 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.25 119.8 6.87 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.042 1.828 . . . . 0.0 112.904 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -125.23 132.59 52.95 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.598 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -83.37 140.88 32.15 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.429 0.455 . . . . 0.0 110.676 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.62 -34.09 77.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -72.66 -48.83 35.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.068 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.7 p -95.16 -28.94 14.81 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 50.3 32.02 5.84 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.391 0.676 . . . . 0.0 111.76 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 101' ' ' THR . 85.1 mttt -115.23 150.64 35.83 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.437 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.417 ' CD2' HG21 ' A' ' 95' ' ' ILE . 13.0 t-80 -101.53 138.31 38.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.64 1.8 57.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.591 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 90.04 22.62 35.0 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.175 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -142.83 151.13 40.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.111 0.956 . . . . 0.0 111.326 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 94' ' ' GLN . . . -158.67 166.92 30.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.194 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.471 ' CE2' ' HD2' ' A' ' 67' ' ' TYR . 72.8 m-85 -111.33 139.55 46.64 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.6 p -118.84 132.38 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 123.307 0.379 . . . . 0.0 110.334 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -105.74 133.1 51.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.184 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.433 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 20.4 m-85 -115.32 140.14 49.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.315 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.31 -37.03 85.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.562 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.7 mp -106.2 141.17 37.99 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.47 -19.68 59.27 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.949 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -73.92 -49.94 22.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.263 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.562 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.3 p30 -68.95 -32.43 72.02 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.88 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.9 -43.57 83.02 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.471 0.482 . . . . 0.0 111.016 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.77 69.38 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.051 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.72 -34.94 74.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.154 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.25 82.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.803 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 15.3 mt -69.59 -33.53 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.357 0.41 . . . . 0.0 111.596 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -16.71 46.61 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -100.62 -44.17 5.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.57 ' O ' HG12 ' A' ' 137' ' ' VAL . 62.1 mtt -126.26 45.51 2.63 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.4 t-20 -63.13 -36.61 84.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.611 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 40.8 mt-10 -141.78 79.47 1.68 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.659 0.742 . . . . 0.0 109.625 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 82.0 p -125.07 166.11 16.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.274 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -91.84 120.17 32.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -127.57 129.53 47.49 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.809 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 t80 59.23 18.85 6.93 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.921 0.888 . . . . 0.0 112.31 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.51 -9.63 64.67 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -114.98 152.68 31.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.66 0.384 . . . . 0.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -76.88 137.32 39.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -121.21 156.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.52 0.513 . . . . 0.0 112.299 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 12.8 ptt85 -129.17 132.38 47.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.567 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -125.83 136.49 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.102 0.477 . . . . 0.0 111.212 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -148.41 171.15 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.29 131.04 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.507 0.194 . . . . 0.0 111.171 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.154 -179.624 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.601 0.238 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 85.7 mtp -100.79 137.29 39.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.868 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mtt -99.42 149.75 22.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.937 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -110.96 150.99 28.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.7 t -126.18 133.93 51.41 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.742 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.26 -40.18 96.48 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.993 -0.549 . . . . 0.0 113.819 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -109.61 132.9 53.71 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.514 0.197 . . . . 0.0 110.823 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -132.59 127.91 36.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.949 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.96 -32.84 73.54 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.875 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -84.93 158.54 20.53 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.345 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.47 149.04 46.24 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.47 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.46 157.29 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.664 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -65.18 -28.21 69.24 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.011 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.2 p -59.52 -36.7 76.61 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.46 -30.58 70.33 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 87.8 m -76.7 -6.25 51.38 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.34 -29.9 70.68 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -93.62 125.97 38.52 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.254 0.346 . . . . 0.0 111.044 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tp -107.76 150.77 26.57 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.696 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -71.52 159.29 34.73 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.749 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.29 -34.5 78.27 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.32 -46.89 59.56 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.667 ' SD ' HG11 ' A' ' 65' ' ' VAL . 58.5 mmm -67.31 -37.21 82.99 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.606 0.362 . . . . 0.0 111.875 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.68 -42.38 95.4 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.792 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -70.08 -40.73 74.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.8 mt -66.74 -49.89 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 123.163 0.29 . . . . 0.0 111.778 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 23' ' ' MET . 2.2 mt -69.4 -36.31 76.64 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.3 p -74.99 -25.3 58.73 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -103.06 8.86 38.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.379 0.609 . . . . 0.0 110.231 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.63 120.22 74.95 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.583 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.14 126.25 13.49 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.692 2.262 . . . . 0.0 112.737 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -49.42 -34.29 16.1 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.312 1.045 . . . . 0.0 113.242 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 81.7 p -85.82 -39.1 17.43 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.66 -32.42 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.43 0.157 . . . . 0.0 111.391 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.77 -29.0 65.09 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -159.69 152.59 21.69 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.7 p -98.61 163.13 12.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.371 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.73 -32.47 72.28 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.62 132.72 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 123.306 0.379 . . . . 0.0 110.054 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -90.92 3.55 54.29 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.992 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.9 t -99.69 126.46 45.73 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.946 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.1 t -119.42 -1.51 10.72 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.912 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -70.94 -38.05 72.88 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -71.3 -37.77 71.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -115.94 127.13 54.73 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.339 0.399 . . . . 0.0 110.963 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -46.22 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.194 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -100.68 145.66 28.15 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.766 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.95 -73.48 1.21 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.496 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.17 170.89 30.73 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.466 -0.397 . . . . 0.0 112.792 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 m -66.96 -35.01 79.01 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.922 0.489 . . . . 0.0 112.217 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.92 3.8 60.47 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.269 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.04 175.61 42.4 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 121.666 -0.302 . . . . 0.0 112.934 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.6 p -128.64 154.46 46.23 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.357 0.263 . . . . 0.0 110.994 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.16 164.74 24.79 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.702 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.56 -54.7 2.6 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.607 -0.33 . . . . 0.0 112.946 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.8 p -123.0 152.07 41.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.3 0.24 . . . . 0.0 111.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.41 -170.88 43.11 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.65 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.31 158.79 21.74 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.532 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -123.11 148.48 45.63 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 122.249 0.22 . . . . 0.0 110.995 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.68 140.49 35.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.944 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.33 -63.05 1.2 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.827 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.7 p -146.06 123.24 11.51 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.271 0.357 . . . . 0.0 111.094 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.84 143.36 50.12 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 79.0 mtt180 -79.47 -9.37 59.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.402 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.667 HG11 ' SD ' ' A' ' 23' ' ' MET . 19.3 t -101.63 129.43 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.83 155.34 38.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.015 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.72 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.0 t80 -92.67 130.39 38.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.89 116.6 34.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.345 0.403 . . . . 0.0 110.146 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.76 157.9 22.59 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.769 -0.651 . . . . 0.0 113.026 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.69 26.72 7.9 Favored Glycine 0 C--N 1.333 0.361 0 O-C-N 123.943 0.437 . . . . 0.0 112.158 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 106' ' ' GLY . 1.6 mp -89.83 160.88 16.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.991 0.424 . . . . 0.0 110.729 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -80.66 157.49 25.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 104' ' ' HIS . 44.3 mt-10 -65.94 -27.54 68.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -84.27 7.91 17.69 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.4 m -90.39 142.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -128.21 -176.24 3.74 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.344 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.04 -31.55 68.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.912 0.387 . . . . 0.0 111.523 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -68.46 -40.99 80.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.58 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.8 -47.39 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.911 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.454 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.9 tt -66.55 -38.19 86.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.683 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.52 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.8 t60 -68.17 -49.22 62.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.648 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.39 -20.33 62.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -33.86 23.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.972 0.415 . . . . 0.0 111.342 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 83.6 m-85 -102.56 1.36 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.389 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.3 tp -69.5 -31.73 2.75 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.8 Cg_exo -59.03 -23.46 68.79 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.979 1.786 . . . . 0.0 113.907 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.632 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 64.8 m-85 -77.34 -31.5 54.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.53 -160.27 33.71 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.696 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.58 134.63 34.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.71 0.404 . . . . 0.0 111.81 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.566 HG21 ' O ' ' A' ' 111' ' ' GLU . 13.0 mt -115.76 137.23 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -92.38 -59.35 2.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.285 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.42 154.69 41.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.2 mm -116.85 120.13 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.21 125.24 53.94 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.262 0.351 . . . . 0.0 111.354 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.32 109.42 21.26 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.573 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.34 126.23 18.05 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.274 1.983 . . . . 0.0 112.147 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 136.69 53.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.255 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -91.68 143.33 26.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -64.66 -34.96 79.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.14 -48.79 32.52 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.0 p -93.84 -28.48 15.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.21 24.38 2.78 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.386 0.675 . . . . 0.0 111.9 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 101' ' ' THR . 70.1 mttt -109.15 149.44 29.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.461 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 11.9 p80 -84.94 -14.36 47.86 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 67.75 -7.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.266 1.026 . . . . 0.0 113.502 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.625 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 99.25 23.73 11.01 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.29 -0.728 . . . . 0.0 114.755 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.03 152.25 40.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.794 0.797 . . . . 0.0 111.44 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.62 170.75 20.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.894 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -113.51 145.22 41.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 15.0 p -117.56 131.47 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 90' ' ' ILE . 26.4 tt0 -104.11 125.02 50.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.771 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 21.0 m-85 -112.27 143.07 43.97 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.053 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -69.38 -36.79 77.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.923 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.56 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.8 mp -105.62 139.95 39.44 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.057 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.34 -22.28 57.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.361 0.601 . . . . 0.0 109.896 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -70.02 -49.35 52.25 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.602 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.56 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -67.3 -31.92 72.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.868 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.73 90.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.85 -28.72 69.18 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.025 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.1 -35.81 71.95 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.355 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.6 85.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.062 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.58 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 25.2 mt -70.87 -37.61 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 -18.71 39.85 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -97.25 -43.57 7.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.632 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 83.1 mtp -132.09 52.02 2.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.7 t30 -63.91 -40.2 95.94 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.5 mt-10 -141.25 78.26 1.63 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.402 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.543 ' OG ' ' HE3' ' A' ' 125' ' ' MET . 51.9 p -122.04 164.03 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.642 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -91.44 118.96 31.01 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.1 tp -131.12 130.87 43.67 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.053 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 t80 62.42 15.11 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.694 0.798 . . . . 0.0 112.285 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.52 60.1 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -126.08 154.48 43.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.548 0.339 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.22 133.23 35.24 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.3 pt -116.43 153.78 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.095 0.474 . . . . 0.0 112.265 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -125.83 130.63 51.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.531 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.72 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.84 137.2 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.291 0.369 . . . . 0.0 110.483 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -148.94 171.91 15.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.59 126.29 29.28 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.448 0.299 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.139 -179.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 4' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.492 0.186 . . . . 0.0 110.918 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -104.99 137.2 43.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.82 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.8 mtm 70.85 -46.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.395 1.078 . . . . 0.0 112.612 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' O ' ' HB3' ' A' ' 1' ' ' SER . 87.2 mm-40 -108.55 144.83 35.7 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.206 0.316 . . . . 0.0 110.895 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.2 t -133.24 149.82 51.97 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.09 165.17 19.51 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.954 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -125.28 141.68 51.94 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.5 0.32 . . . . 0.0 110.146 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.4 t -127.26 126.71 43.17 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.502 0.502 . . . . 0.0 111.223 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -106.76 155.33 19.82 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.802 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -113.06 131.23 55.88 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.978 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -131.44 152.89 50.28 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.893 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.5 133.52 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.826 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -65.01 -36.74 85.38 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.233 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 m -62.27 -36.29 81.62 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.134 0.573 . . . . 0.0 112.373 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -61.45 -36.26 79.92 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.012 0.525 . . . . 0.0 111.957 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.9 m -70.68 -45.83 64.3 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 66.01 -56.91 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.339 1.056 . . . . 0.0 113.143 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -96.46 155.72 16.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.757 0.313 . . . . 0.0 111.63 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tp -90.35 151.26 21.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.445 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -68.64 150.58 47.8 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.498 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -61.53 -34.76 76.08 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.447 ' OE2' HG21 ' A' ' 65' ' ' VAL . 31.1 tt0 -65.78 -46.76 77.52 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.293 0.37 . . . . 0.0 111.574 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.555 ' SD ' ' HG3' ' A' ' 111' ' ' GLU . 94.9 mmm -69.08 -38.36 78.97 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -67.07 -43.44 82.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.122 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.15 -39.53 75.31 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.7 mt -69.91 -47.56 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 123.022 0.201 . . . . 0.0 111.53 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.3 mt -69.73 -41.32 75.44 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.9 m -72.96 -35.24 66.91 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -112.3 86.49 2.36 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.611 0.569 . . . . 0.0 110.128 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.32 117.15 59.98 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.398 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.81 129.06 17.88 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.564 2.176 . . . . 0.0 111.786 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -44.49 -35.77 2.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.285 1.034 . . . . 0.0 113.682 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -89.67 -40.71 12.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.57 -32.55 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.29 -29.89 70.96 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -159.19 127.25 5.02 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.717 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 p -126.38 153.56 44.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.1 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.1 m -97.43 -43.2 7.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.428 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.44 137.06 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 O-C-N 123.445 0.465 . . . . 0.0 109.971 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -100.86 126.62 47.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.315 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.2 t -98.99 125.96 44.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.3 p -89.45 -9.7 49.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.292 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.72 -35.38 77.08 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.759 0.424 . . . . 0.0 111.716 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -65.52 -34.24 77.8 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -109.21 136.68 48.29 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.368 0.417 . . . . 0.0 111.249 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.94 142.03 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.581 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -89.12 137.73 32.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.377 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.17 -177.15 47.23 Favored Glycine 0 C--N 1.337 0.617 0 O-C-N 123.776 0.673 . . . . 0.0 112.71 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.42 159.0 25.73 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.458 -0.401 . . . . 0.0 112.604 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.1 m -65.92 -37.17 85.36 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -142.61 -63.8 0.03 OUTLIER Glycine 0 C--N 1.339 0.715 0 O-C-N 123.457 0.473 . . . . 0.0 112.863 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.79 -176.19 48.14 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.667 -0.301 . . . . 0.0 113.288 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 m -63.72 -34.78 78.64 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.24 51.65 0.11 Allowed Glycine 0 C--N 1.339 0.747 0 O-C-N 123.427 0.454 . . . . 0.0 112.692 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.91 -48.2 4.75 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 121.646 -0.312 . . . . 0.0 112.849 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 m -65.18 -35.48 81.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.948 0.499 . . . . 0.0 112.193 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.62 -168.63 33.35 Favored Glycine 0 C--N 1.341 0.817 0 O-C-N 123.542 0.527 . . . . 0.0 112.978 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.28 -116.16 0.76 Allowed Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.576 -0.345 . . . . 0.0 112.29 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.7 m -68.8 -29.11 67.39 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 -12.91 61.7 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.1 p -70.18 -20.91 63.1 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.7 p -74.2 -25.08 59.47 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -98.2 127.11 43.97 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.407 0.442 . . . . 0.0 110.708 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -114.27 8.96 16.91 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.524 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG21 ' OE2' ' A' ' 22' ' ' GLU . 4.5 t -101.86 134.29 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.364 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.87 155.49 37.96 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.655 0.597 . . . . 0.0 111.024 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 67.1 t80 -102.32 130.85 49.15 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 108' ' ' ALA . 12.6 m -126.22 124.57 66.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 O-C-N 123.533 0.52 . . . . 0.0 110.074 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 154.58 22.16 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.1 20.68 10.21 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 123.888 0.405 . . . . 0.0 112.424 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -89.6 160.44 16.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 110.664 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -89.08 155.54 19.39 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.978 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.457 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 43.5 mt-10 -61.69 -26.21 67.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.892 0.477 . . . . 0.0 111.933 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.44 -4.34 33.06 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.1 m -90.43 142.49 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.541 0.21 . . . . 0.0 110.786 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.508 ' OD1' HG22 ' A' ' 79' ' ' VAL . 3.8 p30 -127.71 -173.84 3.03 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.744 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.18 -32.94 71.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.764 0.425 . . . . 0.0 111.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.427 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 90.8 mttt -68.9 -40.25 79.28 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.782 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.508 HG22 ' OD1' ' A' ' 76' ' ' ASP . 44.1 t -66.25 -47.91 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.191 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.449 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -67.22 -38.41 85.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.553 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 11.2 t60 -68.26 -48.7 64.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.54 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.55 -20.51 62.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.41 -34.39 23.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.934 0.397 . . . . 0.0 111.473 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.449 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.9 m-85 -100.79 -0.63 36.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.189 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.6 -31.92 2.81 Favored Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.95 -22.82 65.15 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 121.93 1.753 . . . . 0.0 113.867 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.44 -31.18 47.95 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.08 -162.69 36.43 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.656 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -82.53 134.21 35.2 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.604 0.362 . . . . 0.0 111.72 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 111' ' ' GLU . 12.1 mt -114.67 139.73 39.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.365 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -90.36 -62.9 1.36 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -146.95 153.01 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 14.5 mm -117.94 123.3 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -120.27 121.67 39.19 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.84 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mp -127.7 116.57 20.97 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.979 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.88 124.57 16.0 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.254 1.97 . . . . 0.0 112.514 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.87 134.71 49.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.036 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.18 143.31 26.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.459 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -64.59 -34.6 78.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -71.65 -48.73 45.78 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.1 p -96.04 -28.02 14.83 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 56.27 24.67 8.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.221 0.608 . . . . 0.0 111.562 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -122.21 154.71 37.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.457 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 25.0 p80 -99.49 161.62 13.51 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.293 0.371 . . . . 0.0 110.802 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -86.01 -4.8 59.25 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.487 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.25 27.96 7.04 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.311 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -148.71 149.68 31.85 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.215 0.507 . . . . 0.0 110.887 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 68' ' ' VAL . . . -155.35 163.66 39.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.345 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.466 ' CE1' ' HD1' ' A' ' 67' ' ' TYR . 90.2 m-85 -109.57 134.35 52.02 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.1 p -112.01 132.93 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.327 0.392 . . . . 0.0 110.54 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.555 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 0.2 OUTLIER -107.14 128.8 54.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.615 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -114.14 145.11 42.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.928 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.76 -37.08 76.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.589 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.9 mp -105.38 137.68 42.79 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.058 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.07 -19.75 59.85 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.172 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -71.15 -49.98 38.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.152 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.576 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.7 p30 -69.29 -31.77 70.49 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.73 90.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.99 0.516 . . . . 0.0 111.334 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.84 69.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.073 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.59 -35.16 75.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.962 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.53 -38.73 81.09 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.718 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 72.5 mt -69.78 -33.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 123.096 0.247 . . . . 0.0 111.195 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.33 -35.71 73.8 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -102.53 -36.01 8.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.465 1.284 . . . . 0.0 114.465 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.532 ' O ' HG13 ' A' ' 137' ' ' VAL . 90.9 mmm -90.74 0.43 57.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.646 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.9 t-20 -56.68 -37.01 70.26 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.747 0.248 . . . . 0.0 111.602 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -140.78 71.89 1.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.371 0.605 . . . . 0.0 109.516 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m -121.13 154.03 36.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.295 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -92.01 119.17 31.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.427 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -127.9 127.42 43.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.925 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 61.89 15.91 7.57 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.736 0.814 . . . . 0.0 112.399 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.45 -9.09 62.57 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.01 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -113.45 149.52 34.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.811 0.444 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.46 138.45 36.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.671 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.11 156.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.843 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 10.2 ptp180 -128.32 134.06 48.82 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.181 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.12 143.64 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.384 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -141.8 171.1 14.52 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.976 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tt -81.51 125.55 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.14 -179.764 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.7 p . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.363 0.125 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 99.3 mmm -100.65 136.77 39.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.695 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.8 mtt -125.06 151.92 44.99 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.021 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -116.87 150.17 38.86 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.762 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 p -123.89 123.59 40.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.56 -41.66 0.06 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.801 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -63.17 -36.4 83.51 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.7 m -74.55 -38.51 62.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.178 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -89.01 149.47 23.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.364 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -117.98 149.63 40.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -102.44 147.65 26.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.068 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -109.23 139.0 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.64 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -61.53 -41.54 97.49 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.052 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.0 p -68.84 -37.22 78.99 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -69.84 -37.24 76.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.82 0.448 . . . . 0.0 111.504 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.9 m -65.93 -33.22 75.33 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 64.32 150.1 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.876 0.87 . . . . 0.0 112.039 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -93.62 127.97 39.55 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 tp -97.24 147.34 24.21 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.7 m -62.13 152.69 32.25 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.949 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -63.83 -36.78 85.05 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -68.3 -47.22 68.2 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.294 0.371 . . . . 0.0 111.722 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.672 ' SD ' HG21 ' A' ' 65' ' ' VAL . 89.6 mmm -67.39 -39.29 85.6 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.643 0.377 . . . . 0.0 111.912 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -64.86 -41.24 95.84 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.89 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.14 -39.75 78.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mt -70.45 -48.31 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.41 0.284 . . . . 0.0 111.661 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 23' ' ' MET . 4.8 mt -69.94 -40.21 75.63 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.6 m -77.27 -33.87 55.78 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.67 6.53 43.54 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 2.1 pp -82.01 143.53 49.67 Favored Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 118.534 0.606 . . . . 0.0 111.482 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.5 129.55 15.93 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.863 2.376 . . . . 0.0 111.918 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -46.27 -33.1 3.49 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 m -92.14 -40.48 11.0 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.75 -20.56 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.232 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.5 -28.35 69.24 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.224 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -146.63 160.12 42.59 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.259 0.35 . . . . 0.0 111.692 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.4 t -133.36 166.91 21.42 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.285 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 m -77.83 138.13 38.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.283 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.62 -36.86 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.661 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -118.03 124.15 47.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.043 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 44' ' ' ARG . 1.4 m -127.36 132.09 50.25 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.4 p -77.88 -41.2 37.54 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -140.09 -22.51 0.85 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.634 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 82.7 mtt180 -56.53 -36.26 69.02 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -135.08 150.03 50.17 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.215 0.322 . . . . 0.0 111.577 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 m -131.16 153.41 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.038 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -97.06 146.42 25.03 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.164 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -179.92 -177.9 48.23 Favored Glycine 0 C--N 1.337 0.602 0 O-C-N 123.763 0.664 . . . . 0.0 112.788 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.57 46.38 0.71 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.59 -0.338 . . . . 0.0 112.618 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.6 p -71.9 -26.71 62.43 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.97 -170.13 35.55 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.007 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -137.6 -176.3 14.36 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.654 -0.308 . . . . 0.0 112.72 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -118.47 151.59 37.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.317 0.247 . . . . 0.0 111.156 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.08 41.53 4.9 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.202 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.15 -38.75 39.02 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.576 0.221 . . . . 0.0 113.443 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.3 m -64.01 -35.88 82.16 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.965 0.506 . . . . 0.0 112.357 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.7 36.1 10.85 Favored Glycine 0 C--N 1.342 0.861 0 O-C-N 123.522 0.514 . . . . 0.0 113.306 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.82 125.14 8.29 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.494 -0.384 . . . . 0.0 112.62 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.8 m -122.68 148.17 45.6 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.679 0.282 . . . . 0.0 110.949 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.55 137.87 39.31 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.149 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.3 p -109.5 4.06 21.92 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.859 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.14 -48.73 7.5 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.658 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -101.68 131.98 47.63 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.328 0.393 . . . . 0.0 111.352 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -112.73 7.75 18.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.145 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.672 HG21 ' SD ' ' A' ' 23' ' ' MET . 5.8 t -103.21 134.72 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.429 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.35 155.46 37.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.866 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 76.8 t80 -93.56 137.46 32.81 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.417 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 108' ' ' ALA . 6.7 m -132.64 123.42 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 123.598 0.561 . . . . 0.0 110.226 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.98 151.57 20.48 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.135 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.79 15.71 12.81 Favored Glycine 0 C--N 1.334 0.423 0 O-C-N 123.996 0.468 . . . . 0.0 112.57 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -88.48 164.64 15.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.766 0.317 . . . . 0.0 110.637 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -89.47 154.36 20.09 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.57 -30.34 69.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.556 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.53 1.8 13.29 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.978 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 72' ' ' ALA . 2.9 m -88.95 137.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.598 0.237 . . . . 0.0 110.769 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.561 ' OD1' HG22 ' A' ' 79' ' ' VAL . 3.4 p30 -117.49 -175.77 2.88 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -61.98 -31.16 71.49 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.693 0.397 . . . . 0.0 112.042 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -35.62 76.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.879 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.561 HG22 ' OD1' ' A' ' 76' ' ' ASP . 61.8 t -69.75 -49.03 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.437 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -66.96 -38.64 86.47 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.74 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.502 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 31.2 t-80 -68.62 -47.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.742 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.527 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.27 -20.89 63.02 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.3 -33.98 23.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.009 0.433 . . . . 0.0 111.178 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 70.0 m-85 -100.39 0.04 39.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.254 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.527 HG21 ' O ' ' A' ' 82' ' ' ALA . 4.0 tp -69.36 -31.89 2.9 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 44.8 Cg_exo -59.27 -22.93 67.48 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.879 1.719 . . . . 0.0 113.822 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.63 -31.63 36.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.92 35.49 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.798 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -83.18 137.49 34.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.718 0.407 . . . . 0.0 112.027 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 111' ' ' GLU . 6.8 mt -117.53 138.21 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.519 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.48 -62.1 1.51 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -145.09 153.13 41.09 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.1 mm -119.58 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.454 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 5.8 tp60 -114.38 135.06 54.5 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.263 0.352 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mm -121.81 101.09 42.88 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.91 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.69 124.41 14.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.214 1.943 . . . . 0.0 112.382 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.54 132.12 53.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.961 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.93 141.73 28.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -64.74 -33.56 76.26 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.97 -48.8 51.29 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.1 p -100.59 -28.62 12.77 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 53.08 29.99 8.93 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.253 0.621 . . . . 0.0 111.673 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 101' ' ' THR . 34.1 mttt -121.18 156.89 31.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.193 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -89.42 139.22 30.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.69 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -99.01 3.31 46.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.574 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 93.84 21.77 27.54 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 114.741 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -146.05 150.82 36.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.655 0.728 . . . . 0.0 111.13 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -162.33 -179.83 7.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.875 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.464 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 85.3 m-85 -119.51 151.8 37.99 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.71 132.97 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 123.325 0.391 . . . . 0.0 110.495 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.628 ' O ' HG22 ' A' ' 90' ' ' ILE . 21.1 tt0 -106.04 130.18 54.0 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.287 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.02 147.39 42.38 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.46 -37.94 71.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.456 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.594 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.6 mp -106.7 137.3 44.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.024 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.19 -19.62 60.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.253 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -70.8 -50.03 40.04 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.235 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 13.3 p30 -68.99 -31.71 70.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.7 -44.46 93.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.298 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -30.34 70.3 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.08 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.32 -34.72 75.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.845 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.25 -38.14 81.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.6 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.668 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 74.6 mt -68.79 -35.56 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.129 0.268 . . . . 0.0 111.124 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.17 -37.15 78.04 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -101.14 -35.44 9.31 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.539 ' O ' HG11 ' A' ' 137' ' ' VAL . 92.6 mmm -91.95 1.17 57.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.8 t-20 -57.16 -37.48 72.13 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -140.04 70.28 1.36 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.398 0.618 . . . . 0.0 109.523 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -122.24 157.42 31.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.217 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.88 122.32 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.04 129.46 42.03 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.879 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 62.25 15.43 7.55 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.675 0.79 . . . . 0.0 112.393 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 5.28 59.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.273 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -126.91 154.17 44.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 122.446 0.298 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.25 134.78 35.3 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.88 158.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 O-C-N 123.4 0.438 . . . . 0.0 111.92 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 4.0 ptp180 -128.24 134.31 48.96 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.401 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.566 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.28 143.57 40.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 123.198 0.311 . . . . 0.0 111.128 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -141.75 171.25 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.152 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.14 124.42 28.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.716 0.293 . . . . 0.0 110.532 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.216 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.514 0.197 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.3 mtt -104.67 137.02 43.13 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.703 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.1 mtp -115.62 142.17 47.08 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.55 0.531 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -67.26 -33.54 75.54 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.9 t -117.92 136.94 53.15 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.313 0.383 . . . . 0.0 111.147 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.16 -136.3 4.9 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.498 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -96.69 149.6 21.62 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.645 0.26 . . . . 0.0 111.087 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 p -92.74 -38.88 11.56 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.715 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -89.02 124.38 34.22 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.355 0.409 . . . . 0.0 110.759 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -64.54 -33.41 75.84 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.673 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -98.68 143.47 29.02 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.376 0.423 . . . . 0.0 111.114 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.61 -33.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.053 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -61.39 -35.4 77.4 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -61.94 -36.83 82.53 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.86 -36.97 85.04 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.7 m -89.12 -18.18 27.72 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.921 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -65.81 -23.0 66.6 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.258 0.623 . . . . 0.0 112.111 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -57.74 -37.85 74.32 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tp -108.81 140.61 42.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.701 0.286 . . . . 0.0 110.64 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 m -69.97 157.62 37.14 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.741 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 p30 -64.69 -30.58 71.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -72.18 -44.4 63.08 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.2 mtt -69.92 -37.56 75.97 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -65.13 -41.28 94.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.801 0.44 . . . . 0.0 111.655 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -70.25 -44.9 67.54 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 30.4 mt -70.05 -46.82 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.76 -37.71 79.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.1 m -67.7 -39.57 84.38 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -133.36 105.38 6.92 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.416 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 1.1 mp -107.29 140.99 22.01 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.072 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.46 133.38 45.64 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.225 1.95 . . . . 0.0 111.783 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -42.27 -34.39 0.77 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.0 -39.58 9.28 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.87 -26.32 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.04 -28.49 69.52 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -153.35 162.35 41.37 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.8 p -111.17 159.65 17.67 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.437 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.3 m -129.01 163.49 25.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.76 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -121.67 152.12 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.985 0.422 . . . . 0.0 111.916 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.523 ' ND2' ' HD1' ' A' ' 45' ' ' HIS . 23.0 t30 -103.38 151.93 22.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.605 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.4 t -93.67 138.41 31.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.873 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.3 m -63.79 -38.99 93.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.118 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -66.62 -40.47 88.81 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.314 0.384 . . . . 0.0 111.624 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -72.36 -31.22 65.43 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.426 0.454 . . . . 0.0 112.098 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.523 ' HD1' ' ND2' ' A' ' 40' ' ' ASN . 6.5 t60 -60.97 -37.58 82.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.198 0.599 . . . . 0.0 112.385 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.27 -44.15 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 122.799 0.439 . . . . 0.0 111.781 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -93.19 124.15 36.97 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.282 0.364 . . . . 0.0 111.426 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.15 -164.64 38.76 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.246 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.15 104.44 0.24 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.6 p -70.44 -27.57 64.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.72 -160.92 30.47 Favored Glycine 0 C--N 1.34 0.797 0 O-C-N 123.371 0.419 . . . . 0.0 112.919 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.48 44.17 0.56 Allowed Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.831 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.7 m -65.38 -33.04 75.02 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.16 43.01 4.8 Favored Glycine 0 C--N 1.341 0.853 0 O-C-N 123.438 0.461 . . . . 0.0 112.801 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.3 -28.63 72.59 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 114.061 0.384 . . . . 0.0 114.061 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 p -105.21 152.87 22.32 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.63 0.252 . . . . 0.0 111.353 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.23 -174.59 35.78 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.57 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.51 -173.11 40.2 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.374 -0.441 . . . . 0.0 112.847 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.2 m -118.77 145.9 45.22 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.294 0.238 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.56 151.76 29.66 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.377 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.1 p -88.04 163.28 16.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.906 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.9 p -72.21 117.47 13.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.814 0.34 . . . . 0.0 111.703 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -132.02 143.49 50.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.679 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 74.8 mtt85 -87.35 -3.38 59.03 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.032 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.79 129.18 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.32 156.87 34.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.811 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.768 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 38.8 t80 -92.91 131.48 37.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.791 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 108' ' ' ALA . 1.5 m -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.643 0.589 . . . . 0.0 109.565 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -137.24 162.06 25.3 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.595 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.0 32.92 6.85 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.601 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.3 mp -91.08 164.86 13.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.051 0.54 . . . . 0.0 111.501 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.579 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -84.73 163.3 19.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.643 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.94 -36.35 77.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.803 0.441 . . . . 0.0 112.093 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.66 -10.77 59.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.205 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -74.31 140.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.703 0.287 . . . . 0.0 111.632 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.548 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -126.78 179.09 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.314 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.583 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 2.1 t70 -62.5 -35.72 80.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 112.675 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -65.26 -35.32 80.66 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.106 0.479 . . . . 0.0 111.013 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.548 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -66.69 -39.65 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.707 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -67.84 -37.49 81.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.283 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.536 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 17.4 t60 -68.36 -49.65 58.73 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.342 0.401 . . . . 0.0 111.492 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.535 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.76 -20.93 62.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.05 -34.44 22.28 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.909 0.385 . . . . 0.0 111.351 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' C ' HD12 ' A' ' 90' ' ' ILE . 70.9 m-85 -98.61 -1.38 41.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.163 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.04 -31.89 3.05 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.0 Cg_exo -59.48 -23.86 72.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.953 1.769 . . . . 0.0 113.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -78.28 -31.39 48.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.5 -162.45 36.22 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.501 0.501 . . . . 0.0 112.761 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -81.77 136.91 35.41 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.684 0.393 . . . . 0.0 111.723 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 111' ' ' GLU . 11.1 mt -115.79 139.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.703 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -92.94 -60.76 1.73 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.462 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -145.96 153.1 40.42 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.583 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 16.6 mm -120.01 119.33 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -118.57 129.28 55.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.44 HG21 ' O ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -127.92 114.61 20.51 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.729 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.78 116.49 3.29 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.216 1.944 . . . . 0.0 112.449 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.03 135.82 51.35 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.48 ' HB2' ' OG1' ' A' ' 101' ' ' THR . 9.9 m-20 -92.91 146.41 23.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.298 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.51 -36.24 83.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -77.03 -49.06 16.23 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.932 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 98' ' ' ASP . 33.5 p -88.95 -28.58 20.17 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 49.81 25.3 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.607 0.763 . . . . 0.0 112.242 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 101' ' ' THR . 65.4 mttt -103.8 146.08 29.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.734 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -87.89 -15.84 35.59 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.407 0.442 . . . . 0.0 112.104 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 70.42 -6.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.251 1.02 . . . . 0.0 112.991 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.601 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 95.13 20.28 28.39 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-O 119.138 -0.812 . . . . 0.0 114.98 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.44 ' O ' HG21 ' A' ' 95' ' ' ILE . 53.6 p90 -144.44 150.02 36.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.044 0.922 . . . . 0.0 111.68 178.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.516 ' O ' HG22 ' A' ' 68' ' ' VAL . . . -156.53 174.0 16.09 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.793 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.0 151.12 41.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.57 134.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 111.188 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 90' ' ' ILE . 21.8 tt0 -108.5 131.0 55.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.937 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 62.8 m-85 -116.59 149.16 40.13 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.417 0.448 . . . . 0.0 111.441 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.58 -38.05 70.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.562 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.572 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.7 mp -104.58 139.27 39.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.179 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.05 59.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.527 0.68 . . . . 0.0 109.186 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.94 -50.02 39.15 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.63 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.572 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -68.76 -31.96 71.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.999 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.32 -45.41 88.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.755 0.422 . . . . 0.0 111.02 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.34 70.03 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.48 68.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.015 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -38.75 84.62 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.85 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.605 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 9.6 mt -70.27 -40.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.242 0.339 . . . . 0.0 111.692 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.41 -44.57 11.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.593 ' O ' HG12 ' A' ' 137' ' ' VAL . 87.7 mtp -129.27 50.02 2.19 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 8.8 t-20 -64.36 -37.86 89.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.736 0.303 . . . . 0.0 110.887 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.1 77.63 1.59 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.712 0.767 . . . . 0.0 109.705 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.3 m -122.81 162.73 21.57 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.211 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -89.68 118.33 29.21 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.979 0.418 . . . . 0.0 110.74 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -122.14 128.44 51.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.897 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 56.81 20.51 5.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.073 0.949 . . . . 0.0 112.754 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.03 4.78 58.58 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.875 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -127.75 154.0 45.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.77 0.285 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.96 132.14 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.8 pt -119.55 153.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.595 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 68.8 mtt180 -124.08 134.82 53.3 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.24 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -129.1 135.56 61.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.191 0.52 . . . . 0.0 110.96 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -149.72 174.59 12.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 130.39 40.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.631 0.253 . . . . 0.0 111.245 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.042 -179.541 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.55 0.214 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 74.5 mtm -101.9 136.88 40.99 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.807 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.3 mmm -108.79 138.03 45.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.484 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -122.56 148.81 44.77 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.488 0.493 . . . . 0.0 111.157 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 73.5 m -89.81 -39.01 13.37 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.38 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.64 -178.09 39.51 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.525 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -107.51 131.39 54.38 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.56 0.219 . . . . 0.0 111.027 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.1 m -128.5 -21.83 3.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.516 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -63.48 -35.33 80.08 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.23 0.612 . . . . 0.0 112.579 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -114.24 136.12 53.31 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.363 0.414 . . . . 0.0 110.979 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -116.43 142.54 46.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.771 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -133.6 -37.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.607 0.567 . . . . 0.0 111.746 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -63.37 -33.34 75.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.5 m -61.25 -38.79 87.93 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -67.48 -37.17 82.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.901 0.48 . . . . 0.0 112.163 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.5 m -79.01 -32.04 44.94 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -78.01 132.09 37.65 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -79.45 -30.37 42.17 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.149 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.57 156.97 20.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.487 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.3 p -73.06 158.21 35.84 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.909 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.37 -30.76 71.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.89 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.579 ' OE2' HG22 ' A' ' 65' ' ' VAL . 31.6 tt0 -62.41 -49.43 75.5 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.662 0.385 . . . . 0.0 111.893 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.577 ' SD ' ' HG3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -70.75 -38.89 73.52 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -68.08 -41.79 81.36 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.002 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.15 -39.9 75.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 51.9 mt -67.25 -45.51 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.016 0.198 . . . . 0.0 111.183 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.523 ' O ' HD11 ' A' ' 30' ' ' LEU . 12.1 mt -69.41 -38.6 78.0 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.9 p -76.5 -28.65 56.52 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -112.76 77.83 1.08 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.213 0.53 . . . . 0.0 110.944 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 14.7 mt -117.78 116.86 36.18 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.932 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.93 125.71 12.93 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.423 2.082 . . . . 0.0 111.404 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -45.13 -34.29 2.58 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.536 ' HA ' ' OG1' ' A' ' 37' ' ' THR . 32.6 m -87.88 -43.83 11.51 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.7 -25.67 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.26 0.224 . . . . 0.0 111.429 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.18 -31.94 73.08 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -161.87 -20.96 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.536 ' OG1' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.09 119.74 25.33 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.917 0.389 . . . . 0.0 111.941 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.1 m -98.11 -39.0 9.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.278 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 t -119.41 141.16 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.923 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 66.85 153.29 0.08 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.959 0.904 . . . . 0.0 112.086 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.7 t -117.45 133.73 55.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.872 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 m -66.29 -37.54 85.66 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.911 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -92.3 137.23 32.54 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.359 0.412 . . . . 0.0 111.17 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -68.05 -36.35 79.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.156 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -116.08 130.24 56.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.51 -46.97 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.842 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.53 121.48 34.98 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.549 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.24 -49.54 2.03 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.558 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.45 -110.98 0.89 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 t -115.57 138.97 50.52 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.599 0.235 . . . . 0.0 110.491 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -108.4 128.26 9.01 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.778 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.75 -68.05 0.93 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.7 m -119.55 147.89 43.95 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.691 0.289 . . . . 0.0 110.63 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.92 -178.75 47.55 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 115.997 -0.547 . . . . 0.0 113.073 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.25 -51.77 3.43 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.616 -0.326 . . . . 0.0 112.883 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -122.14 146.58 47.09 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 123.652 0.266 . . . . 0.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.82 161.74 16.72 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.624 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.9 -169.06 41.97 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.656 -0.306 . . . . 0.0 112.891 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 m -122.62 143.4 49.78 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.54 0.2 . . . . 0.0 110.804 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.74 133.42 52.16 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.2 p -84.68 -33.84 23.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.988 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -126.88 157.21 39.96 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.52 0.513 . . . . 0.0 111.315 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.553 ' NZ ' HD13 ' A' ' 139' ' ' LEU . 23.6 mttm -121.84 120.77 35.53 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.567 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -132.63 -40.36 0.97 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.789 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.579 HG22 ' OE2' ' A' ' 22' ' ' GLU . 9.4 t -103.59 125.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.29 158.42 32.59 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.078 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.878 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 36.7 t80 -96.66 123.75 40.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.88 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.47 114.56 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -133.78 160.19 23.96 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.556 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.3 33.5 6.22 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.633 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.7 mp -92.13 165.78 12.98 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 124.016 0.48 . . . . 0.0 111.374 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.576 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -87.9 161.16 17.63 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.06 -33.11 73.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 0.0 111.949 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.78 4.45 25.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.804 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -86.16 139.26 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.859 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -124.68 174.28 7.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' OD2' HD11 ' A' ' 95' ' ' ILE . 7.0 m-20 -61.26 -33.19 73.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.234 0.613 . . . . 0.0 112.23 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -66.0 -39.5 90.33 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.84 -42.28 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.729 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.1 tt -67.98 -37.38 81.45 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.665 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.52 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 7.0 t60 -68.6 -47.86 65.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.476 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.557 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.49 -21.36 62.77 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.08 22.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.147 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 62.3 m-85 -98.14 -1.03 43.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.135 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 82' ' ' ALA . 3.9 tp -70.16 -31.78 2.5 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.3 Cg_exo -59.56 -24.11 73.8 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.942 1.761 . . . . 0.0 113.785 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.514 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 52.1 m-85 -79.05 -31.24 44.46 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.244 0.34 . . . . 0.0 111.902 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.29 -164.83 38.33 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.455 0.472 . . . . 0.0 112.764 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -82.38 136.09 35.04 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.671 0.388 . . . . 0.0 111.638 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.52 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 4.8 mt -116.1 141.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.558 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 4.9 p -88.85 -64.15 1.19 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 123.521 0.513 . . . . 0.0 112.11 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -149.48 157.4 43.26 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.8 mm -116.56 122.85 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.74 132.14 54.89 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 107' ' ' PHE . 1.3 mp -128.13 118.09 20.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.456 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.05 117.13 4.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.938 1.759 . . . . 0.0 112.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.7 mt -117.39 147.29 42.79 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.545 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -86.69 143.81 27.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.523 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -64.82 -32.0 73.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.1 -44.57 68.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.8 p -112.83 -26.47 8.54 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 56.5 21.99 6.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.648 0.779 . . . . 0.0 112.253 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -108.22 147.73 30.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.392 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -86.9 152.38 22.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -89.32 2.32 54.53 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.791 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.633 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 99.39 21.45 14.93 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.466 -0.63 . . . . 0.0 114.165 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 95' ' ' ILE . 44.7 p90 -143.11 149.3 37.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.454 0.627 . . . . 0.0 111.481 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.42 172.09 18.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.65 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -120.01 149.08 42.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.74 135.5 62.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.224 0.328 . . . . 0.0 111.216 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.577 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -109.42 130.79 55.48 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.438 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.449 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 64.9 m-85 -112.26 142.37 44.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.77 -37.78 85.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.677 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.574 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.1 mp -103.58 136.02 44.09 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.597 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -71.4 -23.63 61.91 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.3 0.571 . . . . 0.0 110.399 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.07 -49.58 49.59 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.283 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.574 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.4 p30 -68.35 -32.64 72.88 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.96 -44.88 79.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.521 0.328 . . . . 0.0 111.199 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.5 -30.19 71.35 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.821 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.549 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -70.44 -32.83 70.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.623 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.41 -38.69 88.03 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.376 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 41.3 mt -70.74 -36.6 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.354 0.409 . . . . 0.0 111.749 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.3 p30 -82.82 -16.08 49.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -98.27 -45.23 6.26 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.548 ' O ' HG11 ' A' ' 137' ' ' VAL . 88.9 mtp -130.6 51.87 2.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.598 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 16.7 p30 -67.03 -36.14 81.43 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.502 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.93 80.16 1.7 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.777 0.799 . . . . 0.0 109.468 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.0 p -126.4 165.61 18.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.398 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.33 120.62 33.04 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -125.82 128.97 48.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CD2' HG23 ' A' ' 75' ' ' VAL . 0.4 OUTLIER 55.84 21.69 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.06 0.944 . . . . 0.0 112.813 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.66 4.45 59.2 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 116.186 -0.461 . . . . 0.0 114.059 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -128.63 154.7 45.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.885 0.343 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.5 m -79.33 132.08 36.32 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -118.4 153.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.433 0.458 . . . . 0.0 112.132 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 86.7 mtt180 -125.47 134.25 52.13 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.493 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.878 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -127.42 133.36 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 110.361 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -147.38 172.75 13.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.553 HD13 ' NZ ' ' A' ' 63' ' ' LYS . 4.2 tt -67.85 125.52 26.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.693 0.397 . . . . 0.0 110.476 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.114 -179.751 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.455 0.169 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 74.2 mtm -103.37 137.04 42.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.5 mmm -118.07 151.95 36.52 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.706 0.629 . . . . 0.0 110.783 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -106.67 139.27 41.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.006 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.7 t -132.03 134.98 46.17 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.73 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.78 39.59 2.84 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.87 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.61 144.27 28.09 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.317 0.247 . . . . 0.0 111.015 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.0 m -74.86 -37.29 62.25 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.982 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 57.0 46.41 19.42 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.751 0.82 . . . . 0.0 112.077 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -123.3 140.83 52.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.015 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 48.83 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.304 1.042 . . . . 0.0 112.866 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 m -126.71 0.72 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.052 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -64.81 -43.63 92.51 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.908 0.483 . . . . 0.0 112.012 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.5 p -68.78 -36.98 78.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -69.11 -39.88 78.68 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.878 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -74.98 -44.4 48.48 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -130.59 137.34 49.61 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.212 0.32 . . . . 0.0 111.397 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -142.12 103.63 4.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.787 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tp -118.72 143.61 46.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.661 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.7 p -73.17 160.63 31.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.706 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.78 -37.27 86.01 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -70.25 -42.47 72.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.654 ' SD ' HG23 ' A' ' 65' ' ' VAL . 31.0 mmm -66.74 -38.17 86.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -68.67 -43.58 75.88 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -70.88 -41.92 70.7 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.0 mt -70.3 -47.32 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 23' ' ' MET . 11.3 mt -69.32 -41.37 76.79 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -70.02 -36.03 74.76 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.742 0.306 . . . . 0.0 111.187 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.551 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 74.9 m-20 -104.66 64.28 0.74 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -104.82 93.22 5.94 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.523 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 29' ' ' ASN . 12.2 Cg_exo -70.33 131.0 19.56 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.91 2.407 . . . . 0.0 111.612 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -51.51 -32.48 27.83 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.9 p -86.56 -38.0 17.6 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.8 t -68.15 -29.9 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.596 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.11 71.19 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -152.51 130.56 11.85 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.193 0.308 . . . . 0.0 111.192 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 p -124.8 155.19 39.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.0 m -97.7 -41.05 8.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.621 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -120.04 137.65 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 O-C-N 123.365 0.415 . . . . 0.0 110.115 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -102.61 149.04 24.82 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.76 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.57 ' HG ' ' H ' ' A' ' 43' ' ' GLU . 26.7 t -121.55 134.88 55.04 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.977 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.4 t -97.96 -0.9 43.95 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.96 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.57 ' H ' ' HG ' ' A' ' 41' ' ' CYS . 27.9 tt0 -98.36 138.48 35.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.201 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -124.18 148.4 47.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -126.42 144.98 50.65 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.628 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -112.46 132.63 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.046 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -109.9 155.42 21.74 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.23 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.23 -177.45 43.3 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.965 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.91 -62.25 1.09 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.566 -0.35 . . . . 0.0 112.786 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.9 m -120.86 148.33 44.18 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.618 0.246 . . . . 0.0 111.072 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.83 -53.33 1.2 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.563 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.26 -178.02 43.86 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.52 -0.372 . . . . 0.0 112.818 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.0 p -70.7 -29.44 65.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 179.01 -178.45 48.8 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 123.467 0.479 . . . . 0.0 112.652 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.64 -55.29 2.46 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.638 -0.315 . . . . 0.0 113.127 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.0 p -70.72 -30.44 66.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.1 -176.73 42.21 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.411 0.445 . . . . 0.0 113.041 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.43 37.39 10.89 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 120.095 -0.281 . . . . 0.0 113.526 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.1 p -118.23 148.37 42.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.631 0.253 . . . . 0.0 111.182 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.35 -21.38 49.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.609 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.6 p -74.08 -20.7 60.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.0 p -82.63 -8.91 59.58 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -93.25 128.32 39.18 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.117 0.26 . . . . 0.0 110.978 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -110.31 2.15 18.96 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.598 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.654 HG23 ' SD ' ' A' ' 23' ' ' MET . 45.9 t -99.38 135.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.08 151.25 44.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 110.909 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.665 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 66.0 t80 -94.45 129.46 41.2 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 m -126.21 121.46 59.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 123.468 0.48 . . . . 0.0 110.202 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.35 153.0 20.59 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.645 0.591 . . . . 0.0 112.961 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.8 10.38 Favored Glycine 0 C--N 1.334 0.441 0 O-C-N 124.015 0.479 . . . . 0.0 112.442 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -87.74 161.44 17.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.798 0.333 . . . . 0.0 110.672 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -89.5 158.22 17.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.228 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 44.6 mt-10 -64.32 -27.76 69.25 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.648 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.92 -2.54 34.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.887 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 72' ' ' ALA . 1.7 m -86.11 138.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 120.689 0.28 . . . . 0.0 110.738 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.3 m-20 -117.94 178.56 4.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.598 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.89 -28.82 69.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.566 0.346 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.82 -40.71 79.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.49 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.429 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 5.2 t -65.88 -45.81 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.087 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -65.91 -39.21 90.38 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.549 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 26.9 t-80 -68.31 -48.49 64.78 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.763 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.28 62.99 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.42 -35.41 23.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 82.2 m-85 -100.25 -0.43 38.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.159 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.8 tp -68.07 -32.59 4.17 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.69 -22.87 69.34 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.773 1.649 . . . . 0.0 113.89 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -81.18 -31.46 34.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.35 -167.86 40.05 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.098 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.06 131.79 34.77 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.684 0.394 . . . . 0.0 111.183 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 111' ' ' GLU . 9.2 mt -112.98 135.88 51.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.388 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -91.3 -58.73 2.35 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.544 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -146.57 152.97 39.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.4 mm -118.23 115.14 47.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -114.53 122.77 47.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.035 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.43 123.23 23.11 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.602 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.15 127.6 18.73 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.226 1.951 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.64 135.6 47.06 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -94.01 146.33 24.02 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -64.6 -36.03 82.91 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.55 -49.2 19.35 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.5 p -92.57 -28.58 16.66 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 52.46 22.99 2.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.265 0.626 . . . . 0.0 111.885 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 101' ' ' THR . 66.2 mttt -107.44 148.48 29.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.67 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.557 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 21.8 p80 -93.0 -9.39 39.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.016 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 71.61 -18.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.359 1.063 . . . . 0.0 113.063 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 111.9 26.07 4.56 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 119.507 -0.607 . . . . 0.0 114.551 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -147.5 145.58 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.604 0.702 . . . . 0.0 111.213 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.58 168.26 26.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.949 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -113.29 140.93 47.58 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 7.8 p -116.22 135.22 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 90' ' ' ILE . 19.0 tt0 -104.79 125.59 51.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.261 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -111.52 138.38 48.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.088 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -66.35 -37.0 84.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.65 134.19 52.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.94 63.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.45 -49.54 63.2 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.08 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -68.67 -32.47 72.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.94 -44.09 97.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.534 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.07 68.82 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.252 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.94 73.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.243 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.82 -37.95 87.62 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.717 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.659 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 64.8 mt -69.99 -33.89 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.022 0.201 . . . . 0.0 111.125 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.44 -35.9 80.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -102.58 -35.03 8.87 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.565 ' O ' HG13 ' A' ' 137' ' ' VAL . 95.6 mmm -92.07 0.57 57.47 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.659 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.4 t-20 -56.49 -37.37 70.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.827 0.285 . . . . 0.0 111.728 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -141.9 73.49 1.41 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.345 0.593 . . . . 0.0 109.504 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.2 p -125.41 157.2 37.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.25 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -94.99 120.05 34.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.612 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.11 129.83 44.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.985 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.9 t80 62.64 15.1 7.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.747 0.819 . . . . 0.0 112.366 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.62 4.61 58.04 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.402 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -127.58 154.11 45.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.741 0.271 . . . . 0.0 110.999 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -83.0 134.62 35.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 pt -119.8 156.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 123.421 0.451 . . . . 0.0 112.113 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 31.7 ptt180 -126.06 132.94 51.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.211 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.665 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -128.98 140.19 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.062 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -144.31 170.26 16.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 119.81 15.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.153 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.086 -179.726 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.457 0.17 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.8 mmm -103.55 137.02 42.21 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.814 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.7 mtt -101.09 138.78 37.67 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.653 0.596 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 57.5 41.41 26.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.759 0.823 . . . . 0.0 111.992 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.0 t -133.07 138.44 46.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.963 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.7 42.83 7.1 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.293 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -90.9 133.64 35.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.447 0.299 . . . . 0.0 110.5 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 t -127.96 141.4 51.54 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.056 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -95.9 146.16 24.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.762 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -119.0 150.09 40.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.071 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.81 -8.95 59.84 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.225 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.98 -33.56 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -63.43 -42.29 98.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 m -66.45 -37.18 84.59 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.1 tptp -64.29 -35.84 82.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.062 0.545 . . . . 0.0 111.975 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.65 -36.25 80.39 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.8 147.46 25.45 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.363 0.414 . . . . 0.0 111.016 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -118.93 136.08 54.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.218 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.8 tp -106.77 150.88 25.86 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.454 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -70.25 153.84 42.61 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.565 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -61.24 -37.73 84.11 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.28 -41.86 76.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.478 ' O ' HD11 ' A' ' 27' ' ' LEU . 8.3 mtt -70.39 -38.46 74.7 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -65.79 -43.09 89.77 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.712 0.405 . . . . 0.0 112.079 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -70.97 -46.67 61.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.423 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 31.1 mt -69.93 -45.48 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 23' ' ' MET . 8.2 mt -68.86 -35.52 77.02 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -69.58 -36.53 76.34 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.56 0.219 . . . . 0.0 111.587 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.73 106.54 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.244 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 4.4 mt -103.05 121.7 48.07 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.403 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.72 129.37 20.88 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.533 2.155 . . . . 0.0 111.568 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -44.78 -35.33 2.67 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.6 p -89.53 -40.88 12.36 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.26 -33.63 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.295 0.238 . . . . 0.0 111.373 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.6 -28.2 68.96 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.449 0.468 . . . . 0.0 112.014 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -161.03 128.87 4.31 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.226 0.329 . . . . 0.0 110.771 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.9 p -126.93 157.55 39.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.8 m -87.09 -44.04 11.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.585 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.1 t -125.78 132.58 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 123.41 0.443 . . . . 0.0 109.925 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -118.08 134.81 54.65 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.876 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.7 t -129.61 130.6 45.84 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -132.52 -43.24 0.93 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.359 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -107.95 141.21 39.93 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.415 0.447 . . . . 0.0 110.122 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -120.31 136.39 54.7 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.037 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -76.38 -32.66 58.71 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.63 141.44 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 123.233 0.333 . . . . 0.0 110.912 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -94.79 148.41 22.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.19 48.21 0.01 OUTLIER Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.802 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.08 178.55 48.21 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.484 -0.389 . . . . 0.0 112.723 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.0 p -130.72 153.74 48.68 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.325 0.25 . . . . 0.0 111.06 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.71 179.97 43.2 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.879 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.63 29.74 31.67 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.701 -0.285 . . . . 0.0 113.444 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.5 m -64.12 -36.18 83.2 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 163.82 -118.82 0.84 Allowed Glycine 0 C--N 1.339 0.699 0 O-C-N 123.493 0.495 . . . . 0.0 112.46 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.68 -36.2 92.03 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 113.766 0.266 . . . . 0.0 113.766 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -120.24 148.22 43.97 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 122.313 0.245 . . . . 0.0 110.954 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.37 -178.13 35.98 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.636 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.16 34.67 4.48 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.357 -0.449 . . . . 0.0 113.106 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.6 p -124.87 150.16 46.76 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.508 0.194 . . . . 0.0 111.175 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.55 151.23 31.86 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.23 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.0 p -115.12 162.16 17.41 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.7 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 p -79.09 91.39 4.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.147 0.499 . . . . 0.0 111.348 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.21 143.23 50.43 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 76.1 mtt85 -90.54 -0.44 57.67 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.152 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.551 HG21 ' OE1' ' A' ' 111' ' ' GLU . 6.0 t -106.5 131.3 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.45 156.95 34.55 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.459 0.475 . . . . 0.0 110.837 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.841 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 48.0 t80 -98.71 134.8 41.12 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.704 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.11 114.82 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.9 150.52 19.37 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.656 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.62 36.77 3.67 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 106' ' ' GLY . 3.3 mp -94.4 164.73 12.89 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.004 0.431 . . . . 0.0 111.227 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.624 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -88.7 164.44 15.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.499 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.38 -32.79 72.04 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.14 5.73 21.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.24 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.624 HG11 ' O ' ' A' ' 72' ' ' ALA . 3.9 p -86.41 136.07 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 120.648 0.261 . . . . 0.0 110.854 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -122.35 174.58 6.92 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.467 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.0 m-20 -61.65 -32.53 72.69 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.146 0.578 . . . . 0.0 112.045 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -67.37 -40.25 85.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.684 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.2 -43.08 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.967 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.425 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -68.46 -36.47 79.05 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.809 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.517 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 6.4 t60 -68.56 -49.51 58.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.595 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -71.0 -20.91 62.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.64 -34.35 23.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.209 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 64.9 m-85 -98.14 -2.46 39.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.102 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.548 HG21 ' O ' ' A' ' 82' ' ' ALA . 3.4 tp -67.13 -32.35 4.66 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.5 -23.54 71.21 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 121.782 1.655 . . . . 0.0 113.795 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.505 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 45.0 m-85 -80.3 -31.62 38.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.23 -168.05 40.94 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 123.467 0.48 . . . . 0.0 112.738 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -84.88 133.19 34.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.566 0.347 . . . . 0.0 111.148 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.3 mt -114.08 138.9 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.643 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.459 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.1 p -89.89 -60.31 1.97 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.951 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -149.06 159.22 44.43 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.45 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 17.7 mm -117.93 126.98 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -121.01 126.96 51.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -128.13 115.88 20.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.698 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.45 126.87 22.67 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.284 1.989 . . . . 0.0 112.623 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -127.53 135.09 49.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.173 -179.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -91.32 144.17 25.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -34.9 79.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -71.21 -48.63 50.33 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 p -98.7 -27.69 13.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' O ' HD11 ' A' ' 97' ' ' LEU . 51.4 mt-10 57.18 22.84 7.96 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.29 0.636 . . . . 0.0 111.674 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -121.32 155.44 34.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.292 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -101.32 160.85 14.07 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.236 0.335 . . . . 0.0 110.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.409 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 77.9 mtt180 -88.55 2.95 52.03 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.197 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.638 ' O ' HD13 ' A' ' 71' ' ' LEU . . . 96.34 27.13 10.23 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.326 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.475 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.4 p90 -143.6 148.98 36.68 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.372 0.586 . . . . 0.0 111.127 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.54 169.5 22.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -117.3 144.08 45.25 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.99 134.53 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.211 0.319 . . . . 0.0 111.01 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.551 ' OE1' HG21 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -106.53 128.49 54.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.32 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.503 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 13.6 m-85 -109.25 137.16 47.55 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.04 -35.82 82.39 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.54 134.26 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.82 -26.42 65.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.31 -44.1 84.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.873 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -68.49 -33.06 73.5 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.58 -46.16 91.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.28 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.29 -28.79 66.59 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.314 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.88 72.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.507 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.01 88.78 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.223 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.597 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 12.8 mt -70.73 -33.65 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 123.252 0.345 . . . . 0.0 111.875 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.13 -17.31 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -101.22 -43.03 6.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.598 ' O ' HG13 ' A' ' 137' ' ' VAL . 84.7 mtp -126.24 47.41 2.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 19.0 p-10 -66.29 -33.92 76.83 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.328 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.1 mt-10 -143.06 77.47 1.57 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.733 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.6 m -123.56 162.57 22.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.179 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.32 119.7 30.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.87 0.367 . . . . 0.0 110.77 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.8 129.63 48.7 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.003 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 57.22 20.59 5.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 112.693 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.99 3.99 60.3 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.893 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -127.66 155.08 44.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.686 0.243 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.0 131.25 35.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -116.83 151.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 74.6 mtt180 -122.72 134.3 54.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -128.16 133.78 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.459 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -147.13 172.67 13.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.665 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.506 ' N ' HD21 ' A' ' 139' ' ' LEU . 1.9 mm? -67.9 127.42 32.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.704 0.402 . . . . 0.0 110.66 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.128 -179.651 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 N--CA 1.487 1.406 0 N-CA-C 111.274 0.101 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.5 mmm -100.98 136.87 40.14 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.447 0.467 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.3 mtp -122.39 155.16 36.62 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -106.71 149.97 26.75 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.929 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.7 m -71.38 -36.66 71.51 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.325 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.74 -169.96 31.74 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 116.201 -0.454 . . . . 0.0 113.12 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -32.12 73.63 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t -91.27 130.1 37.18 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.336 0.397 . . . . 0.0 111.461 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -85.59 142.68 28.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.411 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -93.67 1.78 56.5 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.434 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -95.36 140.48 30.18 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.218 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 m -131.3 149.39 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.111 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -65.5 -28.66 69.35 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -59.09 -37.38 77.0 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 86.6 mttt -63.67 -36.15 82.88 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.3 m -72.54 -34.69 67.71 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -66.46 -26.84 67.39 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.14 0.576 . . . . 0.0 112.214 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 15' ' ' LYS . 85.7 m-20 -57.56 -36.71 72.04 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.58 152.41 20.46 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.336 0.398 . . . . 0.0 111.38 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -90.81 157.76 17.2 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.035 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.59 -35.65 76.62 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.85 -45.71 60.47 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.418 ' HE2' ' OE1' ' A' ' 111' ' ' GLU . 3.9 tpp -65.96 -37.91 87.2 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.711 0.404 . . . . 0.0 111.61 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.83 -40.96 92.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.807 0.443 . . . . 0.0 111.534 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.13 -38.59 78.92 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.01 -51.69 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 123.299 0.374 . . . . 0.0 111.562 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.9 -39.69 76.06 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.7 m -68.16 -36.1 79.1 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 120.6 0.238 . . . . 0.0 111.524 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.584 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 82.9 m-20 -105.55 54.35 0.7 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -98.89 98.29 6.08 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.691 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 29' ' ' ASN . 9.6 Cg_exo -72.0 130.27 16.42 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.823 2.349 . . . . 0.0 111.704 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -50.86 -34.0 26.25 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.5 m -82.81 -40.73 19.99 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.61 -32.04 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.489 0.316 . . . . 0.0 111.78 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.76 -31.07 71.84 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -151.83 126.54 9.56 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.207 0.317 . . . . 0.0 111.16 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 p -127.66 154.21 45.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.169 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.4 m -130.72 -44.63 1.08 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.174 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -121.93 143.61 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.87 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.06 151.4 23.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.172 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.403 ' SG ' ' HG3' ' A' ' 43' ' ' GLU . 17.7 t -120.75 137.05 54.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.153 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 p -100.89 57.07 0.87 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.663 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 51.0 mt-10 -62.44 139.33 58.57 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.956 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -69.73 -33.88 73.08 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.465 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -105.54 137.21 43.76 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.312 0.382 . . . . 0.0 111.13 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 m -130.84 154.71 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -104.1 156.8 17.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.198 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 178.1 135.4 2.28 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.95 79.37 0.07 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.421 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.1 m -121.93 148.0 45.31 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.599 0.235 . . . . 0.0 111.01 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.82 178.55 36.76 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.655 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.84 -166.18 29.79 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.39 -0.433 . . . . 0.0 112.638 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.6 m -63.41 -34.4 77.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.915 0.486 . . . . 0.0 112.275 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -131.63 166.13 23.1 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.612 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.21 -48.2 4.67 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 121.572 -0.347 . . . . 0.0 113.247 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.3 p -122.05 153.54 38.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.595 0.236 . . . . 0.0 111.203 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.25 -179.16 33.89 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.674 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.29 111.06 4.13 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.596 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.8 p -78.23 -21.14 50.42 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.85 -37.16 78.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.7 p -79.52 -25.98 41.6 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.83 -44.85 10.2 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.381 0.426 . . . . 0.0 111.748 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -96.34 130.06 43.54 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.287 0.367 . . . . 0.0 111.573 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 72.5 mtt85 -113.39 6.27 17.15 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.886 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.95 136.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.632 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.88 155.97 37.11 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.554 0.533 . . . . 0.0 111.386 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.753 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.0 t80 -92.71 134.79 34.69 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.437 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.64 115.18 19.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 O-C-N 123.654 0.596 . . . . 0.0 109.663 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.22 152.31 20.35 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.989 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.89 8.03 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.99 0.465 . . . . 0.0 112.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.3 OUTLIER -92.01 164.76 13.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.573 0.349 . . . . 0.0 110.592 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -91.09 155.52 18.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.739 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.08 -26.16 68.7 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.67 0.388 . . . . 0.0 111.749 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.79 -3.03 32.72 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.689 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -86.3 135.51 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.907 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -109.49 174.86 5.68 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.547 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -60.52 -29.63 69.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.567 0.347 . . . . 0.0 111.57 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -68.81 -35.39 76.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.42 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.79 -47.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.792 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.62 -38.88 84.56 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.614 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.522 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 7.7 t60 -67.67 -48.94 65.2 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.446 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.59 -20.36 62.78 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.84 -34.04 24.73 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 111.456 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -102.34 0.2 33.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.433 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.569 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -68.83 -32.81 3.75 Favored Pre-proline 0 CA--C 1.565 1.525 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 15.1 Cg_endo -58.61 -23.42 65.22 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 121.94 1.76 . . . . 0.0 113.941 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -78.34 -31.39 48.64 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.87 -161.94 34.81 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.998 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.71 134.79 34.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.689 0.396 . . . . 0.0 111.833 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 111' ' ' GLU . 15.2 mt -116.63 138.67 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -94.21 -60.8 1.65 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -143.86 153.19 42.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.8 mm -119.46 124.64 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.59 127.56 54.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.71 114.37 20.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.935 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.28 130.88 37.99 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.399 2.066 . . . . 0.0 112.734 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.09 132.53 50.61 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.131 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -94.25 142.76 27.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.355 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -64.69 -34.28 77.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.8 -42.58 81.35 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 19.1 p -112.65 -26.71 8.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 60.82 19.61 9.81 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.347 0.659 . . . . 0.0 111.397 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -122.43 155.34 36.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.343 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -107.03 157.88 17.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.645 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -82.75 -1.39 51.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.326 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.569 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.57 41.64 2.49 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-O 119.807 -0.44 . . . . 0.0 113.836 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -147.28 147.47 30.43 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.85 0.357 . . . . 0.0 110.961 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.27 172.76 17.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -115.57 142.33 46.87 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 p -114.05 134.51 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 123.213 0.321 . . . . 0.0 110.599 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.601 ' O ' HG21 ' A' ' 90' ' ' ILE . 17.0 tt0 -108.26 125.64 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.618 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 30.0 m-85 -112.42 137.61 50.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.56 -36.71 84.58 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.571 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.6 mp -105.74 140.23 39.1 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.38 -22.51 57.44 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.924 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -72.8 -49.55 29.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.571 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 21.3 p30 -67.03 -32.3 73.41 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.653 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.73 91.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.01 0.524 . . . . 0.0 111.036 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.1 69.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.209 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.18 -37.31 78.11 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.934 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.05 -38.08 87.47 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.454 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 44.2 mt -70.16 -33.0 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 123.234 0.334 . . . . 0.0 111.281 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.83 -36.18 77.87 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -105.56 -33.04 8.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.584 ' O ' HG13 ' A' ' 137' ' ' VAL . 98.0 mmm -95.85 3.98 53.21 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.6 t-20 -56.57 -37.52 70.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.845 0.293 . . . . 0.0 111.764 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.06 72.85 1.4 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.695 0.76 . . . . 0.0 109.94 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.1 t -124.71 157.33 35.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -93.8 120.85 34.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.6 tp -128.48 128.21 43.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.806 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.98 7.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.658 0.783 . . . . 0.0 112.437 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.92 58.25 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.447 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -127.51 153.81 45.89 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.428 0.291 . . . . 0.0 110.778 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -82.08 134.17 35.32 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.27 154.36 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 73.7 mtt180 -122.26 134.3 54.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.359 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -130.95 138.38 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.896 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -151.67 172.18 16.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.7 mt -70.29 129.9 40.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.553 0.216 . . . . 0.0 111.118 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.459 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.483 0.182 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.2 mmm -100.75 128.4 46.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.829 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.4 mtt -72.38 -36.88 68.82 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.386 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -108.32 143.57 37.02 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.384 0.428 . . . . 0.0 111.048 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.4 m -94.28 -42.14 9.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.43 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 26.64 33.3 Favored Glycine 0 C--N 1.343 0.925 0 O-C-N 123.387 0.43 . . . . 0.0 113.429 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -97.55 149.14 22.53 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.372 0.269 . . . . 0.0 111.067 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -125.91 131.51 52.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.784 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -96.31 146.28 24.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.203 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -123.93 152.33 42.57 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.827 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -98.45 142.0 30.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.094 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.61 136.22 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.625 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -62.34 -40.83 97.66 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 m -65.38 -40.18 93.19 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -68.98 -32.26 71.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.88 0.472 . . . . 0.0 112.261 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.68 -34.69 78.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 62.62 169.03 0.13 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.811 0.844 . . . . 0.0 112.158 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -83.68 159.65 21.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.574 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 tp -97.1 144.62 26.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.792 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.2 p -74.56 160.56 30.73 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.49 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.02 -36.98 83.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' OE2' HG23 ' A' ' 65' ' ' VAL . 29.2 tt0 -67.1 -45.62 76.67 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 123.321 0.388 . . . . 0.0 111.567 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.534 ' O ' HD11 ' A' ' 27' ' ' LEU . 26.1 mtp -69.07 -37.34 78.43 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -61.55 -43.11 99.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.79 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.55 -40.38 73.43 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.1 mt -70.1 -47.39 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 122.22 0.208 . . . . 0.0 111.388 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.534 HD11 ' O ' ' A' ' 23' ' ' MET . 3.3 mt -69.61 -36.46 76.21 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.3 p -76.26 -26.34 55.87 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.57 0.224 . . . . 0.0 111.409 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -113.32 82.99 1.76 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.217 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 27' ' ' LEU . 7.2 mt -106.66 159.84 28.43 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 34' ' ' VAL . 2.8 Cg_endo -81.77 164.74 18.12 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.774 2.316 . . . . 0.0 113.323 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.94 -23.48 66.39 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.971 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.5 p -82.59 21.85 0.94 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.199 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -56.64 -8.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.94 73.5 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 53.87 105.81 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.242 1.017 . . . . 0.0 112.848 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.01 124.53 33.17 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.119 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.34 154.29 51.42 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.504 0.503 . . . . 0.0 111.485 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.01 148.64 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.123 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -96.78 111.94 23.91 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.398 0.436 . . . . 0.0 110.9 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.487 ' HG ' ' H ' ' A' ' 43' ' ' GLU . 34.7 t -134.67 138.78 44.74 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.439 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 p -75.71 -31.9 59.85 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' H ' ' HG ' ' A' ' 41' ' ' CYS . 50.7 mt-10 -73.11 -38.47 66.33 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -69.45 -35.75 75.95 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -111.44 135.97 51.25 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.362 0.414 . . . . 0.0 111.452 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.2 t -121.15 136.21 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.644 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.69 122.53 30.72 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.573 0.545 . . . . 0.0 110.838 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.42 -46.91 1.05 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.761 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.75 118.15 6.07 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.44 -0.409 . . . . 0.0 112.631 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -65.56 -33.66 76.43 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.46 37.43 7.03 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.149 -0.478 . . . . 0.0 113.02 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.62 164.98 33.13 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 121.628 -0.32 . . . . 0.0 112.787 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -123.59 148.92 45.92 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.327 0.251 . . . . 0.0 111.013 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.71 108.47 3.68 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.566 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.02 -41.83 6.95 Favored Glycine 0 C--N 1.339 0.72 0 O-C-N 123.679 0.282 . . . . 0.0 113.292 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 m -119.5 147.77 44.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.571 0.224 . . . . 0.0 111.07 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.02 44.75 0.06 OUTLIER Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.564 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.24 170.84 39.67 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.655 -0.307 . . . . 0.0 112.741 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.5 m -122.81 145.2 48.64 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.53 0.205 . . . . 0.0 110.955 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.67 43.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.906 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.8 p -126.26 156.08 40.88 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.309 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p 51.24 -76.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.686 1.194 . . . . 0.0 113.488 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 113' ' ' GLU . 94.4 mttt -104.7 143.19 33.43 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 122.467 0.307 . . . . 0.0 110.721 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.556 ' NH2' HD11 ' A' ' 139' ' ' LEU . 67.0 ttt180 -122.58 132.85 54.49 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.346 0.404 . . . . 0.0 110.988 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.418 HG23 ' OE2' ' A' ' 22' ' ' GLU . 18.9 t -106.63 136.38 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.0 157.58 34.08 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.457 0.473 . . . . 0.0 111.709 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.812 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 42.8 t80 -96.38 136.16 37.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.302 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.39 115.09 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 109.718 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.04 142.52 13.75 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.821 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.8 29.52 2.61 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.946 0.439 . . . . 0.0 112.616 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER -97.11 163.31 12.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.929 0.395 . . . . 0.0 110.549 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.486 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -84.61 155.79 21.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.13 -27.64 68.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.64 0.376 . . . . 0.0 111.608 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.61 -0.28 29.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.951 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -84.7 140.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.127 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.81 178.71 4.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -59.31 -31.22 68.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.742 0.417 . . . . 0.0 111.482 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.42 -39.97 81.39 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.07 -47.51 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.894 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.458 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.7 tt -67.62 -38.96 84.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.541 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 24.0 t-80 -68.69 -47.64 65.93 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.657 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.503 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.33 -20.69 62.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -32.96 23.65 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 74.9 m-85 -102.32 1.16 35.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.319 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.503 HG21 ' O ' ' A' ' 82' ' ' ALA . 3.9 tp -70.22 -31.64 2.41 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.362 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.6 Cg_exo -59.21 -24.01 72.06 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 121.967 1.778 . . . . 0.0 113.861 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.551 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 55.2 m-85 -79.91 -31.45 40.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.18 -161.51 35.11 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.95 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.16 136.56 33.93 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.793 0.437 . . . . 0.0 111.864 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 111' ' ' GLU . 5.8 mt -116.66 139.24 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.595 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -93.71 -61.27 1.58 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.656 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -143.26 153.51 42.86 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.3 mm -119.84 125.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.81 125.99 50.81 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.23 0.331 . . . . 0.0 111.721 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.35 110.81 21.22 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.04 128.44 27.81 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.43 2.087 . . . . 0.0 112.565 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.505 HD11 ' O ' ' A' ' 102' ' ' GLU . 1.1 tp -124.01 134.24 53.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.165 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.23 139.64 30.41 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.504 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -64.76 -31.98 73.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.09 -41.89 94.59 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 p -117.28 -22.84 8.09 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.505 ' O ' HD11 ' A' ' 97' ' ' LEU . 46.7 mt-10 59.99 22.66 11.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.231 0.613 . . . . 0.0 111.444 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -124.84 154.5 40.92 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.348 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -110.21 154.93 22.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -79.57 -11.1 59.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.025 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.59 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.77 41.47 1.11 Allowed Glycine 0 C--N 1.341 0.847 0 C-N-CA 121.095 -0.574 . . . . 0.0 114.019 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -145.12 145.13 31.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.195 0.497 . . . . 0.0 111.103 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.99 173.09 17.05 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.966 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.94 144.5 43.98 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.2 p -116.17 131.03 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 110.692 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.558 ' O ' HG22 ' A' ' 90' ' ' ILE . 20.3 tt0 -106.37 126.89 52.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.259 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.416 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 47.7 m-85 -111.51 141.94 44.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 26.5 tt0 -64.05 -36.89 85.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.137 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.63 125.1 52.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.758 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.68 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -68.25 -47.87 66.61 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.586 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.416 ' OD1' ' HB3' ' A' ' 112' ' ' PHE . 8.0 p30 -69.03 -32.43 71.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.378 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 64' ' ' ARG . . . -66.58 -42.2 87.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.685 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.17 71.29 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.699 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.657 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -68.48 -33.66 74.54 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.692 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.83 82.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.602 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.589 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 48.0 mt -70.33 -37.76 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.657 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.7 p30 -82.94 -16.72 46.27 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -93.89 -47.86 6.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.551 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 62.7 mtt -130.87 53.49 1.97 Allowed 'General case' 0 C--N 1.346 0.434 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.1 t-20 -64.73 -37.71 88.53 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.552 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.9 mt-10 -143.18 77.22 1.56 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.728 0.775 . . . . 0.0 109.834 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.0 m -119.77 160.72 22.05 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.31 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -90.28 118.25 29.64 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.955 0.407 . . . . 0.0 110.679 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.3 tp -129.17 130.55 46.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.911 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.3 t80 62.86 15.07 7.94 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.727 0.811 . . . . 0.0 112.232 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.19 4.69 59.74 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.209 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -126.93 155.48 43.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.572 0.349 . . . . 0.0 110.817 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.15 133.32 35.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.2 pt -118.05 151.77 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.602 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 57.7 mtt180 -122.81 134.71 54.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.424 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.812 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.73 134.99 61.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.89 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -154.2 172.13 18.09 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.494 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.556 HD11 ' NH2' ' A' ' 64' ' ' ARG . 5.4 tt -69.21 129.69 40.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.578 0.228 . . . . 0.0 110.628 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.136 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.473 0.177 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.32 129.96 45.57 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.909 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.4 mtm -69.65 -35.37 75.14 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.374 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -105.02 151.69 23.64 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m 71.26 -47.56 0.66 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.514 1.126 . . . . 0.0 112.609 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.44 39.84 8.77 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.195 0.309 . . . . 0.0 113.098 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -63.02 -31.7 72.9 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -90.56 125.52 35.64 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.43 0.456 . . . . 0.0 111.444 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -102.99 156.31 17.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.804 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.0 mtp-105 -104.65 136.13 44.76 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -120.89 150.35 41.21 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 t -110.66 128.32 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -65.67 -39.49 91.38 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.721 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.1 p -66.06 -36.49 83.37 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -65.74 -39.63 91.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.836 0.455 . . . . 0.0 111.861 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.6 m -82.27 -44.53 16.17 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -127.81 150.65 49.73 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.265 0.353 . . . . 0.0 111.355 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -111.87 131.02 55.63 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.642 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tp -100.99 150.15 23.19 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -73.0 153.69 40.81 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.58 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.24 -35.74 78.06 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.13 -48.39 68.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.604 0.362 . . . . 0.0 111.537 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.565 ' SD ' HG22 ' A' ' 65' ' ' VAL . 92.5 mmm -68.42 -36.63 79.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -64.45 -44.28 91.61 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.187 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.88 -39.7 76.15 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.561 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 36.4 mt -66.02 -49.79 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 122.144 0.178 . . . . 0.0 111.215 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.536 HD12 ' O ' ' A' ' 23' ' ' MET . 3.1 mt -70.31 -38.5 74.95 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.3 p -72.8 -27.2 61.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -98.48 9.97 41.95 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.53 0.681 . . . . 0.0 110.05 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 9.5 tp -98.68 137.7 20.64 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.487 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.429 ' O ' HG21 ' A' ' 34' ' ' VAL . 22.1 Cg_exo -63.61 149.83 89.97 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.345 2.03 . . . . 0.0 112.077 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.68 -37.78 74.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 81.0 p -96.68 -15.93 21.2 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.544 0.528 . . . . 0.0 111.519 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 31' ' ' PRO . 1.8 t 53.57 9.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 124.148 0.979 . . . . 0.0 112.876 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 62.49 15.98 8.31 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' O ' ' HE2' ' A' ' 107' ' ' PHE . 63.5 m-85 -112.27 118.28 34.84 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 110.927 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.77 114.82 6.16 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.894 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.7 m 56.48 -73.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.377 1.071 . . . . 0.0 113.226 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.78 149.76 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.678 0.275 . . . . 0.0 110.833 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -63.65 -36.89 85.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.9 p -119.6 122.3 41.25 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.775 0.321 . . . . 0.0 111.232 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.5 p -81.16 -27.13 35.55 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.441 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -105.98 139.87 39.86 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.283 0.364 . . . . 0.0 111.051 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -71.05 -35.53 71.97 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.178 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -114.22 138.02 51.02 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.408 0.443 . . . . 0.0 111.033 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -133.25 142.54 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.561 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -87.59 138.25 31.63 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.288 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.59 172.33 41.13 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.858 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.46 166.27 25.33 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.397 -0.43 . . . . 0.0 112.903 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 t -131.86 143.7 50.36 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.402 0.281 . . . . 0.0 110.62 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.11 178.5 43.45 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.083 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.03 -175.95 42.38 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 121.629 -0.319 . . . . 0.0 112.86 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.1 p -124.05 152.95 42.07 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.606 0.239 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.08 43.07 7.27 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.35 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.03 -50.65 10.23 Favored Glycine 0 C--N 1.343 0.921 0 C-N-CA 121.801 -0.238 . . . . 0.0 113.141 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -73.75 -36.88 65.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.755 0.422 . . . . 0.0 111.99 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.88 179.69 43.09 Favored Glycine 0 C--N 1.341 0.847 0 O-C-N 123.52 0.512 . . . . 0.0 112.92 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 170.37 -176.57 43.95 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.542 -0.361 . . . . 0.0 112.829 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.6 m -121.42 143.45 49.22 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.589 0.233 . . . . 0.0 110.981 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.51 -24.73 29.25 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.351 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.2 p -77.1 -14.42 59.81 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.2 p -74.4 -28.01 60.9 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -114.45 133.48 55.72 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.275 0.359 . . . . 0.0 110.363 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -102.4 -3.63 26.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.764 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.565 HG22 ' SD ' ' A' ' 23' ' ' MET . 21.2 t -105.49 133.13 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.11 156.99 33.87 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.535 0.522 . . . . 0.0 111.411 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.0 t80 -101.04 134.61 43.78 Favored 'General case' 0 N--CA 1.458 -0.042 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.98 116.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 O-C-N 123.548 0.53 . . . . 0.0 109.769 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.2 152.96 18.88 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.762 -0.733 . . . . 0.0 113.384 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.02 23.72 7.6 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.985 0.462 . . . . 0.0 112.588 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 106' ' ' GLY . 0.3 OUTLIER -92.0 163.09 14.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -90.61 157.86 17.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.869 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 38.8 mt-10 -64.71 -26.67 68.47 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.722 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -77.41 -1.53 30.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.766 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -86.53 139.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 120.572 0.225 . . . . 0.0 110.66 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.1 m-20 -121.71 179.02 4.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.803 0.441 . . . . 0.0 111.54 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.54 -40.77 80.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.702 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.447 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.3 t -67.06 -46.98 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.212 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.449 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -67.04 -39.42 86.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.644 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.551 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 9.1 t60 -68.07 -48.68 64.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.023 0.529 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' O ' HG21 ' A' ' 85' ' ' ILE . . . -70.41 -20.62 62.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.43 -34.03 23.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 111.402 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.449 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.8 m-85 -101.54 0.21 36.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.285 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -70.25 -31.85 2.49 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.5 Cg_exo -59.01 -23.4 68.42 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.007 1.805 . . . . 0.0 113.882 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -78.02 -31.29 50.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.43 -162.67 36.26 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.827 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.88 134.0 35.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.72 0.408 . . . . 0.0 111.769 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 111' ' ' GLU . 12.7 mt -114.41 139.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.267 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -62.63 1.42 Allowed 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.668 0.605 . . . . 0.0 112.303 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.9 154.91 41.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.5 mm -117.2 125.51 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.07 128.22 52.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 107' ' ' PHE . 1.4 mp -127.73 116.72 20.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.706 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.37 121.74 10.39 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.209 1.939 . . . . 0.0 112.413 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 134.57 49.74 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.175 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.81 143.07 26.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.73 -33.47 76.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.66 -48.57 54.22 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.2 p -100.46 -27.85 13.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.82 23.88 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.235 0.614 . . . . 0.0 111.569 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -121.37 156.83 31.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.522 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.585 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 9.5 p80 -110.18 159.36 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.928 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 85.5 mtt-85 -87.77 3.6 47.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.015 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.536 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 94.51 35.02 6.07 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.594 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' O ' HG21 ' A' ' 95' ' ' ILE . 1.3 p90 -143.73 147.12 33.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.65 0.262 . . . . 0.0 110.941 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.0 169.52 23.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.639 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -116.19 144.42 44.21 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.84 133.15 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.425 0.453 . . . . 0.0 110.434 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.538 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -108.05 127.33 53.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.521 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.417 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 32.2 m-85 -113.8 141.69 46.99 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.271 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -67.47 -37.23 82.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.606 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.506 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -102.77 138.95 38.99 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -19.54 59.37 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.483 0.658 . . . . 0.0 109.267 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.19 -50.99 23.29 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.754 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.506 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 24.0 p30 -69.33 -31.86 70.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.15 -45.02 86.71 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.931 0.492 . . . . 0.0 111.423 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.66 -30.51 71.22 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.6 77.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.101 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -67.29 -39.52 85.98 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.8 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.629 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 52.7 mt -69.16 -33.82 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.862 -0.154 . . . . 0.0 111.32 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -68.72 -36.4 78.37 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.36 -34.46 8.28 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.52 ' O ' HG12 ' A' ' 137' ' ' VAL . 94.0 mmm -91.68 0.54 57.49 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.629 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 10.1 t-20 -56.64 -36.95 70.09 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.847 0.294 . . . . 0.0 111.678 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.74 70.96 1.36 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.619 0.723 . . . . 0.0 110.061 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 55.0 m -121.81 154.7 36.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.336 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.7 119.4 32.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.471 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tp -129.94 130.18 44.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.013 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 61.99 15.68 7.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.658 0.783 . . . . 0.0 112.443 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 4.92 59.22 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.298 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -127.0 154.39 44.68 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.514 0.326 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.53 134.35 34.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.02 154.79 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.024 0.44 . . . . 0.0 112.135 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 22.8 ttp-105 -124.24 131.78 53.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.785 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.27 139.49 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.316 0.385 . . . . 0.0 110.738 179.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -145.25 171.94 13.85 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.2 mt -68.95 133.33 48.05 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.24 0.216 . . . . 0.0 110.921 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.34 -179.438 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.483 0.183 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.4 mtt -101.57 137.03 40.43 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.819 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.5 mtm -103.49 145.8 29.48 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.879 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -111.61 141.33 45.34 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.742 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.82 -39.51 11.72 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.863 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.77 134.47 12.44 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 123.433 0.458 . . . . 0.0 112.992 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -88.55 -12.33 43.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -132.83 142.44 48.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -93.15 10.25 32.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.584 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -108.32 154.75 21.37 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -101.26 152.22 20.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.43 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.98 141.07 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.742 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -60.22 -42.98 96.33 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.273 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.9 p -69.42 -36.9 77.14 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.27 -39.72 86.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.0 p -73.36 -36.71 66.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.4 126.44 43.93 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.203 0.314 . . . . 0.0 111.074 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -147.33 159.98 43.05 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.954 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 tp -107.7 141.73 38.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.014 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.9 p -71.12 156.47 39.55 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.739 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.36 -35.18 80.03 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.515 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.24 -45.52 73.0 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.714 0.406 . . . . 0.0 111.642 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.599 ' SD ' HG21 ' A' ' 65' ' ' VAL . 97.6 mmm -68.08 -38.58 82.54 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -65.57 -42.59 91.62 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.045 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.24 -39.57 74.97 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.3 mt -68.78 -47.24 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 123.007 0.192 . . . . 0.0 111.262 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 23' ' ' MET . 5.3 mt -69.52 -36.9 76.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 96.3 p -76.31 -24.52 54.35 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -114.99 80.92 1.48 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.17 0.509 . . . . 0.0 110.76 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.8 mt -108.39 122.13 41.38 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.245 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.52 138.56 65.69 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.751 2.301 . . . . 0.0 112.379 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -37.45 -35.53 0.13 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 t -118.27 -23.09 7.41 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t -67.86 -25.16 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.3 73.7 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -157.19 138.73 13.97 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.273 0.358 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.4 p -130.19 154.4 47.58 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.043 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.0 m -120.53 -51.42 2.17 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.153 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.67 160.89 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.689 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -94.52 122.96 37.64 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.316 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.67 ' SG ' ' HG3' ' A' ' 43' ' ' GLU . 4.4 t -128.36 151.05 49.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.092 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -90.83 23.53 3.09 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.616 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.67 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 45.4 mt-10 -65.51 -29.25 69.86 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.228 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -79.01 147.39 32.89 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.492 0.495 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -104.56 141.68 35.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -73.93 -30.59 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.583 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -90.86 127.15 36.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.379 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 55' ' ' GLY . . . -89.96 -171.26 44.53 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.872 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.38 14.69 50.03 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.407 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.0 p -68.26 -24.82 64.93 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.34 50.23 0.24 Allowed Glycine 0 C--N 1.338 0.685 0 O-C-N 123.506 0.504 . . . . 0.0 112.594 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.21 178.37 32.75 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.426 -0.416 . . . . 0.0 112.784 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.6 p -78.45 -20.08 51.75 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.15 32.98 5.33 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.37 0.419 . . . . 0.0 113.153 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -65.16 -36.7 93.22 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 113.849 0.3 . . . . 0.0 113.849 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 m -121.28 148.84 43.77 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.584 0.226 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.01 -168.75 37.35 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.668 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.41 13.01 49.78 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-O 119.89 -0.395 . . . . 0.0 113.531 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -118.0 144.77 45.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.818 0.309 . . . . 0.0 110.831 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.22 150.04 31.44 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.618 0.574 . . . . 0.0 111.431 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.436 ' OG1' ' HE2' ' A' ' 63' ' ' LYS . 27.4 p -120.69 163.24 18.37 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.659 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -74.13 99.59 3.41 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.218 0.532 . . . . 0.0 111.347 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HE2' ' OG1' ' A' ' 61' ' ' THR . 60.3 mttm -129.85 143.34 50.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.854 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.2 mtt85 -91.58 3.59 54.64 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.715 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' SD ' ' A' ' 23' ' ' MET . 10.2 t -107.54 128.94 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.33 155.64 36.88 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.678 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.798 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 52.5 t80 -92.29 136.02 33.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.834 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' ARG . 2.9 m -134.54 115.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.43 142.23 13.5 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.563 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.26 24.9 4.3 Favored Glycine 0 C--N 1.332 0.315 0 O-C-N 123.954 0.444 . . . . 0.0 112.429 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -95.53 164.6 12.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.264 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -79.58 151.79 30.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.72 -30.42 71.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.652 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -83.88 13.61 4.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.883 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 72' ' ' ALA . 5.6 m -88.8 133.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.707 0.289 . . . . 0.0 110.856 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -102.42 173.52 6.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.457 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -59.34 -30.1 68.14 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.697 0.399 . . . . 0.0 111.248 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.44 -38.36 81.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.431 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.81 -48.32 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.017 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.8 tt -68.74 -37.25 79.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.3 t60 -68.52 -49.32 60.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.634 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.28 -20.75 63.02 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.62 -32.53 23.66 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 73.1 m-85 -103.0 2.5 35.03 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.465 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 82' ' ' ALA . 4.5 tp -71.31 -31.46 1.93 Allowed Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.206 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.9 Cg_exo -59.7 -23.54 72.08 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.901 1.734 . . . . 0.0 114.033 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.67 -31.43 46.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.52 -158.41 30.71 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.49 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -85.73 139.66 31.15 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.672 0.389 . . . . 0.0 111.426 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 111' ' ' GLU . 8.3 mt -117.09 140.54 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 p -93.86 -62.49 1.34 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.308 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -144.89 152.52 40.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.4 mm -121.04 130.59 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.617 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.562 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 86.4 mm-40 -120.51 137.1 54.55 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.222 0.326 . . . . 0.0 111.583 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.405 HG23 ' CD2' ' A' ' 104' ' ' HIS . 4.4 mp -126.73 100.39 28.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.787 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.52 128.09 23.71 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.543 2.162 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -128.07 133.76 49.09 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.774 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.24 138.51 31.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.422 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -64.53 -33.69 76.48 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.17 -44.68 75.42 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.979 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.516 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.5 p -102.42 -29.04 11.86 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 52.86 32.56 12.64 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.19 0.596 . . . . 0.0 110.785 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 101' ' ' THR . 58.4 mttt -124.33 154.22 40.63 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.062 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.405 ' CD2' HG23 ' A' ' 95' ' ' ILE . 18.2 t-80 -94.77 134.8 36.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.63 4.65 53.62 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.561 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.04 25.91 23.21 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.43 -0.891 . . . . 0.0 114.695 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -143.7 148.3 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 117.668 0.734 . . . . 0.0 111.378 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.09 176.34 12.39 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.539 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.05 150.45 39.96 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -121.63 134.56 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.989 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.497 ' O ' HG23 ' A' ' 90' ' ' ILE . 20.1 tt0 -111.03 133.15 53.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.093 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 80.7 m-85 -117.19 150.62 38.43 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.42 0.45 . . . . 0.0 111.261 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -69.07 -39.04 79.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.038 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mp -111.27 141.13 45.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -21.21 62.67 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.613 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.18 -42.99 99.79 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.131 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.89 -32.05 68.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.051 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.418 ' O ' HD11 ' A' ' 122' ' ' ILE . . . -57.64 -46.88 83.6 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.374 0.421 . . . . 0.0 111.057 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.51 63.29 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.383 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.28 63.25 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.582 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.72 91.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.607 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 16.2 mt -70.83 -43.42 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.28 -32.49 68.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -79.42 -49.6 12.1 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.568 ' O ' HG12 ' A' ' 137' ' ' VAL . 64.0 mtt -135.17 63.69 1.61 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.098 0.475 . . . . 0.0 112.227 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 17.6 p30 -69.82 -35.17 74.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.044 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.7 mt-10 -142.99 78.65 1.62 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.698 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.9 m -120.58 161.23 21.68 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.282 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -90.36 117.19 28.89 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.019 0.437 . . . . 0.0 110.752 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -129.06 131.78 47.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.88 14.49 8.39 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.765 0.826 . . . . 0.0 112.189 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.16 60.28 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.237 -0.438 . . . . 0.0 113.085 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -127.66 157.19 40.94 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.612 0.365 . . . . 0.0 110.721 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.55 133.89 34.85 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.6 pt -118.19 152.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 58.6 mtt-85 -122.81 134.55 54.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.259 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.798 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.46 133.31 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 110.766 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -151.01 172.31 15.91 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.986 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.28 131.29 42.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.662 0.268 . . . . 0.0 111.369 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.158 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.112 -179.69 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.337 0.113 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 97.2 mmm -99.9 128.78 45.96 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 123.353 0.408 . . . . 0.0 110.843 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.0 mtt -131.65 -51.79 0.99 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.901 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -136.9 118.09 14.48 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.399 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 t -139.77 128.74 23.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.332 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.34 178.7 48.42 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.593 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -128.11 151.79 48.78 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.853 0.384 . . . . 0.0 110.708 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -93.97 120.84 34.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -136.47 158.61 44.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.921 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -120.95 147.88 44.85 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.529 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -106.29 136.87 45.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.25 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 t -124.6 138.31 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.573 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.481 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 93.0 m-70 -61.21 -39.94 92.1 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t -63.31 -39.43 94.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -65.7 -37.38 86.3 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.2 m -76.86 -33.27 57.88 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 13' ' ' HIS . 49.1 mt-10 -66.14 -31.93 73.08 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -88.0 -73.21 0.49 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 123.129 0.268 . . . . 0.0 111.564 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.97 150.54 31.97 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.693 0.282 . . . . 0.0 111.045 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.5 m -87.6 159.2 18.66 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.47 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -58.94 -39.35 81.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -67.35 -39.98 85.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.854 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.476 ' O ' HD13 ' A' ' 27' ' ' LEU . 17.1 mtt -68.03 -38.51 82.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -65.46 -45.54 83.35 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.61 -45.36 62.35 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 34.0 mt -66.67 -46.37 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' HD11 ' A' ' 30' ' ' LEU . 10.5 mt -68.8 -32.18 71.72 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.5 p -68.06 -36.58 80.1 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -124.1 97.85 5.52 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.12 0.486 . . . . 0.0 111.071 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.48 HD11 ' O ' ' A' ' 27' ' ' LEU . 5.7 mt -121.51 125.66 26.76 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.169 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.04 119.76 6.54 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.31 2.007 . . . . 0.0 111.344 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -46.72 -34.81 5.47 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -84.05 -43.73 14.82 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.49 -36.99 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.291 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.54 -27.83 63.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -169.81 159.63 8.11 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 120.658 0.266 . . . . 0.0 111.657 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.6 p -101.78 160.05 14.8 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.03 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.3 m -122.79 155.97 35.46 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.08 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t 61.87 160.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.836 0.855 . . . . 0.0 111.416 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -95.64 126.31 40.83 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.8 t -134.56 153.8 51.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.0 p -71.73 -23.48 61.62 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.289 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.25 -31.99 71.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.942 0.497 . . . . 0.0 112.274 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -62.37 -33.0 73.88 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -72.87 -20.67 61.06 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.62 135.01 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -79.65 143.77 34.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.71 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 172.5 37.83 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.908 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.25 42.25 8.08 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.68 -0.295 . . . . 0.0 113.217 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.7 m -117.98 147.91 42.72 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.242 0.217 . . . . 0.0 111.044 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.47 -175.62 46.02 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.068 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.84 -171.18 40.99 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.513 -0.375 . . . . 0.0 112.664 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.5 p -68.12 -27.03 66.1 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.61 138.24 2.6 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 123.433 0.458 . . . . 0.0 112.45 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.33 -49.71 4.1 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 121.672 -0.299 . . . . 0.0 112.924 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.6 m -65.32 -34.76 79.1 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -136.85 177.9 19.34 Favored Glycine 0 C--N 1.34 0.76 0 O-C-N 123.451 0.469 . . . . 0.0 112.893 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.7 117.7 3.23 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.623 -0.322 . . . . 0.0 112.403 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -121.61 146.83 46.58 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.288 0.235 . . . . 0.0 111.098 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.87 150.8 27.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.058 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.9 p -87.35 159.47 18.73 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.146 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.2 p -82.15 125.96 31.5 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.686 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -132.06 143.25 49.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 84.4 mtt180 -78.83 -12.48 60.03 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.452 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 20.5 t -102.44 129.29 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.79 158.85 30.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.304 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.553 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 31.3 t80 -93.84 132.88 37.82 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.013 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -132.51 115.49 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.91 156.45 21.73 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.355 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.14 20.82 9.39 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.146 -0.527 . . . . 0.0 112.448 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.553 HD11 ' O ' ' A' ' 106' ' ' GLY . 0.4 OUTLIER -89.32 163.11 15.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.49 ' O ' HG11 ' A' ' 75' ' ' VAL . . . -89.71 156.62 18.42 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.946 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.03 -26.66 68.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.654 0.382 . . . . 0.0 111.678 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -76.95 -2.2 32.54 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.676 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -87.41 139.57 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 120.577 0.227 . . . . 0.0 110.747 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 78' ' ' LYS . 4.3 p30 -120.64 -176.64 3.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.5 -31.11 71.09 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.879 0.472 . . . . 0.0 111.788 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 91.5 mttt -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.714 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.5 t -65.42 -47.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.056 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.4 tt -67.38 -39.14 85.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.411 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.505 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.8 t60 -68.15 -47.85 66.94 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.572 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 85' ' ' ILE . . . -70.82 -20.22 62.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.86 -34.81 24.53 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-O 120.845 0.355 . . . . 0.0 111.38 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 76.3 m-85 -99.87 -2.05 35.85 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.391 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 4.9 tp -68.51 -32.48 3.78 Favored Pre-proline 0 CA--C 1.566 1.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 11.4 Cg_endo -56.66 -24.81 56.47 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.035 1.823 . . . . 0.0 113.874 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -79.43 -31.32 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.287 0.367 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.9 -169.71 42.85 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.308 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -86.03 130.77 34.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.314 0.246 . . . . 0.0 110.748 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.5 mt -105.89 141.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.919 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 p -88.37 -60.5 1.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.757 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -146.29 153.21 40.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.0 mm -120.53 122.26 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.9 125.85 48.52 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.522 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mp -127.15 117.37 21.83 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.811 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.89 121.86 8.94 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.994 1.796 . . . . 0.0 112.521 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.93 136.56 54.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.076 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -86.87 139.42 30.67 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.6 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 87.4 m-85 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.06 -42.72 89.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -108.58 -27.02 10.11 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' OE2' ' HA ' ' A' ' 99' ' ' TYR . 73.2 mm-40 57.7 24.84 11.07 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.231 0.612 . . . . 0.0 111.474 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -124.48 154.88 39.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.269 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.421 ' HD1' ' N ' ' A' ' 106' ' ' GLY . 26.3 p80 -115.34 148.71 38.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.344 0.402 . . . . 0.0 110.81 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.293 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' HD11 ' A' ' 71' ' ' LEU . . . 110.71 39.19 1.47 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.918 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.09 149.23 36.26 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 117.084 0.442 . . . . 0.0 110.823 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.58 170.96 21.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.092 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -118.02 145.55 44.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 10.4 p -118.69 137.87 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.068 0.461 . . . . 0.0 111.43 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.652 ' O ' HG23 ' A' ' 90' ' ' ILE . 23.1 tt0 -107.23 128.99 54.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.23 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.44 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 45.4 m-85 -116.87 146.0 43.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -70.75 -37.4 73.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.862 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.599 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -107.37 143.19 36.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -25.87 58.85 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.745 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.13 -47.24 59.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.599 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.7 p30 -67.23 -32.02 72.78 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.962 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.04 -45.18 82.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.079 0.552 . . . . 0.0 111.343 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.68 70.52 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.23 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.62 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -69.67 -33.92 73.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.59 78.67 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.723 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.609 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 74.3 mt -66.65 -47.68 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.62 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 4.3 p30 -67.47 -34.31 76.91 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -88.36 -35.04 17.39 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.476 ' O ' HG11 ' A' ' 137' ' ' VAL . 83.6 mtp -110.73 14.39 22.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.5 t-20 -57.47 -37.26 72.6 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.813 0.278 . . . . 0.0 111.572 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -142.71 77.14 1.56 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.624 0.726 . . . . 0.0 109.908 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.5 t -127.17 157.0 40.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.118 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -93.21 118.99 31.89 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.6 tp -131.0 130.41 43.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.982 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.6 15.52 8.03 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.573 0.749 . . . . 0.0 112.361 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.39 60.08 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.301 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -126.55 153.96 44.5 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.502 0.321 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.97 133.36 34.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 pt -116.1 152.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 5.0 tpt180 -124.66 128.45 48.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.599 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.43 139.18 51.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.38 0.425 . . . . 0.0 110.764 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 28.5 p30 -145.27 173.76 11.68 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.496 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.0 tt -69.79 123.67 22.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.321 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 81.3 mtm-85 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.53 0.205 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.5 t -104.02 134.94 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.854 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.65 154.36 39.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.816 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.4 t80 -94.48 134.44 37.01 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.652 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.435 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -134.27 114.75 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.614 0.571 . . . . 0.0 109.687 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.83 146.98 18.75 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.556 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.18 23.34 6.12 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 123.881 0.4 . . . . 0.0 112.425 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.621 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -93.42 165.12 12.92 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.548 0.339 . . . . 0.0 110.262 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -81.09 151.75 28.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.044 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.58 -29.97 70.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.714 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.77 9.13 6.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 72' ' ' ALA . 3.5 m -90.55 136.93 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 120.635 0.255 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -107.79 174.72 5.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -61.42 -28.05 68.98 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.619 0.368 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.5 -39.03 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.0 -47.81 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.086 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.4 -38.27 84.4 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.354 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 46.4 t-80 -68.09 -49.07 63.56 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.566 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.44 -20.49 62.89 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.26 -33.62 24.0 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 111.271 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.33 1.88 33.35 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.437 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -69.75 -31.97 2.77 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.25 -0.881 . . . . 0.0 113.339 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.6 Cg_exo -59.8 -23.3 71.6 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.861 1.707 . . . . 0.0 113.955 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.527 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 47.8 m-85 -80.04 -31.27 39.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.89 -168.56 41.44 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.804 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.18 134.06 34.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.468 0.307 . . . . 0.0 110.97 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.562 HG21 HD11 ' A' ' 93' ' ' ILE . 9.6 mt -113.54 140.86 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.851 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 -64.99 1.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.226 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -145.34 153.84 41.68 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.562 HD11 HG21 ' A' ' 90' ' ' ILE . 21.2 mm -117.84 128.73 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.415 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 63.7 mt-30 -115.52 133.87 55.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.875 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.62 104.19 24.35 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.06 96.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.471 2.114 . . . . 0.0 112.387 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -111.56 133.63 53.69 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -85.03 141.71 30.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -64.67 -34.55 78.56 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -73.05 -49.12 30.49 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 31.3 p -93.89 -28.79 15.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 49.71 30.81 3.91 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.394 0.678 . . . . 0.0 111.823 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 101' ' ' THR . 42.8 mttt -112.24 153.41 27.17 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.346 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -101.21 143.78 30.88 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.617 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -99.12 1.62 45.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 92.28 20.82 34.26 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 120.336 -0.935 . . . . 0.0 114.904 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.82 146.73 31.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.863 0.832 . . . . 0.0 111.458 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.66 173.02 16.72 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.66 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.448 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 76.7 m-85 -118.08 150.64 39.0 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 93' ' ' ILE . 11.0 p -119.41 136.17 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 123.47 0.481 . . . . 0.0 111.027 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -106.46 121.17 43.74 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.213 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 9.1 m-85 -105.84 133.07 51.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.076 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.66 -34.73 78.89 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.794 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.81 135.9 49.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.92 61.6 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.642 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.93 -40.95 75.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.59 -31.75 71.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.425 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -62.44 -45.66 92.08 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.267 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.62 -28.98 67.39 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.267 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.527 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.27 -40.25 71.07 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.27 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.1 89.84 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.653 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.82 HD11 HD22 ' A' ' 66' ' ' LEU . 11.4 mt -71.21 -34.21 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.9 p30 -83.01 -16.77 45.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -100.02 -42.05 6.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.527 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 86.5 mtp -128.82 45.05 2.85 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.8 t-20 -63.72 -38.54 91.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.676 0.274 . . . . 0.0 111.238 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 39.3 mt-10 -142.09 78.13 1.61 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.729 0.776 . . . . 0.0 109.656 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.0 p -125.13 162.68 24.08 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -91.99 118.73 31.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.035 0.445 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.29 130.78 48.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.675 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.36 15.02 8.36 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.25 5.28 59.4 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.164 -0.471 . . . . 0.0 113.344 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -127.86 156.87 41.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.56 0.344 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.94 134.1 35.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.0 pt -120.23 154.85 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 123.37 0.419 . . . . 0.0 112.075 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 52.9 mtt180 -125.83 134.68 51.58 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.466 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.816 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.8 134.02 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.044 0.45 . . . . 0.0 110.834 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 13.4 p-10 -151.14 171.47 17.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.498 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 14.3 mt -71.06 130.72 42.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.533 0.206 . . . . 0.0 111.168 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.51 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.4 128.67 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.539 0.209 . . . . 0.0 110.575 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.747 HD22 HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -124.14 159.73 29.38 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.66 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.755 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.7 OUTLIER -112.66 117.4 32.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.952 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -108.71 115.32 49.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 178.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -127.86 148.8 17.83 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.027 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.8 41.27 3.15 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.706 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -91.33 159.82 15.81 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.106 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.617 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -82.16 174.54 11.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.358 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -69.03 -32.51 72.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.841 0.456 . . . . 0.0 111.519 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -98.83 63.26 1.38 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.405 0.621 . . . . 0.0 111.527 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 71' ' ' LEU . 12.2 p -139.05 137.59 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.705 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.841 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.0 m-20 -140.94 -175.9 4.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.486 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.76 -37.06 86.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.85 0.46 . . . . 0.0 112.203 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -66.25 -43.52 86.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.982 0.513 . . . . 0.0 112.186 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.841 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 16.8 m -73.34 -39.53 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 123.322 0.389 . . . . 0.0 111.769 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.67 -35.75 82.04 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.519 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 24.9 t-80 -68.31 -46.2 70.91 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.517 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.12 -20.73 63.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.91 -35.12 22.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' C ' HD11 ' A' ' 90' ' ' ILE . 56.7 m-85 -97.38 -0.9 45.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.021 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -70.39 -31.67 2.35 Favored Pre-proline 0 CA--C 1.565 1.548 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.4 Cg_exo -59.73 -24.14 74.52 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.917 1.744 . . . . 0.0 113.798 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -78.05 -31.28 50.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.89 -159.14 32.13 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.458 0.474 . . . . 0.0 112.612 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -85.94 137.91 32.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.636 0.374 . . . . 0.0 111.456 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.425 HD11 ' C ' ' A' ' 84' ' ' PHE . 5.4 mt -118.4 144.33 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.809 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 1.4 p -91.2 -67.33 0.86 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.896 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -148.63 158.04 43.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' HG23 ' A' ' 110' ' ' VAL . 10.8 mm -116.94 129.4 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -126.61 127.02 44.57 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.2 mp -127.83 118.1 20.99 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.795 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.54 126.11 20.35 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.304 2.003 . . . . 0.0 112.642 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -128.02 134.67 49.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -89.55 143.38 26.86 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.278 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -64.58 -34.65 78.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.11 -48.71 41.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.8 p -94.72 -28.33 15.36 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 55.35 24.7 6.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.21 0.604 . . . . 0.0 111.513 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -120.31 156.83 30.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.1 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -92.77 158.58 15.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.973 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -88.52 0.54 56.21 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.017 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.85 19.46 29.05 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 119.453 -0.637 . . . . 0.0 114.305 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 55.1 p90 -144.55 151.15 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.464 0.632 . . . . 0.0 111.191 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.44 164.73 36.1 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.954 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -115.31 138.64 50.75 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.436 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.2 p -118.32 133.78 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.93 0.395 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.436 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 1.1 mm-40 -109.0 137.62 46.64 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.417 ' CE2' HG12 ' A' ' 90' ' ' ILE . 82.6 m-85 -117.65 147.32 43.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.21 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.87 -39.52 90.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.07 141.74 39.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.705 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.23 -22.13 63.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.071 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.76 -42.17 95.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.177 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.96 -33.05 71.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.586 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -61.73 -45.74 92.65 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.207 0.317 . . . . 0.0 111.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.51 -28.9 64.22 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.12 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.63 -45.24 59.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.426 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.26 90.17 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.747 HD11 HD22 ' A' ' 66' ' ' LEU . 46.8 mt -70.65 -39.98 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.67 -28.3 60.79 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.8 -49.7 10.09 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.4 mtp -135.24 61.33 1.67 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.091 0.472 . . . . 0.0 111.993 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 11.3 t-20 -69.21 -41.68 76.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.482 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.6 mt-10 -140.61 79.18 1.69 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.678 0.751 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 p -126.68 164.57 21.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.366 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -87.15 116.14 25.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.02 0.438 . . . . 0.0 110.513 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -133.31 130.49 38.97 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.136 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 64.92 17.05 10.87 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.089 0.955 . . . . 0.0 112.168 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.55 -0.19 61.24 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.735 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.97 156.8 43.2 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.353 0.261 . . . . 0.0 111.099 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -77.97 128.69 34.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 3.0 pt -112.58 148.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 112.158 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 13.0 ttp180 -121.77 128.95 52.29 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -127.74 133.18 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 110.342 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -157.16 170.87 21.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.828 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.3 tt -71.87 130.88 42.1 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.073 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.165 -179.758 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 62.8 mtt180 . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 4.5 t -95.66 129.31 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.02 154.52 39.75 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.524 0.515 . . . . 0.0 110.818 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.741 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.5 t80 -98.97 122.45 42.25 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.929 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.698 HG12 HG12 ' A' ' 137' ' ' VAL . 2.9 m -117.54 116.9 53.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.965 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.54 151.09 18.8 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.876 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.26 5.24 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.739 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -91.56 165.45 13.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.715 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -88.59 161.84 16.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.412 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.15 -31.45 70.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.59 3.02 26.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.036 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 71' ' ' LEU . 2.3 p -86.42 138.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 120.542 0.211 . . . . 0.0 110.923 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -124.83 176.38 6.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.354 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -61.36 -31.87 71.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.196 0.598 . . . . 0.0 112.079 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -67.74 -40.91 84.1 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.57 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.33 -42.3 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.024 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.4 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.2 tt -68.41 -37.79 80.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.396 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.2 t60 -68.48 -48.59 64.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.329 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.506 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.7 -20.52 62.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -35.38 23.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.851 0.358 . . . . 0.0 111.298 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' C ' HD11 ' A' ' 90' ' ' ILE . 71.2 m-85 -97.83 -2.26 41.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -68.28 -31.11 2.95 Favored Pre-proline 0 CA--C 1.567 1.599 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.57 -24.12 60.32 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 121.922 1.748 . . . . 0.0 113.691 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.69 -31.2 46.48 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.367 0.417 . . . . 0.0 111.692 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.96 33.8 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.262 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.23 134.23 34.74 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 93' ' ' ILE . 5.4 mt -109.87 141.99 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.855 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -89.21 -64.29 1.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.673 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -145.75 153.44 40.95 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 90' ' ' ILE . 14.2 mm -119.42 123.69 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -123.46 129.34 51.1 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' PHE . 0.9 OUTLIER -128.0 124.1 23.0 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.724 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.7 119.95 7.46 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.111 1.874 . . . . 0.0 112.191 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.57 135.66 50.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.362 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.18 144.31 25.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.312 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -64.81 -34.32 78.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.54 -46.82 62.86 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.2 p -101.43 -27.66 13.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.07 25.45 8.93 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.25 0.62 . . . . 0.0 111.709 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -121.87 154.99 36.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.648 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -106.78 164.39 12.14 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.415 0.447 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -88.02 -1.49 58.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 100.3 25.87 8.59 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.479 -0.623 . . . . 0.0 114.57 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.9 p90 -145.07 147.11 32.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.445 0.622 . . . . 0.0 111.108 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.91 167.31 27.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.264 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.473 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 75.9 m-85 -111.65 137.49 49.47 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.476 HG23 ' CD1' ' A' ' 93' ' ' ILE . 7.1 p -112.55 132.09 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 O-C-N 123.243 0.34 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.9 tt0 -103.81 130.73 51.39 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.762 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 52.3 m-85 -117.12 146.99 42.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.66 -36.07 65.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.04 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.577 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -105.72 141.05 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.503 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.55 -19.99 58.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.559 0.695 . . . . 0.0 109.162 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.92 -49.96 33.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.431 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.577 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.7 p30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.1 -45.52 84.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.795 0.438 . . . . 0.0 111.135 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.39 69.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.049 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.4 72.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.143 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.03 82.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 66' ' ' LEU . 14.2 mt -70.48 -34.12 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.271 0.357 . . . . 0.0 111.473 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.96 -16.84 49.07 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -101.52 -43.71 5.82 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 61.8 mtt -124.79 44.48 2.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.3 t30 -63.22 -37.95 89.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.618 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.3 mt-10 -142.85 77.57 1.58 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.667 0.746 . . . . 0.0 109.809 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.6 p -123.09 165.03 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.301 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -91.99 120.38 32.58 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.624 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -125.54 129.13 49.11 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.098 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 56.56 20.45 4.91 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.905 0.882 . . . . 0.0 112.814 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.67 3.85 59.39 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.848 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -126.9 153.2 46.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.86 0.33 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.2 m -78.57 132.28 37.09 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -119.54 156.46 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 14.1 ptt-85 -129.39 136.13 49.58 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.001 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -127.17 140.73 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 14.9 p-10 -150.78 171.63 16.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.805 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 mt -69.34 133.2 47.55 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.529 0.332 . . . . 0.0 111.146 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.137 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.095 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 50.9 mtm180 . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.9 132.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.15 152.56 41.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.3 t80 -100.68 116.33 32.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.583 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.33 117.7 56.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.976 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.05 153.08 19.91 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.074 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.91 26.06 5.94 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.9 0.412 . . . . 0.0 112.502 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -94.27 163.47 13.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.54 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -91.0 157.35 17.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.902 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 45.7 mt-10 -63.66 -26.9 68.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.64 0.376 . . . . 0.0 111.744 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.7 -4.05 35.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.801 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.0 m -86.71 141.1 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.671 0.272 . . . . 0.0 110.855 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.519 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -122.08 179.1 4.64 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -59.87 -30.44 68.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.845 0.458 . . . . 0.0 111.669 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.57 -40.91 80.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.721 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.519 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.1 t -66.66 -46.74 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.292 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD22 HD12 ' A' ' 93' ' ' ILE . 2.2 tt -67.02 -39.38 87.04 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.594 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.521 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 25.6 t-80 -68.01 -48.42 65.77 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.78 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.485 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.6 62.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.16 -32.7 24.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.98 0.419 . . . . 0.0 111.268 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -103.78 1.76 32.03 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.416 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -70.23 -33.12 3.14 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 19.8 Cg_endo -59.7 -23.5 71.93 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.867 1.711 . . . . 0.0 114.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -80.76 -31.26 35.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.84 -170.28 43.18 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.773 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -84.01 133.55 34.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.53 0.332 . . . . 0.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 6.9 mt -113.0 139.4 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.854 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -90.19 -62.59 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.174 -179.205 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.5 155.21 42.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.491 HD12 HD22 ' A' ' 80' ' ' LEU . 20.6 mm -116.64 124.98 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -120.13 126.23 50.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.88 117.45 20.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.961 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.68 126.64 21.85 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.313 2.009 . . . . 0.0 112.519 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -125.36 134.36 52.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.143 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.13 142.25 27.9 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.22 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -64.64 -33.46 75.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -71.05 -48.28 53.69 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.7 p -98.69 -27.75 13.84 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.445 ' O ' HD11 ' A' ' 97' ' ' LEU . 47.0 mt-10 57.92 22.59 8.89 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.178 0.591 . . . . 0.0 111.506 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -123.07 156.34 35.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.212 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.558 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 13.5 p80 -99.89 160.15 14.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.431 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 24.2 mtp180 -88.5 0.08 56.67 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 98.95 29.3 7.32 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.15 -0.548 . . . . 0.0 114.269 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 36.5 p90 -145.09 145.47 31.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.155 0.477 . . . . 0.0 111.028 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.14 165.91 34.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.105 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -111.96 143.5 42.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 93' ' ' ILE . 13.0 p -116.78 135.94 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.821 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -107.62 125.77 51.75 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.86 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 28.4 m-85 -111.12 136.08 50.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -64.66 -36.58 84.73 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.664 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.26 132.51 52.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.58 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.68 -24.54 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.206 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.74 -44.57 81.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.808 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -68.89 -32.7 72.53 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.397 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.41 -48.51 81.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.375 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.56 69.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.207 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.564 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.66 -37.41 70.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.299 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.39 88.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.828 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.69 HD11 HD22 ' A' ' 66' ' ' LEU . 14.3 mt -70.4 -38.91 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.6 p30 -76.34 -25.88 55.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.36 -50.05 9.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 63.5 mtt -132.73 58.97 1.74 Allowed 'General case' 0 C--N 1.347 0.482 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.6 t30 -67.36 -37.82 83.81 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 33.9 mt-10 -140.7 79.48 1.7 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.915 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.2 t -122.15 160.97 24.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.187 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -90.77 118.24 30.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -129.35 129.78 45.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.993 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 62.54 15.31 7.79 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.671 0.788 . . . . 0.0 112.389 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.83 3.95 59.13 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.222 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -126.02 154.22 43.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.533 0.333 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 133.74 35.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -117.81 152.91 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 1.8 tpt180 -125.54 131.43 52.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.237 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -126.95 135.68 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 123.196 0.31 . . . . 0.0 110.319 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -147.24 171.75 14.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.368 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HG ' HD13 ' A' ' 122' ' ' ILE . 8.5 mt -72.61 129.67 38.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.227 0.211 . . . . 0.0 110.894 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.0 mtt85 . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.69 HG22 ' HG2' ' A' ' 111' ' ' GLU . 14.4 t -103.49 129.42 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.973 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.92 157.81 33.42 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.501 0.501 . . . . 0.0 111.324 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.795 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 37.0 t80 -99.6 136.21 39.87 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.321 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -134.42 115.33 19.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 123.546 0.529 . . . . 0.0 109.927 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.95 149.28 19.12 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.631 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.83 19.22 9.29 Favored Glycine 0 C--N 1.331 0.298 0 O-C-N 123.914 0.42 . . . . 0.0 112.271 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.62 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -90.94 166.24 13.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 122.604 0.361 . . . . 0.0 110.438 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -90.7 156.97 17.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.44 -27.52 68.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.36 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.1 -4.75 40.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.849 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.3 m -82.52 138.12 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 120.606 0.241 . . . . 0.0 110.664 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 77.3 m-20 -119.01 178.9 4.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 22.9 m-20 -59.19 -30.93 68.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.904 0.482 . . . . 0.0 111.64 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -68.56 -40.51 80.57 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.764 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.513 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.2 t -67.32 -47.33 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.522 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.477 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.5 tt -68.14 -39.74 82.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.714 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.547 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 21.3 t-80 -68.32 -47.76 66.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.46 -20.62 62.87 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.11 -33.19 24.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.912 0.387 . . . . 0.0 111.156 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -102.31 0.79 34.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.381 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 tp -69.95 -32.75 3.08 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 14.9 Cg_endo -58.48 -23.23 63.21 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.941 1.761 . . . . 0.0 113.931 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -78.85 -31.17 45.57 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.345 0.403 . . . . 0.0 112.085 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.75 -163.74 37.45 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.898 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -82.9 135.27 34.97 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.775 0.43 . . . . 0.0 111.823 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.547 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 7.2 mt -116.85 140.34 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.389 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 9.1 p -88.47 -64.23 1.18 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.85 157.04 43.55 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.473 ' CD1' HG23 ' A' ' 110' ' ' VAL . 12.7 mm -119.38 128.75 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.428 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.458 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 65.4 mt-30 -114.96 131.81 56.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.692 0.282 . . . . 0.0 111.683 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.431 HG23 ' CD2' ' A' ' 104' ' ' HIS . 4.1 mp -126.6 102.75 25.55 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.824 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.36 121.42 9.87 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.533 2.156 . . . . 0.0 112.546 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tp -129.52 134.9 48.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.939 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -87.74 140.83 29.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -64.42 -34.31 77.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.14 -48.75 32.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.892 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.559 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.4 p -93.03 -29.22 15.93 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 50.65 32.27 6.69 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.247 0.619 . . . . 0.0 111.018 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 101' ' ' THR . 51.6 mttt -118.03 154.82 31.38 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.359 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.431 ' CD2' HG23 ' A' ' 95' ' ' ILE . 12.3 t-80 -97.32 142.45 29.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.594 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -93.95 -1.68 54.28 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.46 20.42 38.01 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 120.393 -0.908 . . . . 0.0 114.669 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -145.6 148.1 32.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.708 0.754 . . . . 0.0 111.192 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -157.49 172.78 17.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.857 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -117.94 149.32 41.1 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.3 p -125.89 136.46 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 123.257 0.348 . . . . 0.0 111.214 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.69 ' HG2' HG22 ' A' ' 65' ' ' VAL . 1.1 tm-20 -109.9 130.0 55.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.082 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 15.9 m-85 -109.42 143.2 39.31 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.974 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.26 -37.07 82.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.376 0.422 . . . . 0.0 110.624 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.575 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -105.7 141.44 37.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.898 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.01 56.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.763 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -72.25 -48.61 41.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.347 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 23.2 p30 -66.58 -32.36 73.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.974 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.973 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.88 -43.48 83.38 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.49 0.494 . . . . 0.0 111.131 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.89 69.83 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.352 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.43 75.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.13 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.98 86.35 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.781 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.712 HD11 HD22 ' A' ' 66' ' ' LEU . 35.4 mt -70.71 -33.49 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.63 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -32.75 69.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -104.32 -35.68 7.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.488 ' O ' HG13 ' A' ' 137' ' ' VAL . 77.8 mtp -103.37 14.83 30.61 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.619 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.1 t-20 -57.2 -36.69 71.15 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.691 0.281 . . . . 0.0 111.253 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.9 74.25 1.44 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.742 0.782 . . . . 0.0 109.765 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.3 p -124.09 161.25 25.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.333 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -94.31 120.59 34.78 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -128.35 128.8 45.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.808 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.22 15.82 7.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.728 0.811 . . . . 0.0 112.364 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.06 5.27 58.37 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.475 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mtp85 -127.22 154.81 44.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.427 0.291 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -81.12 132.97 35.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.1 pt -119.41 154.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 55.5 mtt85 -123.04 133.58 54.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.186 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.99 136.08 59.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.531 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -149.82 171.86 16.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.74 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.459 ' HG ' HD13 ' A' ' 122' ' ' ILE . 11.6 mt -71.98 128.85 37.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.606 0.241 . . . . 0.0 110.898 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.421 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.309 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 120.581 0.229 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 111' ' ' GLU . 14.6 t -104.74 135.88 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.982 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.21 155.31 37.37 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.358 0.411 . . . . 0.0 111.473 -179.084 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.784 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.3 t80 -96.32 135.1 38.62 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.171 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 m -134.37 115.65 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.333 0.396 . . . . 0.0 110.006 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.42 154.41 21.04 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.94 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.87 26.49 6.71 Favored Glycine 0 C--N 1.332 0.352 0 O-C-N 123.935 0.432 . . . . 0.0 112.309 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -92.9 159.88 15.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.955 0.407 . . . . 0.0 110.652 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -83.62 154.08 23.94 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.027 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 24.1 tp10 -60.03 -30.89 69.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.678 0.391 . . . . 0.0 111.454 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -72.17 -18.7 61.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -68.58 139.03 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.686 0.279 . . . . 0.0 111.487 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.402 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.8 m-20 -117.63 179.03 4.18 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.31 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -61.96 -28.95 69.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.972 0.415 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.05 -40.53 78.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 36.6 t -64.86 -46.48 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.084 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.7 tt -65.77 -39.57 91.13 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.908 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.616 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 23.7 t-80 -68.49 -47.97 65.65 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.944 0.498 . . . . 0.0 111.82 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.31 -20.59 63.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.42 23.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 75.0 m-85 -102.38 1.39 35.37 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.239 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 82' ' ' ALA . 4.0 tp -70.79 -31.62 2.16 Favored Pre-proline 0 CA--C 1.565 1.553 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.3 Cg_exo -59.5 -23.9 72.68 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.954 1.769 . . . . 0.0 113.859 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.567 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 60.1 m-85 -78.89 -31.31 45.36 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.95 -163.28 36.69 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.032 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -83.85 134.34 34.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.868 0.467 . . . . 0.0 111.97 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.616 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 6.2 mt -116.67 139.81 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.426 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 6.4 p -86.97 -61.23 1.77 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.817 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -152.53 159.67 43.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.948 0.404 . . . . 0.0 111.949 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.445 ' CD1' HG23 ' A' ' 110' ' ' VAL . 18.7 mm -115.23 124.58 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -117.76 127.45 53.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.233 0.333 . . . . 0.0 111.818 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.62 121.12 22.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.665 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.77 96.69 0.31 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 121.937 1.758 . . . . 0.0 112.082 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.33 135.87 48.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.234 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -87.37 141.18 28.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.67 -34.18 77.69 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -70.85 -48.8 52.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 29.9 p -95.85 -28.31 14.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 54.36 24.76 5.38 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.256 0.622 . . . . 0.0 111.672 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 101' ' ' THR . 61.5 mttt -117.13 152.27 35.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.178 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.54 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.4 p80 -103.76 157.64 16.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.227 0.329 . . . . 0.0 110.692 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -88.05 0.81 55.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.186 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 96.22 24.73 13.86 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.199 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.66 150.38 34.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 117.216 0.508 . . . . 0.0 111.037 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.36 171.09 18.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -115.73 140.2 49.43 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.3 p -116.09 134.17 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.155 0.284 . . . . 0.0 111.192 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.505 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.5 OUTLIER -106.45 126.83 52.74 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.413 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 21.8 m-85 -111.07 139.35 46.51 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.755 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.48 -37.92 89.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.78 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.585 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.3 mp -103.87 136.47 43.48 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.958 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.45 60.6 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.441 0.639 . . . . 0.0 109.374 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.4 -50.45 31.84 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.371 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 19.2 p30 -69.72 -32.13 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.878 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.982 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.18 -44.48 91.87 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.96 69.01 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.943 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.45 74.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.114 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.51 84.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.93 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.692 HD11 HD22 ' A' ' 66' ' ' LEU . 21.2 mt -70.56 -34.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.301 0.375 . . . . 0.0 111.944 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.76 -17.07 45.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -99.48 -44.48 6.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.567 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 61.4 mtt -130.18 50.55 2.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.6 t-20 -64.08 -37.1 86.22 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.962 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.8 tt0 -143.77 76.65 1.52 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.068 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.8 t -119.4 162.73 18.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.85 118.15 29.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.015 0.436 . . . . 0.0 110.796 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.35 131.77 42.24 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 t80 62.93 14.66 7.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.771 0.828 . . . . 0.0 112.307 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.9 2.31 59.59 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.204 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -126.96 156.39 41.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.559 0.344 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.22 133.71 35.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -115.66 154.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.425 0.453 . . . . 0.0 112.046 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 6.0 tpt180 -124.42 132.23 53.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.03 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.784 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -131.39 133.62 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.421 178.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -147.38 171.44 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' A' ' 122' ' ' ILE . 13.2 mt -71.21 129.78 39.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.517 0.199 . . . . 0.0 111.123 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.204 -179.518 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 52.9 mtm180 . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 t -107.49 126.63 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.789 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.56 156.16 36.26 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.363 0.414 . . . . 0.0 111.008 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.833 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 50.9 t80 -95.22 133.64 38.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.706 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 80' ' ' LEU . 4.5 m -134.77 115.27 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 123.378 0.424 . . . . 0.0 109.974 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -134.73 153.01 20.89 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.891 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.06 32.78 4.86 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 106' ' ' GLY . 1.1 mp -94.0 164.0 13.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.446 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -80.59 153.0 28.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.977 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -61.84 -26.6 68.22 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.842 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.69 9.05 22.77 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.7 m -90.63 142.24 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.383 -0.198 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.6 p30 -126.01 -175.8 3.46 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.507 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 17.3 m-20 -58.87 -33.34 70.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.725 0.41 . . . . 0.0 111.786 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -69.4 -36.27 76.59 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.914 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.581 HG23 ' OD1' ' A' ' 76' ' ' ASP . 55.9 t -69.48 -48.57 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.797 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 68' ' ' VAL . 1.9 tt -66.55 -38.82 87.92 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.625 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 27.0 t-80 -68.38 -47.96 65.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.79 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.72 62.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.21 -33.07 24.21 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 111.126 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.53 1.24 34.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.37 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.04 -32.02 2.67 Favored Pre-proline 0 CA--C 1.565 1.519 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 32.4 Cg_exo -60.39 -23.9 76.11 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 121.982 1.788 . . . . 0.0 113.922 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 44.1 m-85 -81.46 -31.53 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.69 -170.0 42.62 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.89 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.9 134.67 34.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.598 0.359 . . . . 0.0 110.894 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.513 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 5.7 mt -115.6 140.12 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.005 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 3.8 p -89.15 -62.47 1.47 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.892 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -148.09 158.42 44.06 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.038 0.447 . . . . 0.0 112.11 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.507 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 mm -118.02 125.59 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.438 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -116.11 121.98 43.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.543 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.65 118.83 21.34 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.822 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.36 114.88 2.17 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.24 1.96 . . . . 0.0 112.222 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.19 135.5 51.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.193 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -89.61 144.2 26.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.415 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.64 -35.07 79.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.22 -49.06 29.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.8 p -93.72 -28.54 15.88 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 53.55 24.64 4.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.355 0.662 . . . . 0.0 111.615 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 101' ' ' THR . 79.1 mttt -114.15 156.12 24.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.371 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -106.47 158.34 16.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.718 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -88.57 -0.13 56.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.21 25.55 13.99 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 119.56 -0.578 . . . . 0.0 114.488 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 95' ' ' ILE . 53.1 p90 -146.51 150.0 34.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.337 0.569 . . . . 0.0 111.034 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.47 169.48 24.54 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.39 143.72 45.2 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.1 p -118.48 134.95 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.717 0.294 . . . . 0.0 111.415 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -108.08 125.51 51.67 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.958 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 16.3 m-85 -106.49 138.86 41.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.981 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.94 -36.65 85.07 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.73 132.96 53.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.742 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.9 64.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -42.99 84.68 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.756 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.27 -32.82 72.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.251 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.789 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.89 -46.53 90.26 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.304 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.94 67.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.141 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.85 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.344 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.24 92.34 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.086 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.672 HD11 HD22 ' A' ' 66' ' ' LEU . 17.6 mt -70.94 -34.24 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.278 0.361 . . . . 0.0 111.74 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.87 -17.12 44.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -94.7 -48.68 5.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.499 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 64.3 mtt -133.51 59.03 1.75 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.035 0.445 . . . . 0.0 112.156 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 15.8 p30 -69.4 -36.73 77.05 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.432 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.34 79.62 1.67 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.652 0.739 . . . . 0.0 109.728 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -124.96 163.25 22.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.46 119.44 32.54 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 110.619 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -128.53 130.1 46.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.903 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.57 15.23 7.74 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.04 4.34 58.72 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 116.261 -0.427 . . . . 0.0 113.22 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -126.34 155.07 42.61 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.455 0.302 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.05 131.98 35.14 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.4 pt -117.17 149.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 123.359 0.412 . . . . 0.0 111.873 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 76.9 mtt180 -123.2 133.74 54.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.593 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.12 134.02 63.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.874 0.368 . . . . 0.0 110.421 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -150.15 172.78 14.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.668 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mt -68.95 129.66 40.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.953 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.113 -179.518 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.644 0.259 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.541 HG22 ' HG2' ' A' ' 111' ' ' GLU . 26.0 t -101.86 134.97 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.686 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -124.06 147.23 48.02 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.381 0.426 . . . . 0.0 110.582 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.1 t80 -99.93 125.13 45.89 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.924 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.673 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -118.71 118.92 59.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 123.547 0.529 . . . . 0.0 110.028 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.49 149.08 18.19 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.544 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.39 23.93 7.75 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.1 mp -90.02 168.61 11.87 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.968 0.507 . . . . 0.0 110.824 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -96.4 161.82 13.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.337 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.62 -32.2 71.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.657 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -75.7 -7.65 54.86 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.917 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 72' ' ' ALA . 1.7 p -78.44 131.08 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 120.66 0.267 . . . . 0.0 110.577 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -114.84 175.47 5.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.952 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.3 m-20 -60.69 -33.65 73.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.459 0.704 . . . . 0.0 112.131 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -67.19 -40.32 86.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.584 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.56 -45.09 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tt -69.55 -37.66 77.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.428 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.55 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 33.3 t-80 -68.14 -48.78 64.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.502 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.75 -21.25 62.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -34.32 23.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.266 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.443 ' C ' HD11 ' A' ' 90' ' ' ILE . 61.7 m-85 -98.09 -2.36 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.7 tp -69.44 -31.31 2.54 Favored Pre-proline 0 CA--C 1.566 1.596 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.97 -24.18 71.87 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.93 1.753 . . . . 0.0 113.637 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -79.64 -31.22 41.53 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.563 0.345 . . . . 0.0 111.693 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.03 37.0 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.247 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.23 132.61 36.0 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.594 0.235 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 111' ' ' GLU . 4.4 mt -109.34 142.04 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.956 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.2 p -85.73 -61.59 1.72 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.901 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -151.48 158.04 43.11 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.497 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 15.1 mm -117.73 129.8 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.57 127.89 55.57 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.75 100.66 33.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.12 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.25 119.8 6.87 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.042 1.828 . . . . 0.0 112.904 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -125.23 132.59 52.95 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.598 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -83.37 140.88 32.15 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.429 0.455 . . . . 0.0 110.676 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.62 -34.09 77.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -72.66 -48.83 35.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.068 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.543 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.7 p -95.16 -28.94 14.81 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 50.3 32.02 5.84 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.391 0.676 . . . . 0.0 111.76 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 101' ' ' THR . 85.1 mttt -115.23 150.64 35.83 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.437 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -101.53 138.31 38.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.64 1.8 57.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 90.04 22.62 35.0 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.175 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -142.83 151.13 40.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.111 0.956 . . . . 0.0 111.326 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.67 166.92 30.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.194 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.472 ' CE2' ' HD2' ' A' ' 67' ' ' TYR . 72.8 m-85 -111.33 139.55 46.64 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.463 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.6 p -118.84 132.38 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 123.307 0.379 . . . . 0.0 110.334 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HG2' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -105.74 133.1 51.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.184 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 20.4 m-85 -115.32 140.14 49.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.315 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.31 -37.03 85.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.569 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.7 mp -106.2 141.17 37.99 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.47 -19.68 59.27 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.949 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -73.92 -49.94 22.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.263 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.3 p30 -68.95 -32.43 72.02 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.88 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.9 -43.57 83.02 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.471 0.482 . . . . 0.0 111.016 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.77 69.38 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.051 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.72 -34.94 74.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.154 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.25 82.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.803 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 66' ' ' LEU . 15.3 mt -69.59 -33.53 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.357 0.41 . . . . 0.0 111.596 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -16.71 46.61 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -100.62 -44.17 5.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 62.1 mtt -126.26 45.51 2.63 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.635 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.4 t-20 -63.13 -36.61 84.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.611 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 40.8 mt-10 -141.78 79.47 1.68 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.659 0.742 . . . . 0.0 109.625 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 82.0 p -125.07 166.11 16.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.274 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -91.84 120.17 32.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -127.57 129.53 47.49 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.809 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 t80 59.23 18.85 6.93 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.921 0.888 . . . . 0.0 112.31 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.51 -9.63 64.67 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -114.98 152.68 31.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.66 0.384 . . . . 0.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -76.88 137.32 39.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -121.21 156.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.52 0.513 . . . . 0.0 112.299 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 12.8 ptt85 -129.17 132.38 47.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.567 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -125.83 136.49 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.102 0.477 . . . . 0.0 111.212 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -148.41 171.15 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HG ' HD13 ' A' ' 122' ' ' ILE . 12.0 mt -74.29 131.04 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.507 0.194 . . . . 0.0 111.171 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.531 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.154 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 79.0 mtt180 . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 19.3 t -101.63 129.43 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.921 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.83 155.34 38.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.015 -178.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.0 t80 -92.67 130.39 38.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.89 116.6 34.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.345 0.403 . . . . 0.0 110.146 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.76 157.9 22.59 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.769 -0.651 . . . . 0.0 113.026 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.69 26.72 7.9 Favored Glycine 0 C--N 1.333 0.361 0 O-C-N 123.943 0.437 . . . . 0.0 112.158 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 75' ' ' VAL . 1.6 mp -89.83 160.88 16.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.991 0.424 . . . . 0.0 110.729 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -80.66 157.49 25.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 44.3 mt-10 -65.94 -27.54 68.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -84.27 7.91 17.69 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -90.39 142.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -128.21 -176.24 3.74 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.344 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.04 -31.55 68.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.912 0.387 . . . . 0.0 111.523 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -68.46 -40.99 80.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.58 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.8 -47.39 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.911 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 93' ' ' ILE . 1.9 tt -66.55 -38.19 86.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.683 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.541 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.8 t60 -68.17 -49.22 62.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.648 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.33 62.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -33.86 23.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.972 0.415 . . . . 0.0 111.342 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 83.6 m-85 -102.56 1.36 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.389 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.3 tp -69.5 -31.73 2.75 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.8 Cg_exo -59.03 -23.46 68.79 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.979 1.786 . . . . 0.0 113.907 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.633 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 64.8 m-85 -77.34 -31.5 54.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.53 -160.27 33.71 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.696 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.58 134.63 34.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.71 0.404 . . . . 0.0 111.81 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.47 HG21 HD11 ' A' ' 93' ' ' ILE . 13.0 mt -115.76 137.23 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -92.38 -59.35 2.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.285 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.42 154.69 41.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 80' ' ' LEU . 17.2 mm -116.85 120.13 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.21 125.24 53.94 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.262 0.351 . . . . 0.0 111.354 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.32 109.42 21.26 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.573 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.34 126.23 18.05 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.274 1.983 . . . . 0.0 112.147 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 136.69 53.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.255 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -91.68 143.33 26.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -64.66 -34.96 79.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.14 -48.79 32.52 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.0 p -93.84 -28.48 15.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.21 24.38 2.78 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.386 0.675 . . . . 0.0 111.9 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 101' ' ' THR . 70.1 mttt -109.15 149.44 29.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.461 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.517 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.9 p80 -84.94 -14.36 47.86 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 67.75 -7.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.266 1.026 . . . . 0.0 113.502 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 99.25 23.73 11.01 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.29 -0.728 . . . . 0.0 114.755 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.03 152.25 40.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.794 0.797 . . . . 0.0 111.44 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.62 170.75 20.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.894 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -113.51 145.22 41.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.448 HG23 ' CD1' ' A' ' 93' ' ' ILE . 15.0 p -117.56 131.47 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -104.11 125.02 50.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.771 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 21.0 m-85 -112.27 143.07 43.97 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.053 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -69.38 -36.79 77.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.923 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.565 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.8 mp -105.62 139.95 39.44 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.057 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.34 -22.28 57.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.361 0.601 . . . . 0.0 109.896 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -70.02 -49.35 52.25 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.602 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.565 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -67.3 -31.92 72.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.868 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.921 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.28 -44.73 90.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.85 -28.72 69.18 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.025 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.1 -35.81 71.95 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.355 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.6 85.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.062 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.713 HD11 HD22 ' A' ' 66' ' ' LEU . 25.2 mt -70.87 -37.61 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 -18.71 39.85 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -97.25 -43.57 7.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.633 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 83.1 mtp -132.09 52.02 2.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.7 t30 -63.91 -40.2 95.94 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.5 mt-10 -141.25 78.26 1.63 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.402 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.9 p -122.04 164.03 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.642 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -91.44 118.96 31.01 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.1 tp -131.12 130.87 43.67 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.053 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 t80 62.42 15.11 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.694 0.798 . . . . 0.0 112.285 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.52 60.1 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -126.08 154.48 43.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.548 0.339 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.22 133.23 35.24 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.3 pt -116.43 153.78 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.095 0.474 . . . . 0.0 112.265 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -125.83 130.63 51.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.531 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.84 137.2 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.291 0.369 . . . . 0.0 110.483 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.94 171.91 15.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.59 126.29 29.28 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.448 0.299 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.139 -179.839 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 . . . . . 0 CA--C 1.543 0.684 0 CA-C-O 120.586 0.232 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.86 134.29 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.364 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.898 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.87 155.49 37.96 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.655 0.597 . . . . 0.0 111.024 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 67.1 t80 -102.32 130.85 49.15 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.463 HG12 ' CG1' ' A' ' 137' ' ' VAL . 12.6 m -126.22 124.57 66.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 O-C-N 123.533 0.52 . . . . 0.0 110.074 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 154.58 22.16 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.1 20.68 10.21 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 123.888 0.405 . . . . 0.0 112.424 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -89.6 160.44 16.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 110.664 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.511 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.08 155.54 19.39 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.978 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 43.5 mt-10 -61.69 -26.21 67.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.892 0.477 . . . . 0.0 111.933 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.44 -4.34 33.06 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.1 m -90.43 142.49 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.541 0.21 . . . . 0.0 110.786 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.599 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.8 p30 -127.71 -173.84 3.03 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.744 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.18 -32.94 71.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.764 0.425 . . . . 0.0 111.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 90.8 mttt -68.9 -40.25 79.28 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.782 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.599 HG23 ' OD1' ' A' ' 76' ' ' ASP . 44.1 t -66.25 -47.91 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.191 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -67.22 -38.41 85.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.576 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 32.3 t-80 -68.26 -48.7 64.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.54 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.55 -20.51 62.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.41 -34.39 23.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.934 0.397 . . . . 0.0 111.473 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.9 m-85 -100.79 -0.63 36.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.189 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.6 -31.92 2.81 Favored Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.95 -22.82 65.15 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 121.93 1.753 . . . . 0.0 113.867 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.44 -31.18 47.95 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.08 -162.69 36.43 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.656 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -82.53 134.21 35.2 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.604 0.362 . . . . 0.0 111.72 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.516 HG21 HD11 ' A' ' 93' ' ' ILE . 12.1 mt -114.67 139.73 39.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.365 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -90.36 -62.9 1.36 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -146.95 153.01 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.516 HD11 HG21 ' A' ' 90' ' ' ILE . 14.5 mm -117.94 123.3 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -120.27 121.67 39.19 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.84 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mp -127.7 116.57 20.97 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.979 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.88 124.57 16.0 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.254 1.97 . . . . 0.0 112.514 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.87 134.71 49.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.036 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.18 143.31 26.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.459 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -64.59 -34.6 78.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -71.65 -48.73 45.78 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.1 p -96.04 -28.02 14.83 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 56.27 24.67 8.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.221 0.608 . . . . 0.0 111.562 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -122.21 154.71 37.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.475 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 25.0 p80 -99.49 161.62 13.51 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.293 0.371 . . . . 0.0 110.802 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -86.01 -4.8 59.25 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.25 27.96 7.04 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.311 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -148.71 149.68 31.85 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.215 0.507 . . . . 0.0 110.887 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.66 39.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.345 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.467 ' CE1' ' HD1' ' A' ' 67' ' ' TYR . 90.2 m-85 -109.57 134.35 52.02 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 93' ' ' ILE . 9.1 p -112.01 132.93 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.327 0.392 . . . . 0.0 110.54 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.445 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -107.14 128.8 54.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.615 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -114.14 145.11 42.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.928 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.76 -37.08 76.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.589 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.584 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.9 mp -105.38 137.68 42.79 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.058 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.07 -19.75 59.85 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.172 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -71.15 -49.98 38.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.152 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.7 p30 -69.29 -31.77 70.49 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.898 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.45 -44.73 90.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.99 0.516 . . . . 0.0 111.334 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.84 69.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.073 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.59 -35.16 75.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.962 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.53 -38.73 81.09 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.718 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.706 HD11 HD22 ' A' ' 66' ' ' LEU . 72.5 mt -69.78 -33.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 123.096 0.247 . . . . 0.0 111.195 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.33 -35.71 73.8 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -102.53 -36.01 8.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.465 1.284 . . . . 0.0 114.465 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.492 ' O ' HG13 ' A' ' 137' ' ' VAL . 90.9 mmm -90.74 0.43 57.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.653 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.9 t-20 -56.68 -37.01 70.26 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.747 0.248 . . . . 0.0 111.602 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -140.78 71.89 1.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.371 0.605 . . . . 0.0 109.516 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m -121.13 154.03 36.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.295 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -92.01 119.17 31.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.427 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -127.9 127.42 43.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.925 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 61.89 15.91 7.57 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.736 0.814 . . . . 0.0 112.399 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.45 -9.09 62.57 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.01 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -113.45 149.52 34.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.811 0.444 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.46 138.45 36.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.671 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.11 156.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.843 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 10.2 ptp180 -128.32 134.06 48.82 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.181 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.12 143.64 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.384 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -141.8 171.1 14.52 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.976 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tt -81.51 125.55 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.14 -179.764 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 120.622 0.249 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 111' ' ' GLU . 5.8 t -103.21 134.72 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.429 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.854 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -123.35 155.46 37.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.866 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 76.8 t80 -93.56 137.46 32.81 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.417 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.64 123.42 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 123.598 0.561 . . . . 0.0 110.226 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.98 151.57 20.48 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.135 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.79 15.71 12.81 Favored Glycine 0 C--N 1.334 0.423 0 O-C-N 123.996 0.468 . . . . 0.0 112.57 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -88.48 164.64 15.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.766 0.317 . . . . 0.0 110.637 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.47 154.36 20.09 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.57 -30.34 69.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.556 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.53 1.8 13.29 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.978 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.9 m -88.95 137.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.598 0.237 . . . . 0.0 110.769 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.4 p30 -117.49 -175.77 2.88 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -61.98 -31.16 71.49 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.693 0.397 . . . . 0.0 112.042 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -35.62 76.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.879 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.581 HG23 ' OD1' ' A' ' 76' ' ' ASP . 61.8 t -69.75 -49.03 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -66.96 -38.64 86.47 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.74 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 31.2 t-80 -68.62 -47.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.742 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.27 -20.89 63.02 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.3 -33.98 23.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.009 0.433 . . . . 0.0 111.178 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 70.0 m-85 -100.39 0.04 39.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.254 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.0 tp -69.36 -31.89 2.9 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 44.8 Cg_exo -59.27 -22.93 67.48 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.879 1.719 . . . . 0.0 113.822 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.63 -31.63 36.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.92 35.49 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.798 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -83.18 137.49 34.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.718 0.407 . . . . 0.0 112.027 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 93' ' ' ILE . 6.8 mt -117.53 138.21 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.519 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.48 -62.1 1.51 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -145.09 153.13 41.09 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 90' ' ' ILE . 18.1 mm -119.58 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.529 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 5.8 tp60 -114.38 135.06 54.5 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.263 0.352 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mm -121.81 101.09 42.88 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.91 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.69 124.41 14.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.214 1.943 . . . . 0.0 112.382 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.54 132.12 53.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.961 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.93 141.73 28.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -64.74 -33.56 76.26 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.97 -48.8 51.29 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.1 p -100.59 -28.62 12.77 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 53.08 29.99 8.93 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.253 0.621 . . . . 0.0 111.673 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 101' ' ' THR . 34.1 mttt -121.18 156.89 31.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.193 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -89.42 139.22 30.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.69 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -99.01 3.31 46.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 93.84 21.77 27.54 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 114.741 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -146.05 150.82 36.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.655 0.728 . . . . 0.0 111.13 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -162.33 -179.83 7.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.875 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.463 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 85.3 m-85 -119.51 151.8 37.99 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.1 p -122.71 132.97 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 123.325 0.391 . . . . 0.0 110.495 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.497 ' HG3' HG22 ' A' ' 65' ' ' VAL . 21.1 tt0 -106.04 130.18 54.0 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.287 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.02 147.39 42.38 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.46 -37.94 71.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.456 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.6 mp -106.7 137.3 44.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.024 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.19 -19.62 60.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.253 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -70.8 -50.03 40.04 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.235 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.604 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 13.3 p30 -68.99 -31.71 70.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -63.7 -44.46 93.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.298 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -30.34 70.3 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.08 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.32 -34.72 75.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.845 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.25 -38.14 81.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.6 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.675 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 74.6 mt -68.79 -35.56 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.129 0.268 . . . . 0.0 111.124 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.17 -37.15 78.04 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -101.14 -35.44 9.31 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.496 ' O ' HG13 ' A' ' 137' ' ' VAL . 92.6 mmm -91.95 1.17 57.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.675 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.8 t-20 -57.16 -37.48 72.13 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -140.04 70.28 1.36 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.398 0.618 . . . . 0.0 109.523 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -122.24 157.42 31.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.217 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.88 122.32 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.04 129.46 42.03 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.879 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 62.25 15.43 7.55 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.675 0.79 . . . . 0.0 112.393 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 5.28 59.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.273 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -126.91 154.17 44.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 122.446 0.298 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.25 134.78 35.3 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.88 158.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 O-C-N 123.4 0.438 . . . . 0.0 111.92 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 4.0 ptp180 -128.24 134.31 48.96 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.401 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.578 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.28 143.57 40.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 123.198 0.311 . . . . 0.0 111.128 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -141.75 171.25 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.152 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.14 124.42 28.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.716 0.293 . . . . 0.0 110.532 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.216 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 74.8 mtt85 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.79 129.18 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.915 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -123.32 156.87 34.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.811 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.785 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 38.8 t80 -92.91 131.48 37.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.791 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.436 HG21 HD21 ' A' ' 80' ' ' LEU . 1.5 m -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.643 0.589 . . . . 0.0 109.565 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -137.24 162.06 25.3 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.595 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.0 32.92 6.85 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.759 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.3 mp -91.08 164.86 13.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.051 0.54 . . . . 0.0 111.501 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.69 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -84.73 163.3 19.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.643 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.94 -36.35 77.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.803 0.441 . . . . 0.0 112.093 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.66 -10.77 59.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.205 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -74.31 140.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.703 0.287 . . . . 0.0 111.632 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.611 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -126.78 179.09 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.314 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 2.1 t70 -62.5 -35.72 80.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 112.675 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -65.26 -35.32 80.66 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.106 0.479 . . . . 0.0 111.013 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.611 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -66.69 -39.65 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.707 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.436 HD21 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -67.84 -37.49 81.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.283 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.556 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 26.0 t-80 -68.36 -49.65 58.73 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.342 0.401 . . . . 0.0 111.492 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.76 -20.93 62.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.05 -34.44 22.28 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.909 0.385 . . . . 0.0 111.351 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.434 ' C ' HD11 ' A' ' 90' ' ' ILE . 70.9 m-85 -98.61 -1.38 41.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.163 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.04 -31.89 3.05 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.0 Cg_exo -59.48 -23.86 72.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.953 1.769 . . . . 0.0 113.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -78.28 -31.39 48.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.5 -162.45 36.22 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.501 0.501 . . . . 0.0 112.761 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -81.77 136.91 35.41 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.684 0.393 . . . . 0.0 111.723 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.522 HG21 HD11 ' A' ' 93' ' ' ILE . 11.1 mt -115.79 139.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.703 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -92.94 -60.76 1.73 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.462 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -145.96 153.1 40.42 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.578 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 16.6 mm -120.01 119.33 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -118.57 129.28 55.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -127.92 114.61 20.51 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.729 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.78 116.49 3.29 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.216 1.944 . . . . 0.0 112.449 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.03 135.82 51.35 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.487 ' HB2' ' OG1' ' A' ' 101' ' ' THR . 9.9 m-20 -92.91 146.41 23.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.298 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.51 -36.24 83.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -77.03 -49.06 16.23 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.932 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.5 p -88.95 -28.58 20.17 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 49.81 25.3 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.607 0.763 . . . . 0.0 112.242 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 101' ' ' THR . 65.4 mttt -103.8 146.08 29.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.734 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -87.89 -15.84 35.59 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.407 0.442 . . . . 0.0 112.104 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 70.42 -6.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.251 1.02 . . . . 0.0 112.991 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.434 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.13 20.28 28.39 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-O 119.138 -0.812 . . . . 0.0 114.98 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.44 150.02 36.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.044 0.922 . . . . 0.0 111.68 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 95' ' ' ILE . . . -156.53 174.0 16.09 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.793 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.0 151.12 41.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.7 p -121.57 134.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 111.188 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 90' ' ' ILE . 21.8 tt0 -108.5 131.0 55.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.937 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 62.8 m-85 -116.59 149.16 40.13 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.417 0.448 . . . . 0.0 111.441 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.58 -38.05 70.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.562 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.7 mp -104.58 139.27 39.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.179 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.05 59.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.527 0.68 . . . . 0.0 109.186 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.94 -50.02 39.15 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.63 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.581 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -68.76 -31.96 71.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.999 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.915 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.32 -45.41 88.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.755 0.422 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.34 70.03 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.48 68.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.015 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -38.75 84.62 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.85 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.756 HD11 HD22 ' A' ' 66' ' ' LEU . 9.6 mt -70.27 -40.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.242 0.339 . . . . 0.0 111.692 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.41 -44.57 11.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.7 mtp -129.27 50.02 2.19 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 8.8 t-20 -64.36 -37.86 89.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.736 0.303 . . . . 0.0 110.887 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.1 77.63 1.59 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.712 0.767 . . . . 0.0 109.705 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.3 m -122.81 162.73 21.57 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.211 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -89.68 118.33 29.21 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.979 0.418 . . . . 0.0 110.74 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -122.14 128.44 51.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.897 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 56.81 20.51 5.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.073 0.949 . . . . 0.0 112.754 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.03 4.78 58.58 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.875 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -127.75 154.0 45.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.77 0.285 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.96 132.14 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.8 pt -119.55 153.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 68.8 mtt180 -124.08 134.82 53.3 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.24 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -129.1 135.56 61.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.191 0.52 . . . . 0.0 110.96 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -149.72 174.59 12.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 130.39 40.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.631 0.253 . . . . 0.0 111.245 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.042 -179.541 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.62 HG22 ' HG2' ' A' ' 111' ' ' GLU . 9.4 t -103.59 125.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.8 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.29 158.42 32.59 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.078 -179.103 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.89 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 36.7 t80 -96.66 123.75 40.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.88 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.562 HG12 HG12 ' A' ' 137' ' ' VAL . 2.4 m -124.47 114.56 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -133.78 160.19 23.96 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.556 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.3 33.5 6.22 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.742 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -92.13 165.78 12.98 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 124.016 0.48 . . . . 0.0 111.374 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -87.9 161.16 17.63 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.06 -33.11 73.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 0.0 111.949 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.78 4.45 25.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.804 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.742 HG11 ' HB3' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -86.16 139.26 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.859 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -124.68 174.28 7.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.26 -33.19 73.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.234 0.613 . . . . 0.0 112.23 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -66.0 -39.5 90.33 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.84 -42.28 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.729 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.1 tt -67.98 -37.38 81.45 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.665 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 22.8 t-80 -68.6 -47.86 65.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.476 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.527 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.49 -21.36 62.77 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.08 22.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.147 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 62.3 m-85 -98.14 -1.03 43.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.135 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.16 -31.78 2.5 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.3 Cg_exo -59.56 -24.11 73.8 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.942 1.761 . . . . 0.0 113.785 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.516 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 52.1 m-85 -79.05 -31.24 44.46 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.244 0.34 . . . . 0.0 111.902 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.29 -164.83 38.33 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.455 0.472 . . . . 0.0 112.764 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -82.38 136.09 35.04 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.671 0.388 . . . . 0.0 111.638 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.413 HD11 ' C ' ' A' ' 84' ' ' PHE . 4.8 mt -116.1 141.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.558 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 4.9 p -88.85 -64.15 1.19 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 123.521 0.513 . . . . 0.0 112.11 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -149.48 157.4 43.26 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.458 ' CD1' HG23 ' A' ' 110' ' ' VAL . 11.8 mm -116.56 122.85 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.74 132.14 54.89 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.3 mp -128.13 118.09 20.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.456 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.05 117.13 4.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.938 1.759 . . . . 0.0 112.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.7 mt -117.39 147.29 42.79 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.545 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -86.69 143.81 27.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.523 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -64.82 -32.0 73.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.1 -44.57 68.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.8 p -112.83 -26.47 8.54 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 56.5 21.99 6.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.648 0.779 . . . . 0.0 112.253 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -108.22 147.73 30.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.392 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -86.9 152.38 22.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 66.9 mtt-85 -89.32 2.32 54.53 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.791 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.423 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 99.39 21.45 14.93 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.466 -0.63 . . . . 0.0 114.165 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.47 ' O ' HG23 ' A' ' 95' ' ' ILE . 44.7 p90 -143.11 149.3 37.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.454 0.627 . . . . 0.0 111.481 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.42 172.09 18.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.65 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -120.01 149.08 42.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.1 p -122.74 135.5 62.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.224 0.328 . . . . 0.0 111.216 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.62 ' HG2' HG22 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -109.42 130.79 55.48 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.438 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 64.9 m-85 -112.26 142.37 44.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.77 -37.78 85.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.677 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.584 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.1 mp -103.58 136.02 44.09 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.597 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.4 -23.63 61.91 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.3 0.571 . . . . 0.0 110.399 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.07 -49.58 49.59 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.283 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.4 p30 -68.35 -32.64 72.88 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.8 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -44.88 79.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.521 0.328 . . . . 0.0 111.199 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.5 -30.19 71.35 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.821 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.559 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -70.44 -32.83 70.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.623 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.41 -38.69 88.03 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.376 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.645 HD11 HD22 ' A' ' 66' ' ' LEU . 41.3 mt -70.74 -36.6 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.354 0.409 . . . . 0.0 111.749 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.3 p30 -82.82 -16.08 49.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -98.27 -45.23 6.26 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.516 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 88.9 mtp -130.6 51.87 2.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 16.7 p30 -67.03 -36.14 81.43 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.502 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.93 80.16 1.7 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.777 0.799 . . . . 0.0 109.468 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.0 p -126.4 165.61 18.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.398 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.33 120.62 33.04 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -125.82 128.97 48.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 55.84 21.69 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.06 0.944 . . . . 0.0 112.813 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.66 4.45 59.2 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 116.186 -0.461 . . . . 0.0 114.059 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -128.63 154.7 45.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.885 0.343 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.5 m -79.33 132.08 36.32 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -118.4 153.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.433 0.458 . . . . 0.0 112.132 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 86.7 mtt180 -125.47 134.25 52.13 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.493 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.89 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -127.42 133.36 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 110.361 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -147.38 172.75 13.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 tt -67.85 125.52 26.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.693 0.397 . . . . 0.0 110.476 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.114 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 45.9 t -99.38 135.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.82 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -124.08 151.25 44.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 110.909 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 66.0 t80 -94.45 129.46 41.2 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.519 HG12 HG12 ' A' ' 137' ' ' VAL . 5.0 m -126.21 121.46 59.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 123.468 0.48 . . . . 0.0 110.202 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.35 153.0 20.59 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.645 0.591 . . . . 0.0 112.961 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.8 10.38 Favored Glycine 0 C--N 1.334 0.441 0 O-C-N 124.015 0.479 . . . . 0.0 112.442 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.74 161.44 17.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.798 0.333 . . . . 0.0 110.672 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.5 158.22 17.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.228 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.61 ' HA ' ' HE2' ' A' ' 104' ' ' HIS . 44.6 mt-10 -64.32 -27.76 69.25 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.648 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.92 -2.54 34.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.887 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.7 m -86.11 138.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 120.689 0.28 . . . . 0.0 110.738 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.484 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.3 m-20 -117.94 178.56 4.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.598 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.89 -28.82 69.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.566 0.346 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.82 -40.71 79.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.49 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 5.2 t -65.88 -45.81 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.087 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -65.91 -39.21 90.38 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.571 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 26.9 t-80 -68.31 -48.49 64.78 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.763 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.28 62.99 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.42 -35.41 23.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 82.2 m-85 -100.25 -0.43 38.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.159 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.8 tp -68.07 -32.59 4.17 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.69 -22.87 69.34 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.773 1.649 . . . . 0.0 113.89 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -81.18 -31.46 34.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.35 -167.86 40.05 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.098 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.06 131.79 34.77 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.684 0.394 . . . . 0.0 111.183 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.513 HG21 HD11 ' A' ' 93' ' ' ILE . 9.2 mt -112.98 135.88 51.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.388 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -91.3 -58.73 2.35 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.544 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -146.57 152.97 39.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.513 HD11 HG21 ' A' ' 90' ' ' ILE . 19.4 mm -118.23 115.14 47.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -114.53 122.77 47.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.035 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -127.43 123.23 23.11 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.602 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.15 127.6 18.73 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.226 1.951 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.64 135.6 47.06 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -94.01 146.33 24.02 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -64.6 -36.03 82.91 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.55 -49.2 19.35 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.5 p -92.57 -28.58 16.66 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 52.46 22.99 2.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.265 0.626 . . . . 0.0 111.885 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 101' ' ' THR . 66.2 mttt -107.44 148.48 29.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.67 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 21.8 p80 -93.0 -9.39 39.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.016 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 71.61 -18.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.359 1.063 . . . . 0.0 113.063 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.495 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.9 26.07 4.56 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 119.507 -0.607 . . . . 0.0 114.551 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -147.5 145.58 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.604 0.702 . . . . 0.0 111.213 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.403 ' HB2' HG23 ' A' ' 95' ' ' ILE . . . -152.58 168.26 26.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.949 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -113.29 140.93 47.58 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 93' ' ' ILE . 7.8 p -116.22 135.22 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 90' ' ' ILE . 19.0 tt0 -104.79 125.59 51.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.261 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -111.52 138.38 48.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.088 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -66.35 -37.0 84.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.65 134.19 52.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.94 63.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.45 -49.54 63.2 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.08 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -68.67 -32.47 72.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.82 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.94 -44.09 97.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.534 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.07 68.82 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.252 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.94 73.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.243 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.82 -37.95 87.62 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.717 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.734 HD11 HD22 ' A' ' 66' ' ' LEU . 64.8 mt -69.99 -33.89 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.022 0.201 . . . . 0.0 111.125 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.44 -35.9 80.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -102.58 -35.03 8.87 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.503 ' O ' HG13 ' A' ' 137' ' ' VAL . 95.6 mmm -92.07 0.57 57.47 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.4 t-20 -56.49 -37.37 70.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.827 0.285 . . . . 0.0 111.728 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -141.9 73.49 1.41 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.345 0.593 . . . . 0.0 109.504 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.2 p -125.41 157.2 37.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.25 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -94.99 120.05 34.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.612 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.11 129.83 44.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.985 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.9 t80 62.64 15.1 7.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.747 0.819 . . . . 0.0 112.366 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.62 4.61 58.04 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.402 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -127.58 154.11 45.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.741 0.271 . . . . 0.0 110.999 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -83.0 134.62 35.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 pt -119.8 156.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 123.421 0.451 . . . . 0.0 112.113 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 31.7 ptt180 -126.06 132.94 51.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.211 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -128.98 140.19 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.062 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -144.31 170.26 16.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 119.81 15.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.153 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.086 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 76.1 mtt85 . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 111' ' ' GLU . 6.0 t -106.5 131.3 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.636 HD22 HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -123.45 156.95 34.55 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.459 0.475 . . . . 0.0 110.837 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.865 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 48.0 t80 -98.71 134.8 41.12 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.704 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 137' ' ' VAL . 2.6 m -134.11 114.82 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.9 150.52 19.37 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.656 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.62 36.77 3.67 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.784 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.3 mp -94.4 164.73 12.89 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.004 0.431 . . . . 0.0 111.227 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.77 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -88.7 164.44 15.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.499 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.38 -32.79 72.04 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.14 5.73 21.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.24 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.784 HG11 ' HB3' ' A' ' 71' ' ' LEU . 3.9 p -86.41 136.07 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 120.648 0.261 . . . . 0.0 110.854 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -122.35 174.58 6.92 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.467 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.0 m-20 -61.65 -32.53 72.69 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.146 0.578 . . . . 0.0 112.045 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -67.37 -40.25 85.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.684 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.2 -43.08 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.967 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -68.46 -36.47 79.05 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.809 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 22.4 t-80 -68.56 -49.51 58.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.595 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.522 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -71.0 -20.91 62.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.64 -34.35 23.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.209 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 64.9 m-85 -98.14 -2.46 39.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.102 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.4 tp -67.13 -32.35 4.66 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.5 -23.54 71.21 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 121.782 1.655 . . . . 0.0 113.795 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 45.0 m-85 -80.3 -31.62 38.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.23 -168.05 40.94 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 123.467 0.48 . . . . 0.0 112.738 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -84.88 133.19 34.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.566 0.347 . . . . 0.0 111.148 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.3 mt -114.08 138.9 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.643 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.1 p -89.89 -60.31 1.97 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.951 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -149.06 159.22 44.43 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.441 ' CD1' HG23 ' A' ' 110' ' ' VAL . 17.7 mm -117.93 126.98 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -121.01 126.96 51.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -128.13 115.88 20.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.698 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.45 126.87 22.67 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.284 1.989 . . . . 0.0 112.623 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -127.53 135.09 49.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.173 -179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -91.32 144.17 25.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -34.9 79.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -71.21 -48.63 50.33 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 p -98.7 -27.69 13.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' HD11 ' A' ' 97' ' ' LEU . 51.4 mt-10 57.18 22.84 7.96 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.29 0.636 . . . . 0.0 111.674 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -121.32 155.44 34.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.292 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -101.32 160.85 14.07 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.236 0.335 . . . . 0.0 110.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 77.9 mtt180 -88.55 2.95 52.03 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.197 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 96.34 27.13 10.23 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.326 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.4 p90 -143.6 148.98 36.68 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.372 0.586 . . . . 0.0 111.127 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.54 169.5 22.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -117.3 144.08 45.25 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.441 HG23 ' CD1' ' A' ' 93' ' ' ILE . 10.6 p -120.99 134.53 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.211 0.319 . . . . 0.0 111.01 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.5 OUTLIER -106.53 128.49 54.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.32 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 13.6 m-85 -109.25 137.16 47.55 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.04 -35.82 82.39 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.54 134.26 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.82 -26.42 65.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.31 -44.1 84.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.873 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -68.49 -33.06 73.5 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.58 -46.16 91.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.28 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.29 -28.79 66.59 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.314 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.88 72.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.507 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.01 88.78 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.223 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.781 HD13 HD22 ' A' ' 139' ' ' LEU . 12.8 mt -70.73 -33.65 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 123.252 0.345 . . . . 0.0 111.875 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.13 -17.31 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -101.22 -43.03 6.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.506 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 84.7 mtp -126.24 47.41 2.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 19.0 p-10 -66.29 -33.92 76.83 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.328 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.1 mt-10 -143.06 77.47 1.57 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.733 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.6 m -123.56 162.57 22.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.179 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.32 119.7 30.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.87 0.367 . . . . 0.0 110.77 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.8 129.63 48.7 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.003 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 57.22 20.59 5.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 112.693 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.99 3.99 60.3 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.893 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -127.66 155.08 44.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.686 0.243 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.0 131.25 35.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -116.83 151.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 74.6 mtt180 -122.72 134.3 54.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -128.16 133.78 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.459 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -147.13 172.67 13.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.665 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.781 HD22 HD13 ' A' ' 122' ' ' ILE . 1.9 mm? -67.9 127.42 32.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.704 0.402 . . . . 0.0 110.66 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.128 -179.651 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 72.5 mtt85 . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.663 0.268 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 111' ' ' GLU . 22.0 t -104.95 136.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.632 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.98 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.88 155.97 37.11 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.554 0.533 . . . . 0.0 111.386 -178.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.769 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.0 t80 -92.71 134.79 34.69 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.437 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.545 HG12 HG12 ' A' ' 137' ' ' VAL . 2.6 m -134.64 115.18 19.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 O-C-N 123.654 0.596 . . . . 0.0 109.663 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.22 152.31 20.35 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.989 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.89 8.03 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.99 0.465 . . . . 0.0 112.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -92.01 164.76 13.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.573 0.349 . . . . 0.0 110.592 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -91.09 155.52 18.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.739 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.08 -26.16 68.7 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.67 0.388 . . . . 0.0 111.749 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.79 -3.03 32.72 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.689 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -86.3 135.51 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.907 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -109.49 174.86 5.68 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.547 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -60.52 -29.63 69.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.567 0.347 . . . . 0.0 111.57 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -68.81 -35.39 76.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.42 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.79 -47.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.792 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 68' ' ' VAL . 1.5 tt -67.62 -38.88 84.56 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.614 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.543 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 33.1 t-80 -67.67 -48.94 65.2 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.446 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.59 -20.36 62.78 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.84 -34.04 24.73 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 111.456 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' C ' HD11 ' A' ' 90' ' ' ILE . 77.5 m-85 -102.34 0.2 33.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.433 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -68.83 -32.81 3.75 Favored Pre-proline 0 CA--C 1.565 1.525 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 15.1 Cg_endo -58.61 -23.42 65.22 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 121.94 1.76 . . . . 0.0 113.941 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -78.34 -31.39 48.64 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.87 -161.94 34.81 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.998 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.71 134.79 34.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.689 0.396 . . . . 0.0 111.833 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.514 HG21 HD11 ' A' ' 93' ' ' ILE . 15.2 mt -116.63 138.67 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -94.21 -60.8 1.65 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 111' ' ' GLU . 75.4 m-20 -143.86 153.19 42.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.514 HD11 HG21 ' A' ' 90' ' ' ILE . 20.8 mm -119.46 124.64 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.59 127.56 54.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.71 114.37 20.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.935 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.28 130.88 37.99 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.399 2.066 . . . . 0.0 112.734 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.09 132.53 50.61 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.131 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -94.25 142.76 27.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.355 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -64.69 -34.28 77.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.8 -42.58 81.35 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 19.1 p -112.65 -26.71 8.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 60.82 19.61 9.81 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.347 0.659 . . . . 0.0 111.397 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -122.43 155.34 36.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.343 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -107.03 157.88 17.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.645 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -82.75 -1.39 51.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.326 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.57 41.64 2.49 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-O 119.807 -0.44 . . . . 0.0 113.836 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -147.28 147.47 30.43 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.85 0.357 . . . . 0.0 110.961 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.27 172.76 17.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -115.57 142.33 46.87 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.7 p -114.05 134.51 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 123.213 0.321 . . . . 0.0 110.599 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HG3' HG22 ' A' ' 65' ' ' VAL . 17.0 tt0 -108.26 125.64 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.618 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 30.0 m-85 -112.42 137.61 50.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.56 -36.71 84.58 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.58 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.6 mp -105.74 140.23 39.1 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.38 -22.51 57.44 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.924 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -72.8 -49.55 29.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.58 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 21.3 p30 -67.03 -32.3 73.41 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.653 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.98 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.6 -42.73 91.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.01 0.524 . . . . 0.0 111.036 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.1 69.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.209 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.18 -37.31 78.11 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.934 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.05 -38.08 87.47 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.454 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.764 HD11 HD22 ' A' ' 66' ' ' LEU . 44.2 mt -70.16 -33.0 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 123.234 0.334 . . . . 0.0 111.281 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.83 -36.18 77.87 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -105.56 -33.04 8.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.485 ' O ' HG13 ' A' ' 137' ' ' VAL . 98.0 mmm -95.85 3.98 53.21 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.647 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.6 t-20 -56.57 -37.52 70.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.845 0.293 . . . . 0.0 111.764 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.06 72.85 1.4 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.695 0.76 . . . . 0.0 109.94 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.1 t -124.71 157.33 35.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -93.8 120.85 34.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.6 tp -128.48 128.21 43.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.806 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.98 7.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.658 0.783 . . . . 0.0 112.437 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.92 58.25 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.447 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -127.51 153.81 45.89 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.428 0.291 . . . . 0.0 110.778 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -82.08 134.17 35.32 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.27 154.36 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 73.7 mtt180 -122.26 134.3 54.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.359 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -130.95 138.38 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.896 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -151.67 172.18 16.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' HG ' HD13 ' A' ' 122' ' ' ILE . 19.7 mt -70.29 129.9 40.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.553 0.216 . . . . 0.0 111.118 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.459 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 139' ' ' LEU . 67.0 ttt180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.614 0.245 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 111' ' ' GLU . 18.9 t -106.63 136.38 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.976 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.0 157.58 34.08 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.457 0.473 . . . . 0.0 111.709 -178.269 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.824 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 42.8 t80 -96.38 136.16 37.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.302 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.446 HG12 HG12 ' A' ' 137' ' ' VAL . 4.1 m -134.39 115.09 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 109.718 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.04 142.52 13.75 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.821 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.8 29.52 2.61 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.946 0.439 . . . . 0.0 112.616 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER -97.11 163.31 12.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.929 0.395 . . . . 0.0 110.549 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -84.61 155.79 21.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.13 -27.64 68.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.64 0.376 . . . . 0.0 111.608 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.61 -0.28 29.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.951 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -84.7 140.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.127 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.81 178.71 4.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -59.31 -31.22 68.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.742 0.417 . . . . 0.0 111.482 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.42 -39.97 81.39 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.07 -47.51 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.894 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD22 HD12 ' A' ' 93' ' ' ILE . 1.7 tt -67.62 -38.96 84.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.553 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 24.0 t-80 -68.69 -47.64 65.93 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.657 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.33 -20.69 62.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -32.96 23.65 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 74.9 m-85 -102.32 1.16 35.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.319 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.22 -31.64 2.41 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.362 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.6 Cg_exo -59.21 -24.01 72.06 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 121.967 1.778 . . . . 0.0 113.861 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.551 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 55.2 m-85 -79.91 -31.45 40.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.18 -161.51 35.11 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.95 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.16 136.56 33.93 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.793 0.437 . . . . 0.0 111.864 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.553 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 5.8 mt -116.66 139.24 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.595 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -93.71 -61.27 1.58 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.656 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -143.26 153.51 42.86 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.554 HD12 HD22 ' A' ' 80' ' ' LEU . 18.3 mm -119.84 125.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.81 125.99 50.81 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.23 0.331 . . . . 0.0 111.721 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.35 110.81 21.22 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.04 128.44 27.81 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.43 2.087 . . . . 0.0 112.565 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 102' ' ' GLU . 1.1 tp -124.01 134.24 53.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.165 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.23 139.64 30.41 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.504 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -64.76 -31.98 73.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.09 -41.89 94.59 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 p -117.28 -22.84 8.09 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' O ' HD11 ' A' ' 97' ' ' LEU . 46.7 mt-10 59.99 22.66 11.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.231 0.613 . . . . 0.0 111.444 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -124.84 154.5 40.92 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.348 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -110.21 154.93 22.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -79.57 -11.1 59.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.025 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.77 41.47 1.11 Allowed Glycine 0 C--N 1.341 0.847 0 C-N-CA 121.095 -0.574 . . . . 0.0 114.019 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -145.12 145.13 31.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.195 0.497 . . . . 0.0 111.103 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.99 173.09 17.05 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.966 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.94 144.5 43.98 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.453 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.2 p -116.17 131.03 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 110.692 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.496 ' HG3' HG22 ' A' ' 65' ' ' VAL . 20.3 tt0 -106.37 126.89 52.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.259 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 47.7 m-85 -111.51 141.94 44.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.05 -36.89 85.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -115.63 125.1 52.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.758 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.68 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.405 ' HB2' HD23 ' A' ' 114' ' ' LEU . 70.3 mm-40 -68.25 -47.87 66.61 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.586 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 112' ' ' PHE . 8.0 p30 -69.03 -32.43 71.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.378 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.976 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.58 -42.2 87.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.685 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.17 71.29 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.699 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.665 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -68.48 -33.66 74.54 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.692 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.83 82.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.602 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.74 HD11 HD22 ' A' ' 66' ' ' LEU . 48.0 mt -70.33 -37.76 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.7 p30 -82.94 -16.72 46.27 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -93.89 -47.86 6.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.551 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 62.7 mtt -130.87 53.49 1.97 Allowed 'General case' 0 C--N 1.346 0.434 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.1 t-20 -64.73 -37.71 88.53 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.9 mt-10 -143.18 77.22 1.56 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.728 0.775 . . . . 0.0 109.834 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.0 m -119.77 160.72 22.05 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.31 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -90.28 118.25 29.64 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.955 0.407 . . . . 0.0 110.679 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.3 tp -129.17 130.55 46.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.911 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.3 t80 62.86 15.07 7.94 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.727 0.811 . . . . 0.0 112.232 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.19 4.69 59.74 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.209 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -126.93 155.48 43.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.572 0.349 . . . . 0.0 110.817 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.15 133.32 35.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.2 pt -118.05 151.77 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 57.7 mtt180 -122.81 134.71 54.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.424 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.824 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.73 134.99 61.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.89 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -154.2 172.13 18.09 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.494 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.603 HD12 ' NH2' ' A' ' 64' ' ' ARG . 5.4 tt -69.21 129.69 40.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.578 0.228 . . . . 0.0 110.628 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.136 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 133.13 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.93 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.11 156.99 33.87 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.535 0.522 . . . . 0.0 111.411 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.0 t80 -101.04 134.61 43.78 Favored 'General case' 0 N--CA 1.458 -0.042 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.455 HG12 ' CG1' ' A' ' 137' ' ' VAL . 4.0 m -128.98 116.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 O-C-N 123.548 0.53 . . . . 0.0 109.769 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.2 152.96 18.88 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.762 -0.733 . . . . 0.0 113.384 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.02 23.72 7.6 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.985 0.462 . . . . 0.0 112.588 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -92.0 163.09 14.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -90.61 157.86 17.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.869 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.6 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 38.8 mt-10 -64.71 -26.67 68.47 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.722 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -77.41 -1.53 30.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.766 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -86.53 139.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 120.572 0.225 . . . . 0.0 110.66 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.504 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.1 m-20 -121.71 179.02 4.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.803 0.441 . . . . 0.0 111.54 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.54 -40.77 80.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.702 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.504 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.3 t -67.06 -46.98 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.212 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -67.04 -39.42 86.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.644 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.569 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 31.7 t-80 -68.07 -48.68 64.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.023 0.529 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.41 -20.62 62.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.43 -34.03 23.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 111.402 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.8 m-85 -101.54 0.21 36.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.285 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -70.25 -31.85 2.49 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.5 Cg_exo -59.01 -23.4 68.42 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.007 1.805 . . . . 0.0 113.882 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -78.02 -31.29 50.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.43 -162.67 36.26 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.827 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.88 134.0 35.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.72 0.408 . . . . 0.0 111.769 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.507 HG21 HD11 ' A' ' 93' ' ' ILE . 12.7 mt -114.41 139.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.267 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -62.63 1.42 Allowed 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.668 0.605 . . . . 0.0 112.303 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.9 154.91 41.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 90' ' ' ILE . 17.5 mm -117.2 125.51 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.07 128.22 52.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -127.73 116.72 20.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.706 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.37 121.74 10.39 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.209 1.939 . . . . 0.0 112.413 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 134.57 49.74 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.175 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.81 143.07 26.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.73 -33.47 76.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.66 -48.57 54.22 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.2 p -100.46 -27.85 13.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.82 23.88 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.235 0.614 . . . . 0.0 111.569 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -121.37 156.83 31.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.522 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 9.5 p80 -110.18 159.36 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.928 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 85.5 mtt-85 -87.77 3.6 47.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.015 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 94.51 35.02 6.07 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.594 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 1.3 p90 -143.73 147.12 33.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.65 0.262 . . . . 0.0 110.941 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.0 169.52 23.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.639 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -116.19 144.42 44.21 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.0 p -118.84 133.15 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.425 0.453 . . . . 0.0 110.434 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.05 127.33 53.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 32.2 m-85 -113.8 141.69 46.99 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.271 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -67.47 -37.23 82.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.606 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -102.77 138.95 38.99 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -19.54 59.37 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.483 0.658 . . . . 0.0 109.267 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.19 -50.99 23.29 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.754 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 24.0 p30 -69.33 -31.86 70.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.93 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.15 -45.02 86.71 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.931 0.492 . . . . 0.0 111.423 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.66 -30.51 71.22 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.6 77.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.101 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -67.29 -39.52 85.98 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.8 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 52.7 mt -69.16 -33.82 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.862 -0.154 . . . . 0.0 111.32 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -68.72 -36.4 78.37 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.36 -34.46 8.28 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.482 ' O ' HG13 ' A' ' 137' ' ' VAL . 94.0 mmm -91.68 0.54 57.49 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 10.1 t-20 -56.64 -36.95 70.09 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.847 0.294 . . . . 0.0 111.678 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.74 70.96 1.36 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.619 0.723 . . . . 0.0 110.061 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 55.0 m -121.81 154.7 36.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.336 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.7 119.4 32.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.471 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tp -129.94 130.18 44.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.013 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 61.99 15.68 7.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.658 0.783 . . . . 0.0 112.443 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 4.92 59.22 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.298 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -127.0 154.39 44.68 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.514 0.326 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.53 134.35 34.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.02 154.79 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.024 0.44 . . . . 0.0 112.135 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 22.8 ttp-105 -124.24 131.78 53.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.785 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.27 139.49 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.316 0.385 . . . . 0.0 110.738 179.144 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -145.25 171.94 13.85 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 122' ' ' ILE . 9.2 mt -68.95 133.33 48.05 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.24 0.216 . . . . 0.0 110.921 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.34 -179.438 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.2 mtt85 . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 ' HG3' ' A' ' 111' ' ' GLU . 10.2 t -107.54 128.94 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.796 HD22 HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -123.33 155.64 36.88 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.678 -179.322 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 52.5 t80 -92.29 136.02 33.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.834 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 136' ' ' ARG . 2.9 m -134.54 115.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.43 142.23 13.5 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.563 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.26 24.9 4.3 Favored Glycine 0 C--N 1.332 0.315 0 O-C-N 123.954 0.444 . . . . 0.0 112.429 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -95.53 164.6 12.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.264 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -79.58 151.79 30.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.72 -30.42 71.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.652 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -83.88 13.61 4.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.883 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 72' ' ' ALA . 5.6 m -88.8 133.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.707 0.289 . . . . 0.0 110.856 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 2.6 t70 -102.42 173.52 6.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.457 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -59.34 -30.1 68.14 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.697 0.399 . . . . 0.0 111.248 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.44 -38.36 81.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.431 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 43.2 t -63.81 -48.32 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.017 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 HD12 ' A' ' 93' ' ' ILE . 1.8 tt -68.74 -37.25 79.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.494 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.3 t60 -68.52 -49.32 60.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.634 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.492 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.28 -20.75 63.02 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.62 -32.53 23.66 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 73.1 m-85 -103.0 2.5 35.03 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.465 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.5 tp -71.31 -31.46 1.93 Allowed Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.206 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.9 Cg_exo -59.7 -23.54 72.08 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.901 1.734 . . . . 0.0 114.033 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.67 -31.43 46.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.52 -158.41 30.71 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.49 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -85.73 139.66 31.15 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.672 0.389 . . . . 0.0 111.426 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.563 HG21 HD11 ' A' ' 93' ' ' ILE . 8.3 mt -117.09 140.54 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 p -93.86 -62.49 1.34 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.308 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.4 ' O ' HD13 ' A' ' 93' ' ' ILE . 75.8 m-20 -144.89 152.52 40.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.563 HD11 HG21 ' A' ' 90' ' ' ILE . 17.4 mm -121.04 130.59 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.617 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.482 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 86.4 mm-40 -120.51 137.1 54.55 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.222 0.326 . . . . 0.0 111.583 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.73 100.39 28.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.787 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.52 128.09 23.71 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.543 2.162 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -128.07 133.76 49.09 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.774 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.24 138.51 31.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.422 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -64.53 -33.69 76.48 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.17 -44.68 75.42 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.979 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.55 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.5 p -102.42 -29.04 11.86 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 52.86 32.56 12.64 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.19 0.596 . . . . 0.0 110.785 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 101' ' ' THR . 58.4 mttt -124.33 154.22 40.63 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.062 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -94.77 134.8 36.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.63 4.65 53.62 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.04 25.91 23.21 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.43 -0.891 . . . . 0.0 114.695 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -143.7 148.3 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 117.668 0.734 . . . . 0.0 111.378 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.09 176.34 12.39 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.539 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.05 150.45 39.96 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.471 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.0 p -121.63 134.56 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.989 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.411 ' HG3' HG22 ' A' ' 65' ' ' VAL . 20.1 tt0 -111.03 133.15 53.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.093 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 80.7 m-85 -117.19 150.62 38.43 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.42 0.45 . . . . 0.0 111.261 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -69.07 -39.04 79.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.038 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mp -111.27 141.13 45.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -21.21 62.67 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.613 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.18 -42.99 99.79 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.131 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.89 -32.05 68.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.051 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.603 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -57.64 -46.88 83.6 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.374 0.421 . . . . 0.0 111.057 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.51 63.29 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.383 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.28 63.25 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.582 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.72 91.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.796 HD11 HD22 ' A' ' 66' ' ' LEU . 16.2 mt -70.83 -43.42 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.28 -32.49 68.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -79.42 -49.6 12.1 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 64.0 mtt -135.17 63.69 1.61 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.098 0.475 . . . . 0.0 112.227 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 17.6 p30 -69.82 -35.17 74.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.044 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.7 mt-10 -142.99 78.65 1.62 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.698 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.9 m -120.58 161.23 21.68 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.282 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -90.36 117.19 28.89 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.019 0.437 . . . . 0.0 110.752 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -129.06 131.78 47.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.88 14.49 8.39 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.765 0.826 . . . . 0.0 112.189 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.16 60.28 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.237 -0.438 . . . . 0.0 113.085 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -127.66 157.19 40.94 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.612 0.365 . . . . 0.0 110.721 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.55 133.89 34.85 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.6 pt -118.19 152.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 58.6 mtt-85 -122.81 134.55 54.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.259 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.81 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.46 133.31 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 110.766 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -151.01 172.31 15.91 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.986 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.28 131.29 42.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.662 0.268 . . . . 0.0 111.369 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.158 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.112 -179.69 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 84.4 mtt180 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 20.5 t -102.44 129.29 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -123.79 158.85 30.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.304 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 31.3 t80 -93.84 132.88 37.82 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.013 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -132.51 115.49 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.91 156.45 21.73 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.355 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.14 20.82 9.39 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.146 -0.527 . . . . 0.0 112.448 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -89.32 163.11 15.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.71 156.62 18.42 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.946 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.03 -26.66 68.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.654 0.382 . . . . 0.0 111.678 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -76.95 -2.2 32.54 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.676 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -87.41 139.57 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 120.577 0.227 . . . . 0.0 110.747 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 79' ' ' VAL . 4.3 p30 -120.64 -176.64 3.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.5 -31.11 71.09 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.879 0.472 . . . . 0.0 111.788 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 91.5 mttt -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.714 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 76' ' ' ASP . 91.5 t -65.42 -47.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.056 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.433 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.4 tt -67.38 -39.14 85.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.411 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.8 t60 -68.15 -47.85 66.94 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.572 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.82 -20.22 62.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.86 -34.81 24.53 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-O 120.845 0.355 . . . . 0.0 111.38 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' C ' HD11 ' A' ' 90' ' ' ILE . 76.3 m-85 -99.87 -2.05 35.85 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.391 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 4.9 tp -68.51 -32.48 3.78 Favored Pre-proline 0 CA--C 1.566 1.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 11.4 Cg_endo -56.66 -24.81 56.47 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.035 1.823 . . . . 0.0 113.874 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -79.43 -31.32 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.287 0.367 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.9 -169.71 42.85 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.308 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -86.03 130.77 34.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.314 0.246 . . . . 0.0 110.748 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.552 HG21 HD11 ' A' ' 93' ' ' ILE . 5.5 mt -105.89 141.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.919 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 p -88.37 -60.5 1.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.757 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -146.29 153.21 40.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.552 HD11 HG21 ' A' ' 90' ' ' ILE . 18.0 mm -120.53 122.26 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.9 125.85 48.52 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.522 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mp -127.15 117.37 21.83 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.811 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.89 121.86 8.94 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.994 1.796 . . . . 0.0 112.521 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.93 136.56 54.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.076 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -86.87 139.42 30.67 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.614 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 87.4 m-85 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.06 -42.72 89.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -108.58 -27.02 10.11 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.614 ' OE2' ' HA ' ' A' ' 99' ' ' TYR . 73.2 mm-40 57.7 24.84 11.07 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.231 0.612 . . . . 0.0 111.474 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -124.48 154.88 39.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.269 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -115.34 148.71 38.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.344 0.402 . . . . 0.0 110.81 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.293 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 110.71 39.19 1.47 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.918 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.09 149.23 36.26 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 117.084 0.442 . . . . 0.0 110.823 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.58 170.96 21.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.092 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -118.02 145.55 44.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 10.4 p -118.69 137.87 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.068 0.461 . . . . 0.0 111.43 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 90' ' ' ILE . 23.1 tt0 -107.23 128.99 54.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.23 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 45.4 m-85 -116.87 146.0 43.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -70.75 -37.4 73.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.862 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.606 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -107.37 143.19 36.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -25.87 58.85 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.745 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.13 -47.24 59.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.7 p30 -67.23 -32.02 72.78 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.962 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.04 -45.18 82.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.079 0.552 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.68 70.52 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.23 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.632 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -69.67 -33.92 73.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.59 78.67 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.723 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 66' ' ' LEU . 74.3 mt -66.65 -47.68 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.632 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 4.3 p30 -67.47 -34.31 76.91 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -88.36 -35.04 17.39 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 137' ' ' VAL . 83.6 mtp -110.73 14.39 22.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.5 t-20 -57.47 -37.26 72.6 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.813 0.278 . . . . 0.0 111.572 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -142.71 77.14 1.56 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.624 0.726 . . . . 0.0 109.908 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.5 t -127.17 157.0 40.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.118 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -93.21 118.99 31.89 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.6 tp -131.0 130.41 43.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.982 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.6 15.52 8.03 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.573 0.749 . . . . 0.0 112.361 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.39 60.08 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.301 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -126.55 153.96 44.5 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.502 0.321 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.97 133.36 34.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 pt -116.1 152.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.657 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 5.0 tpt180 -124.66 128.45 48.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.599 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.43 139.18 51.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.38 0.425 . . . . 0.0 110.764 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 28.5 p30 -145.27 173.76 11.68 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.496 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.0 tt -69.79 123.67 22.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.321 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.339 0.114 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.1 mtt -101.74 136.93 40.74 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.349 0.406 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.3 mtp -101.21 141.74 33.65 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.703 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -117.5 153.45 33.14 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.121 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.0 t -122.62 143.87 49.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.744 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.77 -65.15 1.19 Allowed Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.936 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -93.72 134.76 35.71 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.364 0.265 . . . . 0.0 111.03 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 t -130.47 121.55 26.02 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.621 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -70.85 -38.36 73.17 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.559 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -126.73 154.32 44.31 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.348 0.405 . . . . 0.0 111.241 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -96.82 134.4 40.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.71 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -86.17 -39.9 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.386 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -64.97 -43.54 92.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 t -66.32 -39.13 89.08 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -69.74 -39.93 76.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.907 0.483 . . . . 0.0 111.88 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -76.71 -42.91 39.6 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.67 140.72 49.09 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.23 0.331 . . . . 0.0 111.298 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -139.73 156.79 46.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.055 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.9 tp -108.06 147.4 31.23 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.262 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -68.05 149.23 49.94 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.722 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -63.12 -35.33 79.92 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.805 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -65.6 -47.32 76.1 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.297 0.373 . . . . 0.0 111.599 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.476 ' O ' HD12 ' A' ' 27' ' ' LEU . 91.7 mmm -70.19 -37.98 75.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -66.72 -41.88 87.2 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.072 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 44.5 mt-10 -70.06 -40.83 74.84 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.536 HG21 ' HB1' ' A' ' 140' ' ' ALA . 38.7 mt -70.57 -47.34 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.0 mt -69.62 -41.42 75.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 m -77.88 -38.06 46.75 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 85.5 m-20 -93.74 10.03 34.64 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 2.2 pp -73.27 146.08 86.34 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-N 118.487 0.585 . . . . 0.0 111.865 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.3 129.84 14.43 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.732 2.288 . . . . 0.0 112.003 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -51.66 -33.23 32.77 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 81.7 p -84.32 -39.31 19.31 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.13 -28.69 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.167 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' HD13 ' A' ' 30' ' ' LEU . . . -63.55 -29.05 70.37 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.931 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -154.8 126.01 7.27 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.328 0.393 . . . . 0.0 110.87 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -123.3 135.44 54.21 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.491 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 89.8 m -98.76 -38.66 8.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.49 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.86 139.34 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 123.372 0.42 . . . . 0.0 110.065 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -95.02 133.76 38.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.488 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.2 t -111.47 139.02 47.23 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.919 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.1 p -78.24 -16.54 57.72 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.436 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.33 -36.8 79.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.79 0.436 . . . . 0.0 112.165 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -69.14 -40.03 78.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.755 0.422 . . . . 0.0 112.073 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -133.12 128.24 35.67 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.479 0.487 . . . . 0.0 110.299 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.79 142.32 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.782 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -87.72 136.84 32.78 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.132 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.02 -122.74 1.65 Allowed Glycine 0 C--N 1.336 0.566 0 O-C-N 123.628 0.58 . . . . 0.0 112.542 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.75 -175.97 46.93 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.616 -0.326 . . . . 0.0 112.977 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.0 p -69.95 -26.17 63.99 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.76 -177.79 46.56 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.448 0.468 . . . . 0.0 113.03 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.77 -77.18 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.434 -0.413 . . . . 0.0 112.437 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.0 m -63.82 -35.33 80.27 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.18 -169.88 33.77 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 116.178 -0.464 . . . . 0.0 112.999 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.81 -38.56 89.53 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 113.801 0.28 . . . . 0.0 113.801 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.4 p -123.75 151.79 42.86 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.571 0.225 . . . . 0.0 111.201 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.33 -167.43 35.72 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.001 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.9 -56.5 1.31 Allowed Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.652 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.0 m -122.25 146.93 46.81 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.667 0.275 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 139' ' ' LEU . . . -105.51 143.07 34.19 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.0 t -115.74 -1.13 12.73 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.7 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.8 p -76.81 -24.37 52.78 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.08 134.45 39.11 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.345 0.403 . . . . 0.0 110.987 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 81.3 mtm-85 -105.98 1.9 26.95 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.322 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 23' ' ' MET . 8.5 t -104.02 134.94 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.854 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.65 154.36 39.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.816 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.4 t80 -94.48 134.44 37.01 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.652 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.435 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -134.27 114.75 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.614 0.571 . . . . 0.0 109.687 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.83 146.98 18.75 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.556 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.18 23.34 6.12 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 123.881 0.4 . . . . 0.0 112.425 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.621 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -93.42 165.12 12.92 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.548 0.339 . . . . 0.0 110.262 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -81.09 151.75 28.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.044 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.58 -29.97 70.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.714 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.77 9.13 6.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 72' ' ' ALA . 3.5 m -90.55 136.93 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 120.635 0.255 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -107.79 174.72 5.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -61.42 -28.05 68.98 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.619 0.368 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.5 -39.03 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.0 -47.81 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.086 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.4 -38.27 84.4 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.354 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 46.4 t-80 -68.09 -49.07 63.56 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.566 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.44 -20.49 62.89 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.26 -33.62 24.0 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 111.271 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.33 1.88 33.35 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.437 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -69.75 -31.97 2.77 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.25 -0.881 . . . . 0.0 113.339 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.6 Cg_exo -59.8 -23.3 71.6 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.861 1.707 . . . . 0.0 113.955 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.527 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 47.8 m-85 -80.04 -31.27 39.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.89 -168.56 41.44 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.804 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.18 134.06 34.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.468 0.307 . . . . 0.0 110.97 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.562 HG21 HD11 ' A' ' 93' ' ' ILE . 9.6 mt -113.54 140.86 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.851 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 -64.99 1.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.226 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -145.34 153.84 41.68 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.562 HD11 HG21 ' A' ' 90' ' ' ILE . 21.2 mm -117.84 128.73 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.415 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 34.6 mt-30 -115.52 133.87 55.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.875 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.62 104.19 24.35 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.06 96.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.471 2.114 . . . . 0.0 112.387 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -111.56 133.63 53.69 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -85.03 141.71 30.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -64.67 -34.55 78.56 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -73.05 -49.12 30.49 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 31.3 p -93.89 -28.79 15.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 49.71 30.81 3.91 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.394 0.678 . . . . 0.0 111.823 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 101' ' ' THR . 42.8 mttt -112.24 153.41 27.17 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.346 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -101.21 143.78 30.88 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.617 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -99.12 1.62 45.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 92.28 20.82 34.26 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 120.336 -0.935 . . . . 0.0 114.904 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.82 146.73 31.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.863 0.832 . . . . 0.0 111.458 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.66 173.02 16.72 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.66 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.448 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 76.7 m-85 -118.08 150.64 39.0 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 93' ' ' ILE . 11.0 p -119.41 136.17 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 123.47 0.481 . . . . 0.0 111.027 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -106.46 121.17 43.74 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.213 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 9.1 m-85 -105.84 133.07 51.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.076 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.66 -34.73 78.89 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.794 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.81 135.9 49.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.92 61.6 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.642 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.93 -40.95 75.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.59 -31.75 71.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.425 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -62.44 -45.66 92.08 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.267 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.62 -28.98 67.39 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.267 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.527 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.27 -40.25 71.07 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.27 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.1 89.84 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.653 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.82 HD11 HD22 ' A' ' 66' ' ' LEU . 11.4 mt -71.21 -34.21 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.9 p30 -83.01 -16.77 45.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -100.02 -42.05 6.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.527 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 86.5 mtp -128.82 45.05 2.85 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.8 t-20 -63.72 -38.54 91.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.676 0.274 . . . . 0.0 111.238 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 39.3 mt-10 -142.09 78.13 1.61 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.729 0.776 . . . . 0.0 109.656 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.0 p -125.13 162.68 24.08 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -91.99 118.73 31.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.035 0.445 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.29 130.78 48.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.675 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.36 15.02 8.36 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.25 5.28 59.4 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.164 -0.471 . . . . 0.0 113.344 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -127.86 156.87 41.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.56 0.344 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.94 134.1 35.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.0 pt -120.23 154.85 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 123.37 0.419 . . . . 0.0 112.075 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 52.9 mtt180 -125.83 134.68 51.58 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.466 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.816 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.8 134.02 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.044 0.45 . . . . 0.0 110.834 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 13.4 p-10 -151.14 171.47 17.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.498 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 60' ' ' ALA . 14.3 mt -71.06 130.72 42.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.533 0.206 . . . . 0.0 111.168 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.536 ' HB1' HG21 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 111.305 0.113 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.0 mtp -99.09 122.7 42.67 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.343 0.402 . . . . 0.0 110.833 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.4 mmm -90.72 -40.33 11.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.595 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -124.56 153.48 42.07 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.487 0.492 . . . . 0.0 111.025 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.9 t -126.34 131.44 51.81 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.656 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.77 -108.11 0.72 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.636 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.78 149.0 21.6 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.467 0.307 . . . . 0.0 111.19 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -124.46 131.46 53.5 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.648 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -87.01 133.12 33.61 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.525 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtt-85 -125.88 151.28 47.1 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.579 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -94.12 111.44 23.16 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.435 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -129.74 145.66 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.562 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -57.15 -38.1 73.05 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 m -64.63 -37.2 86.77 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -64.3 -29.9 70.97 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.2 m -58.4 -39.06 78.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -108.87 123.69 49.46 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -133.26 124.74 27.89 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.068 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.71 140.54 43.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.88 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 m -62.81 153.54 32.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.735 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -61.57 -38.16 86.47 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.72 -42.51 70.49 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.494 ' O ' HD12 ' A' ' 27' ' ' LEU . 78.1 mmm -64.69 -38.45 91.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -68.82 -46.52 68.4 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.948 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -71.64 -43.77 65.54 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.8 mt -66.84 -45.83 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 23' ' ' MET . 10.6 mt -69.3 -40.46 77.67 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -74.46 -36.29 63.34 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.661 0.267 . . . . 0.0 111.186 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -115.0 90.65 3.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.436 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 mt -104.18 113.8 64.91 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.651 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.31 126.16 12.03 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.737 2.292 . . . . 0.0 111.391 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -45.29 -35.3 3.36 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.006 0.922 . . . . 0.0 113.449 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.1 m -85.62 -43.7 13.23 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.01 -32.94 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.363 0.265 . . . . 0.0 111.349 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.94 -30.27 70.36 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -159.73 143.68 14.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.761 0.315 . . . . 0.0 111.494 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.7 p -115.19 34.06 5.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.8 m -78.11 167.88 20.74 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.761 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -122.18 151.86 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.694 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -57.4 -32.02 66.42 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 43' ' ' GLU . 35.1 t -89.63 123.9 34.1 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.279 0.362 . . . . 0.0 111.418 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.7 p -96.66 2.83 52.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.662 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 45.7 mt-10 -65.94 -30.3 70.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.045 0.538 . . . . 0.0 112.429 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -105.23 134.48 48.27 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.402 0.439 . . . . 0.0 110.847 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -98.31 -6.94 29.91 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.823 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.93 134.55 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -98.86 152.8 19.34 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.28 -130.45 3.9 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.784 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.12 -179.47 47.08 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.577 -0.345 . . . . 0.0 113.144 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.2 p -126.63 154.62 43.76 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.325 0.25 . . . . 0.0 111.07 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.37 -177.23 47.24 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.978 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.82 -115.06 1.93 Allowed Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.525 -0.369 . . . . 0.0 112.486 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.7 p -116.94 151.14 37.3 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.279 0.232 . . . . 0.0 111.038 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -109.67 -126.75 5.26 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.486 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.37 -35.42 91.43 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 113.784 0.274 . . . . 0.0 113.784 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.5 p -119.19 151.92 37.5 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.365 0.266 . . . . 0.0 111.017 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.46 -174.35 41.97 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.746 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.03 -177.15 40.7 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.467 -0.396 . . . . 0.0 112.716 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.8 p -126.94 153.56 45.66 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.624 0.249 . . . . 0.0 111.157 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.61 145.02 30.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.969 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.94 -49.35 7.43 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.299 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.9 p -125.72 156.51 39.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 89.2 mttt -110.09 112.28 24.17 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.768 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -141.18 -27.98 0.68 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.4 128.67 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.539 0.209 . . . . 0.0 110.575 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.747 HD22 HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -124.14 159.73 29.38 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.66 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.755 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.7 OUTLIER -112.66 117.4 32.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.952 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -108.71 115.32 49.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 178.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -127.86 148.8 17.83 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.027 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.8 41.27 3.15 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.706 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -91.33 159.82 15.81 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.106 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.617 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -82.16 174.54 11.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.358 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -69.03 -32.51 72.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.841 0.456 . . . . 0.0 111.519 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -98.83 63.26 1.38 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.405 0.621 . . . . 0.0 111.527 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 71' ' ' LEU . 12.2 p -139.05 137.59 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.705 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.841 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.0 m-20 -140.94 -175.9 4.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.486 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.76 -37.06 86.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.85 0.46 . . . . 0.0 112.203 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -66.25 -43.52 86.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.982 0.513 . . . . 0.0 112.186 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.841 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 16.8 m -73.34 -39.53 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 123.322 0.389 . . . . 0.0 111.769 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.67 -35.75 82.04 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.519 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 24.9 t-80 -68.31 -46.2 70.91 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.517 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.12 -20.73 63.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.91 -35.12 22.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' C ' HD11 ' A' ' 90' ' ' ILE . 56.7 m-85 -97.38 -0.9 45.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.021 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -70.39 -31.67 2.35 Favored Pre-proline 0 CA--C 1.565 1.548 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.4 Cg_exo -59.73 -24.14 74.52 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.917 1.744 . . . . 0.0 113.798 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -78.05 -31.28 50.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.89 -159.14 32.13 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.458 0.474 . . . . 0.0 112.612 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -85.94 137.91 32.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.636 0.374 . . . . 0.0 111.456 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.425 HD11 ' C ' ' A' ' 84' ' ' PHE . 5.4 mt -118.4 144.33 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.809 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 1.4 p -91.2 -67.33 0.86 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.896 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -148.63 158.04 43.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' HG23 ' A' ' 110' ' ' VAL . 10.8 mm -116.94 129.4 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -126.61 127.02 44.57 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.2 mp -127.83 118.1 20.99 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.795 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.54 126.11 20.35 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.304 2.003 . . . . 0.0 112.642 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -128.02 134.67 49.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -89.55 143.38 26.86 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.278 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -64.58 -34.65 78.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.11 -48.71 41.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.8 p -94.72 -28.33 15.36 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 55.35 24.7 6.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.21 0.604 . . . . 0.0 111.513 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -120.31 156.83 30.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.1 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -92.77 158.58 15.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.973 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -88.52 0.54 56.21 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.017 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.85 19.46 29.05 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 119.453 -0.637 . . . . 0.0 114.305 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 55.1 p90 -144.55 151.15 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.464 0.632 . . . . 0.0 111.191 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.44 164.73 36.1 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.954 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -115.31 138.64 50.75 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.436 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.2 p -118.32 133.78 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.93 0.395 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.436 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 1.1 mm-40 -109.0 137.62 46.64 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.417 ' CE2' HG12 ' A' ' 90' ' ' ILE . 82.6 m-85 -117.65 147.32 43.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.21 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.87 -39.52 90.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.07 141.74 39.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.705 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -69.23 -22.13 63.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.071 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.76 -42.17 95.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.177 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.96 -33.05 71.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.586 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -61.73 -45.74 92.65 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.207 0.317 . . . . 0.0 111.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.51 -28.9 64.22 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.12 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.63 -45.24 59.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.426 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.26 90.17 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.747 HD11 HD22 ' A' ' 66' ' ' LEU . 46.8 mt -70.65 -39.98 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.67 -28.3 60.79 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.8 -49.7 10.09 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.4 mtp -135.24 61.33 1.67 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.091 0.472 . . . . 0.0 111.993 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 11.3 t-20 -69.21 -41.68 76.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.482 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.6 mt-10 -140.61 79.18 1.69 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.678 0.751 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 p -126.68 164.57 21.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.366 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -87.15 116.14 25.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.02 0.438 . . . . 0.0 110.513 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -133.31 130.49 38.97 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.136 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 64.92 17.05 10.87 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.089 0.955 . . . . 0.0 112.168 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.55 -0.19 61.24 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.735 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.97 156.8 43.2 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.353 0.261 . . . . 0.0 111.099 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -77.97 128.69 34.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 3.0 pt -112.58 148.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 112.158 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 13.0 ttp180 -121.77 128.95 52.29 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -127.74 133.18 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 110.342 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -157.16 170.87 21.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.828 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.3 tt -71.87 130.88 42.1 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.073 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.165 -179.758 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.611 0.243 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.2 mtp -101.15 137.18 39.85 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.801 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.1 mtt -95.93 129.4 43.19 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.036 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -69.51 -35.5 75.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.919 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.8 t -111.5 139.24 47.09 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.167 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.52 120.87 3.36 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.332 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -97.76 129.9 44.75 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.27 0.228 . . . . 0.0 110.924 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.6 t -133.67 131.13 39.15 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.84 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -93.55 129.42 39.8 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.924 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.88 -37.67 82.06 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.187 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -116.67 151.35 36.5 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.506 0.504 . . . . 0.0 111.079 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 m -123.87 153.32 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.293 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -64.99 -31.59 72.91 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 m -65.27 -38.34 90.0 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -69.97 -43.29 71.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -84.4 -42.15 15.98 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -108.15 151.81 25.4 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.338 0.399 . . . . 0.0 111.108 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -104.63 140.44 38.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.932 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tp -97.53 148.59 23.09 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.355 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.5 p -67.32 157.28 34.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.005 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -64.97 -36.16 83.51 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.42 ' OE2' HG23 ' A' ' 65' ' ' VAL . 29.6 tt0 -67.81 -47.38 69.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.548 0.339 . . . . 0.0 111.539 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.472 ' O ' HD12 ' A' ' 27' ' ' LEU . 90.8 mmm -68.71 -36.94 79.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -66.95 -44.18 81.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.006 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.01 -39.31 79.37 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.3 mt -70.01 -47.66 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.208 0.203 . . . . 0.0 111.269 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 23' ' ' MET . 6.9 mt -69.77 -37.23 76.32 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.3 p -76.22 -27.48 56.82 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -111.44 80.61 1.33 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.325 0.584 . . . . 0.0 110.117 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 5.4 mt -95.71 158.95 33.53 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.397 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' O ' HG13 ' A' ' 34' ' ' VAL . 6.3 Cg_exo -79.92 162.18 23.76 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.892 2.395 . . . . 0.0 113.264 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.47 -25.04 66.98 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.033 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.2 p -84.14 24.2 0.97 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.066 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -56.01 -12.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.65 -43.92 71.62 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 54.42 24.98 5.62 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.908 0.883 . . . . 0.0 112.913 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -126.59 33.05 5.05 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.942 0.401 . . . . 0.0 111.548 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.9 p -127.19 151.96 48.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.98 142.16 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.719 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -68.85 -37.86 79.39 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.045 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 46' ' ' VAL . 35.9 t -126.99 131.15 51.1 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 123.363 0.415 . . . . 0.0 111.044 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.8 p -92.61 -10.17 38.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.277 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -110.82 140.18 45.48 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.163 0.289 . . . . 0.0 111.223 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 mtp-105 -72.68 -32.83 66.1 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.211 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -72.86 -20.89 61.03 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.517 ' HB ' ' SG ' ' A' ' 41' ' ' CYS . 12.0 t -103.61 131.48 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -98.36 144.92 27.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.078 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.93 166.84 26.51 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.46 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.93 48.0 5.97 Favored Glycine 0 C--N 1.342 0.88 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.083 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.6 m -115.45 149.86 37.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 122.343 0.257 . . . . 0.0 111.138 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.17 38.32 7.34 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.822 -0.627 . . . . 0.0 113.262 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.54 175.13 43.8 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 121.473 -0.394 . . . . 0.0 113.039 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t -135.21 149.15 49.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.328 0.251 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.57 67.22 0.85 Allowed Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.922 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.26 -55.4 2.49 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.536 -0.364 . . . . 0.0 112.398 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.4 t -70.43 -35.47 73.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.867 0.467 . . . . 0.0 111.683 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.01 -173.62 40.25 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.454 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.13 -149.59 5.88 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.43 -0.415 . . . . 0.0 112.421 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -66.65 -25.29 66.51 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.74 138.89 37.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.64 -61.24 1.54 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.8 p -145.91 119.55 9.16 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.983 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mttt -130.88 137.5 49.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.14 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 62.8 mtt180 -71.92 -24.48 61.64 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.576 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.42 HG23 ' OE2' ' A' ' 22' ' ' GLU . 4.5 t -95.66 129.31 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.02 154.52 39.75 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.524 0.515 . . . . 0.0 110.818 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.741 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.5 t80 -98.97 122.45 42.25 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.929 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.698 HG12 HG12 ' A' ' 137' ' ' VAL . 2.9 m -117.54 116.9 53.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.965 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.54 151.09 18.8 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.876 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.26 5.24 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.739 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -91.56 165.45 13.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.715 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -88.59 161.84 16.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.412 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.15 -31.45 70.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.59 3.02 26.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.036 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 71' ' ' LEU . 2.3 p -86.42 138.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 120.542 0.211 . . . . 0.0 110.923 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -124.83 176.38 6.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.354 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -61.36 -31.87 71.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.196 0.598 . . . . 0.0 112.079 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -67.74 -40.91 84.1 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.57 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.33 -42.3 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.024 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.4 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.2 tt -68.41 -37.79 80.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.396 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.2 t60 -68.48 -48.59 64.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.329 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.506 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.7 -20.52 62.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -35.38 23.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.851 0.358 . . . . 0.0 111.298 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' C ' HD11 ' A' ' 90' ' ' ILE . 71.2 m-85 -97.83 -2.26 41.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -68.28 -31.11 2.95 Favored Pre-proline 0 CA--C 1.567 1.599 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.57 -24.12 60.32 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 121.922 1.748 . . . . 0.0 113.691 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.69 -31.2 46.48 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.367 0.417 . . . . 0.0 111.692 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.96 33.8 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.262 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.23 134.23 34.74 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 93' ' ' ILE . 5.4 mt -109.87 141.99 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.855 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -89.21 -64.29 1.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.673 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -145.75 153.44 40.95 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 90' ' ' ILE . 14.2 mm -119.42 123.69 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -123.46 129.34 51.1 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' PHE . 0.9 OUTLIER -128.0 124.1 23.0 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.724 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.7 119.95 7.46 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.111 1.874 . . . . 0.0 112.191 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.57 135.66 50.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.362 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.18 144.31 25.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.312 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -64.81 -34.32 78.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.54 -46.82 62.86 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.2 p -101.43 -27.66 13.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.07 25.45 8.93 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.25 0.62 . . . . 0.0 111.709 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -121.87 154.99 36.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.648 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -106.78 164.39 12.14 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.415 0.447 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -88.02 -1.49 58.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 100.3 25.87 8.59 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.479 -0.623 . . . . 0.0 114.57 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.9 p90 -145.07 147.11 32.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.445 0.622 . . . . 0.0 111.108 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.91 167.31 27.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.264 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.473 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 75.9 m-85 -111.65 137.49 49.47 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.476 HG23 ' CD1' ' A' ' 93' ' ' ILE . 7.1 p -112.55 132.09 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 O-C-N 123.243 0.34 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.9 tt0 -103.81 130.73 51.39 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.762 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 52.3 m-85 -117.12 146.99 42.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.66 -36.07 65.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.04 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.577 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -105.72 141.05 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.503 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.55 -19.99 58.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.559 0.695 . . . . 0.0 109.162 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.92 -49.96 33.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.431 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.577 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.7 p30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.1 -45.52 84.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.795 0.438 . . . . 0.0 111.135 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.39 69.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.049 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.4 72.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.143 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.03 82.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 66' ' ' LEU . 14.2 mt -70.48 -34.12 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.271 0.357 . . . . 0.0 111.473 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.96 -16.84 49.07 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -101.52 -43.71 5.82 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 61.8 mtt -124.79 44.48 2.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.3 t30 -63.22 -37.95 89.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.618 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.3 mt-10 -142.85 77.57 1.58 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.667 0.746 . . . . 0.0 109.809 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.6 p -123.09 165.03 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.301 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -91.99 120.38 32.58 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.624 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -125.54 129.13 49.11 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.098 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 56.56 20.45 4.91 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.905 0.882 . . . . 0.0 112.814 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.67 3.85 59.39 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.848 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -126.9 153.2 46.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.86 0.33 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.2 m -78.57 132.28 37.09 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -119.54 156.46 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 14.1 ptt-85 -129.39 136.13 49.58 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.001 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -127.17 140.73 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 14.9 p-10 -150.78 171.63 16.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.805 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 mt -69.34 133.2 47.55 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.529 0.332 . . . . 0.0 111.146 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.137 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.095 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 111.319 0.118 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.5 mtp -99.21 132.0 44.83 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.365 0.416 . . . . 0.0 110.837 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.8 mtp -68.8 -37.27 79.15 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.253 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -118.59 148.43 42.69 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.395 0.435 . . . . 0.0 111.164 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.2 t -130.31 133.53 46.52 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.498 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.28 -112.16 0.45 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.948 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -92.73 152.42 19.51 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.57 0.348 . . . . 0.0 111.316 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.4 t -122.25 131.04 53.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.61 150.08 20.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.21 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -119.51 141.2 49.41 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.646 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -70.47 -38.63 74.46 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -100.86 86.61 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.16 0.505 . . . . 0.0 111.454 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.35 -40.66 89.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.662 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -63.56 -38.68 92.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -69.03 -35.99 77.24 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.476 0.546 . . . . 0.0 112.476 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.2 m -85.7 -40.29 16.29 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -100.45 146.21 27.32 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.278 0.361 . . . . 0.0 111.186 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -110.17 150.57 28.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.922 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 tp -95.31 142.81 27.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.4 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.3 p -70.69 159.28 34.74 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.779 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -62.73 -35.05 78.49 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -68.12 -46.48 70.78 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.324 0.39 . . . . 0.0 111.824 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.534 ' O ' HD12 ' A' ' 27' ' ' LEU . 91.1 mmm -67.39 -39.13 85.58 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -63.67 -42.05 98.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.69 0.396 . . . . 0.0 111.772 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -70.44 -38.66 74.57 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mt -68.2 -45.78 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 122.162 0.185 . . . . 0.0 111.169 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 23' ' ' MET . 5.4 mt -69.45 -40.96 76.87 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.0 p -76.58 -29.98 56.81 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.268 0.355 . . . . 0.0 111.812 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -123.33 88.88 3.0 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.472 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.687 HD13 ' HB2' ' A' ' 35' ' ' ALA . 2.0 pp -123.12 152.76 64.06 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.109 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.39 125.8 9.9 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.495 2.13 . . . . 0.0 111.824 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -50.93 -32.91 22.23 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 37' ' ' THR . 80.9 p -82.61 -41.73 19.13 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.314 0.384 . . . . 0.0 111.89 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.94 -27.0 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.595 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' HD13 ' A' ' 30' ' ' LEU . . . -67.28 -31.43 71.74 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.753 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -166.32 -47.13 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 33' ' ' SER . 10.9 t 47.73 24.23 0.53 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.49 1.116 . . . . 0.0 113.704 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.5 m -96.18 -42.14 8.35 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.573 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.25 133.28 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 123.374 0.421 . . . . 0.0 110.099 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -113.58 130.21 56.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.135 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.5 t -120.73 116.45 25.29 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.013 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 p -97.17 -18.17 19.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.626 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.67 -33.08 73.38 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.933 0.493 . . . . 0.0 112.207 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -119.0 138.15 53.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -130.52 152.01 50.37 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.79 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.9 139.66 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.77 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -96.22 131.28 42.86 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.599 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.87 8.56 55.5 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.4 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.41 1.62 84.33 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 121.592 -0.337 . . . . 0.0 113.318 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -122.16 142.01 50.85 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.45 0.3 . . . . 0.0 110.675 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.1 -173.74 42.02 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.568 0.543 . . . . 0.0 112.767 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.58 129.39 6.65 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.588 -0.339 . . . . 0.0 112.431 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -64.21 -36.73 85.01 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.56 3.96 64.28 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.509 0.505 . . . . 0.0 113.342 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.94 -40.81 62.72 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 113.687 0.235 . . . . 0.0 113.687 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.6 p -126.13 152.58 45.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.574 0.226 . . . . 0.0 111.21 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.54 -172.87 45.53 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.676 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.64 -93.32 1.04 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.459 -0.401 . . . . 0.0 112.727 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 t -115.71 145.37 42.82 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.598 0.237 . . . . 0.0 111.071 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' O ' HD13 ' A' ' 139' ' ' LEU . . . -101.96 146.24 28.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.002 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.1 p -124.54 157.66 34.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.463 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p 48.06 38.57 9.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.284 1.034 . . . . 0.0 113.202 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 70.5 mmtt -101.78 137.23 40.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.999 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 50.9 mtm180 -104.75 -2.47 24.84 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.632 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.9 132.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.15 152.56 41.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.3 t80 -100.68 116.33 32.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.583 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.33 117.7 56.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.976 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.05 153.08 19.91 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.074 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.91 26.06 5.94 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.9 0.412 . . . . 0.0 112.502 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -94.27 163.47 13.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.54 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -91.0 157.35 17.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.902 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 45.7 mt-10 -63.66 -26.9 68.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.64 0.376 . . . . 0.0 111.744 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.7 -4.05 35.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.801 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.0 m -86.71 141.1 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.671 0.272 . . . . 0.0 110.855 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.519 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -122.08 179.1 4.64 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -59.87 -30.44 68.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.845 0.458 . . . . 0.0 111.669 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.57 -40.91 80.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.721 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.519 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.1 t -66.66 -46.74 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.292 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD22 HD12 ' A' ' 93' ' ' ILE . 2.2 tt -67.02 -39.38 87.04 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.594 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.521 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 25.6 t-80 -68.01 -48.42 65.77 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.78 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.485 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.6 62.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.16 -32.7 24.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.98 0.419 . . . . 0.0 111.268 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -103.78 1.76 32.03 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.416 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -70.23 -33.12 3.14 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 19.8 Cg_endo -59.7 -23.5 71.93 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.867 1.711 . . . . 0.0 114.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -80.76 -31.26 35.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.84 -170.28 43.18 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.773 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -84.01 133.55 34.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.53 0.332 . . . . 0.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 6.9 mt -113.0 139.4 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.854 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -90.19 -62.59 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.174 -179.205 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.5 155.21 42.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.491 HD12 HD22 ' A' ' 80' ' ' LEU . 20.6 mm -116.64 124.98 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -120.13 126.23 50.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.88 117.45 20.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.961 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.68 126.64 21.85 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.313 2.009 . . . . 0.0 112.519 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -125.36 134.36 52.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.143 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.13 142.25 27.9 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.22 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -64.64 -33.46 75.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -71.05 -48.28 53.69 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.7 p -98.69 -27.75 13.84 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.445 ' O ' HD11 ' A' ' 97' ' ' LEU . 47.0 mt-10 57.92 22.59 8.89 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.178 0.591 . . . . 0.0 111.506 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -123.07 156.34 35.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.212 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.558 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 13.5 p80 -99.89 160.15 14.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.431 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 24.2 mtp180 -88.5 0.08 56.67 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 98.95 29.3 7.32 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.15 -0.548 . . . . 0.0 114.269 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 36.5 p90 -145.09 145.47 31.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.155 0.477 . . . . 0.0 111.028 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.14 165.91 34.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.105 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -111.96 143.5 42.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 93' ' ' ILE . 13.0 p -116.78 135.94 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.821 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -107.62 125.77 51.75 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.86 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 28.4 m-85 -111.12 136.08 50.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -64.66 -36.58 84.73 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.664 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.26 132.51 52.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.58 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.68 -24.54 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.206 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.74 -44.57 81.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.808 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -68.89 -32.7 72.53 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.397 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.41 -48.51 81.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.375 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.56 69.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.207 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.564 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.66 -37.41 70.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.299 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.39 88.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.828 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.69 HD11 HD22 ' A' ' 66' ' ' LEU . 14.3 mt -70.4 -38.91 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.6 p30 -76.34 -25.88 55.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.36 -50.05 9.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 63.5 mtt -132.73 58.97 1.74 Allowed 'General case' 0 C--N 1.347 0.482 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.6 t30 -67.36 -37.82 83.81 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 33.9 mt-10 -140.7 79.48 1.7 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.915 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.2 t -122.15 160.97 24.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.187 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -90.77 118.24 30.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -129.35 129.78 45.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.993 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 62.54 15.31 7.79 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.671 0.788 . . . . 0.0 112.389 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.83 3.95 59.13 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.222 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -126.02 154.22 43.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.533 0.333 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 133.74 35.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -117.81 152.91 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 1.8 tpt180 -125.54 131.43 52.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.237 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -126.95 135.68 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 123.196 0.31 . . . . 0.0 110.319 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -147.24 171.75 14.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.368 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HG ' HD13 ' A' ' 122' ' ' ILE . 8.5 mt -72.61 129.67 38.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.227 0.211 . . . . 0.0 110.894 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.442 0.163 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 86.0 mtp -104.38 137.15 42.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.83 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.4 mtt -120.99 156.34 32.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -103.18 152.28 21.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.1 t -119.9 134.16 55.33 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.92 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.65 -30.07 12.46 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.468 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -94.32 134.93 36.29 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.603 0.239 . . . . 0.0 111.212 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -133.37 134.24 43.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.69 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -91.33 117.96 30.1 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -71.87 -41.74 67.69 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -125.72 137.11 53.81 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.188 0.305 . . . . 0.0 111.804 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.97 131.72 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.336 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -65.84 -41.64 91.51 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 m -65.25 -38.61 90.89 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.3 -35.34 80.13 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.9 m -75.89 -41.85 50.89 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.62 -39.07 70.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -131.93 151.98 51.37 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.316 0.385 . . . . 0.0 111.252 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -93.21 161.62 14.34 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.701 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.652 ' H ' HD23 ' A' ' 19' ' ' LEU . 99.9 p -65.19 158.93 24.75 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.87 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.04 -33.7 76.34 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.09 -46.06 75.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.576 ' HB2' HD22 ' A' ' 19' ' ' LEU . 23.8 mtt -73.66 -38.12 65.05 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -68.31 -45.66 72.38 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -71.31 -42.7 68.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 56.7 mt -70.34 -48.57 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 23' ' ' MET . 9.5 mt -68.95 -41.49 77.97 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 m -73.1 -34.88 66.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.551 0.215 . . . . 0.0 111.256 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -116.26 91.42 3.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.79 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 7.2 mt -109.55 107.14 59.25 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.752 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.74 129.62 19.05 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 123.022 2.481 . . . . 0.0 111.336 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -44.36 -33.55 1.68 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m -93.56 -40.62 10.2 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.64 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 54.4 t -68.15 -30.12 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.84 71.9 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.53 125.32 11.19 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.232 0.332 . . . . 0.0 110.819 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 54.65 100.54 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.946 0.898 . . . . 0.0 112.198 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.64 ' SG ' ' HA ' ' A' ' 34' ' ' VAL . 83.6 m -105.84 -49.05 3.48 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.344 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 t -124.9 136.22 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 123.44 0.462 . . . . 0.0 110.175 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -118.36 137.88 52.8 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.964 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.1 t -129.5 130.73 46.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.954 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.8 p -79.46 -27.57 41.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.409 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -111.74 153.22 26.81 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.297 0.373 . . . . 0.0 111.078 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -120.48 149.11 42.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.771 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -111.28 137.28 49.21 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.904 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -129.68 143.52 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.586 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.05 121.28 29.3 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.684 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.79 -114.42 2.77 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.25 48.22 1.57 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.874 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 m -63.48 -36.64 84.43 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.34 36.36 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 123.498 0.499 . . . . 0.0 113.232 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.48 -134.75 3.74 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.618 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.7 m -117.42 150.48 38.82 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.438 0.295 . . . . 0.0 110.899 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.94 -169.97 46.6 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.773 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.23 67.61 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 113.664 0.226 . . . . 0.0 113.664 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.3 p -115.32 150.64 35.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.401 0.281 . . . . 0.0 110.74 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.8 172.99 24.23 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.768 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.52 105.41 1.13 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.417 -0.421 . . . . 0.0 112.65 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.6 m -123.08 144.06 49.56 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.306 0.242 . . . . 0.0 110.793 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.42 140.13 44.96 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.237 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.0 p -130.65 158.23 40.6 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.563 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.6 p 56.46 -0.71 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -102.66 122.75 45.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.71 0.291 . . . . 0.0 110.945 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.0 mtt85 -122.36 -1.02 9.2 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.359 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.69 HG22 ' HG2' ' A' ' 111' ' ' GLU . 14.4 t -103.49 129.42 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.973 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.92 157.81 33.42 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.501 0.501 . . . . 0.0 111.324 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.795 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 37.0 t80 -99.6 136.21 39.87 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.321 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -134.42 115.33 19.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 123.546 0.529 . . . . 0.0 109.927 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.95 149.28 19.12 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.631 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.83 19.22 9.29 Favored Glycine 0 C--N 1.331 0.298 0 O-C-N 123.914 0.42 . . . . 0.0 112.271 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.62 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -90.94 166.24 13.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 122.604 0.361 . . . . 0.0 110.438 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -90.7 156.97 17.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.44 -27.52 68.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.36 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.1 -4.75 40.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.849 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.3 m -82.52 138.12 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 120.606 0.241 . . . . 0.0 110.664 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 77.3 m-20 -119.01 178.9 4.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 22.9 m-20 -59.19 -30.93 68.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.904 0.482 . . . . 0.0 111.64 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -68.56 -40.51 80.57 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.764 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.513 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.2 t -67.32 -47.33 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.522 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.477 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.5 tt -68.14 -39.74 82.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.714 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.547 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 21.3 t-80 -68.32 -47.76 66.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.46 -20.62 62.87 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.11 -33.19 24.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.912 0.387 . . . . 0.0 111.156 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -102.31 0.79 34.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.381 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 tp -69.95 -32.75 3.08 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 14.9 Cg_endo -58.48 -23.23 63.21 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.941 1.761 . . . . 0.0 113.931 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -78.85 -31.17 45.57 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.345 0.403 . . . . 0.0 112.085 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.75 -163.74 37.45 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.898 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -82.9 135.27 34.97 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.775 0.43 . . . . 0.0 111.823 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.547 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 7.2 mt -116.85 140.34 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.389 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 9.1 p -88.47 -64.23 1.18 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.85 157.04 43.55 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.473 ' CD1' HG23 ' A' ' 110' ' ' VAL . 12.7 mm -119.38 128.75 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.428 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.458 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 65.4 mt-30 -114.96 131.81 56.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.692 0.282 . . . . 0.0 111.683 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.431 HG23 ' CD2' ' A' ' 104' ' ' HIS . 4.1 mp -126.6 102.75 25.55 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.824 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.36 121.42 9.87 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.533 2.156 . . . . 0.0 112.546 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tp -129.52 134.9 48.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.939 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -87.74 140.83 29.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -64.42 -34.31 77.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.14 -48.75 32.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.892 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.559 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.4 p -93.03 -29.22 15.93 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 50.65 32.27 6.69 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.247 0.619 . . . . 0.0 111.018 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 101' ' ' THR . 51.6 mttt -118.03 154.82 31.38 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.359 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.431 ' CD2' HG23 ' A' ' 95' ' ' ILE . 12.3 t-80 -97.32 142.45 29.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.594 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -93.95 -1.68 54.28 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.46 20.42 38.01 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 120.393 -0.908 . . . . 0.0 114.669 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -145.6 148.1 32.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.708 0.754 . . . . 0.0 111.192 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -157.49 172.78 17.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.857 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -117.94 149.32 41.1 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.3 p -125.89 136.46 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 123.257 0.348 . . . . 0.0 111.214 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.69 ' HG2' HG22 ' A' ' 65' ' ' VAL . 1.1 tm-20 -109.9 130.0 55.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.082 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 15.9 m-85 -109.42 143.2 39.31 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.974 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.26 -37.07 82.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.376 0.422 . . . . 0.0 110.624 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.575 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -105.7 141.44 37.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.898 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.01 56.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.763 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -72.25 -48.61 41.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.347 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 23.2 p30 -66.58 -32.36 73.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.974 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.973 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.88 -43.48 83.38 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.49 0.494 . . . . 0.0 111.131 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.89 69.83 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.352 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.43 75.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.13 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.98 86.35 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.781 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.712 HD11 HD22 ' A' ' 66' ' ' LEU . 35.4 mt -70.71 -33.49 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.63 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -32.75 69.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -104.32 -35.68 7.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.488 ' O ' HG13 ' A' ' 137' ' ' VAL . 77.8 mtp -103.37 14.83 30.61 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.619 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.1 t-20 -57.2 -36.69 71.15 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.691 0.281 . . . . 0.0 111.253 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.9 74.25 1.44 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.742 0.782 . . . . 0.0 109.765 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.3 p -124.09 161.25 25.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.333 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -94.31 120.59 34.78 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -128.35 128.8 45.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.808 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.22 15.82 7.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.728 0.811 . . . . 0.0 112.364 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.06 5.27 58.37 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.475 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mtp85 -127.22 154.81 44.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.427 0.291 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -81.12 132.97 35.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.1 pt -119.41 154.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 55.5 mtt85 -123.04 133.58 54.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.186 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.99 136.08 59.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.531 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -149.82 171.86 16.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.74 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.459 ' HG ' HD13 ' A' ' 122' ' ' ILE . 11.6 mt -71.98 128.85 37.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.606 0.241 . . . . 0.0 110.898 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.421 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.309 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 111.286 0.106 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 86.8 mtp -106.42 136.97 45.25 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.43 0.456 . . . . 0.0 110.71 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.9 mtt -111.8 142.56 44.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.57 -34.12 77.2 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.4 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.5 t -108.35 131.94 54.24 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.384 0.427 . . . . 0.0 111.062 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.55 -41.27 2.76 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 123.735 0.647 . . . . 0.0 112.953 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -92.62 151.02 20.35 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.458 0.303 . . . . 0.0 111.198 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.0 t -101.78 141.41 34.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.932 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -89.67 7.7 35.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.172 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -118.87 141.3 48.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -131.26 -1.88 3.97 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.992 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.07 141.56 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -65.62 -28.44 69.12 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.979 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 m -58.1 -37.01 73.72 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.61 -36.9 83.71 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.0 m -86.5 -44.03 12.28 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.301 0.375 . . . . 0.0 112.005 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -115.01 142.36 46.74 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.395 0.435 . . . . 0.0 110.7 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.34 -44.05 22.33 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.149 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 tp -133.37 150.45 51.83 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.328 0.393 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.2 p -80.6 160.55 25.07 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.249 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.93 -39.45 92.12 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.11 -40.87 78.07 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.588 ' SD ' ' HG3' ' A' ' 111' ' ' GLU . 10.1 mtt -67.68 -39.04 84.5 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -65.33 -42.01 93.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.612 0.365 . . . . 0.0 111.687 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.81 -47.72 57.98 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 24.3 mt -67.59 -45.4 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 23' ' ' MET . 6.7 mt -68.88 -33.86 74.48 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.0 p -69.35 -35.9 76.33 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -131.65 101.45 5.49 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 123.363 0.414 . . . . 0.0 111.026 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 4.6 mt -114.69 124.75 30.03 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.149 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.04 128.51 17.78 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.427 2.084 . . . . 0.0 111.561 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -46.14 -34.4 4.23 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.9 p -89.24 -41.11 12.39 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.35 -32.62 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.248 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.09 69.5 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -156.92 130.34 8.03 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.208 0.318 . . . . 0.0 111.348 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.0 p -128.44 157.64 40.53 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.8 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 94.2 m -92.76 -50.9 5.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.308 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.45 133.27 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -116.24 -50.72 2.64 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.189 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.6 t -136.29 128.74 30.33 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.325 0.39 . . . . 0.0 110.949 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.8 p -85.23 -24.76 27.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.115 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -110.27 152.68 25.85 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 123.395 0.435 . . . . 0.0 110.425 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -110.73 142.58 42.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.65 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -91.66 -20.32 21.73 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.808 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 t -72.7 -42.24 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.708 0.403 . . . . 0.0 111.343 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -84.99 131.31 34.49 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.44 0.462 . . . . 0.0 111.294 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.11 -31.15 7.62 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.844 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.12 -166.36 39.46 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 121.766 -0.254 . . . . 0.0 112.773 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.7 p -107.72 151.4 25.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.595 0.236 . . . . 0.0 111.037 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.97 -172.0 46.05 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.074 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.43 172.31 33.62 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 121.601 -0.333 . . . . 0.0 112.822 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 m -64.75 -33.97 77.23 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.37 175.62 34.34 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.691 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.43 -50.73 3.71 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.715 -0.279 . . . . 0.0 113.284 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.8 m -121.9 149.36 43.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.607 0.242 . . . . 0.0 111.47 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.66 178.21 37.63 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.374 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.65 157.0 27.11 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.952 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.0 p -133.92 153.63 51.63 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.52 0.328 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.36 131.01 49.26 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -108.53 -12.65 14.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.963 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.2 p -84.78 -29.32 25.54 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -118.65 126.19 51.39 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.223 0.327 . . . . 0.0 111.311 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -115.39 1.83 13.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.183 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 111' ' ' GLU . 14.6 t -104.74 135.88 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.982 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.21 155.31 37.37 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.358 0.411 . . . . 0.0 111.473 -179.084 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.784 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.3 t80 -96.32 135.1 38.62 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.171 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 m -134.37 115.65 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.333 0.396 . . . . 0.0 110.006 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.42 154.41 21.04 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.94 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.87 26.49 6.71 Favored Glycine 0 C--N 1.332 0.352 0 O-C-N 123.935 0.432 . . . . 0.0 112.309 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -92.9 159.88 15.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.955 0.407 . . . . 0.0 110.652 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -83.62 154.08 23.94 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.027 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 24.1 tp10 -60.03 -30.89 69.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.678 0.391 . . . . 0.0 111.454 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -72.17 -18.7 61.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -68.58 139.03 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.686 0.279 . . . . 0.0 111.487 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.402 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.8 m-20 -117.63 179.03 4.18 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.31 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -61.96 -28.95 69.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.972 0.415 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.05 -40.53 78.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 36.6 t -64.86 -46.48 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.084 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.7 tt -65.77 -39.57 91.13 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.908 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.616 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 23.7 t-80 -68.49 -47.97 65.65 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.944 0.498 . . . . 0.0 111.82 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.31 -20.59 63.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.42 23.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 75.0 m-85 -102.38 1.39 35.37 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.239 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 82' ' ' ALA . 4.0 tp -70.79 -31.62 2.16 Favored Pre-proline 0 CA--C 1.565 1.553 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.3 Cg_exo -59.5 -23.9 72.68 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.954 1.769 . . . . 0.0 113.859 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.567 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 60.1 m-85 -78.89 -31.31 45.36 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.95 -163.28 36.69 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.032 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -83.85 134.34 34.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.868 0.467 . . . . 0.0 111.97 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.616 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 6.2 mt -116.67 139.81 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.426 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 6.4 p -86.97 -61.23 1.77 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.817 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -152.53 159.67 43.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.948 0.404 . . . . 0.0 111.949 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.445 ' CD1' HG23 ' A' ' 110' ' ' VAL . 18.7 mm -115.23 124.58 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -117.76 127.45 53.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.233 0.333 . . . . 0.0 111.818 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.62 121.12 22.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.665 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.77 96.69 0.31 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 121.937 1.758 . . . . 0.0 112.082 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.33 135.87 48.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.234 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -87.37 141.18 28.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.67 -34.18 77.69 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -70.85 -48.8 52.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 29.9 p -95.85 -28.31 14.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 54.36 24.76 5.38 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.256 0.622 . . . . 0.0 111.672 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 101' ' ' THR . 61.5 mttt -117.13 152.27 35.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.178 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.54 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.4 p80 -103.76 157.64 16.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.227 0.329 . . . . 0.0 110.692 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -88.05 0.81 55.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.186 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 96.22 24.73 13.86 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.199 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.66 150.38 34.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 117.216 0.508 . . . . 0.0 111.037 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.36 171.09 18.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -115.73 140.2 49.43 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.3 p -116.09 134.17 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.155 0.284 . . . . 0.0 111.192 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.588 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -106.45 126.83 52.74 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.413 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 21.8 m-85 -111.07 139.35 46.51 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.755 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.48 -37.92 89.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.78 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.585 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.3 mp -103.87 136.47 43.48 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.958 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.45 60.6 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.441 0.639 . . . . 0.0 109.374 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.4 -50.45 31.84 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.371 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 19.2 p30 -69.72 -32.13 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.878 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.982 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.18 -44.48 91.87 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.96 69.01 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.943 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.45 74.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.114 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.51 84.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.93 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.692 HD11 HD22 ' A' ' 66' ' ' LEU . 21.2 mt -70.56 -34.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.301 0.375 . . . . 0.0 111.944 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.76 -17.07 45.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -99.48 -44.48 6.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.567 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 61.4 mtt -130.18 50.55 2.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.6 t-20 -64.08 -37.1 86.22 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.962 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.8 tt0 -143.77 76.65 1.52 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.068 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.8 t -119.4 162.73 18.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.85 118.15 29.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.015 0.436 . . . . 0.0 110.796 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.35 131.77 42.24 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 t80 62.93 14.66 7.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.771 0.828 . . . . 0.0 112.307 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.9 2.31 59.59 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.204 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -126.96 156.39 41.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.559 0.344 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.22 133.71 35.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -115.66 154.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.425 0.453 . . . . 0.0 112.046 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 6.0 tpt180 -124.42 132.23 53.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.03 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.784 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -131.39 133.62 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.421 178.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -147.38 171.44 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' A' ' 122' ' ' ILE . 13.2 mt -71.21 129.78 39.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.517 0.199 . . . . 0.0 111.123 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.204 -179.518 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.531 0.205 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.0 mtp -101.1 137.1 39.91 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.859 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.5 mtt -102.08 144.5 30.58 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -65.31 -35.85 82.25 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.529 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.1 t -127.72 135.44 50.17 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.387 0.429 . . . . 0.0 111.196 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.55 132.01 3.67 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.244 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -98.85 139.75 34.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.613 0.244 . . . . 0.0 111.069 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 76.3 m -85.83 -37.1 19.57 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.753 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.21 136.84 35.88 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.444 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -98.01 0.01 45.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.704 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -100.46 140.8 34.2 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.09 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.09 -30.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.584 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -63.63 -30.81 71.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.103 0.561 . . . . 0.0 112.402 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.9 m -60.84 -36.3 78.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.075 0.55 . . . . 0.0 112.467 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -60.38 -38.1 82.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.034 0.533 . . . . 0.0 111.768 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.3 m -72.69 -34.64 67.31 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.136 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.93 -26.95 67.1 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.16 0.584 . . . . 0.0 112.424 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.86 160.36 29.3 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.761 0.424 . . . . 0.0 111.729 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -82.14 165.49 20.5 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.082 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.78 ' H ' HD23 ' A' ' 19' ' ' LEU . 98.9 p -62.93 159.7 16.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.953 0.501 . . . . 0.0 112.014 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.46 -31.0 72.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -64.65 -49.31 71.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.618 ' HB2' HD22 ' A' ' 19' ' ' LEU . 74.2 mmm -73.19 -39.08 65.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -69.04 -44.99 71.56 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.66 -41.21 72.38 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 53.8 mt -70.14 -47.32 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 23' ' ' MET . 8.7 mt -69.56 -41.72 75.52 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.6 m -74.43 -35.31 63.37 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -111.3 84.28 1.91 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.214 0.53 . . . . 0.0 110.266 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 4.1 mt -90.81 133.67 31.92 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.972 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 2.8 Cg_exo -76.03 29.99 0.39 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.664 2.243 . . . . 0.0 113.342 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 50.64 -80.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.77 1.228 . . . . 0.0 113.869 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 m -62.25 -40.08 95.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.86 -34.42 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-O 120.472 0.177 . . . . 0.0 111.071 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.63 -32.58 71.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -151.88 144.58 24.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.674 0.273 . . . . 0.0 111.701 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.2 p -87.84 1.96 52.61 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.249 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.0 m -64.77 -27.45 68.9 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 p -123.59 150.81 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 123.365 0.416 . . . . 0.0 110.618 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -97.44 160.98 14.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.234 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.0 t -94.67 127.86 40.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.84 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.6 p -76.96 -26.38 53.9 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -104.19 130.36 51.95 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.345 0.403 . . . . 0.0 110.901 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -77.26 -37.09 53.71 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.169 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -119.87 142.53 48.58 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.418 0.448 . . . . 0.0 111.169 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 m -130.04 156.8 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.239 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -89.33 129.37 35.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.386 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 179.1 -128.74 1.28 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.31 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.02 -179.75 45.65 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.531 -0.366 . . . . 0.0 112.857 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.4 p -126.5 150.79 48.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.578 0.228 . . . . 0.0 111.235 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.49 174.61 19.67 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.689 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.34 175.09 37.42 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.86 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.0 m -67.83 -37.43 81.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.23 -178.75 41.47 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.982 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.28 -43.3 6.29 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.684 -0.293 . . . . 0.0 113.043 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 t -118.67 145.29 45.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.308 0.243 . . . . 0.0 110.772 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.41 55.87 0.11 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.567 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.46 9.08 59.29 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.539 -0.362 . . . . 0.0 113.444 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 m -64.06 -37.41 87.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.7 148.31 41.18 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.457 0.473 . . . . 0.0 111.125 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.45 155.25 16.84 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.439 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.0 p -74.47 112.71 10.91 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.443 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -131.37 143.06 50.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.884 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 52.9 mtm180 -93.09 -0.47 57.05 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.603 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 t -107.49 126.63 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.789 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.56 156.16 36.26 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.363 0.414 . . . . 0.0 111.008 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.833 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 50.9 t80 -95.22 133.64 38.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.706 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 80' ' ' LEU . 4.5 m -134.77 115.27 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 123.378 0.424 . . . . 0.0 109.974 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -134.73 153.01 20.89 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.891 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.06 32.78 4.86 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 106' ' ' GLY . 1.1 mp -94.0 164.0 13.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.446 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -80.59 153.0 28.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.977 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -61.84 -26.6 68.22 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.842 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.69 9.05 22.77 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.7 m -90.63 142.24 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.383 -0.198 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.6 p30 -126.01 -175.8 3.46 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.507 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 17.3 m-20 -58.87 -33.34 70.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.725 0.41 . . . . 0.0 111.786 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -69.4 -36.27 76.59 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.914 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.581 HG23 ' OD1' ' A' ' 76' ' ' ASP . 55.9 t -69.48 -48.57 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.797 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 68' ' ' VAL . 1.9 tt -66.55 -38.82 87.92 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.625 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 27.0 t-80 -68.38 -47.96 65.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.79 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.72 62.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.21 -33.07 24.21 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 111.126 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.53 1.24 34.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.37 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.04 -32.02 2.67 Favored Pre-proline 0 CA--C 1.565 1.519 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 32.4 Cg_exo -60.39 -23.9 76.11 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 121.982 1.788 . . . . 0.0 113.922 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 44.1 m-85 -81.46 -31.53 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.69 -170.0 42.62 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.89 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.9 134.67 34.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.598 0.359 . . . . 0.0 110.894 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.513 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 5.7 mt -115.6 140.12 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.005 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 3.8 p -89.15 -62.47 1.47 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.892 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -148.09 158.42 44.06 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.038 0.447 . . . . 0.0 112.11 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.507 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 mm -118.02 125.59 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.438 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -116.11 121.98 43.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.543 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.65 118.83 21.34 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.822 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.36 114.88 2.17 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.24 1.96 . . . . 0.0 112.222 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.19 135.5 51.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.193 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -89.61 144.2 26.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.415 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.64 -35.07 79.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.22 -49.06 29.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.8 p -93.72 -28.54 15.88 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 53.55 24.64 4.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.355 0.662 . . . . 0.0 111.615 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 101' ' ' THR . 79.1 mttt -114.15 156.12 24.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.371 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -106.47 158.34 16.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.718 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -88.57 -0.13 56.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.21 25.55 13.99 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 119.56 -0.578 . . . . 0.0 114.488 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 95' ' ' ILE . 53.1 p90 -146.51 150.0 34.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.337 0.569 . . . . 0.0 111.034 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.47 169.48 24.54 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.39 143.72 45.2 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.1 p -118.48 134.95 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.717 0.294 . . . . 0.0 111.415 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -108.08 125.51 51.67 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.958 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 16.3 m-85 -106.49 138.86 41.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.981 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.94 -36.65 85.07 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.73 132.96 53.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.742 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.9 64.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -42.99 84.68 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.756 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.27 -32.82 72.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.251 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.789 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.89 -46.53 90.26 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.304 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.94 67.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.141 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.85 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.344 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.24 92.34 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.086 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.672 HD11 HD22 ' A' ' 66' ' ' LEU . 17.6 mt -70.94 -34.24 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.278 0.361 . . . . 0.0 111.74 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.87 -17.12 44.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -94.7 -48.68 5.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.499 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 64.3 mtt -133.51 59.03 1.75 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.035 0.445 . . . . 0.0 112.156 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 15.8 p30 -69.4 -36.73 77.05 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.432 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.34 79.62 1.67 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.652 0.739 . . . . 0.0 109.728 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -124.96 163.25 22.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.46 119.44 32.54 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 110.619 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -128.53 130.1 46.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.903 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.57 15.23 7.74 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.04 4.34 58.72 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 116.261 -0.427 . . . . 0.0 113.22 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -126.34 155.07 42.61 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.455 0.302 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.05 131.98 35.14 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.4 pt -117.17 149.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 123.359 0.412 . . . . 0.0 111.873 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 76.9 mtt180 -123.2 133.74 54.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.593 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.12 134.02 63.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.874 0.368 . . . . 0.0 110.421 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -150.15 172.78 14.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.668 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mt -68.95 129.66 40.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.953 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.113 -179.518 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.506 0.193 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -104.37 136.52 43.79 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.5 mtp -71.82 -36.99 70.41 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.247 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.47 -36.91 85.28 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.0 t -127.74 131.62 49.67 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.352 0.407 . . . . 0.0 111.232 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.35 -179.93 38.1 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.734 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -105.36 150.88 24.83 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.388 0.275 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -123.24 128.01 49.39 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -95.54 3.39 54.18 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.757 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -115.49 132.73 56.53 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -115.41 136.88 52.63 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.803 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -85.78 -36.74 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.21 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.554 ' HA ' ' SG ' ' A' ' 16' ' ' CYS . 90.2 m-70 -64.93 -40.02 94.4 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.0 m -65.38 -39.92 92.85 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -68.69 -36.31 78.31 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 13' ' ' HIS . 26.0 p -82.79 -31.95 27.98 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.433 0.458 . . . . 0.0 112.181 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.19 140.74 29.32 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.278 0.361 . . . . 0.0 111.053 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -89.85 -45.47 9.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.207 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 tp -112.19 144.17 42.03 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.36 0.412 . . . . 0.0 110.307 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -75.42 152.95 37.91 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.465 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.54 -35.71 76.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.387 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -66.0 -41.88 90.47 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.455 0.472 . . . . 0.0 111.399 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.0 mmm -71.93 -39.88 69.13 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.916 0.486 . . . . 0.0 112.075 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -68.23 -41.27 81.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.068 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -70.18 -49.5 49.74 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.4 mt -65.13 -47.2 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.45 -31.79 70.33 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.9 p -66.19 -38.8 88.87 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.473 0.178 . . . . 0.0 111.351 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.64 98.62 6.47 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.447 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.61 79.08 55.5 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.324 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.01 133.12 39.72 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.007 2.471 . . . . 0.0 111.867 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -47.17 -36.16 8.26 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.869 0.868 . . . . 0.0 113.286 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 m -84.57 -41.38 16.51 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.51 -19.89 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.134 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.88 69.6 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.912 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -141.98 130.56 22.63 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.38 0.425 . . . . 0.0 111.16 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.8 t -138.96 158.49 44.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.068 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.2 m -72.96 -40.79 65.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.985 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.58 145.18 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 123.424 0.452 . . . . 0.0 110.847 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -108.64 128.24 54.67 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.934 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 t -123.09 119.32 29.95 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.497 0.498 . . . . 0.0 111.179 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.6 p -139.76 -6.71 1.29 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.485 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.19 -31.77 71.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.0 mtm105 -92.46 142.74 27.09 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.308 0.38 . . . . 0.0 111.121 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -122.74 140.76 52.54 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -42.65 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.399 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -88.3 152.49 21.91 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.324 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.55 -160.95 23.76 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.928 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.64 -32.87 7.08 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.596 -0.335 . . . . 0.0 112.824 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.2 m -67.52 -35.39 79.02 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.816 0.446 . . . . 0.0 112.178 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.3 147.84 4.78 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.366 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.89 64.31 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.5 -0.381 . . . . 0.0 113.369 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.0 t -119.85 143.64 47.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.253 0.221 . . . . 0.0 110.762 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.66 6.18 Favored Glycine 0 C--N 1.34 0.789 0 O-C-N 123.656 0.598 . . . . 0.0 113.077 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.02 -54.39 2.76 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.619 -0.324 . . . . 0.0 113.179 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.7 t -126.4 140.52 52.42 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.584 0.23 . . . . 0.0 111.143 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.38 -168.33 37.16 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.738 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.25 54.03 0.98 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.77 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.9 p -71.79 -24.14 61.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.56 -30.64 69.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.2 p -79.63 -8.28 59.1 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.455 0.472 . . . . 0.0 112.223 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.49 -42.7 15.3 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.642 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.15 134.64 38.98 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.37 0.419 . . . . 0.0 111.446 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -110.33 2.42 19.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.16 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.541 HG22 ' HG2' ' A' ' 111' ' ' GLU . 26.0 t -101.86 134.97 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.686 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -124.06 147.23 48.02 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.381 0.426 . . . . 0.0 110.582 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.1 t80 -99.93 125.13 45.89 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.924 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.673 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -118.71 118.92 59.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 123.547 0.529 . . . . 0.0 110.028 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.49 149.08 18.19 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.544 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.39 23.93 7.75 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.1 mp -90.02 168.61 11.87 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.968 0.507 . . . . 0.0 110.824 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -96.4 161.82 13.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.337 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.62 -32.2 71.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.657 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -75.7 -7.65 54.86 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.917 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 72' ' ' ALA . 1.7 p -78.44 131.08 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 120.66 0.267 . . . . 0.0 110.577 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -114.84 175.47 5.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.952 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.3 m-20 -60.69 -33.65 73.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.459 0.704 . . . . 0.0 112.131 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -67.19 -40.32 86.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.584 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.56 -45.09 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tt -69.55 -37.66 77.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.428 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.55 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 33.3 t-80 -68.14 -48.78 64.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.502 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.75 -21.25 62.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -34.32 23.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.266 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.443 ' C ' HD11 ' A' ' 90' ' ' ILE . 61.7 m-85 -98.09 -2.36 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.7 tp -69.44 -31.31 2.54 Favored Pre-proline 0 CA--C 1.566 1.596 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.97 -24.18 71.87 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.93 1.753 . . . . 0.0 113.637 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -79.64 -31.22 41.53 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.563 0.345 . . . . 0.0 111.693 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.03 37.0 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.247 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.23 132.61 36.0 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.594 0.235 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 111' ' ' GLU . 4.4 mt -109.34 142.04 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.956 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.2 p -85.73 -61.59 1.72 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.901 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -151.48 158.04 43.11 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.497 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 15.1 mm -117.73 129.8 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.57 127.89 55.57 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.75 100.66 33.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.12 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.25 119.8 6.87 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.042 1.828 . . . . 0.0 112.904 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -125.23 132.59 52.95 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.598 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -83.37 140.88 32.15 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.429 0.455 . . . . 0.0 110.676 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.62 -34.09 77.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -72.66 -48.83 35.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.068 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.543 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.7 p -95.16 -28.94 14.81 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 50.3 32.02 5.84 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.391 0.676 . . . . 0.0 111.76 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 101' ' ' THR . 85.1 mttt -115.23 150.64 35.83 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.437 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -101.53 138.31 38.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.64 1.8 57.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 90.04 22.62 35.0 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.175 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -142.83 151.13 40.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.111 0.956 . . . . 0.0 111.326 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.67 166.92 30.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.194 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.472 ' CE2' ' HD2' ' A' ' 67' ' ' TYR . 72.8 m-85 -111.33 139.55 46.64 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.463 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.6 p -118.84 132.38 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 123.307 0.379 . . . . 0.0 110.334 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HG2' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -105.74 133.1 51.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.184 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 20.4 m-85 -115.32 140.14 49.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.315 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.31 -37.03 85.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.569 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.7 mp -106.2 141.17 37.99 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.47 -19.68 59.27 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.949 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -73.92 -49.94 22.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.263 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.3 p30 -68.95 -32.43 72.02 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.88 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.9 -43.57 83.02 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.471 0.482 . . . . 0.0 111.016 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.77 69.38 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.051 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.72 -34.94 74.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.154 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.25 82.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.803 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 66' ' ' LEU . 15.3 mt -69.59 -33.53 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.357 0.41 . . . . 0.0 111.596 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -16.71 46.61 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -100.62 -44.17 5.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 62.1 mtt -126.26 45.51 2.63 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.635 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.4 t-20 -63.13 -36.61 84.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.611 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 40.8 mt-10 -141.78 79.47 1.68 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.659 0.742 . . . . 0.0 109.625 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 82.0 p -125.07 166.11 16.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.274 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -91.84 120.17 32.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -127.57 129.53 47.49 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.809 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 t80 59.23 18.85 6.93 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.921 0.888 . . . . 0.0 112.31 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.51 -9.63 64.67 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -114.98 152.68 31.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.66 0.384 . . . . 0.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -76.88 137.32 39.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -121.21 156.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.52 0.513 . . . . 0.0 112.299 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 12.8 ptt85 -129.17 132.38 47.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.567 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -125.83 136.49 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.102 0.477 . . . . 0.0 111.212 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -148.41 171.15 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HG ' HD13 ' A' ' 122' ' ' ILE . 12.0 mt -74.29 131.04 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.507 0.194 . . . . 0.0 111.171 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.531 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.154 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.601 0.238 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 85.7 mtp -100.79 137.29 39.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.868 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mtt -99.42 149.75 22.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.937 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -110.96 150.99 28.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.7 t -126.18 133.93 51.41 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.742 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.26 -40.18 96.48 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.993 -0.549 . . . . 0.0 113.819 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -109.61 132.9 53.71 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.514 0.197 . . . . 0.0 110.823 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -132.59 127.91 36.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.949 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.96 -32.84 73.54 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.875 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -84.93 158.54 20.53 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.345 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.47 149.04 46.24 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.47 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.46 157.29 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.664 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -65.18 -28.21 69.24 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.011 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.2 p -59.52 -36.7 76.61 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.46 -30.58 70.33 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 87.8 m -76.7 -6.25 51.38 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.34 -29.9 70.68 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -93.62 125.97 38.52 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.254 0.346 . . . . 0.0 111.044 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tp -107.76 150.77 26.57 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.696 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -71.52 159.29 34.73 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.749 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.29 -34.5 78.27 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.32 -46.89 59.56 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.538 ' O ' HD12 ' A' ' 27' ' ' LEU . 58.5 mmm -67.31 -37.21 82.99 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.606 0.362 . . . . 0.0 111.875 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.68 -42.38 95.4 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.792 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -70.08 -40.73 74.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 31.8 mt -66.74 -49.89 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 123.163 0.29 . . . . 0.0 111.778 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 23' ' ' MET . 2.2 mt -69.4 -36.31 76.64 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.3 p -74.99 -25.3 58.73 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -103.06 8.86 38.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.379 0.609 . . . . 0.0 110.231 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -83.63 120.22 74.95 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.583 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.14 126.25 13.49 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.692 2.262 . . . . 0.0 112.737 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -49.42 -34.29 16.1 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.312 1.045 . . . . 0.0 113.242 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 81.7 p -85.82 -39.1 17.43 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.66 -32.42 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.43 0.157 . . . . 0.0 111.391 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.77 -29.0 65.09 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -159.69 152.59 21.69 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.7 p -98.61 163.13 12.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.371 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.73 -32.47 72.28 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 41' ' ' CYS . 4.5 t -101.62 132.72 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 123.306 0.379 . . . . 0.0 110.054 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -90.92 3.55 54.29 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.992 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.624 ' H ' HG12 ' A' ' 39' ' ' VAL . 35.9 t -99.69 126.46 45.73 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.946 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.1 t -119.42 -1.51 10.72 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.912 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -70.94 -38.05 72.88 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -71.3 -37.77 71.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -115.94 127.13 54.73 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.339 0.399 . . . . 0.0 110.963 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -46.22 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.194 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -100.68 145.66 28.15 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.766 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.95 -73.48 1.21 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.496 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.17 170.89 30.73 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.466 -0.397 . . . . 0.0 112.792 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 m -66.96 -35.01 79.01 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.922 0.489 . . . . 0.0 112.217 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.92 3.8 60.47 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.269 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.04 175.61 42.4 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 121.666 -0.302 . . . . 0.0 112.934 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.6 p -128.64 154.46 46.23 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.357 0.263 . . . . 0.0 110.994 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.16 164.74 24.79 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.702 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.56 -54.7 2.6 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.607 -0.33 . . . . 0.0 112.946 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.8 p -123.0 152.07 41.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.3 0.24 . . . . 0.0 111.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.41 -170.88 43.11 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.65 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.31 158.79 21.74 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.532 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -123.11 148.48 45.63 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 122.249 0.22 . . . . 0.0 110.995 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.68 140.49 35.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.944 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.33 -63.05 1.2 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.827 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.7 p -146.06 123.24 11.51 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.271 0.357 . . . . 0.0 111.094 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.84 143.36 50.12 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 79.0 mtt180 -79.47 -9.37 59.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.402 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 19.3 t -101.63 129.43 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.921 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.83 155.34 38.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.015 -178.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.0 t80 -92.67 130.39 38.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.89 116.6 34.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.345 0.403 . . . . 0.0 110.146 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.76 157.9 22.59 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.769 -0.651 . . . . 0.0 113.026 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.69 26.72 7.9 Favored Glycine 0 C--N 1.333 0.361 0 O-C-N 123.943 0.437 . . . . 0.0 112.158 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 75' ' ' VAL . 1.6 mp -89.83 160.88 16.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.991 0.424 . . . . 0.0 110.729 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -80.66 157.49 25.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 44.3 mt-10 -65.94 -27.54 68.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -84.27 7.91 17.69 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -90.39 142.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -128.21 -176.24 3.74 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.344 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.04 -31.55 68.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.912 0.387 . . . . 0.0 111.523 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -68.46 -40.99 80.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.58 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.8 -47.39 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.911 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 93' ' ' ILE . 1.9 tt -66.55 -38.19 86.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.683 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.541 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.8 t60 -68.17 -49.22 62.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.648 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.33 62.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -33.86 23.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.972 0.415 . . . . 0.0 111.342 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 83.6 m-85 -102.56 1.36 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.389 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.3 tp -69.5 -31.73 2.75 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.8 Cg_exo -59.03 -23.46 68.79 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.979 1.786 . . . . 0.0 113.907 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.633 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 64.8 m-85 -77.34 -31.5 54.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.53 -160.27 33.71 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.696 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.58 134.63 34.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.71 0.404 . . . . 0.0 111.81 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.47 HG21 HD11 ' A' ' 93' ' ' ILE . 13.0 mt -115.76 137.23 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -92.38 -59.35 2.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.285 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.42 154.69 41.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 80' ' ' LEU . 17.2 mm -116.85 120.13 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.21 125.24 53.94 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.262 0.351 . . . . 0.0 111.354 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.32 109.42 21.26 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.573 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.34 126.23 18.05 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.274 1.983 . . . . 0.0 112.147 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 136.69 53.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.255 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -91.68 143.33 26.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -64.66 -34.96 79.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.14 -48.79 32.52 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.0 p -93.84 -28.48 15.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.21 24.38 2.78 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.386 0.675 . . . . 0.0 111.9 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 101' ' ' THR . 70.1 mttt -109.15 149.44 29.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.461 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.517 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.9 p80 -84.94 -14.36 47.86 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 67.75 -7.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.266 1.026 . . . . 0.0 113.502 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 99.25 23.73 11.01 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.29 -0.728 . . . . 0.0 114.755 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.03 152.25 40.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.794 0.797 . . . . 0.0 111.44 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.62 170.75 20.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.894 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -113.51 145.22 41.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.448 HG23 ' CD1' ' A' ' 93' ' ' ILE . 15.0 p -117.56 131.47 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -104.11 125.02 50.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.771 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 21.0 m-85 -112.27 143.07 43.97 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.053 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -69.38 -36.79 77.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.923 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.565 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.8 mp -105.62 139.95 39.44 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.057 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.34 -22.28 57.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.361 0.601 . . . . 0.0 109.896 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -70.02 -49.35 52.25 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.602 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.565 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -67.3 -31.92 72.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.868 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.921 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.28 -44.73 90.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.85 -28.72 69.18 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.025 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.1 -35.81 71.95 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.355 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.6 85.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.062 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.713 HD11 HD22 ' A' ' 66' ' ' LEU . 25.2 mt -70.87 -37.61 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 -18.71 39.85 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -97.25 -43.57 7.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.633 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 83.1 mtp -132.09 52.02 2.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.7 t30 -63.91 -40.2 95.94 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.5 mt-10 -141.25 78.26 1.63 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.402 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.9 p -122.04 164.03 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.642 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -91.44 118.96 31.01 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.1 tp -131.12 130.87 43.67 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.053 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 t80 62.42 15.11 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.694 0.798 . . . . 0.0 112.285 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.52 60.1 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -126.08 154.48 43.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.548 0.339 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.22 133.23 35.24 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.3 pt -116.43 153.78 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.095 0.474 . . . . 0.0 112.265 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -125.83 130.63 51.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.531 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.84 137.2 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.291 0.369 . . . . 0.0 110.483 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -148.94 171.91 15.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.59 126.29 29.28 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.448 0.299 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.139 -179.839 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.555 ' HB3' ' O ' ' A' ' 4' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.492 0.186 . . . . 0.0 110.918 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -104.99 137.2 43.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.82 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.8 mtm 70.85 -46.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.395 1.078 . . . . 0.0 112.612 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 1' ' ' SER . 87.2 mm-40 -108.55 144.83 35.7 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.206 0.316 . . . . 0.0 110.895 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.2 t -133.24 149.82 51.97 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.09 165.17 19.51 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.954 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -125.28 141.68 51.94 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.5 0.32 . . . . 0.0 110.146 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.4 t -127.26 126.71 43.17 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.502 0.502 . . . . 0.0 111.223 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -106.76 155.33 19.82 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.802 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -113.06 131.23 55.88 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.978 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -131.44 152.89 50.28 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.893 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.5 133.52 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.826 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -65.01 -36.74 85.38 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.233 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 m -62.27 -36.29 81.62 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.134 0.573 . . . . 0.0 112.373 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -61.45 -36.26 79.92 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.012 0.525 . . . . 0.0 111.957 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.9 m -70.68 -45.83 64.3 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 66.01 -56.91 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.339 1.056 . . . . 0.0 113.143 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -96.46 155.72 16.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.757 0.313 . . . . 0.0 111.63 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tp -90.35 151.26 21.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.445 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -68.64 150.58 47.8 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.498 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -61.53 -34.76 76.08 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.78 -46.76 77.52 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.293 0.37 . . . . 0.0 111.574 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.561 ' SD ' ' HG3' ' A' ' 111' ' ' GLU . 94.9 mmm -69.08 -38.36 78.97 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -67.07 -43.44 82.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.122 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.15 -39.53 75.31 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.7 mt -69.91 -47.56 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 123.022 0.201 . . . . 0.0 111.53 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 23' ' ' MET . 12.3 mt -69.73 -41.32 75.44 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.9 m -72.96 -35.24 66.91 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -112.3 86.49 2.36 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.611 0.569 . . . . 0.0 110.128 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.32 117.15 59.98 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.398 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.81 129.06 17.88 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.564 2.176 . . . . 0.0 111.786 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -44.49 -35.77 2.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.285 1.034 . . . . 0.0 113.682 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -89.67 -40.71 12.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.57 -32.55 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.29 -29.89 70.96 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -159.19 127.25 5.02 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.717 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 p -126.38 153.56 44.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.1 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.1 m -97.43 -43.2 7.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.428 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.44 137.06 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 O-C-N 123.445 0.465 . . . . 0.0 109.971 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -100.86 126.62 47.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.315 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.2 t -98.99 125.96 44.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.3 p -89.45 -9.7 49.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.292 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.72 -35.38 77.08 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.759 0.424 . . . . 0.0 111.716 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -65.52 -34.24 77.8 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -109.21 136.68 48.29 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.368 0.417 . . . . 0.0 111.249 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.94 142.03 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.581 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -89.12 137.73 32.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.377 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.17 -177.15 47.23 Favored Glycine 0 C--N 1.337 0.617 0 O-C-N 123.776 0.673 . . . . 0.0 112.71 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.42 159.0 25.73 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.458 -0.401 . . . . 0.0 112.604 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.1 m -65.92 -37.17 85.36 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -142.61 -63.8 0.03 OUTLIER Glycine 0 C--N 1.339 0.715 0 O-C-N 123.457 0.473 . . . . 0.0 112.863 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.79 -176.19 48.14 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.667 -0.301 . . . . 0.0 113.288 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 m -63.72 -34.78 78.64 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.24 51.65 0.11 Allowed Glycine 0 C--N 1.339 0.747 0 O-C-N 123.427 0.454 . . . . 0.0 112.692 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.91 -48.2 4.75 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 121.646 -0.312 . . . . 0.0 112.849 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 m -65.18 -35.48 81.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.948 0.499 . . . . 0.0 112.193 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.62 -168.63 33.35 Favored Glycine 0 C--N 1.341 0.817 0 O-C-N 123.542 0.527 . . . . 0.0 112.978 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.28 -116.16 0.76 Allowed Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.576 -0.345 . . . . 0.0 112.29 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.7 m -68.8 -29.11 67.39 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 -12.91 61.7 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.1 p -70.18 -20.91 63.1 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.7 p -74.2 -25.08 59.47 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -98.2 127.11 43.97 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.407 0.442 . . . . 0.0 110.708 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -114.27 8.96 16.91 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.524 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.86 134.29 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.364 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.898 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.87 155.49 37.96 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.655 0.597 . . . . 0.0 111.024 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 67.1 t80 -102.32 130.85 49.15 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.463 HG12 ' CG1' ' A' ' 137' ' ' VAL . 12.6 m -126.22 124.57 66.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 O-C-N 123.533 0.52 . . . . 0.0 110.074 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 154.58 22.16 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.1 20.68 10.21 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 123.888 0.405 . . . . 0.0 112.424 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -89.6 160.44 16.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 110.664 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.511 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.08 155.54 19.39 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.978 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 43.5 mt-10 -61.69 -26.21 67.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.892 0.477 . . . . 0.0 111.933 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.44 -4.34 33.06 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.1 m -90.43 142.49 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.541 0.21 . . . . 0.0 110.786 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.599 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.8 p30 -127.71 -173.84 3.03 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.744 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.18 -32.94 71.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.764 0.425 . . . . 0.0 111.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 90.8 mttt -68.9 -40.25 79.28 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.782 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.599 HG23 ' OD1' ' A' ' 76' ' ' ASP . 44.1 t -66.25 -47.91 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.191 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -67.22 -38.41 85.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.576 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 32.3 t-80 -68.26 -48.7 64.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.54 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.55 -20.51 62.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.41 -34.39 23.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.934 0.397 . . . . 0.0 111.473 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.9 m-85 -100.79 -0.63 36.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.189 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.6 -31.92 2.81 Favored Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.95 -22.82 65.15 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 121.93 1.753 . . . . 0.0 113.867 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.44 -31.18 47.95 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.08 -162.69 36.43 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.656 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -82.53 134.21 35.2 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.604 0.362 . . . . 0.0 111.72 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.516 HG21 HD11 ' A' ' 93' ' ' ILE . 12.1 mt -114.67 139.73 39.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.365 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -90.36 -62.9 1.36 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -146.95 153.01 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.516 HD11 HG21 ' A' ' 90' ' ' ILE . 14.5 mm -117.94 123.3 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -120.27 121.67 39.19 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.84 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mp -127.7 116.57 20.97 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.979 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.88 124.57 16.0 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.254 1.97 . . . . 0.0 112.514 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.87 134.71 49.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.036 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.18 143.31 26.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.459 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -64.59 -34.6 78.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -71.65 -48.73 45.78 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.1 p -96.04 -28.02 14.83 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 56.27 24.67 8.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.221 0.608 . . . . 0.0 111.562 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -122.21 154.71 37.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.475 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 25.0 p80 -99.49 161.62 13.51 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.293 0.371 . . . . 0.0 110.802 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -86.01 -4.8 59.25 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.25 27.96 7.04 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.311 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -148.71 149.68 31.85 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.215 0.507 . . . . 0.0 110.887 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.66 39.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.345 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.467 ' CE1' ' HD1' ' A' ' 67' ' ' TYR . 90.2 m-85 -109.57 134.35 52.02 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 93' ' ' ILE . 9.1 p -112.01 132.93 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.327 0.392 . . . . 0.0 110.54 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.561 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 0.2 OUTLIER -107.14 128.8 54.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.615 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -114.14 145.11 42.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.928 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.76 -37.08 76.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.589 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.584 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.9 mp -105.38 137.68 42.79 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.058 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.07 -19.75 59.85 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.172 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -71.15 -49.98 38.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.152 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.7 p30 -69.29 -31.77 70.49 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.898 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.45 -44.73 90.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.99 0.516 . . . . 0.0 111.334 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.84 69.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.073 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.59 -35.16 75.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.962 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.53 -38.73 81.09 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.718 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.706 HD11 HD22 ' A' ' 66' ' ' LEU . 72.5 mt -69.78 -33.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 123.096 0.247 . . . . 0.0 111.195 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.33 -35.71 73.8 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -102.53 -36.01 8.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.465 1.284 . . . . 0.0 114.465 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.492 ' O ' HG13 ' A' ' 137' ' ' VAL . 90.9 mmm -90.74 0.43 57.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.653 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.9 t-20 -56.68 -37.01 70.26 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.747 0.248 . . . . 0.0 111.602 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -140.78 71.89 1.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.371 0.605 . . . . 0.0 109.516 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m -121.13 154.03 36.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.295 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -92.01 119.17 31.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.427 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -127.9 127.42 43.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.925 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 61.89 15.91 7.57 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.736 0.814 . . . . 0.0 112.399 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.45 -9.09 62.57 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.01 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -113.45 149.52 34.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.811 0.444 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.46 138.45 36.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.671 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.11 156.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.843 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 10.2 ptp180 -128.32 134.06 48.82 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.181 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.12 143.64 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.384 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -141.8 171.1 14.52 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.976 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tt -81.51 125.55 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.14 -179.764 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.7 p . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.363 0.125 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 99.3 mmm -100.65 136.77 39.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.695 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.8 mtt -125.06 151.92 44.99 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.021 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -116.87 150.17 38.86 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.762 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 p -123.89 123.59 40.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.56 -41.66 0.06 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.801 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -63.17 -36.4 83.51 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.7 m -74.55 -38.51 62.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.178 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -89.01 149.47 23.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.364 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -117.98 149.63 40.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -102.44 147.65 26.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.068 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -109.23 139.0 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.64 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -61.53 -41.54 97.49 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.052 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.0 p -68.84 -37.22 78.99 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -69.84 -37.24 76.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.82 0.448 . . . . 0.0 111.504 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.9 m -65.93 -33.22 75.33 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 64.32 150.1 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.876 0.87 . . . . 0.0 112.039 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -93.62 127.97 39.55 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.486 HD11 ' OE1' ' A' ' 94' ' ' GLN . 11.4 tp -97.24 147.34 24.21 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.509 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.7 m -62.13 152.69 32.25 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.949 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -63.83 -36.78 85.05 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -68.3 -47.22 68.2 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.294 0.371 . . . . 0.0 111.722 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.549 ' O ' HD12 ' A' ' 27' ' ' LEU . 89.6 mmm -67.39 -39.29 85.6 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.643 0.377 . . . . 0.0 111.912 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -64.86 -41.24 95.84 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.89 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.14 -39.75 78.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mt -70.45 -48.31 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.41 0.284 . . . . 0.0 111.661 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 23' ' ' MET . 4.8 mt -69.94 -40.21 75.63 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.6 m -77.27 -33.87 55.78 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.67 6.53 43.54 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 35' ' ' ALA . 2.1 pp -82.01 143.53 49.67 Favored Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 118.534 0.606 . . . . 0.0 111.482 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.5 129.55 15.93 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.863 2.376 . . . . 0.0 111.918 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -46.27 -33.1 3.49 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 m -92.14 -40.48 11.0 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.75 -20.56 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.232 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.654 ' HB2' HD13 ' A' ' 30' ' ' LEU . . . -61.5 -28.35 69.24 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.224 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -146.63 160.12 42.59 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.259 0.35 . . . . 0.0 111.692 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.4 t -133.36 166.91 21.42 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.285 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 m -77.83 138.13 38.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.283 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.62 -36.86 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.661 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -118.03 124.15 47.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.043 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 44' ' ' ARG . 1.4 m -127.36 132.09 50.25 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.4 p -77.88 -41.2 37.54 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -140.09 -22.51 0.85 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.649 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 82.7 mtt180 -56.53 -36.26 69.02 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -135.08 150.03 50.17 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.215 0.322 . . . . 0.0 111.577 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 m -131.16 153.41 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.038 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -97.06 146.42 25.03 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.164 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -179.92 -177.9 48.23 Favored Glycine 0 C--N 1.337 0.602 0 O-C-N 123.763 0.664 . . . . 0.0 112.788 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.57 46.38 0.71 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.59 -0.338 . . . . 0.0 112.618 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.6 p -71.9 -26.71 62.43 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.97 -170.13 35.55 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.007 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -137.6 -176.3 14.36 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.654 -0.308 . . . . 0.0 112.72 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -118.47 151.59 37.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.317 0.247 . . . . 0.0 111.156 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.08 41.53 4.9 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.202 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.15 -38.75 39.02 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.576 0.221 . . . . 0.0 113.443 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.3 m -64.01 -35.88 82.16 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.965 0.506 . . . . 0.0 112.357 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.7 36.1 10.85 Favored Glycine 0 C--N 1.342 0.861 0 O-C-N 123.522 0.514 . . . . 0.0 113.306 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.82 125.14 8.29 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.494 -0.384 . . . . 0.0 112.62 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.8 m -122.68 148.17 45.6 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.679 0.282 . . . . 0.0 110.949 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.55 137.87 39.31 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.149 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.3 p -109.5 4.06 21.92 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.859 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.14 -48.73 7.5 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.658 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -101.68 131.98 47.63 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.328 0.393 . . . . 0.0 111.352 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -112.73 7.75 18.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.145 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 111' ' ' GLU . 5.8 t -103.21 134.72 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.429 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.854 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -123.35 155.46 37.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.866 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 76.8 t80 -93.56 137.46 32.81 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.417 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.64 123.42 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 123.598 0.561 . . . . 0.0 110.226 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.98 151.57 20.48 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.135 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.79 15.71 12.81 Favored Glycine 0 C--N 1.334 0.423 0 O-C-N 123.996 0.468 . . . . 0.0 112.57 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -88.48 164.64 15.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.766 0.317 . . . . 0.0 110.637 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.47 154.36 20.09 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.57 -30.34 69.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.556 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.53 1.8 13.29 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.978 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.9 m -88.95 137.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.598 0.237 . . . . 0.0 110.769 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.4 p30 -117.49 -175.77 2.88 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -61.98 -31.16 71.49 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.693 0.397 . . . . 0.0 112.042 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -35.62 76.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.879 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.581 HG23 ' OD1' ' A' ' 76' ' ' ASP . 61.8 t -69.75 -49.03 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -66.96 -38.64 86.47 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.74 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 31.2 t-80 -68.62 -47.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.742 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.27 -20.89 63.02 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.3 -33.98 23.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.009 0.433 . . . . 0.0 111.178 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 70.0 m-85 -100.39 0.04 39.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.254 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.0 tp -69.36 -31.89 2.9 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 44.8 Cg_exo -59.27 -22.93 67.48 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.879 1.719 . . . . 0.0 113.822 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.63 -31.63 36.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.92 35.49 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.798 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -83.18 137.49 34.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.718 0.407 . . . . 0.0 112.027 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 93' ' ' ILE . 6.8 mt -117.53 138.21 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.519 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.48 -62.1 1.51 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -145.09 153.13 41.09 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 90' ' ' ILE . 18.1 mm -119.58 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.529 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 5.8 tp60 -114.38 135.06 54.5 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.263 0.352 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mm -121.81 101.09 42.88 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.91 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.69 124.41 14.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.214 1.943 . . . . 0.0 112.382 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.54 132.12 53.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.961 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.93 141.73 28.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -64.74 -33.56 76.26 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.97 -48.8 51.29 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.1 p -100.59 -28.62 12.77 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 53.08 29.99 8.93 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.253 0.621 . . . . 0.0 111.673 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 101' ' ' THR . 34.1 mttt -121.18 156.89 31.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.193 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -89.42 139.22 30.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.69 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -99.01 3.31 46.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 93.84 21.77 27.54 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 114.741 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -146.05 150.82 36.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.655 0.728 . . . . 0.0 111.13 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -162.33 -179.83 7.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.875 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.463 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 85.3 m-85 -119.51 151.8 37.99 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.1 p -122.71 132.97 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 123.325 0.391 . . . . 0.0 110.495 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.497 ' HG3' HG22 ' A' ' 65' ' ' VAL . 21.1 tt0 -106.04 130.18 54.0 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.287 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.02 147.39 42.38 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.46 -37.94 71.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.456 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.6 mp -106.7 137.3 44.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.024 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.19 -19.62 60.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.253 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -70.8 -50.03 40.04 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.235 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.604 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 13.3 p30 -68.99 -31.71 70.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -63.7 -44.46 93.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.298 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -30.34 70.3 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.08 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.32 -34.72 75.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.845 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.25 -38.14 81.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.6 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.675 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 74.6 mt -68.79 -35.56 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.129 0.268 . . . . 0.0 111.124 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.17 -37.15 78.04 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -101.14 -35.44 9.31 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.496 ' O ' HG13 ' A' ' 137' ' ' VAL . 92.6 mmm -91.95 1.17 57.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.675 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.8 t-20 -57.16 -37.48 72.13 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -140.04 70.28 1.36 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.398 0.618 . . . . 0.0 109.523 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -122.24 157.42 31.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.217 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.88 122.32 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.04 129.46 42.03 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.879 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 62.25 15.43 7.55 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.675 0.79 . . . . 0.0 112.393 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 5.28 59.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.273 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -126.91 154.17 44.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 122.446 0.298 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.25 134.78 35.3 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.88 158.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 O-C-N 123.4 0.438 . . . . 0.0 111.92 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 4.0 ptp180 -128.24 134.31 48.96 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.401 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.578 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.28 143.57 40.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 123.198 0.311 . . . . 0.0 111.128 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -141.75 171.25 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.152 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.14 124.42 28.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.716 0.293 . . . . 0.0 110.532 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.216 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.514 0.197 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.3 mtt -104.67 137.02 43.13 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.703 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.1 mtp -115.62 142.17 47.08 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.55 0.531 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -67.26 -33.54 75.54 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.9 t -117.92 136.94 53.15 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.313 0.383 . . . . 0.0 111.147 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.16 -136.3 4.9 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.498 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -96.69 149.6 21.62 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.645 0.26 . . . . 0.0 111.087 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 p -92.74 -38.88 11.56 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.715 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -89.02 124.38 34.22 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.355 0.409 . . . . 0.0 110.759 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -64.54 -33.41 75.84 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.673 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -98.68 143.47 29.02 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.376 0.423 . . . . 0.0 111.114 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.61 -33.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.053 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -61.39 -35.4 77.4 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -61.94 -36.83 82.53 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.86 -36.97 85.04 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.7 m -89.12 -18.18 27.72 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.921 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -65.81 -23.0 66.6 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.258 0.623 . . . . 0.0 112.111 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -57.74 -37.85 74.32 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tp -108.81 140.61 42.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.701 0.286 . . . . 0.0 110.64 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 m -69.97 157.62 37.14 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.741 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 p30 -64.69 -30.58 71.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -72.18 -44.4 63.08 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.465 ' O ' HD12 ' A' ' 27' ' ' LEU . 9.2 mtt -69.92 -37.56 75.97 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -65.13 -41.28 94.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.801 0.44 . . . . 0.0 111.655 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -70.25 -44.9 67.54 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 30.4 mt -70.05 -46.82 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 23' ' ' MET . 4.5 mt -68.76 -37.71 79.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.1 m -67.7 -39.57 84.38 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -133.36 105.38 6.92 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.416 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 1.1 mp -107.29 140.99 22.01 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.072 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.46 133.38 45.64 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.225 1.95 . . . . 0.0 111.783 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -42.27 -34.39 0.77 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.0 -39.58 9.28 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.87 -26.32 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.04 -28.49 69.52 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -153.35 162.35 41.37 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.8 p -111.17 159.65 17.67 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.437 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.3 m -129.01 163.49 25.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.76 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -121.67 152.12 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.985 0.422 . . . . 0.0 111.916 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -103.38 151.93 22.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.605 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.4 t -93.67 138.41 31.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.873 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.3 m -63.79 -38.99 93.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.118 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -66.62 -40.47 88.81 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.314 0.384 . . . . 0.0 111.624 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -72.36 -31.22 65.43 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.426 0.454 . . . . 0.0 112.098 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -60.97 -37.58 82.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.198 0.599 . . . . 0.0 112.385 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.27 -44.15 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 122.799 0.439 . . . . 0.0 111.781 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -93.19 124.15 36.97 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.282 0.364 . . . . 0.0 111.426 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.15 -164.64 38.76 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.246 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.15 104.44 0.24 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.6 p -70.44 -27.57 64.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.72 -160.92 30.47 Favored Glycine 0 C--N 1.34 0.797 0 O-C-N 123.371 0.419 . . . . 0.0 112.919 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.48 44.17 0.56 Allowed Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.831 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.7 m -65.38 -33.04 75.02 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.16 43.01 4.8 Favored Glycine 0 C--N 1.341 0.853 0 O-C-N 123.438 0.461 . . . . 0.0 112.801 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.3 -28.63 72.59 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 114.061 0.384 . . . . 0.0 114.061 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 p -105.21 152.87 22.32 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.63 0.252 . . . . 0.0 111.353 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.23 -174.59 35.78 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.57 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.51 -173.11 40.2 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.374 -0.441 . . . . 0.0 112.847 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.2 m -118.77 145.9 45.22 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.294 0.238 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.56 151.76 29.66 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.377 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.1 p -88.04 163.28 16.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.906 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.9 p -72.21 117.47 13.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.814 0.34 . . . . 0.0 111.703 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -132.02 143.49 50.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.679 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 74.8 mtt85 -87.35 -3.38 59.03 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.032 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.79 129.18 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.915 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -123.32 156.87 34.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.811 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.785 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 38.8 t80 -92.91 131.48 37.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.791 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.436 HG21 HD21 ' A' ' 80' ' ' LEU . 1.5 m -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.643 0.589 . . . . 0.0 109.565 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -137.24 162.06 25.3 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.595 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.0 32.92 6.85 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.759 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.3 mp -91.08 164.86 13.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.051 0.54 . . . . 0.0 111.501 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.69 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -84.73 163.3 19.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.643 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.94 -36.35 77.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.803 0.441 . . . . 0.0 112.093 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.66 -10.77 59.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.205 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -74.31 140.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.703 0.287 . . . . 0.0 111.632 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.611 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -126.78 179.09 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.314 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 2.1 t70 -62.5 -35.72 80.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 112.675 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -65.26 -35.32 80.66 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.106 0.479 . . . . 0.0 111.013 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.611 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -66.69 -39.65 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.707 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.436 HD21 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -67.84 -37.49 81.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.283 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.556 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 26.0 t-80 -68.36 -49.65 58.73 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.342 0.401 . . . . 0.0 111.492 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.76 -20.93 62.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.05 -34.44 22.28 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.909 0.385 . . . . 0.0 111.351 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.434 ' C ' HD11 ' A' ' 90' ' ' ILE . 70.9 m-85 -98.61 -1.38 41.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.163 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.04 -31.89 3.05 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.0 Cg_exo -59.48 -23.86 72.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.953 1.769 . . . . 0.0 113.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -78.28 -31.39 48.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.5 -162.45 36.22 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.501 0.501 . . . . 0.0 112.761 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -81.77 136.91 35.41 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.684 0.393 . . . . 0.0 111.723 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.522 HG21 HD11 ' A' ' 93' ' ' ILE . 11.1 mt -115.79 139.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.703 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -92.94 -60.76 1.73 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.462 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -145.96 153.1 40.42 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.578 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 16.6 mm -120.01 119.33 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -118.57 129.28 55.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -127.92 114.61 20.51 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.729 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.78 116.49 3.29 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.216 1.944 . . . . 0.0 112.449 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.03 135.82 51.35 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.487 ' HB2' ' OG1' ' A' ' 101' ' ' THR . 9.9 m-20 -92.91 146.41 23.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.298 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.51 -36.24 83.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -77.03 -49.06 16.23 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.932 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.5 p -88.95 -28.58 20.17 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 49.81 25.3 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.607 0.763 . . . . 0.0 112.242 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 101' ' ' THR . 65.4 mttt -103.8 146.08 29.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.734 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -87.89 -15.84 35.59 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.407 0.442 . . . . 0.0 112.104 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 70.42 -6.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.251 1.02 . . . . 0.0 112.991 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.434 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.13 20.28 28.39 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-O 119.138 -0.812 . . . . 0.0 114.98 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.44 150.02 36.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.044 0.922 . . . . 0.0 111.68 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 95' ' ' ILE . . . -156.53 174.0 16.09 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.793 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.0 151.12 41.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.7 p -121.57 134.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 111.188 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 90' ' ' ILE . 21.8 tt0 -108.5 131.0 55.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.937 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 62.8 m-85 -116.59 149.16 40.13 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.417 0.448 . . . . 0.0 111.441 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.58 -38.05 70.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.562 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.7 mp -104.58 139.27 39.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.179 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.05 59.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.527 0.68 . . . . 0.0 109.186 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.94 -50.02 39.15 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.63 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.581 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -68.76 -31.96 71.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.999 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.915 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.32 -45.41 88.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.755 0.422 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.34 70.03 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.48 68.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.015 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -38.75 84.62 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.85 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.756 HD11 HD22 ' A' ' 66' ' ' LEU . 9.6 mt -70.27 -40.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.242 0.339 . . . . 0.0 111.692 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.41 -44.57 11.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.7 mtp -129.27 50.02 2.19 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 8.8 t-20 -64.36 -37.86 89.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.736 0.303 . . . . 0.0 110.887 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.1 77.63 1.59 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.712 0.767 . . . . 0.0 109.705 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.3 m -122.81 162.73 21.57 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.211 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -89.68 118.33 29.21 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.979 0.418 . . . . 0.0 110.74 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -122.14 128.44 51.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.897 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 56.81 20.51 5.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.073 0.949 . . . . 0.0 112.754 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.03 4.78 58.58 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.875 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -127.75 154.0 45.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.77 0.285 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.96 132.14 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.8 pt -119.55 153.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 68.8 mtt180 -124.08 134.82 53.3 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.24 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -129.1 135.56 61.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.191 0.52 . . . . 0.0 110.96 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -149.72 174.59 12.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 130.39 40.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.631 0.253 . . . . 0.0 111.245 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.042 -179.541 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.55 0.214 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 74.5 mtm -101.9 136.88 40.99 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.807 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.3 mmm -108.79 138.03 45.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.484 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -122.56 148.81 44.77 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.488 0.493 . . . . 0.0 111.157 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 73.5 m -89.81 -39.01 13.37 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.38 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.64 -178.09 39.51 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.525 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -107.51 131.39 54.38 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.56 0.219 . . . . 0.0 111.027 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.1 m -128.5 -21.83 3.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.516 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -63.48 -35.33 80.08 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.23 0.612 . . . . 0.0 112.579 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -114.24 136.12 53.31 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.363 0.414 . . . . 0.0 110.979 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -116.43 142.54 46.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.771 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -133.6 -37.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.607 0.567 . . . . 0.0 111.746 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -63.37 -33.34 75.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.5 m -61.25 -38.79 87.93 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -67.48 -37.17 82.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.901 0.48 . . . . 0.0 112.163 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.5 m -79.01 -32.04 44.94 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -78.01 132.09 37.65 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -79.45 -30.37 42.17 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.149 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -85.57 156.97 20.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.487 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.542 ' H ' HD23 ' A' ' 19' ' ' LEU . 99.3 p -73.06 158.21 35.84 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.909 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.37 -30.76 71.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.89 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.41 -49.43 75.5 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.662 0.385 . . . . 0.0 111.893 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.595 ' SD ' ' HG3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -70.75 -38.89 73.52 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -68.08 -41.79 81.36 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.002 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.15 -39.9 75.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 51.9 mt -67.25 -45.51 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.016 0.198 . . . . 0.0 111.183 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 23' ' ' MET . 12.1 mt -69.41 -38.6 78.0 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.9 p -76.5 -28.65 56.52 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -112.76 77.83 1.08 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.213 0.53 . . . . 0.0 110.944 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 14.7 mt -117.78 116.86 36.18 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.932 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.93 125.71 12.93 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.423 2.082 . . . . 0.0 111.404 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -45.13 -34.29 2.58 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.551 ' HA ' ' OG1' ' A' ' 37' ' ' THR . 32.6 m -87.88 -43.83 11.51 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.7 -25.67 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.26 0.224 . . . . 0.0 111.429 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.18 -31.94 73.08 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -161.87 -20.96 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.09 119.74 25.33 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.917 0.389 . . . . 0.0 111.941 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.1 m -98.11 -39.0 9.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.278 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 t -119.41 141.16 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.923 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 66.85 153.29 0.08 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.959 0.904 . . . . 0.0 112.086 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.7 t -117.45 133.73 55.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.872 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 m -66.29 -37.54 85.66 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.911 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -92.3 137.23 32.54 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.359 0.412 . . . . 0.0 111.17 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -68.05 -36.35 79.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.156 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -116.08 130.24 56.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.51 -46.97 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.842 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.53 121.48 34.98 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.549 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.24 -49.54 2.03 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.558 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.45 -110.98 0.89 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 t -115.57 138.97 50.52 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.599 0.235 . . . . 0.0 110.491 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -108.4 128.26 9.01 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.778 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.75 -68.05 0.93 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.7 m -119.55 147.89 43.95 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.691 0.289 . . . . 0.0 110.63 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.92 -178.75 47.55 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 115.997 -0.547 . . . . 0.0 113.073 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.25 -51.77 3.43 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.616 -0.326 . . . . 0.0 112.883 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -122.14 146.58 47.09 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 123.652 0.266 . . . . 0.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.82 161.74 16.72 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.624 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.9 -169.06 41.97 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.656 -0.306 . . . . 0.0 112.891 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 m -122.62 143.4 49.78 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.54 0.2 . . . . 0.0 110.804 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.74 133.42 52.16 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.2 p -84.68 -33.84 23.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.988 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -126.88 157.21 39.96 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.52 0.513 . . . . 0.0 111.315 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' NZ ' HD12 ' A' ' 139' ' ' LEU . 23.6 mttm -121.84 120.77 35.53 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.567 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -132.63 -40.36 0.97 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.789 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.62 HG22 ' HG2' ' A' ' 111' ' ' GLU . 9.4 t -103.59 125.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.8 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.29 158.42 32.59 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.078 -179.103 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.89 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 36.7 t80 -96.66 123.75 40.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.88 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.562 HG12 HG12 ' A' ' 137' ' ' VAL . 2.4 m -124.47 114.56 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -133.78 160.19 23.96 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.556 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.3 33.5 6.22 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.742 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -92.13 165.78 12.98 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 124.016 0.48 . . . . 0.0 111.374 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -87.9 161.16 17.63 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.06 -33.11 73.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 0.0 111.949 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.78 4.45 25.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.804 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.742 HG11 ' HB3' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -86.16 139.26 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.859 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -124.68 174.28 7.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.26 -33.19 73.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.234 0.613 . . . . 0.0 112.23 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -66.0 -39.5 90.33 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.84 -42.28 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.729 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.1 tt -67.98 -37.38 81.45 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.665 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 22.8 t-80 -68.6 -47.86 65.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.476 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.527 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.49 -21.36 62.77 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.08 22.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.147 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 62.3 m-85 -98.14 -1.03 43.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.135 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.16 -31.78 2.5 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.3 Cg_exo -59.56 -24.11 73.8 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.942 1.761 . . . . 0.0 113.785 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.516 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 52.1 m-85 -79.05 -31.24 44.46 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.244 0.34 . . . . 0.0 111.902 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.29 -164.83 38.33 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.455 0.472 . . . . 0.0 112.764 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -82.38 136.09 35.04 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.671 0.388 . . . . 0.0 111.638 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.413 HD11 ' C ' ' A' ' 84' ' ' PHE . 4.8 mt -116.1 141.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.558 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 4.9 p -88.85 -64.15 1.19 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 123.521 0.513 . . . . 0.0 112.11 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -149.48 157.4 43.26 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.458 ' CD1' HG23 ' A' ' 110' ' ' VAL . 11.8 mm -116.56 122.85 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.74 132.14 54.89 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.3 mp -128.13 118.09 20.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.456 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.05 117.13 4.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.938 1.759 . . . . 0.0 112.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.7 mt -117.39 147.29 42.79 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.545 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -86.69 143.81 27.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.523 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -64.82 -32.0 73.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.1 -44.57 68.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.8 p -112.83 -26.47 8.54 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 56.5 21.99 6.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.648 0.779 . . . . 0.0 112.253 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -108.22 147.73 30.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.392 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -86.9 152.38 22.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 66.9 mtt-85 -89.32 2.32 54.53 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.791 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.423 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 99.39 21.45 14.93 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.466 -0.63 . . . . 0.0 114.165 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.47 ' O ' HG23 ' A' ' 95' ' ' ILE . 44.7 p90 -143.11 149.3 37.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.454 0.627 . . . . 0.0 111.481 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.42 172.09 18.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.65 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -120.01 149.08 42.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.1 p -122.74 135.5 62.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.224 0.328 . . . . 0.0 111.216 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.62 ' HG2' HG22 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -109.42 130.79 55.48 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.438 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 64.9 m-85 -112.26 142.37 44.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.77 -37.78 85.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.677 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.584 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.1 mp -103.58 136.02 44.09 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.597 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -71.4 -23.63 61.91 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.3 0.571 . . . . 0.0 110.399 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.07 -49.58 49.59 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.283 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.4 p30 -68.35 -32.64 72.88 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.8 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -44.88 79.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.521 0.328 . . . . 0.0 111.199 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.5 -30.19 71.35 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.821 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.559 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -70.44 -32.83 70.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.623 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.41 -38.69 88.03 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.376 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.645 HD11 HD22 ' A' ' 66' ' ' LEU . 41.3 mt -70.74 -36.6 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.354 0.409 . . . . 0.0 111.749 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.3 p30 -82.82 -16.08 49.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -98.27 -45.23 6.26 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.516 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 88.9 mtp -130.6 51.87 2.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 16.7 p30 -67.03 -36.14 81.43 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.502 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.93 80.16 1.7 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.777 0.799 . . . . 0.0 109.468 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.0 p -126.4 165.61 18.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.398 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.33 120.62 33.04 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -125.82 128.97 48.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 55.84 21.69 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.06 0.944 . . . . 0.0 112.813 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.66 4.45 59.2 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 116.186 -0.461 . . . . 0.0 114.059 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -128.63 154.7 45.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.885 0.343 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.5 m -79.33 132.08 36.32 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -118.4 153.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.433 0.458 . . . . 0.0 112.132 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 86.7 mtt180 -125.47 134.25 52.13 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.493 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.89 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -127.42 133.36 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 110.361 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -147.38 172.75 13.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.555 HD12 ' NZ ' ' A' ' 63' ' ' LYS . 4.2 tt -67.85 125.52 26.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.693 0.397 . . . . 0.0 110.476 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.114 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.455 0.169 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 74.2 mtm -103.37 137.04 42.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.5 mmm -118.07 151.95 36.52 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.706 0.629 . . . . 0.0 110.783 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -106.67 139.27 41.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.006 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.7 t -132.03 134.98 46.17 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.73 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.78 39.59 2.84 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.87 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.61 144.27 28.09 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.317 0.247 . . . . 0.0 111.015 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.0 m -74.86 -37.29 62.25 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.982 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 57.0 46.41 19.42 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.751 0.82 . . . . 0.0 112.077 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -123.3 140.83 52.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.015 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 48.83 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.304 1.042 . . . . 0.0 112.866 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 m -126.71 0.72 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.052 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -64.81 -43.63 92.51 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.908 0.483 . . . . 0.0 112.012 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.5 p -68.78 -36.98 78.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -69.11 -39.88 78.68 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.878 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -74.98 -44.4 48.48 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -130.59 137.34 49.61 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.212 0.32 . . . . 0.0 111.397 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -142.12 103.63 4.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.787 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tp -118.72 143.61 46.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.661 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.7 p -73.17 160.63 31.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.706 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.78 -37.27 86.01 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -70.25 -42.47 72.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.494 ' O ' HD12 ' A' ' 27' ' ' LEU . 31.0 mmm -66.74 -38.17 86.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -68.67 -43.58 75.88 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -70.88 -41.92 70.7 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.0 mt -70.3 -47.32 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 23' ' ' MET . 11.3 mt -69.32 -41.37 76.79 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -70.02 -36.03 74.76 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.742 0.306 . . . . 0.0 111.187 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.569 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 74.9 m-20 -104.66 64.28 0.74 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -104.82 93.22 5.94 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.523 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 29' ' ' ASN . 12.2 Cg_exo -70.33 131.0 19.56 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.91 2.407 . . . . 0.0 111.612 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -51.51 -32.48 27.83 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.9 p -86.56 -38.0 17.6 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.8 t -68.15 -29.9 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.596 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.11 71.19 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -152.51 130.56 11.85 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.193 0.308 . . . . 0.0 111.192 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 p -124.8 155.19 39.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.0 m -97.7 -41.05 8.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.621 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -120.04 137.65 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 O-C-N 123.365 0.415 . . . . 0.0 110.115 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -102.61 149.04 24.82 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.76 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 t -121.55 134.88 55.04 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.977 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.4 t -97.96 -0.9 43.95 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.96 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.36 138.48 35.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.201 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -124.18 148.4 47.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -126.42 144.98 50.65 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.628 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -112.46 132.63 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.046 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -109.9 155.42 21.74 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.23 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.23 -177.45 43.3 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.965 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.91 -62.25 1.09 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.566 -0.35 . . . . 0.0 112.786 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.9 m -120.86 148.33 44.18 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.618 0.246 . . . . 0.0 111.072 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.83 -53.33 1.2 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.563 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.26 -178.02 43.86 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.52 -0.372 . . . . 0.0 112.818 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.0 p -70.7 -29.44 65.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 179.01 -178.45 48.8 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 123.467 0.479 . . . . 0.0 112.652 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.64 -55.29 2.46 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.638 -0.315 . . . . 0.0 113.127 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.0 p -70.72 -30.44 66.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.1 -176.73 42.21 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.411 0.445 . . . . 0.0 113.041 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.43 37.39 10.89 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 120.095 -0.281 . . . . 0.0 113.526 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.1 p -118.23 148.37 42.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.631 0.253 . . . . 0.0 111.182 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.35 -21.38 49.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.609 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.6 p -74.08 -20.7 60.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.0 p -82.63 -8.91 59.58 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -93.25 128.32 39.18 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.117 0.26 . . . . 0.0 110.978 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -110.31 2.15 18.96 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.598 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG11 ' SD ' ' A' ' 23' ' ' MET . 45.9 t -99.38 135.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.82 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -124.08 151.25 44.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 110.909 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 66.0 t80 -94.45 129.46 41.2 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.519 HG12 HG12 ' A' ' 137' ' ' VAL . 5.0 m -126.21 121.46 59.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 123.468 0.48 . . . . 0.0 110.202 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.35 153.0 20.59 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.645 0.591 . . . . 0.0 112.961 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.8 10.38 Favored Glycine 0 C--N 1.334 0.441 0 O-C-N 124.015 0.479 . . . . 0.0 112.442 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.74 161.44 17.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.798 0.333 . . . . 0.0 110.672 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.5 158.22 17.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.228 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.61 ' HA ' ' HE2' ' A' ' 104' ' ' HIS . 44.6 mt-10 -64.32 -27.76 69.25 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.648 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.92 -2.54 34.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.887 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.7 m -86.11 138.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 120.689 0.28 . . . . 0.0 110.738 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.484 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.3 m-20 -117.94 178.56 4.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.598 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.89 -28.82 69.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.566 0.346 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.82 -40.71 79.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.49 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 5.2 t -65.88 -45.81 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.087 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -65.91 -39.21 90.38 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.571 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 26.9 t-80 -68.31 -48.49 64.78 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.763 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.28 62.99 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.42 -35.41 23.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 82.2 m-85 -100.25 -0.43 38.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.159 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.8 tp -68.07 -32.59 4.17 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.69 -22.87 69.34 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.773 1.649 . . . . 0.0 113.89 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -81.18 -31.46 34.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.35 -167.86 40.05 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.098 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.06 131.79 34.77 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.684 0.394 . . . . 0.0 111.183 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.513 HG21 HD11 ' A' ' 93' ' ' ILE . 9.2 mt -112.98 135.88 51.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.388 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -91.3 -58.73 2.35 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.544 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -146.57 152.97 39.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.513 HD11 HG21 ' A' ' 90' ' ' ILE . 19.4 mm -118.23 115.14 47.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -114.53 122.77 47.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.035 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -127.43 123.23 23.11 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.602 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.15 127.6 18.73 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.226 1.951 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.64 135.6 47.06 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -94.01 146.33 24.02 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -64.6 -36.03 82.91 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.55 -49.2 19.35 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.5 p -92.57 -28.58 16.66 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 52.46 22.99 2.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.265 0.626 . . . . 0.0 111.885 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 101' ' ' THR . 66.2 mttt -107.44 148.48 29.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.67 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 21.8 p80 -93.0 -9.39 39.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.016 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 71.61 -18.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.359 1.063 . . . . 0.0 113.063 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.495 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.9 26.07 4.56 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 119.507 -0.607 . . . . 0.0 114.551 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -147.5 145.58 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.604 0.702 . . . . 0.0 111.213 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.403 ' HB2' HG23 ' A' ' 95' ' ' ILE . . . -152.58 168.26 26.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.949 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -113.29 140.93 47.58 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 93' ' ' ILE . 7.8 p -116.22 135.22 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 90' ' ' ILE . 19.0 tt0 -104.79 125.59 51.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.261 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -111.52 138.38 48.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.088 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -66.35 -37.0 84.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.65 134.19 52.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.94 63.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.45 -49.54 63.2 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.08 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -68.67 -32.47 72.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.82 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.94 -44.09 97.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.534 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.07 68.82 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.252 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.94 73.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.243 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.82 -37.95 87.62 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.717 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.734 HD11 HD22 ' A' ' 66' ' ' LEU . 64.8 mt -69.99 -33.89 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.022 0.201 . . . . 0.0 111.125 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.44 -35.9 80.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -102.58 -35.03 8.87 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.503 ' O ' HG13 ' A' ' 137' ' ' VAL . 95.6 mmm -92.07 0.57 57.47 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.4 t-20 -56.49 -37.37 70.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.827 0.285 . . . . 0.0 111.728 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -141.9 73.49 1.41 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.345 0.593 . . . . 0.0 109.504 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.2 p -125.41 157.2 37.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.25 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -94.99 120.05 34.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.612 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.11 129.83 44.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.985 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.9 t80 62.64 15.1 7.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.747 0.819 . . . . 0.0 112.366 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.62 4.61 58.04 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.402 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -127.58 154.11 45.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.741 0.271 . . . . 0.0 110.999 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -83.0 134.62 35.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 pt -119.8 156.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 123.421 0.451 . . . . 0.0 112.113 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 31.7 ptt180 -126.06 132.94 51.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.211 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -128.98 140.19 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.062 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -144.31 170.26 16.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 119.81 15.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.153 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.086 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.457 0.17 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.8 mmm -103.55 137.02 42.21 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.814 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.7 mtt -101.09 138.78 37.67 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.653 0.596 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 57.5 41.41 26.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.759 0.823 . . . . 0.0 111.992 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.0 t -133.07 138.44 46.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.963 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.7 42.83 7.1 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.293 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -90.9 133.64 35.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.447 0.299 . . . . 0.0 110.5 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 t -127.96 141.4 51.54 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.056 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -95.9 146.16 24.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.762 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 10' ' ' ARG . 51.1 mtt180 -119.0 150.09 40.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.071 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.81 -8.95 59.84 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.225 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.98 -33.56 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -63.43 -42.29 98.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 m -66.45 -37.18 84.59 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.1 tptp -64.29 -35.84 82.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.062 0.545 . . . . 0.0 111.975 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.65 -36.25 80.39 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.8 147.46 25.45 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.363 0.414 . . . . 0.0 111.016 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -118.93 136.08 54.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.218 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.8 tp -106.77 150.88 25.86 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.454 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -70.25 153.84 42.61 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.565 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -61.24 -37.73 84.11 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.28 -41.86 76.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.469 ' O ' HD12 ' A' ' 27' ' ' LEU . 8.3 mtt -70.39 -38.46 74.7 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -65.79 -43.09 89.77 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.712 0.405 . . . . 0.0 112.079 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -70.97 -46.67 61.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 31.1 mt -69.93 -45.48 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 23' ' ' MET . 8.2 mt -68.86 -35.52 77.02 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -69.58 -36.53 76.34 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.56 0.219 . . . . 0.0 111.587 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.73 106.54 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.244 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 4.4 mt -103.05 121.7 48.07 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.403 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.72 129.37 20.88 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.533 2.155 . . . . 0.0 111.568 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -44.78 -35.33 2.67 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.6 p -89.53 -40.88 12.36 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.26 -33.63 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.295 0.238 . . . . 0.0 111.373 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.6 -28.2 68.96 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.449 0.468 . . . . 0.0 112.014 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -161.03 128.87 4.31 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.226 0.329 . . . . 0.0 110.771 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.9 p -126.93 157.55 39.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.8 m -87.09 -44.04 11.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.585 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.1 t -125.78 132.58 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 123.41 0.443 . . . . 0.0 109.925 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -118.08 134.81 54.65 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.876 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.7 t -129.61 130.6 45.84 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -132.52 -43.24 0.93 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.359 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -107.95 141.21 39.93 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.415 0.447 . . . . 0.0 110.122 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -120.31 136.39 54.7 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.037 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -76.38 -32.66 58.71 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.63 141.44 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 123.233 0.333 . . . . 0.0 110.912 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -94.79 148.41 22.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.19 48.21 0.01 OUTLIER Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.802 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.08 178.55 48.21 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.484 -0.389 . . . . 0.0 112.723 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.0 p -130.72 153.74 48.68 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.325 0.25 . . . . 0.0 111.06 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.71 179.97 43.2 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.879 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.63 29.74 31.67 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.701 -0.285 . . . . 0.0 113.444 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.5 m -64.12 -36.18 83.2 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 163.82 -118.82 0.84 Allowed Glycine 0 C--N 1.339 0.699 0 O-C-N 123.493 0.495 . . . . 0.0 112.46 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.68 -36.2 92.03 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 113.766 0.266 . . . . 0.0 113.766 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -120.24 148.22 43.97 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 122.313 0.245 . . . . 0.0 110.954 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.37 -178.13 35.98 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.636 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.16 34.67 4.48 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.357 -0.449 . . . . 0.0 113.106 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.6 p -124.87 150.16 46.76 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.508 0.194 . . . . 0.0 111.175 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.55 151.23 31.86 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.23 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.0 p -115.12 162.16 17.41 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.7 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 p -79.09 91.39 4.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.147 0.499 . . . . 0.0 111.348 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.21 143.23 50.43 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 76.1 mtt85 -90.54 -0.44 57.67 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.152 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 111' ' ' GLU . 6.0 t -106.5 131.3 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.636 HD22 HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -123.45 156.95 34.55 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.459 0.475 . . . . 0.0 110.837 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.865 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 48.0 t80 -98.71 134.8 41.12 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.704 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 137' ' ' VAL . 2.6 m -134.11 114.82 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.9 150.52 19.37 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.656 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.62 36.77 3.67 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.784 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.3 mp -94.4 164.73 12.89 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.004 0.431 . . . . 0.0 111.227 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.77 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -88.7 164.44 15.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.499 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.38 -32.79 72.04 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.14 5.73 21.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.24 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.784 HG11 ' HB3' ' A' ' 71' ' ' LEU . 3.9 p -86.41 136.07 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 120.648 0.261 . . . . 0.0 110.854 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -122.35 174.58 6.92 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.467 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.0 m-20 -61.65 -32.53 72.69 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.146 0.578 . . . . 0.0 112.045 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -67.37 -40.25 85.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.684 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.2 -43.08 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.967 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -68.46 -36.47 79.05 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.809 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 22.4 t-80 -68.56 -49.51 58.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.595 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.522 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -71.0 -20.91 62.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.64 -34.35 23.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.209 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 64.9 m-85 -98.14 -2.46 39.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.102 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.4 tp -67.13 -32.35 4.66 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.5 -23.54 71.21 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 121.782 1.655 . . . . 0.0 113.795 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 45.0 m-85 -80.3 -31.62 38.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.23 -168.05 40.94 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 123.467 0.48 . . . . 0.0 112.738 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -84.88 133.19 34.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.566 0.347 . . . . 0.0 111.148 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 111' ' ' GLU . 5.3 mt -114.08 138.9 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.643 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.1 p -89.89 -60.31 1.97 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.951 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -149.06 159.22 44.43 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.441 ' CD1' HG23 ' A' ' 110' ' ' VAL . 17.7 mm -117.93 126.98 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -121.01 126.96 51.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -128.13 115.88 20.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.698 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.45 126.87 22.67 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.284 1.989 . . . . 0.0 112.623 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -127.53 135.09 49.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.173 -179.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -91.32 144.17 25.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -34.9 79.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -71.21 -48.63 50.33 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 p -98.7 -27.69 13.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' HD11 ' A' ' 97' ' ' LEU . 51.4 mt-10 57.18 22.84 7.96 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.29 0.636 . . . . 0.0 111.674 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -121.32 155.44 34.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.292 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -101.32 160.85 14.07 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.236 0.335 . . . . 0.0 110.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 77.9 mtt180 -88.55 2.95 52.03 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.197 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 96.34 27.13 10.23 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.326 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.4 p90 -143.6 148.98 36.68 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.372 0.586 . . . . 0.0 111.127 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.54 169.5 22.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -117.3 144.08 45.25 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.441 HG23 ' CD1' ' A' ' 93' ' ' ILE . 10.6 p -120.99 134.53 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.211 0.319 . . . . 0.0 111.01 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.5 OUTLIER -106.53 128.49 54.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.32 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 13.6 m-85 -109.25 137.16 47.55 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.04 -35.82 82.39 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.54 134.26 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.82 -26.42 65.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.31 -44.1 84.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.873 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -68.49 -33.06 73.5 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.58 -46.16 91.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.28 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.29 -28.79 66.59 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.314 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.88 72.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.507 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.01 88.78 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.223 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.781 HD13 HD22 ' A' ' 139' ' ' LEU . 12.8 mt -70.73 -33.65 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 123.252 0.345 . . . . 0.0 111.875 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.13 -17.31 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -101.22 -43.03 6.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.506 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 84.7 mtp -126.24 47.41 2.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 19.0 p-10 -66.29 -33.92 76.83 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.328 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.1 mt-10 -143.06 77.47 1.57 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.733 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.6 m -123.56 162.57 22.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.179 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.32 119.7 30.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.87 0.367 . . . . 0.0 110.77 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.8 129.63 48.7 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.003 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 57.22 20.59 5.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 112.693 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.99 3.99 60.3 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.893 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -127.66 155.08 44.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.686 0.243 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.0 131.25 35.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -116.83 151.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 74.6 mtt180 -122.72 134.3 54.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -128.16 133.78 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.459 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -147.13 172.67 13.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.665 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.781 HD22 HD13 ' A' ' 122' ' ' ILE . 1.9 mm? -67.9 127.42 32.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.704 0.402 . . . . 0.0 110.66 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.128 -179.651 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 N--CA 1.487 1.406 0 N-CA-C 111.274 0.101 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.5 mmm -100.98 136.87 40.14 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.447 0.467 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.3 mtp -122.39 155.16 36.62 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -106.71 149.97 26.75 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.929 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.7 m -71.38 -36.66 71.51 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.325 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.74 -169.96 31.74 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 116.201 -0.454 . . . . 0.0 113.12 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -32.12 73.63 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t -91.27 130.1 37.18 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.336 0.397 . . . . 0.0 111.461 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -85.59 142.68 28.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.411 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -93.67 1.78 56.5 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.434 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -95.36 140.48 30.18 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.218 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 m -131.3 149.39 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.111 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -65.5 -28.66 69.35 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -59.09 -37.38 77.0 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -63.67 -36.15 82.88 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.3 m -72.54 -34.69 67.71 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -66.46 -26.84 67.39 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.14 0.576 . . . . 0.0 112.214 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -57.56 -36.71 72.04 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.58 152.41 20.46 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.336 0.398 . . . . 0.0 111.38 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -90.81 157.76 17.2 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.035 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.59 -35.65 76.62 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.85 -45.71 60.47 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.9 tpp -65.96 -37.91 87.2 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.711 0.404 . . . . 0.0 111.61 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.83 -40.96 92.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.807 0.443 . . . . 0.0 111.534 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.13 -38.59 78.92 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.01 -51.69 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 123.299 0.374 . . . . 0.0 111.562 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.9 -39.69 76.06 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.7 m -68.16 -36.1 79.1 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 120.6 0.238 . . . . 0.0 111.524 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.595 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 82.9 m-20 -105.55 54.35 0.7 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -98.89 98.29 6.08 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.691 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 29' ' ' ASN . 9.6 Cg_exo -72.0 130.27 16.42 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.823 2.349 . . . . 0.0 111.704 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -50.86 -34.0 26.25 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.5 m -82.81 -40.73 19.99 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.61 -32.04 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.489 0.316 . . . . 0.0 111.78 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.76 -31.07 71.84 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -151.83 126.54 9.56 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.207 0.317 . . . . 0.0 111.16 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 p -127.66 154.21 45.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.169 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.4 m -130.72 -44.63 1.08 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.174 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -121.93 143.61 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.87 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.06 151.4 23.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.172 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.425 ' SG ' ' HG3' ' A' ' 43' ' ' GLU . 17.7 t -120.75 137.05 54.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.153 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 p -100.89 57.07 0.87 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.663 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 51.0 mt-10 -62.44 139.33 58.57 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.956 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -69.73 -33.88 73.08 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.465 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -105.54 137.21 43.76 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.312 0.382 . . . . 0.0 111.13 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 m -130.84 154.71 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -104.1 156.8 17.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.198 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 178.1 135.4 2.28 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.95 79.37 0.07 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.421 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.1 m -121.93 148.0 45.31 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.599 0.235 . . . . 0.0 111.01 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.82 178.55 36.76 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.655 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.84 -166.18 29.79 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.39 -0.433 . . . . 0.0 112.638 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.6 m -63.41 -34.4 77.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.915 0.486 . . . . 0.0 112.275 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -131.63 166.13 23.1 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.612 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.21 -48.2 4.67 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 121.572 -0.347 . . . . 0.0 113.247 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.3 p -122.05 153.54 38.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.595 0.236 . . . . 0.0 111.203 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.25 -179.16 33.89 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.674 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.29 111.06 4.13 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.596 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.8 p -78.23 -21.14 50.42 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.85 -37.16 78.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.7 p -79.52 -25.98 41.6 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.83 -44.85 10.2 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.381 0.426 . . . . 0.0 111.748 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -96.34 130.06 43.54 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.287 0.367 . . . . 0.0 111.573 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 72.5 mtt85 -113.39 6.27 17.15 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.886 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 111' ' ' GLU . 22.0 t -104.95 136.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.632 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.98 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.88 155.97 37.11 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.554 0.533 . . . . 0.0 111.386 -178.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.769 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.0 t80 -92.71 134.79 34.69 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.437 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.545 HG12 HG12 ' A' ' 137' ' ' VAL . 2.6 m -134.64 115.18 19.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 O-C-N 123.654 0.596 . . . . 0.0 109.663 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.22 152.31 20.35 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.989 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.89 8.03 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.99 0.465 . . . . 0.0 112.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -92.01 164.76 13.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.573 0.349 . . . . 0.0 110.592 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -91.09 155.52 18.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.739 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.08 -26.16 68.7 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.67 0.388 . . . . 0.0 111.749 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.79 -3.03 32.72 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.689 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -86.3 135.51 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.907 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -109.49 174.86 5.68 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.547 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -60.52 -29.63 69.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.567 0.347 . . . . 0.0 111.57 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -68.81 -35.39 76.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.42 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.79 -47.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.792 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 68' ' ' VAL . 1.5 tt -67.62 -38.88 84.56 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.614 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.543 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 33.1 t-80 -67.67 -48.94 65.2 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.446 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.59 -20.36 62.78 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.84 -34.04 24.73 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 111.456 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' C ' HD11 ' A' ' 90' ' ' ILE . 77.5 m-85 -102.34 0.2 33.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.433 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -68.83 -32.81 3.75 Favored Pre-proline 0 CA--C 1.565 1.525 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 15.1 Cg_endo -58.61 -23.42 65.22 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 121.94 1.76 . . . . 0.0 113.941 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -78.34 -31.39 48.64 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.87 -161.94 34.81 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.998 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.71 134.79 34.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.689 0.396 . . . . 0.0 111.833 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.514 HG21 HD11 ' A' ' 93' ' ' ILE . 15.2 mt -116.63 138.67 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -94.21 -60.8 1.65 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 111' ' ' GLU . 75.4 m-20 -143.86 153.19 42.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.514 HD11 HG21 ' A' ' 90' ' ' ILE . 20.8 mm -119.46 124.64 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.59 127.56 54.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.71 114.37 20.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.935 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.28 130.88 37.99 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.399 2.066 . . . . 0.0 112.734 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.09 132.53 50.61 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.131 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -94.25 142.76 27.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.355 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -64.69 -34.28 77.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.8 -42.58 81.35 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 19.1 p -112.65 -26.71 8.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 60.82 19.61 9.81 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.347 0.659 . . . . 0.0 111.397 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -122.43 155.34 36.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.343 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -107.03 157.88 17.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.645 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -82.75 -1.39 51.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.326 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.57 41.64 2.49 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-O 119.807 -0.44 . . . . 0.0 113.836 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -147.28 147.47 30.43 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.85 0.357 . . . . 0.0 110.961 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.27 172.76 17.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -115.57 142.33 46.87 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.7 p -114.05 134.51 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 123.213 0.321 . . . . 0.0 110.599 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HG3' HG22 ' A' ' 65' ' ' VAL . 17.0 tt0 -108.26 125.64 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.618 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 30.0 m-85 -112.42 137.61 50.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.56 -36.71 84.58 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.58 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.6 mp -105.74 140.23 39.1 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.38 -22.51 57.44 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.924 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -72.8 -49.55 29.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.58 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 21.3 p30 -67.03 -32.3 73.41 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.653 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.98 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.6 -42.73 91.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.01 0.524 . . . . 0.0 111.036 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.1 69.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.209 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.18 -37.31 78.11 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.934 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.05 -38.08 87.47 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.454 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.764 HD11 HD22 ' A' ' 66' ' ' LEU . 44.2 mt -70.16 -33.0 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 123.234 0.334 . . . . 0.0 111.281 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.83 -36.18 77.87 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -105.56 -33.04 8.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.485 ' O ' HG13 ' A' ' 137' ' ' VAL . 98.0 mmm -95.85 3.98 53.21 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.647 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.6 t-20 -56.57 -37.52 70.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.845 0.293 . . . . 0.0 111.764 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.06 72.85 1.4 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.695 0.76 . . . . 0.0 109.94 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.1 t -124.71 157.33 35.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -93.8 120.85 34.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.6 tp -128.48 128.21 43.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.806 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.98 7.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.658 0.783 . . . . 0.0 112.437 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.92 58.25 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.447 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -127.51 153.81 45.89 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.428 0.291 . . . . 0.0 110.778 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -82.08 134.17 35.32 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.27 154.36 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 73.7 mtt180 -122.26 134.3 54.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.359 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -130.95 138.38 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.896 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -151.67 172.18 16.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' HG ' HD13 ' A' ' 122' ' ' ILE . 19.7 mt -70.29 129.9 40.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.553 0.216 . . . . 0.0 111.118 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.459 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.483 0.182 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.2 mmm -100.75 128.4 46.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.829 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.4 mtt -72.38 -36.88 68.82 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.386 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -108.32 143.57 37.02 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.384 0.428 . . . . 0.0 111.048 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.4 m -94.28 -42.14 9.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.43 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 26.64 33.3 Favored Glycine 0 C--N 1.343 0.925 0 O-C-N 123.387 0.43 . . . . 0.0 113.429 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -97.55 149.14 22.53 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.372 0.269 . . . . 0.0 111.067 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -125.91 131.51 52.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.784 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -96.31 146.28 24.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.203 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -123.93 152.33 42.57 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.827 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -98.45 142.0 30.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.094 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.61 136.22 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.625 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -62.34 -40.83 97.66 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 m -65.38 -40.18 93.19 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -68.98 -32.26 71.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.88 0.472 . . . . 0.0 112.261 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.68 -34.69 78.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 62.62 169.03 0.13 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.811 0.844 . . . . 0.0 112.158 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -83.68 159.65 21.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.574 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 tp -97.1 144.62 26.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.792 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.2 p -74.56 160.56 30.73 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.49 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.02 -36.98 83.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' OE2' HG23 ' A' ' 65' ' ' VAL . 29.2 tt0 -67.1 -45.62 76.67 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 123.321 0.388 . . . . 0.0 111.567 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.526 ' O ' HD12 ' A' ' 27' ' ' LEU . 26.1 mtp -69.07 -37.34 78.43 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -61.55 -43.11 99.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.79 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.55 -40.38 73.43 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.1 mt -70.1 -47.39 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 122.22 0.208 . . . . 0.0 111.388 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 23' ' ' MET . 3.3 mt -69.61 -36.46 76.21 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.3 p -76.26 -26.34 55.87 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.57 0.224 . . . . 0.0 111.409 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -113.32 82.99 1.76 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.217 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 7.2 mt -106.66 159.84 28.43 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.594 ' O ' HG13 ' A' ' 34' ' ' VAL . 2.8 Cg_endo -81.77 164.74 18.12 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.774 2.316 . . . . 0.0 113.323 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.94 -23.48 66.39 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.971 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.5 p -82.59 21.85 0.94 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.199 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -56.64 -8.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.94 73.5 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 53.87 105.81 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.242 1.017 . . . . 0.0 112.848 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.01 124.53 33.17 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.119 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.34 154.29 51.42 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.504 0.503 . . . . 0.0 111.485 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.01 148.64 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.123 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -96.78 111.94 23.91 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.398 0.436 . . . . 0.0 110.9 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 t -134.67 138.78 44.74 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.439 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 p -75.71 -31.9 59.85 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -73.11 -38.47 66.33 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -69.45 -35.75 75.95 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -111.44 135.97 51.25 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.362 0.414 . . . . 0.0 111.452 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.2 t -121.15 136.21 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.644 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.69 122.53 30.72 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.573 0.545 . . . . 0.0 110.838 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.42 -46.91 1.05 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.761 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.75 118.15 6.07 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.44 -0.409 . . . . 0.0 112.631 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -65.56 -33.66 76.43 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.46 37.43 7.03 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.149 -0.478 . . . . 0.0 113.02 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.62 164.98 33.13 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 121.628 -0.32 . . . . 0.0 112.787 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -123.59 148.92 45.92 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.327 0.251 . . . . 0.0 111.013 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.71 108.47 3.68 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.566 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.02 -41.83 6.95 Favored Glycine 0 C--N 1.339 0.72 0 O-C-N 123.679 0.282 . . . . 0.0 113.292 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 m -119.5 147.77 44.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.571 0.224 . . . . 0.0 111.07 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.02 44.75 0.06 OUTLIER Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.564 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.24 170.84 39.67 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.655 -0.307 . . . . 0.0 112.741 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.5 m -122.81 145.2 48.64 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.53 0.205 . . . . 0.0 110.955 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.67 43.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.906 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.8 p -126.26 156.08 40.88 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.309 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p 51.24 -76.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.686 1.194 . . . . 0.0 113.488 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 113' ' ' GLU . 94.4 mttt -104.7 143.19 33.43 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 122.467 0.307 . . . . 0.0 110.721 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 139' ' ' LEU . 67.0 ttt180 -122.58 132.85 54.49 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.346 0.404 . . . . 0.0 110.988 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 111' ' ' GLU . 18.9 t -106.63 136.38 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.976 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.0 157.58 34.08 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.457 0.473 . . . . 0.0 111.709 -178.269 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.824 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 42.8 t80 -96.38 136.16 37.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.302 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.446 HG12 HG12 ' A' ' 137' ' ' VAL . 4.1 m -134.39 115.09 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 109.718 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.04 142.52 13.75 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.821 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.8 29.52 2.61 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.946 0.439 . . . . 0.0 112.616 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER -97.11 163.31 12.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.929 0.395 . . . . 0.0 110.549 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -84.61 155.79 21.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.13 -27.64 68.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.64 0.376 . . . . 0.0 111.608 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.61 -0.28 29.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.951 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -84.7 140.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.127 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.81 178.71 4.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -59.31 -31.22 68.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.742 0.417 . . . . 0.0 111.482 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.42 -39.97 81.39 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.07 -47.51 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.894 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD22 HD12 ' A' ' 93' ' ' ILE . 1.7 tt -67.62 -38.96 84.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.553 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 24.0 t-80 -68.69 -47.64 65.93 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.657 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.33 -20.69 62.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -32.96 23.65 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 74.9 m-85 -102.32 1.16 35.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.319 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.22 -31.64 2.41 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.362 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.6 Cg_exo -59.21 -24.01 72.06 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 121.967 1.778 . . . . 0.0 113.861 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.551 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 55.2 m-85 -79.91 -31.45 40.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.18 -161.51 35.11 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.95 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.16 136.56 33.93 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.793 0.437 . . . . 0.0 111.864 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.553 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 5.8 mt -116.66 139.24 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.595 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -93.71 -61.27 1.58 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.656 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -143.26 153.51 42.86 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.554 HD12 HD22 ' A' ' 80' ' ' LEU . 18.3 mm -119.84 125.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.81 125.99 50.81 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.23 0.331 . . . . 0.0 111.721 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.35 110.81 21.22 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.04 128.44 27.81 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.43 2.087 . . . . 0.0 112.565 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 102' ' ' GLU . 1.1 tp -124.01 134.24 53.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.165 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.23 139.64 30.41 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.504 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -64.76 -31.98 73.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.09 -41.89 94.59 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 p -117.28 -22.84 8.09 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' O ' HD11 ' A' ' 97' ' ' LEU . 46.7 mt-10 59.99 22.66 11.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.231 0.613 . . . . 0.0 111.444 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -124.84 154.5 40.92 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.348 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -110.21 154.93 22.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -79.57 -11.1 59.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.025 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.77 41.47 1.11 Allowed Glycine 0 C--N 1.341 0.847 0 C-N-CA 121.095 -0.574 . . . . 0.0 114.019 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -145.12 145.13 31.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.195 0.497 . . . . 0.0 111.103 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.99 173.09 17.05 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.966 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.94 144.5 43.98 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.453 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.2 p -116.17 131.03 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 110.692 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.496 ' HG3' HG22 ' A' ' 65' ' ' VAL . 20.3 tt0 -106.37 126.89 52.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.259 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 47.7 m-85 -111.51 141.94 44.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 26.5 tt0 -64.05 -36.89 85.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.137 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -115.63 125.1 52.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.758 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.68 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.405 ' HB2' HD23 ' A' ' 114' ' ' LEU . 70.3 mm-40 -68.25 -47.87 66.61 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.586 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 112' ' ' PHE . 8.0 p30 -69.03 -32.43 71.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.378 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.976 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.58 -42.2 87.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.685 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.17 71.29 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.699 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.665 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -68.48 -33.66 74.54 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.692 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.83 82.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.602 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.74 HD11 HD22 ' A' ' 66' ' ' LEU . 48.0 mt -70.33 -37.76 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.7 p30 -82.94 -16.72 46.27 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -93.89 -47.86 6.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.551 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 62.7 mtt -130.87 53.49 1.97 Allowed 'General case' 0 C--N 1.346 0.434 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.1 t-20 -64.73 -37.71 88.53 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.9 mt-10 -143.18 77.22 1.56 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.728 0.775 . . . . 0.0 109.834 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.0 m -119.77 160.72 22.05 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.31 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -90.28 118.25 29.64 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.955 0.407 . . . . 0.0 110.679 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.3 tp -129.17 130.55 46.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.911 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.3 t80 62.86 15.07 7.94 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.727 0.811 . . . . 0.0 112.232 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.19 4.69 59.74 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.209 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -126.93 155.48 43.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.572 0.349 . . . . 0.0 110.817 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.15 133.32 35.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.2 pt -118.05 151.77 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 57.7 mtt180 -122.81 134.71 54.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.424 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.824 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.73 134.99 61.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.89 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -154.2 172.13 18.09 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.494 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.603 HD12 ' NH2' ' A' ' 64' ' ' ARG . 5.4 tt -69.21 129.69 40.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.578 0.228 . . . . 0.0 110.628 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.136 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.473 0.177 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.32 129.96 45.57 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.909 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.4 mtm -69.65 -35.37 75.14 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.374 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -105.02 151.69 23.64 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m 71.26 -47.56 0.66 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.514 1.126 . . . . 0.0 112.609 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.44 39.84 8.77 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.195 0.309 . . . . 0.0 113.098 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -63.02 -31.7 72.9 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -90.56 125.52 35.64 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.43 0.456 . . . . 0.0 111.444 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -102.99 156.31 17.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.804 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.0 mtp-105 -104.65 136.13 44.76 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -120.89 150.35 41.21 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 t -110.66 128.32 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -65.67 -39.49 91.38 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.721 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.1 p -66.06 -36.49 83.37 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -65.74 -39.63 91.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.836 0.455 . . . . 0.0 111.861 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.6 m -82.27 -44.53 16.17 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -127.81 150.65 49.73 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.265 0.353 . . . . 0.0 111.355 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -111.87 131.02 55.63 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.642 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tp -100.99 150.15 23.19 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -73.0 153.69 40.81 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.58 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.24 -35.74 78.06 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.13 -48.39 68.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.604 0.362 . . . . 0.0 111.537 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.534 ' O ' HD12 ' A' ' 27' ' ' LEU . 92.5 mmm -68.42 -36.63 79.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -64.45 -44.28 91.61 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.187 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.88 -39.7 76.15 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 36.4 mt -66.02 -49.79 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 122.144 0.178 . . . . 0.0 111.215 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 23' ' ' MET . 3.1 mt -70.31 -38.5 74.95 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.3 p -72.8 -27.2 61.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -98.48 9.97 41.95 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.53 0.681 . . . . 0.0 110.05 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 9.5 tp -98.68 137.7 20.64 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.487 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.61 149.83 89.97 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.345 2.03 . . . . 0.0 112.077 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.68 -37.78 74.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 81.0 p -96.68 -15.93 21.2 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.544 0.528 . . . . 0.0 111.519 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t 53.57 9.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 124.148 0.979 . . . . 0.0 112.876 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 62.49 15.98 8.31 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.425 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 63.5 m-85 -112.27 118.28 34.84 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 110.927 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.77 114.82 6.16 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.894 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.7 m 56.48 -73.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.377 1.071 . . . . 0.0 113.226 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.78 149.76 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.678 0.275 . . . . 0.0 110.833 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -63.65 -36.89 85.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.9 p -119.6 122.3 41.25 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.775 0.321 . . . . 0.0 111.232 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.5 p -81.16 -27.13 35.55 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.441 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -105.98 139.87 39.86 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.283 0.364 . . . . 0.0 111.051 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -71.05 -35.53 71.97 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.178 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -114.22 138.02 51.02 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.408 0.443 . . . . 0.0 111.033 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -133.25 142.54 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.561 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -87.59 138.25 31.63 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.288 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.59 172.33 41.13 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.858 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.46 166.27 25.33 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.397 -0.43 . . . . 0.0 112.903 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 t -131.86 143.7 50.36 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.402 0.281 . . . . 0.0 110.62 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.11 178.5 43.45 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.083 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.03 -175.95 42.38 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 121.629 -0.319 . . . . 0.0 112.86 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.1 p -124.05 152.95 42.07 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.606 0.239 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.08 43.07 7.27 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.35 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.03 -50.65 10.23 Favored Glycine 0 C--N 1.343 0.921 0 C-N-CA 121.801 -0.238 . . . . 0.0 113.141 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -73.75 -36.88 65.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.755 0.422 . . . . 0.0 111.99 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.88 179.69 43.09 Favored Glycine 0 C--N 1.341 0.847 0 O-C-N 123.52 0.512 . . . . 0.0 112.92 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 170.37 -176.57 43.95 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.542 -0.361 . . . . 0.0 112.829 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.6 m -121.42 143.45 49.22 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.589 0.233 . . . . 0.0 110.981 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.51 -24.73 29.25 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.351 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.2 p -77.1 -14.42 59.81 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.2 p -74.4 -28.01 60.9 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HE2' ' C ' ' A' ' 140' ' ' ALA . 29.6 tptt -114.45 133.48 55.72 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.275 0.359 . . . . 0.0 110.363 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -102.4 -3.63 26.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.764 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 133.13 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.93 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.11 156.99 33.87 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.535 0.522 . . . . 0.0 111.411 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.0 t80 -101.04 134.61 43.78 Favored 'General case' 0 N--CA 1.458 -0.042 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.455 HG12 ' CG1' ' A' ' 137' ' ' VAL . 4.0 m -128.98 116.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 O-C-N 123.548 0.53 . . . . 0.0 109.769 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.2 152.96 18.88 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.762 -0.733 . . . . 0.0 113.384 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.02 23.72 7.6 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.985 0.462 . . . . 0.0 112.588 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -92.0 163.09 14.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -90.61 157.86 17.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.869 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.6 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 38.8 mt-10 -64.71 -26.67 68.47 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.722 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -77.41 -1.53 30.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.766 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -86.53 139.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 120.572 0.225 . . . . 0.0 110.66 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.1 m-20 -121.71 179.02 4.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.803 0.441 . . . . 0.0 111.54 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.54 -40.77 80.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.702 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.504 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.3 t -67.06 -46.98 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.212 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -67.04 -39.42 86.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.644 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.569 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 31.7 t-80 -68.07 -48.68 64.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.023 0.529 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.41 -20.62 62.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.43 -34.03 23.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 111.402 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.8 m-85 -101.54 0.21 36.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.285 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -70.25 -31.85 2.49 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.5 Cg_exo -59.01 -23.4 68.42 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.007 1.805 . . . . 0.0 113.882 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -78.02 -31.29 50.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.43 -162.67 36.26 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.827 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.88 134.0 35.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.72 0.408 . . . . 0.0 111.769 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.507 HG21 HD11 ' A' ' 93' ' ' ILE . 12.7 mt -114.41 139.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.267 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -62.63 1.42 Allowed 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.668 0.605 . . . . 0.0 112.303 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.9 154.91 41.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 90' ' ' ILE . 17.5 mm -117.2 125.51 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.07 128.22 52.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -127.73 116.72 20.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.706 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.37 121.74 10.39 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.209 1.939 . . . . 0.0 112.413 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 134.57 49.74 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.175 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.81 143.07 26.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.73 -33.47 76.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.66 -48.57 54.22 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.2 p -100.46 -27.85 13.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.82 23.88 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.235 0.614 . . . . 0.0 111.569 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -121.37 156.83 31.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.522 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 9.5 p80 -110.18 159.36 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.928 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 85.5 mtt-85 -87.77 3.6 47.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.015 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 94.51 35.02 6.07 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.594 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 1.3 p90 -143.73 147.12 33.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.65 0.262 . . . . 0.0 110.941 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.0 169.52 23.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.639 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -116.19 144.42 44.21 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.0 p -118.84 133.15 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.425 0.453 . . . . 0.0 110.434 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.05 127.33 53.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 32.2 m-85 -113.8 141.69 46.99 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.271 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -67.47 -37.23 82.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.606 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -102.77 138.95 38.99 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -19.54 59.37 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.483 0.658 . . . . 0.0 109.267 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.19 -50.99 23.29 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.754 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 24.0 p30 -69.33 -31.86 70.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.93 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.15 -45.02 86.71 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.931 0.492 . . . . 0.0 111.423 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.66 -30.51 71.22 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.6 77.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.101 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -67.29 -39.52 85.98 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.8 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 52.7 mt -69.16 -33.82 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.862 -0.154 . . . . 0.0 111.32 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -68.72 -36.4 78.37 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.36 -34.46 8.28 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.482 ' O ' HG13 ' A' ' 137' ' ' VAL . 94.0 mmm -91.68 0.54 57.49 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 10.1 t-20 -56.64 -36.95 70.09 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.847 0.294 . . . . 0.0 111.678 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.74 70.96 1.36 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.619 0.723 . . . . 0.0 110.061 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 55.0 m -121.81 154.7 36.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.336 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.7 119.4 32.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.471 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tp -129.94 130.18 44.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.013 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 61.99 15.68 7.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.658 0.783 . . . . 0.0 112.443 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 4.92 59.22 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.298 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -127.0 154.39 44.68 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.514 0.326 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.53 134.35 34.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.02 154.79 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.024 0.44 . . . . 0.0 112.135 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 22.8 ttp-105 -124.24 131.78 53.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.785 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.27 139.49 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.316 0.385 . . . . 0.0 110.738 179.144 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -145.25 171.94 13.85 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 122' ' ' ILE . 9.2 mt -68.95 133.33 48.05 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.24 0.216 . . . . 0.0 110.921 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.405 ' C ' ' HE2' ' A' ' 63' ' ' LYS . . . . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.34 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.483 0.183 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.4 mtt -101.57 137.03 40.43 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.819 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.5 mtm -103.49 145.8 29.48 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.879 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -111.61 141.33 45.34 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.742 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.82 -39.51 11.72 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.863 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.77 134.47 12.44 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 123.433 0.458 . . . . 0.0 112.992 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -88.55 -12.33 43.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -132.83 142.44 48.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -93.15 10.25 32.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.584 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -108.32 154.75 21.37 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -101.26 152.22 20.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.43 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.98 141.07 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.742 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -60.22 -42.98 96.33 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.273 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.9 p -69.42 -36.9 77.14 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.27 -39.72 86.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.0 p -73.36 -36.71 66.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.4 126.44 43.93 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.203 0.314 . . . . 0.0 111.074 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -147.33 159.98 43.05 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.954 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 tp -107.7 141.73 38.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.014 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.9 p -71.12 156.47 39.55 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.739 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.36 -35.18 80.03 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.515 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.24 -45.52 73.0 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.714 0.406 . . . . 0.0 111.642 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.502 ' O ' HD12 ' A' ' 27' ' ' LEU . 97.6 mmm -68.08 -38.58 82.54 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -65.57 -42.59 91.62 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.045 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.24 -39.57 74.97 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.3 mt -68.78 -47.24 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 123.007 0.192 . . . . 0.0 111.262 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 23' ' ' MET . 5.3 mt -69.52 -36.9 76.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 96.3 p -76.31 -24.52 54.35 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -114.99 80.92 1.48 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.17 0.509 . . . . 0.0 110.76 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.8 mt -108.39 122.13 41.38 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.245 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.52 138.56 65.69 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.751 2.301 . . . . 0.0 112.379 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -37.45 -35.53 0.13 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 t -118.27 -23.09 7.41 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t -67.86 -25.16 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.3 73.7 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -157.19 138.73 13.97 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.273 0.358 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.4 p -130.19 154.4 47.58 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.043 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.0 m -120.53 -51.42 2.17 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.153 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.67 160.89 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.689 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -94.52 122.96 37.64 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.316 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.677 ' SG ' ' HG3' ' A' ' 43' ' ' GLU . 4.4 t -128.36 151.05 49.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.092 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -90.83 23.53 3.09 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.616 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.677 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 45.4 mt-10 -65.51 -29.25 69.86 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.228 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -79.01 147.39 32.89 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.492 0.495 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -104.56 141.68 35.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -73.93 -30.59 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.583 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -90.86 127.15 36.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.379 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 55' ' ' GLY . . . -89.96 -171.26 44.53 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.872 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.38 14.69 50.03 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.407 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.0 p -68.26 -24.82 64.93 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.34 50.23 0.24 Allowed Glycine 0 C--N 1.338 0.685 0 O-C-N 123.506 0.504 . . . . 0.0 112.594 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.21 178.37 32.75 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.426 -0.416 . . . . 0.0 112.784 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.6 p -78.45 -20.08 51.75 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.15 32.98 5.33 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.37 0.419 . . . . 0.0 113.153 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.42 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -65.16 -36.7 93.22 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 113.849 0.3 . . . . 0.0 113.849 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 m -121.28 148.84 43.77 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.584 0.226 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.01 -168.75 37.35 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.668 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.41 13.01 49.78 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-O 119.89 -0.395 . . . . 0.0 113.531 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -118.0 144.77 45.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.818 0.309 . . . . 0.0 110.831 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.22 150.04 31.44 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.618 0.574 . . . . 0.0 111.431 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.449 ' OG1' ' HE2' ' A' ' 63' ' ' LYS . 27.4 p -120.69 163.24 18.37 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.659 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -74.13 99.59 3.41 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.218 0.532 . . . . 0.0 111.347 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HE2' ' OG1' ' A' ' 61' ' ' THR . 60.3 mttm -129.85 143.34 50.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.854 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.2 mtt85 -91.58 3.59 54.64 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.715 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 ' HG3' ' A' ' 111' ' ' GLU . 10.2 t -107.54 128.94 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.796 HD22 HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -123.33 155.64 36.88 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.678 -179.322 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 52.5 t80 -92.29 136.02 33.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.834 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 136' ' ' ARG . 2.9 m -134.54 115.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.43 142.23 13.5 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.563 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.26 24.9 4.3 Favored Glycine 0 C--N 1.332 0.315 0 O-C-N 123.954 0.444 . . . . 0.0 112.429 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -95.53 164.6 12.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.264 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -79.58 151.79 30.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.72 -30.42 71.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.652 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -83.88 13.61 4.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.883 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 72' ' ' ALA . 5.6 m -88.8 133.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.707 0.289 . . . . 0.0 110.856 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 2.6 t70 -102.42 173.52 6.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.457 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -59.34 -30.1 68.14 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.697 0.399 . . . . 0.0 111.248 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.44 -38.36 81.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.431 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 43.2 t -63.81 -48.32 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.017 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 HD12 ' A' ' 93' ' ' ILE . 1.8 tt -68.74 -37.25 79.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.494 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.3 t60 -68.52 -49.32 60.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.634 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.492 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.28 -20.75 63.02 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.62 -32.53 23.66 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 73.1 m-85 -103.0 2.5 35.03 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.465 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.5 tp -71.31 -31.46 1.93 Allowed Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.206 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.9 Cg_exo -59.7 -23.54 72.08 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.901 1.734 . . . . 0.0 114.033 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.67 -31.43 46.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.52 -158.41 30.71 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.49 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -85.73 139.66 31.15 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.672 0.389 . . . . 0.0 111.426 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.563 HG21 HD11 ' A' ' 93' ' ' ILE . 8.3 mt -117.09 140.54 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 p -93.86 -62.49 1.34 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.308 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.4 ' O ' HD13 ' A' ' 93' ' ' ILE . 75.8 m-20 -144.89 152.52 40.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.563 HD11 HG21 ' A' ' 90' ' ' ILE . 17.4 mm -121.04 130.59 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.617 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.482 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 86.4 mm-40 -120.51 137.1 54.55 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.222 0.326 . . . . 0.0 111.583 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.73 100.39 28.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.787 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.52 128.09 23.71 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.543 2.162 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -128.07 133.76 49.09 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.774 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.24 138.51 31.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.422 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -64.53 -33.69 76.48 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.17 -44.68 75.42 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.979 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.55 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.5 p -102.42 -29.04 11.86 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 52.86 32.56 12.64 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.19 0.596 . . . . 0.0 110.785 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 101' ' ' THR . 58.4 mttt -124.33 154.22 40.63 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.062 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -94.77 134.8 36.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.63 4.65 53.62 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.04 25.91 23.21 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.43 -0.891 . . . . 0.0 114.695 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -143.7 148.3 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 117.668 0.734 . . . . 0.0 111.378 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.09 176.34 12.39 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.539 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.05 150.45 39.96 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.471 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.0 p -121.63 134.56 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.989 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.411 ' HG3' HG22 ' A' ' 65' ' ' VAL . 20.1 tt0 -111.03 133.15 53.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.093 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 80.7 m-85 -117.19 150.62 38.43 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.42 0.45 . . . . 0.0 111.261 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -69.07 -39.04 79.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.038 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mp -111.27 141.13 45.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -21.21 62.67 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.613 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.18 -42.99 99.79 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.131 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.89 -32.05 68.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.051 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.603 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -57.64 -46.88 83.6 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.374 0.421 . . . . 0.0 111.057 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.51 63.29 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.383 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.28 63.25 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.582 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.72 91.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.796 HD11 HD22 ' A' ' 66' ' ' LEU . 16.2 mt -70.83 -43.42 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.28 -32.49 68.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -79.42 -49.6 12.1 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 64.0 mtt -135.17 63.69 1.61 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.098 0.475 . . . . 0.0 112.227 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 17.6 p30 -69.82 -35.17 74.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.044 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.7 mt-10 -142.99 78.65 1.62 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.698 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.9 m -120.58 161.23 21.68 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.282 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -90.36 117.19 28.89 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.019 0.437 . . . . 0.0 110.752 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -129.06 131.78 47.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.88 14.49 8.39 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.765 0.826 . . . . 0.0 112.189 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.16 60.28 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.237 -0.438 . . . . 0.0 113.085 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -127.66 157.19 40.94 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.612 0.365 . . . . 0.0 110.721 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.55 133.89 34.85 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.6 pt -118.19 152.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 58.6 mtt-85 -122.81 134.55 54.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.259 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.81 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.46 133.31 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 110.766 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -151.01 172.31 15.91 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.986 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.28 131.29 42.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.662 0.268 . . . . 0.0 111.369 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.158 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.112 -179.69 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.337 0.113 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 97.2 mmm -99.9 128.78 45.96 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 123.353 0.408 . . . . 0.0 110.843 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.0 mtt -131.65 -51.79 0.99 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.901 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -136.9 118.09 14.48 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.399 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 t -139.77 128.74 23.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.332 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.34 178.7 48.42 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.593 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -128.11 151.79 48.78 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.853 0.384 . . . . 0.0 110.708 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -93.97 120.84 34.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -136.47 158.61 44.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.921 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -120.95 147.88 44.85 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.529 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -106.29 136.87 45.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.25 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 t -124.6 138.31 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.573 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 93.0 m-70 -61.21 -39.94 92.1 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t -63.31 -39.43 94.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -65.7 -37.38 86.3 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.2 m -76.86 -33.27 57.88 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' HIS . 49.1 mt-10 -66.14 -31.93 73.08 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -88.0 -73.21 0.49 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 123.129 0.268 . . . . 0.0 111.564 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.97 150.54 31.97 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.693 0.282 . . . . 0.0 111.045 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.5 m -87.6 159.2 18.66 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.47 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -58.94 -39.35 81.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -67.35 -39.98 85.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.854 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.479 ' O ' HD12 ' A' ' 27' ' ' LEU . 17.1 mtt -68.03 -38.51 82.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -65.46 -45.54 83.35 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.61 -45.36 62.35 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.436 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 34.0 mt -66.67 -46.37 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 23' ' ' MET . 10.5 mt -68.8 -32.18 71.72 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.5 p -68.06 -36.58 80.1 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.1 97.85 5.52 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.12 0.486 . . . . 0.0 111.071 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 27' ' ' LEU . 5.7 mt -121.51 125.66 26.76 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.169 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.04 119.76 6.54 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.31 2.007 . . . . 0.0 111.344 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -46.72 -34.81 5.47 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -84.05 -43.73 14.82 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.49 -36.99 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.291 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.54 -27.83 63.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -169.81 159.63 8.11 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 120.658 0.266 . . . . 0.0 111.657 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.6 p -101.78 160.05 14.8 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.03 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.3 m -122.79 155.97 35.46 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.08 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t 61.87 160.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.836 0.855 . . . . 0.0 111.416 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -95.64 126.31 40.83 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.8 t -134.56 153.8 51.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.0 p -71.73 -23.48 61.62 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.289 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.25 -31.99 71.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.942 0.497 . . . . 0.0 112.274 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -62.37 -33.0 73.88 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -72.87 -20.67 61.06 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.62 135.01 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -79.65 143.77 34.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.71 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 172.5 37.83 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.908 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.25 42.25 8.08 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.68 -0.295 . . . . 0.0 113.217 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.7 m -117.98 147.91 42.72 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.242 0.217 . . . . 0.0 111.044 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.47 -175.62 46.02 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.068 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.84 -171.18 40.99 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.513 -0.375 . . . . 0.0 112.664 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.5 p -68.12 -27.03 66.1 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.61 138.24 2.6 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 123.433 0.458 . . . . 0.0 112.45 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.33 -49.71 4.1 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 121.672 -0.299 . . . . 0.0 112.924 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.6 m -65.32 -34.76 79.1 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -136.85 177.9 19.34 Favored Glycine 0 C--N 1.34 0.76 0 O-C-N 123.451 0.469 . . . . 0.0 112.893 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.7 117.7 3.23 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.623 -0.322 . . . . 0.0 112.403 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -121.61 146.83 46.58 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.288 0.235 . . . . 0.0 111.098 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.87 150.8 27.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.058 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.9 p -87.35 159.47 18.73 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.146 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.2 p -82.15 125.96 31.5 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.686 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -132.06 143.25 49.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 84.4 mtt180 -78.83 -12.48 60.03 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.452 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 20.5 t -102.44 129.29 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -123.79 158.85 30.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.304 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 31.3 t80 -93.84 132.88 37.82 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.013 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -132.51 115.49 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.91 156.45 21.73 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.355 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.14 20.82 9.39 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.146 -0.527 . . . . 0.0 112.448 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -89.32 163.11 15.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.71 156.62 18.42 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.946 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.03 -26.66 68.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.654 0.382 . . . . 0.0 111.678 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -76.95 -2.2 32.54 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.676 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -87.41 139.57 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 120.577 0.227 . . . . 0.0 110.747 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 79' ' ' VAL . 4.3 p30 -120.64 -176.64 3.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.5 -31.11 71.09 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.879 0.472 . . . . 0.0 111.788 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 91.5 mttt -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.714 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 76' ' ' ASP . 91.5 t -65.42 -47.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.056 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.433 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.4 tt -67.38 -39.14 85.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.411 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.8 t60 -68.15 -47.85 66.94 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.572 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.82 -20.22 62.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.86 -34.81 24.53 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-O 120.845 0.355 . . . . 0.0 111.38 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' C ' HD11 ' A' ' 90' ' ' ILE . 76.3 m-85 -99.87 -2.05 35.85 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.391 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 4.9 tp -68.51 -32.48 3.78 Favored Pre-proline 0 CA--C 1.566 1.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 11.4 Cg_endo -56.66 -24.81 56.47 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.035 1.823 . . . . 0.0 113.874 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -79.43 -31.32 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.287 0.367 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.9 -169.71 42.85 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.308 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -86.03 130.77 34.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.314 0.246 . . . . 0.0 110.748 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.552 HG21 HD11 ' A' ' 93' ' ' ILE . 5.5 mt -105.89 141.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.919 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 p -88.37 -60.5 1.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.757 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -146.29 153.21 40.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.552 HD11 HG21 ' A' ' 90' ' ' ILE . 18.0 mm -120.53 122.26 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.9 125.85 48.52 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.522 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mp -127.15 117.37 21.83 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.811 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.89 121.86 8.94 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.994 1.796 . . . . 0.0 112.521 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.93 136.56 54.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.076 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -86.87 139.42 30.67 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.614 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 87.4 m-85 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.06 -42.72 89.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -108.58 -27.02 10.11 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.614 ' OE2' ' HA ' ' A' ' 99' ' ' TYR . 73.2 mm-40 57.7 24.84 11.07 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.231 0.612 . . . . 0.0 111.474 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -124.48 154.88 39.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.269 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -115.34 148.71 38.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.344 0.402 . . . . 0.0 110.81 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.293 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 110.71 39.19 1.47 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.918 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.09 149.23 36.26 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 117.084 0.442 . . . . 0.0 110.823 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.58 170.96 21.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.092 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -118.02 145.55 44.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 10.4 p -118.69 137.87 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.068 0.461 . . . . 0.0 111.43 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 90' ' ' ILE . 23.1 tt0 -107.23 128.99 54.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.23 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 45.4 m-85 -116.87 146.0 43.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -70.75 -37.4 73.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.862 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.606 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -107.37 143.19 36.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -25.87 58.85 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.745 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.13 -47.24 59.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.7 p30 -67.23 -32.02 72.78 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.962 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.04 -45.18 82.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.079 0.552 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.68 70.52 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.23 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.632 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -69.67 -33.92 73.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.59 78.67 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.723 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 66' ' ' LEU . 74.3 mt -66.65 -47.68 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.632 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 4.3 p30 -67.47 -34.31 76.91 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -88.36 -35.04 17.39 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 137' ' ' VAL . 83.6 mtp -110.73 14.39 22.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.5 t-20 -57.47 -37.26 72.6 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.813 0.278 . . . . 0.0 111.572 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -142.71 77.14 1.56 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.624 0.726 . . . . 0.0 109.908 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.5 t -127.17 157.0 40.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.118 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -93.21 118.99 31.89 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.6 tp -131.0 130.41 43.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.982 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.6 15.52 8.03 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.573 0.749 . . . . 0.0 112.361 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.39 60.08 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.301 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -126.55 153.96 44.5 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.502 0.321 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.97 133.36 34.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 pt -116.1 152.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.657 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 5.0 tpt180 -124.66 128.45 48.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.599 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.43 139.18 51.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.38 0.425 . . . . 0.0 110.764 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 28.5 p30 -145.27 173.76 11.68 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.496 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.0 tt -69.79 123.67 22.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.321 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 81.3 mtm-85 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.53 0.205 . . . . 0.0 111.322 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.5 t -104.02 134.94 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.854 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.65 154.36 39.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.816 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.4 t80 -94.48 134.44 37.01 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.652 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.435 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -134.27 114.75 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.614 0.571 . . . . 0.0 109.687 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.83 146.98 18.75 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.556 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.18 23.34 6.12 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 123.881 0.4 . . . . 0.0 112.425 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.621 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -93.42 165.12 12.92 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.548 0.339 . . . . 0.0 110.262 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -81.09 151.75 28.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.044 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.58 -29.97 70.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.714 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.77 9.13 6.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 72' ' ' ALA . 3.5 m -90.55 136.93 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 120.635 0.255 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -107.79 174.72 5.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -61.42 -28.05 68.98 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.619 0.368 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.5 -39.03 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.0 -47.81 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.086 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.4 -38.27 84.4 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.354 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 9.8 t60 -68.09 -49.07 63.56 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.566 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.44 -20.49 62.89 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.26 -33.62 24.0 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 111.271 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.33 1.88 33.35 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.437 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -69.75 -31.97 2.77 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.25 -0.881 . . . . 0.0 113.339 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.6 Cg_exo -59.8 -23.3 71.6 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.861 1.707 . . . . 0.0 113.955 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.527 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 47.8 m-85 -80.04 -31.27 39.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.89 -168.56 41.44 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.804 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.18 134.06 34.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.468 0.307 . . . . 0.0 110.97 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.562 HG21 HD11 ' A' ' 93' ' ' ILE . 9.6 mt -113.54 140.86 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.851 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 -64.99 1.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.226 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -145.34 153.84 41.68 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.562 HD11 HG21 ' A' ' 90' ' ' ILE . 21.2 mm -117.84 128.73 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.415 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 63.7 mt-30 -115.52 133.87 55.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.875 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.62 104.19 24.35 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.06 96.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.471 2.114 . . . . 0.0 112.387 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -111.56 133.63 53.69 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -85.03 141.71 30.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -64.67 -34.55 78.56 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -73.05 -49.12 30.49 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 31.3 p -93.89 -28.79 15.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 49.71 30.81 3.91 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.394 0.678 . . . . 0.0 111.823 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 101' ' ' THR . 42.8 mttt -112.24 153.41 27.17 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.346 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -101.21 143.78 30.88 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.617 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -99.12 1.62 45.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 92.28 20.82 34.26 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 120.336 -0.935 . . . . 0.0 114.904 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.82 146.73 31.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.863 0.832 . . . . 0.0 111.458 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.66 173.02 16.72 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.66 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.448 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 76.7 m-85 -118.08 150.64 39.0 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 93' ' ' ILE . 11.0 p -119.41 136.17 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 123.47 0.481 . . . . 0.0 111.027 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -106.46 121.17 43.74 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.213 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 9.1 m-85 -105.84 133.07 51.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.076 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.66 -34.73 78.89 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.794 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.81 135.9 49.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.92 61.6 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.642 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.93 -40.95 75.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.59 -31.75 71.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.425 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -62.44 -45.66 92.08 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.267 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.62 -28.98 67.39 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.267 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.527 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.27 -40.25 71.07 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.27 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.1 89.84 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.653 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.82 HD11 HD22 ' A' ' 66' ' ' LEU . 11.4 mt -71.21 -34.21 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.9 p30 -83.01 -16.77 45.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -100.02 -42.05 6.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.527 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 86.5 mtp -128.82 45.05 2.85 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.8 t-20 -63.72 -38.54 91.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.676 0.274 . . . . 0.0 111.238 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 39.3 mt-10 -142.09 78.13 1.61 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.729 0.776 . . . . 0.0 109.656 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.0 p -125.13 162.68 24.08 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -91.99 118.73 31.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.035 0.445 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.29 130.78 48.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.675 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.36 15.02 8.36 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.25 5.28 59.4 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.164 -0.471 . . . . 0.0 113.344 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -127.86 156.87 41.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.56 0.344 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.94 134.1 35.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.0 pt -120.23 154.85 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 123.37 0.419 . . . . 0.0 112.075 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 52.9 mtt180 -125.83 134.68 51.58 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.466 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.816 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.8 134.02 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.044 0.45 . . . . 0.0 110.834 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 13.4 p-10 -151.14 171.47 17.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.498 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 14.3 mt -71.06 130.72 42.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.533 0.206 . . . . 0.0 111.168 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.51 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.4 128.67 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.539 0.209 . . . . 0.0 110.575 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.747 HD22 HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -124.14 159.73 29.38 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.66 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.755 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.7 OUTLIER -112.66 117.4 32.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.952 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -108.71 115.32 49.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 178.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -127.86 148.8 17.83 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.027 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.8 41.27 3.15 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.706 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -91.33 159.82 15.81 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.106 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.617 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -82.16 174.54 11.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.358 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -69.03 -32.51 72.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.841 0.456 . . . . 0.0 111.519 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -98.83 63.26 1.38 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.405 0.621 . . . . 0.0 111.527 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 71' ' ' LEU . 12.2 p -139.05 137.59 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.705 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.841 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.0 m-20 -140.94 -175.9 4.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.486 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.76 -37.06 86.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.85 0.46 . . . . 0.0 112.203 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -66.25 -43.52 86.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.982 0.513 . . . . 0.0 112.186 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.841 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 16.8 m -73.34 -39.53 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 123.322 0.389 . . . . 0.0 111.769 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.67 -35.75 82.04 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.533 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 6.8 t60 -68.31 -46.2 70.91 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.517 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.12 -20.73 63.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.91 -35.12 22.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' C ' HD11 ' A' ' 90' ' ' ILE . 56.7 m-85 -97.38 -0.9 45.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.021 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -70.39 -31.67 2.35 Favored Pre-proline 0 CA--C 1.565 1.548 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.4 Cg_exo -59.73 -24.14 74.52 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.917 1.744 . . . . 0.0 113.798 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -78.05 -31.28 50.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.89 -159.14 32.13 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.458 0.474 . . . . 0.0 112.612 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -85.94 137.91 32.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.636 0.374 . . . . 0.0 111.456 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 5.4 mt -118.4 144.33 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.809 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 1.4 p -91.2 -67.33 0.86 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.896 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -148.63 158.04 43.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' HG23 ' A' ' 110' ' ' VAL . 10.8 mm -116.94 129.4 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -126.61 127.02 44.57 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.2 mp -127.83 118.1 20.99 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.795 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.54 126.11 20.35 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.304 2.003 . . . . 0.0 112.642 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -128.02 134.67 49.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -89.55 143.38 26.86 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.278 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -64.58 -34.65 78.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.11 -48.71 41.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.8 p -94.72 -28.33 15.36 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 55.35 24.7 6.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.21 0.604 . . . . 0.0 111.513 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -120.31 156.83 30.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.1 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -92.77 158.58 15.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.973 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -88.52 0.54 56.21 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.017 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.85 19.46 29.05 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 119.453 -0.637 . . . . 0.0 114.305 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 55.1 p90 -144.55 151.15 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.464 0.632 . . . . 0.0 111.191 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.44 164.73 36.1 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.954 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -115.31 138.64 50.75 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.436 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.2 p -118.32 133.78 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.93 0.395 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.436 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 1.1 mm-40 -109.0 137.62 46.64 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.417 ' CE2' HG12 ' A' ' 90' ' ' ILE . 82.6 m-85 -117.65 147.32 43.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.21 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.87 -39.52 90.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.07 141.74 39.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.705 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.23 -22.13 63.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.071 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.76 -42.17 95.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.177 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.96 -33.05 71.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.586 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -61.73 -45.74 92.65 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.207 0.317 . . . . 0.0 111.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.51 -28.9 64.22 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.12 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.63 -45.24 59.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.426 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.26 90.17 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.747 HD11 HD22 ' A' ' 66' ' ' LEU . 46.8 mt -70.65 -39.98 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.67 -28.3 60.79 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.8 -49.7 10.09 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.4 mtp -135.24 61.33 1.67 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.091 0.472 . . . . 0.0 111.993 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 11.3 t-20 -69.21 -41.68 76.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.482 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.6 mt-10 -140.61 79.18 1.69 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.678 0.751 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 p -126.68 164.57 21.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.366 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -87.15 116.14 25.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.02 0.438 . . . . 0.0 110.513 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -133.31 130.49 38.97 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.136 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 64.92 17.05 10.87 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.089 0.955 . . . . 0.0 112.168 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.55 -0.19 61.24 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.735 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.97 156.8 43.2 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.353 0.261 . . . . 0.0 111.099 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -77.97 128.69 34.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 3.0 pt -112.58 148.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 112.158 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 13.0 ttp180 -121.77 128.95 52.29 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -127.74 133.18 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 110.342 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -157.16 170.87 21.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.828 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.3 tt -71.87 130.88 42.1 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.073 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.165 -179.758 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 62.8 mtt180 . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 4.5 t -95.66 129.31 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.02 154.52 39.75 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.524 0.515 . . . . 0.0 110.818 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.741 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.5 t80 -98.97 122.45 42.25 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.929 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.698 HG12 HG12 ' A' ' 137' ' ' VAL . 2.9 m -117.54 116.9 53.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.965 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.54 151.09 18.8 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.876 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.26 5.24 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.739 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -91.56 165.45 13.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.715 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -88.59 161.84 16.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.412 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.15 -31.45 70.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.59 3.02 26.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.036 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 71' ' ' LEU . 2.3 p -86.42 138.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 120.542 0.211 . . . . 0.0 110.923 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -124.83 176.38 6.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.354 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -61.36 -31.87 71.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.196 0.598 . . . . 0.0 112.079 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -67.74 -40.91 84.1 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.57 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.33 -42.3 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.024 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.4 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.2 tt -68.41 -37.79 80.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.396 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.2 t60 -68.48 -48.59 64.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.329 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.506 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.7 -20.52 62.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -35.38 23.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.851 0.358 . . . . 0.0 111.298 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.437 ' C ' HD11 ' A' ' 90' ' ' ILE . 71.2 m-85 -97.83 -2.26 41.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -68.28 -31.11 2.95 Favored Pre-proline 0 CA--C 1.567 1.599 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.57 -24.12 60.32 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 121.922 1.748 . . . . 0.0 113.691 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.69 -31.2 46.48 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.367 0.417 . . . . 0.0 111.692 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.96 33.8 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.262 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.23 134.23 34.74 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 93' ' ' ILE . 5.4 mt -109.87 141.99 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.855 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -89.21 -64.29 1.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.673 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -145.75 153.44 40.95 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 90' ' ' ILE . 14.2 mm -119.42 123.69 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -123.46 129.34 51.1 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' PHE . 0.9 OUTLIER -128.0 124.1 23.0 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.724 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.7 119.95 7.46 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.111 1.874 . . . . 0.0 112.191 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.57 135.66 50.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.362 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.18 144.31 25.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.312 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -64.81 -34.32 78.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.54 -46.82 62.86 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.2 p -101.43 -27.66 13.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.07 25.45 8.93 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.25 0.62 . . . . 0.0 111.709 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -121.87 154.99 36.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.648 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -106.78 164.39 12.14 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.415 0.447 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -88.02 -1.49 58.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 100.3 25.87 8.59 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.479 -0.623 . . . . 0.0 114.57 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.9 p90 -145.07 147.11 32.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.445 0.622 . . . . 0.0 111.108 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.91 167.31 27.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.264 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.473 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 75.9 m-85 -111.65 137.49 49.47 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.476 HG23 ' CD1' ' A' ' 93' ' ' ILE . 7.1 p -112.55 132.09 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 O-C-N 123.243 0.34 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.9 tt0 -103.81 130.73 51.39 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.762 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 52.3 m-85 -117.12 146.99 42.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.66 -36.07 65.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.04 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.577 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -105.72 141.05 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.503 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.55 -19.99 58.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.559 0.695 . . . . 0.0 109.162 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.92 -49.96 33.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.431 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.577 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.7 p30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.1 -45.52 84.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.795 0.438 . . . . 0.0 111.135 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.39 69.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.049 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.4 72.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.143 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.03 82.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 66' ' ' LEU . 14.2 mt -70.48 -34.12 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.271 0.357 . . . . 0.0 111.473 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.96 -16.84 49.07 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -101.52 -43.71 5.82 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 61.8 mtt -124.79 44.48 2.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.3 t30 -63.22 -37.95 89.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.618 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.3 mt-10 -142.85 77.57 1.58 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.667 0.746 . . . . 0.0 109.809 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.6 p -123.09 165.03 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.301 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -91.99 120.38 32.58 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.624 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -125.54 129.13 49.11 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.098 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 56.56 20.45 4.91 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.905 0.882 . . . . 0.0 112.814 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.67 3.85 59.39 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.848 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -126.9 153.2 46.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.86 0.33 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.2 m -78.57 132.28 37.09 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -119.54 156.46 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 14.1 ptt-85 -129.39 136.13 49.58 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.001 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -127.17 140.73 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 14.9 p-10 -150.78 171.63 16.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.805 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 mt -69.34 133.2 47.55 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.529 0.332 . . . . 0.0 111.146 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.137 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.095 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 50.9 mtm180 . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.9 132.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.15 152.56 41.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.3 t80 -100.68 116.33 32.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.583 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.33 117.7 56.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.976 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.05 153.08 19.91 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.074 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.91 26.06 5.94 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.9 0.412 . . . . 0.0 112.502 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -94.27 163.47 13.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.54 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -91.0 157.35 17.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.902 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.558 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 45.7 mt-10 -63.66 -26.9 68.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.64 0.376 . . . . 0.0 111.744 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.7 -4.05 35.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.801 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.0 m -86.71 141.1 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.671 0.272 . . . . 0.0 110.855 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.519 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -122.08 179.1 4.64 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -59.87 -30.44 68.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.845 0.458 . . . . 0.0 111.669 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.57 -40.91 80.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.721 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.519 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.1 t -66.66 -46.74 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.292 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD22 HD12 ' A' ' 93' ' ' ILE . 2.2 tt -67.02 -39.38 87.04 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.594 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.521 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 25.6 t-80 -68.01 -48.42 65.77 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.78 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.485 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.6 62.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.16 -32.7 24.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.98 0.419 . . . . 0.0 111.268 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -103.78 1.76 32.03 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.416 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -70.23 -33.12 3.14 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 19.8 Cg_endo -59.7 -23.5 71.93 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.867 1.711 . . . . 0.0 114.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -80.76 -31.26 35.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.84 -170.28 43.18 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.773 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -84.01 133.55 34.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.53 0.332 . . . . 0.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 6.9 mt -113.0 139.4 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.854 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -90.19 -62.59 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.174 -179.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.5 155.21 42.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.491 HD12 HD22 ' A' ' 80' ' ' LEU . 20.6 mm -116.64 124.98 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -120.13 126.23 50.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.88 117.45 20.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.961 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.68 126.64 21.85 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.313 2.009 . . . . 0.0 112.519 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -125.36 134.36 52.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.143 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.13 142.25 27.9 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.22 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -64.64 -33.46 75.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -71.05 -48.28 53.69 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.7 p -98.69 -27.75 13.84 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.445 ' O ' HD11 ' A' ' 97' ' ' LEU . 47.0 mt-10 57.92 22.59 8.89 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.178 0.591 . . . . 0.0 111.506 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -123.07 156.34 35.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.212 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.558 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 13.5 p80 -99.89 160.15 14.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.431 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 24.2 mtp180 -88.5 0.08 56.67 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 98.95 29.3 7.32 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.15 -0.548 . . . . 0.0 114.269 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 36.5 p90 -145.09 145.47 31.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.155 0.477 . . . . 0.0 111.028 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.14 165.91 34.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.105 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -111.96 143.5 42.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 93' ' ' ILE . 13.0 p -116.78 135.94 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.821 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -107.62 125.77 51.75 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.86 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 28.4 m-85 -111.12 136.08 50.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -64.66 -36.58 84.73 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.664 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.26 132.51 52.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.58 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.68 -24.54 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.206 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.74 -44.57 81.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.808 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -68.89 -32.7 72.53 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.397 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.41 -48.51 81.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.375 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.56 69.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.207 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.564 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.66 -37.41 70.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.299 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.39 88.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.828 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.69 HD11 HD22 ' A' ' 66' ' ' LEU . 14.3 mt -70.4 -38.91 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.6 p30 -76.34 -25.88 55.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.36 -50.05 9.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 63.5 mtt -132.73 58.97 1.74 Allowed 'General case' 0 C--N 1.347 0.482 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.6 t30 -67.36 -37.82 83.81 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 33.9 mt-10 -140.7 79.48 1.7 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.915 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.2 t -122.15 160.97 24.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.187 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -90.77 118.24 30.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -129.35 129.78 45.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.993 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 62.54 15.31 7.79 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.671 0.788 . . . . 0.0 112.389 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.83 3.95 59.13 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.222 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -126.02 154.22 43.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.533 0.333 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 133.74 35.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -117.81 152.91 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 1.8 tpt180 -125.54 131.43 52.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.237 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -126.95 135.68 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 123.196 0.31 . . . . 0.0 110.319 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -147.24 171.75 14.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.368 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HG ' HD13 ' A' ' 122' ' ' ILE . 8.5 mt -72.61 129.67 38.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.227 0.211 . . . . 0.0 110.894 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.0 mtt85 . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.69 HG22 ' HG2' ' A' ' 111' ' ' GLU . 14.4 t -103.49 129.42 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.973 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.92 157.81 33.42 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.501 0.501 . . . . 0.0 111.324 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.795 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 37.0 t80 -99.6 136.21 39.87 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.321 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -134.42 115.33 19.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 123.546 0.529 . . . . 0.0 109.927 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.95 149.28 19.12 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.631 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.83 19.22 9.29 Favored Glycine 0 C--N 1.331 0.298 0 O-C-N 123.914 0.42 . . . . 0.0 112.271 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.62 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -90.94 166.24 13.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 122.604 0.361 . . . . 0.0 110.438 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -90.7 156.97 17.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.44 -27.52 68.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.36 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.1 -4.75 40.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.849 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.3 m -82.52 138.12 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 120.606 0.241 . . . . 0.0 110.664 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 77.3 m-20 -119.01 178.9 4.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 22.9 m-20 -59.19 -30.93 68.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.904 0.482 . . . . 0.0 111.64 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -68.56 -40.51 80.57 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.764 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.513 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.2 t -67.32 -47.33 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.522 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.477 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.5 tt -68.14 -39.74 82.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.714 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.547 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 21.3 t-80 -68.32 -47.76 66.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.46 -20.62 62.87 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.11 -33.19 24.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.912 0.387 . . . . 0.0 111.156 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -102.31 0.79 34.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.381 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 tp -69.95 -32.75 3.08 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 14.9 Cg_endo -58.48 -23.23 63.21 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.941 1.761 . . . . 0.0 113.931 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -78.85 -31.17 45.57 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.345 0.403 . . . . 0.0 112.085 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.75 -163.74 37.45 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.898 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -82.9 135.27 34.97 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.775 0.43 . . . . 0.0 111.823 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.547 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 7.2 mt -116.85 140.34 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.389 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 9.1 p -88.47 -64.23 1.18 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.85 157.04 43.55 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.473 ' CD1' HG23 ' A' ' 110' ' ' VAL . 12.7 mm -119.38 128.75 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.428 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.458 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 65.4 mt-30 -114.96 131.81 56.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.692 0.282 . . . . 0.0 111.683 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.431 HG23 ' CD2' ' A' ' 104' ' ' HIS . 4.1 mp -126.6 102.75 25.55 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.824 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.36 121.42 9.87 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.533 2.156 . . . . 0.0 112.546 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tp -129.52 134.9 48.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.939 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -87.74 140.83 29.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -64.42 -34.31 77.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.14 -48.75 32.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.892 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.559 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.4 p -93.03 -29.22 15.93 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 50.65 32.27 6.69 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.247 0.619 . . . . 0.0 111.018 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 101' ' ' THR . 51.6 mttt -118.03 154.82 31.38 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.359 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.431 ' CD2' HG23 ' A' ' 95' ' ' ILE . 12.3 t-80 -97.32 142.45 29.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.594 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -93.95 -1.68 54.28 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.46 20.42 38.01 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 120.393 -0.908 . . . . 0.0 114.669 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -145.6 148.1 32.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.708 0.754 . . . . 0.0 111.192 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -157.49 172.78 17.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.857 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -117.94 149.32 41.1 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.3 p -125.89 136.46 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 123.257 0.348 . . . . 0.0 111.214 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.69 ' HG2' HG22 ' A' ' 65' ' ' VAL . 1.1 tm-20 -109.9 130.0 55.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.082 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 15.9 m-85 -109.42 143.2 39.31 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.974 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.26 -37.07 82.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.376 0.422 . . . . 0.0 110.624 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.575 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -105.7 141.44 37.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.898 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.01 56.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.763 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -72.25 -48.61 41.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.347 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 23.2 p30 -66.58 -32.36 73.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.974 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.973 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.88 -43.48 83.38 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.49 0.494 . . . . 0.0 111.131 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.89 69.83 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.352 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.43 75.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.13 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.98 86.35 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.781 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.712 HD11 HD22 ' A' ' 66' ' ' LEU . 35.4 mt -70.71 -33.49 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.63 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -32.75 69.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -104.32 -35.68 7.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.488 ' O ' HG13 ' A' ' 137' ' ' VAL . 77.8 mtp -103.37 14.83 30.61 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.619 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.1 t-20 -57.2 -36.69 71.15 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.691 0.281 . . . . 0.0 111.253 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.9 74.25 1.44 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.742 0.782 . . . . 0.0 109.765 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.3 p -124.09 161.25 25.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.333 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -94.31 120.59 34.78 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -128.35 128.8 45.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.808 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.22 15.82 7.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.728 0.811 . . . . 0.0 112.364 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.06 5.27 58.37 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.475 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mtp85 -127.22 154.81 44.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.427 0.291 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -81.12 132.97 35.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.1 pt -119.41 154.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 55.5 mtt85 -123.04 133.58 54.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.186 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.99 136.08 59.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.531 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -149.82 171.86 16.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.74 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.459 ' HG ' HD13 ' A' ' 122' ' ' ILE . 11.6 mt -71.98 128.85 37.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.606 0.241 . . . . 0.0 110.898 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.421 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.309 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 120.581 0.229 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 111' ' ' GLU . 14.6 t -104.74 135.88 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.982 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.21 155.31 37.37 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.358 0.411 . . . . 0.0 111.473 -179.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.784 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.3 t80 -96.32 135.1 38.62 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.171 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 m -134.37 115.65 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.333 0.396 . . . . 0.0 110.006 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.42 154.41 21.04 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.94 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.87 26.49 6.71 Favored Glycine 0 C--N 1.332 0.352 0 O-C-N 123.935 0.432 . . . . 0.0 112.309 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -92.9 159.88 15.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.955 0.407 . . . . 0.0 110.652 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -83.62 154.08 23.94 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.027 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 24.1 tp10 -60.03 -30.89 69.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.678 0.391 . . . . 0.0 111.454 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -72.17 -18.7 61.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -68.58 139.03 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.686 0.279 . . . . 0.0 111.487 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.402 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.8 m-20 -117.63 179.03 4.18 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.31 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -61.96 -28.95 69.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.972 0.415 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.05 -40.53 78.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 36.6 t -64.86 -46.48 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.084 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.7 tt -65.77 -39.57 91.13 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.908 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.616 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 23.7 t-80 -68.49 -47.97 65.65 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.944 0.498 . . . . 0.0 111.82 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.31 -20.59 63.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.42 23.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 75.0 m-85 -102.38 1.39 35.37 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.239 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 82' ' ' ALA . 4.0 tp -70.79 -31.62 2.16 Favored Pre-proline 0 CA--C 1.565 1.553 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.3 Cg_exo -59.5 -23.9 72.68 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.954 1.769 . . . . 0.0 113.859 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.567 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 60.1 m-85 -78.89 -31.31 45.36 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.95 -163.28 36.69 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.032 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -83.85 134.34 34.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.868 0.467 . . . . 0.0 111.97 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.616 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 6.2 mt -116.67 139.81 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.426 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 6.4 p -86.97 -61.23 1.77 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.817 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -152.53 159.67 43.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.948 0.404 . . . . 0.0 111.949 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.445 ' CD1' HG23 ' A' ' 110' ' ' VAL . 18.7 mm -115.23 124.58 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -117.76 127.45 53.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.233 0.333 . . . . 0.0 111.818 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.62 121.12 22.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.665 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.77 96.69 0.31 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 121.937 1.758 . . . . 0.0 112.082 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.33 135.87 48.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.234 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -87.37 141.18 28.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.67 -34.18 77.69 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -70.85 -48.8 52.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 29.9 p -95.85 -28.31 14.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 54.36 24.76 5.38 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.256 0.622 . . . . 0.0 111.672 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 101' ' ' THR . 61.5 mttt -117.13 152.27 35.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.178 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.54 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.4 p80 -103.76 157.64 16.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.227 0.329 . . . . 0.0 110.692 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -88.05 0.81 55.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.186 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 96.22 24.73 13.86 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.199 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.66 150.38 34.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 117.216 0.508 . . . . 0.0 111.037 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.36 171.09 18.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -115.73 140.2 49.43 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.3 p -116.09 134.17 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.155 0.284 . . . . 0.0 111.192 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.505 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.5 OUTLIER -106.45 126.83 52.74 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.413 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 21.8 m-85 -111.07 139.35 46.51 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.755 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.48 -37.92 89.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.78 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.585 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.3 mp -103.87 136.47 43.48 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.958 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.45 60.6 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.441 0.639 . . . . 0.0 109.374 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.4 -50.45 31.84 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.371 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 19.2 p30 -69.72 -32.13 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.878 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.982 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.18 -44.48 91.87 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.96 69.01 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.943 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.45 74.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.114 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.51 84.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.93 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.692 HD11 HD22 ' A' ' 66' ' ' LEU . 21.2 mt -70.56 -34.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.301 0.375 . . . . 0.0 111.944 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.76 -17.07 45.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -99.48 -44.48 6.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.567 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 61.4 mtt -130.18 50.55 2.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.6 t-20 -64.08 -37.1 86.22 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.962 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.8 tt0 -143.77 76.65 1.52 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.068 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.8 t -119.4 162.73 18.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.85 118.15 29.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.015 0.436 . . . . 0.0 110.796 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.35 131.77 42.24 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 t80 62.93 14.66 7.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.771 0.828 . . . . 0.0 112.307 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.9 2.31 59.59 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.204 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -126.96 156.39 41.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.559 0.344 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.22 133.71 35.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -115.66 154.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.425 0.453 . . . . 0.0 112.046 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 6.0 tpt180 -124.42 132.23 53.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.03 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.784 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -131.39 133.62 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.421 178.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -147.38 171.44 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' A' ' 122' ' ' ILE . 13.2 mt -71.21 129.78 39.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.517 0.199 . . . . 0.0 111.123 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.204 -179.518 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 52.9 mtm180 . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 t -107.49 126.63 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.789 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.56 156.16 36.26 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.363 0.414 . . . . 0.0 111.008 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.833 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 50.9 t80 -95.22 133.64 38.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.706 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 80' ' ' LEU . 4.5 m -134.77 115.27 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 123.378 0.424 . . . . 0.0 109.974 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -134.73 153.01 20.89 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.891 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.06 32.78 4.86 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 106' ' ' GLY . 1.1 mp -94.0 164.0 13.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.446 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -80.59 153.0 28.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.977 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -61.84 -26.6 68.22 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.842 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.69 9.05 22.77 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.7 m -90.63 142.24 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.383 -0.198 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.6 p30 -126.01 -175.8 3.46 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.507 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 17.3 m-20 -58.87 -33.34 70.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.725 0.41 . . . . 0.0 111.786 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -69.4 -36.27 76.59 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.914 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.581 HG23 ' OD1' ' A' ' 76' ' ' ASP . 55.9 t -69.48 -48.57 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.797 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 68' ' ' VAL . 1.9 tt -66.55 -38.82 87.92 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.625 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 27.0 t-80 -68.38 -47.96 65.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.79 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.72 62.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.21 -33.07 24.21 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 111.126 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.53 1.24 34.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.37 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.04 -32.02 2.67 Favored Pre-proline 0 CA--C 1.565 1.519 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 32.4 Cg_exo -60.39 -23.9 76.11 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 121.982 1.788 . . . . 0.0 113.922 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 44.1 m-85 -81.46 -31.53 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.69 -170.0 42.62 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.89 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.9 134.67 34.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.598 0.359 . . . . 0.0 110.894 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.513 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 5.7 mt -115.6 140.12 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.005 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 3.8 p -89.15 -62.47 1.47 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.892 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -148.09 158.42 44.06 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.038 0.447 . . . . 0.0 112.11 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.507 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 mm -118.02 125.59 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.438 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -116.11 121.98 43.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.543 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.65 118.83 21.34 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.822 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.36 114.88 2.17 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.24 1.96 . . . . 0.0 112.222 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.19 135.5 51.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.193 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -89.61 144.2 26.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.415 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.64 -35.07 79.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.22 -49.06 29.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.8 p -93.72 -28.54 15.88 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 53.55 24.64 4.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.355 0.662 . . . . 0.0 111.615 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 101' ' ' THR . 79.1 mttt -114.15 156.12 24.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.371 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -106.47 158.34 16.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.718 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -88.57 -0.13 56.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.21 25.55 13.99 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 119.56 -0.578 . . . . 0.0 114.488 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 95' ' ' ILE . 53.1 p90 -146.51 150.0 34.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.337 0.569 . . . . 0.0 111.034 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.47 169.48 24.54 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.39 143.72 45.2 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.1 p -118.48 134.95 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.717 0.294 . . . . 0.0 111.415 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -108.08 125.51 51.67 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.958 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 16.3 m-85 -106.49 138.86 41.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.981 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.94 -36.65 85.07 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.73 132.96 53.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.742 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.9 64.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -42.99 84.68 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.756 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.27 -32.82 72.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.251 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.789 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.89 -46.53 90.26 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.304 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.94 67.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.141 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.85 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.344 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.24 92.34 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.086 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.672 HD11 HD22 ' A' ' 66' ' ' LEU . 17.6 mt -70.94 -34.24 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.278 0.361 . . . . 0.0 111.74 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.87 -17.12 44.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -94.7 -48.68 5.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.499 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 64.3 mtt -133.51 59.03 1.75 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.035 0.445 . . . . 0.0 112.156 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 15.8 p30 -69.4 -36.73 77.05 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.432 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.34 79.62 1.67 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.652 0.739 . . . . 0.0 109.728 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -124.96 163.25 22.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.46 119.44 32.54 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 110.619 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -128.53 130.1 46.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.903 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.57 15.23 7.74 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.04 4.34 58.72 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 116.261 -0.427 . . . . 0.0 113.22 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -126.34 155.07 42.61 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.455 0.302 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.05 131.98 35.14 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.4 pt -117.17 149.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 123.359 0.412 . . . . 0.0 111.873 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 76.9 mtt180 -123.2 133.74 54.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.593 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.12 134.02 63.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.874 0.368 . . . . 0.0 110.421 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -150.15 172.78 14.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.668 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mt -68.95 129.66 40.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.953 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.113 -179.518 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.644 0.259 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.541 HG22 ' HG2' ' A' ' 111' ' ' GLU . 26.0 t -101.86 134.97 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.686 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -124.06 147.23 48.02 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.381 0.426 . . . . 0.0 110.582 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.1 t80 -99.93 125.13 45.89 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.924 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.673 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -118.71 118.92 59.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 123.547 0.529 . . . . 0.0 110.028 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.49 149.08 18.19 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.544 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.39 23.93 7.75 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.1 mp -90.02 168.61 11.87 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.968 0.507 . . . . 0.0 110.824 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -96.4 161.82 13.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.337 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.62 -32.2 71.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.657 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -75.7 -7.65 54.86 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.917 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 72' ' ' ALA . 1.7 p -78.44 131.08 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 120.66 0.267 . . . . 0.0 110.577 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -114.84 175.47 5.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.952 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.3 m-20 -60.69 -33.65 73.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.459 0.704 . . . . 0.0 112.131 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -67.19 -40.32 86.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.584 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.56 -45.09 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tt -69.55 -37.66 77.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.428 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.562 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 30.3 t60 -68.14 -48.78 64.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.502 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.75 -21.25 62.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -34.32 23.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.266 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.443 ' C ' HD11 ' A' ' 90' ' ' ILE . 61.7 m-85 -98.09 -2.36 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.7 tp -69.44 -31.31 2.54 Favored Pre-proline 0 CA--C 1.566 1.596 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.97 -24.18 71.87 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.93 1.753 . . . . 0.0 113.637 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -79.64 -31.22 41.53 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.563 0.345 . . . . 0.0 111.693 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.03 37.0 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.247 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.23 132.61 36.0 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.594 0.235 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.562 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 4.4 mt -109.34 142.04 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.956 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.2 p -85.73 -61.59 1.72 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.901 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -151.48 158.04 43.11 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.497 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 15.1 mm -117.73 129.8 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.57 127.89 55.57 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.75 100.66 33.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.12 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.25 119.8 6.87 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.042 1.828 . . . . 0.0 112.904 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -125.23 132.59 52.95 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.598 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -83.37 140.88 32.15 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.429 0.455 . . . . 0.0 110.676 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.62 -34.09 77.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -72.66 -48.83 35.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.068 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.543 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.7 p -95.16 -28.94 14.81 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 50.3 32.02 5.84 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.391 0.676 . . . . 0.0 111.76 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 101' ' ' THR . 85.1 mttt -115.23 150.64 35.83 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.437 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -101.53 138.31 38.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.64 1.8 57.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 90.04 22.62 35.0 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.175 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -142.83 151.13 40.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.111 0.956 . . . . 0.0 111.326 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.67 166.92 30.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.194 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.472 ' CE2' ' HD2' ' A' ' 67' ' ' TYR . 72.8 m-85 -111.33 139.55 46.64 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.463 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.6 p -118.84 132.38 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 123.307 0.379 . . . . 0.0 110.334 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HG2' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -105.74 133.1 51.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.184 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 20.4 m-85 -115.32 140.14 49.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.315 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.31 -37.03 85.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.569 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.7 mp -106.2 141.17 37.99 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.47 -19.68 59.27 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.949 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -73.92 -49.94 22.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.263 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.3 p30 -68.95 -32.43 72.02 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.88 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.9 -43.57 83.02 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.471 0.482 . . . . 0.0 111.016 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.77 69.38 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.051 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.72 -34.94 74.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.154 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.25 82.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.803 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 66' ' ' LEU . 15.3 mt -69.59 -33.53 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.357 0.41 . . . . 0.0 111.596 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -16.71 46.61 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -100.62 -44.17 5.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 62.1 mtt -126.26 45.51 2.63 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.635 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.4 t-20 -63.13 -36.61 84.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.611 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 40.8 mt-10 -141.78 79.47 1.68 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.659 0.742 . . . . 0.0 109.625 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 82.0 p -125.07 166.11 16.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.274 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -91.84 120.17 32.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -127.57 129.53 47.49 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.809 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 t80 59.23 18.85 6.93 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.921 0.888 . . . . 0.0 112.31 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.51 -9.63 64.67 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -114.98 152.68 31.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.66 0.384 . . . . 0.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -76.88 137.32 39.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -121.21 156.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.52 0.513 . . . . 0.0 112.299 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 12.8 ptt85 -129.17 132.38 47.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.567 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -125.83 136.49 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.102 0.477 . . . . 0.0 111.212 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -148.41 171.15 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HG ' HD13 ' A' ' 122' ' ' ILE . 12.0 mt -74.29 131.04 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.507 0.194 . . . . 0.0 111.171 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.531 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.154 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 79.0 mtt180 . . . . . 0 N--CA 1.471 0.611 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 19.3 t -101.63 129.43 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.921 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.83 155.34 38.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.015 -178.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.0 t80 -92.67 130.39 38.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.89 116.6 34.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.345 0.403 . . . . 0.0 110.146 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.76 157.9 22.59 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.769 -0.651 . . . . 0.0 113.026 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.69 26.72 7.9 Favored Glycine 0 C--N 1.333 0.361 0 O-C-N 123.943 0.437 . . . . 0.0 112.158 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 75' ' ' VAL . 1.6 mp -89.83 160.88 16.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.991 0.424 . . . . 0.0 110.729 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -80.66 157.49 25.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 44.3 mt-10 -65.94 -27.54 68.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -84.27 7.91 17.69 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -90.39 142.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -128.21 -176.24 3.74 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.344 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.04 -31.55 68.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.912 0.387 . . . . 0.0 111.523 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -68.46 -40.99 80.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.58 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.8 -47.39 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.911 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 93' ' ' ILE . 1.9 tt -66.55 -38.19 86.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.683 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.541 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.8 t60 -68.17 -49.22 62.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.648 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.33 62.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -33.86 23.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.972 0.415 . . . . 0.0 111.342 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 83.6 m-85 -102.56 1.36 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.389 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.3 tp -69.5 -31.73 2.75 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.8 Cg_exo -59.03 -23.46 68.79 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.979 1.786 . . . . 0.0 113.907 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.633 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 64.8 m-85 -77.34 -31.5 54.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.53 -160.27 33.71 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.696 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.58 134.63 34.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.71 0.404 . . . . 0.0 111.81 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.47 HG21 HD11 ' A' ' 93' ' ' ILE . 13.0 mt -115.76 137.23 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -92.38 -59.35 2.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.285 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.42 154.69 41.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 80' ' ' LEU . 17.2 mm -116.85 120.13 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.21 125.24 53.94 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.262 0.351 . . . . 0.0 111.354 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.32 109.42 21.26 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.573 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.34 126.23 18.05 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.274 1.983 . . . . 0.0 112.147 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 136.69 53.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.255 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -91.68 143.33 26.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -64.66 -34.96 79.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.14 -48.79 32.52 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.0 p -93.84 -28.48 15.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.21 24.38 2.78 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.386 0.675 . . . . 0.0 111.9 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 101' ' ' THR . 70.1 mttt -109.15 149.44 29.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.461 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.517 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.9 p80 -84.94 -14.36 47.86 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 67.75 -7.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.266 1.026 . . . . 0.0 113.502 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 99.25 23.73 11.01 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.29 -0.728 . . . . 0.0 114.755 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.03 152.25 40.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.794 0.797 . . . . 0.0 111.44 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.62 170.75 20.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.894 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -113.51 145.22 41.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.448 HG23 ' CD1' ' A' ' 93' ' ' ILE . 15.0 p -117.56 131.47 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -104.11 125.02 50.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.771 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 21.0 m-85 -112.27 143.07 43.97 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.053 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -69.38 -36.79 77.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.923 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.565 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.8 mp -105.62 139.95 39.44 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.057 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.34 -22.28 57.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.361 0.601 . . . . 0.0 109.896 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -70.02 -49.35 52.25 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.602 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.565 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -67.3 -31.92 72.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.868 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.921 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.28 -44.73 90.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.85 -28.72 69.18 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.025 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.1 -35.81 71.95 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.355 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.6 85.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.062 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.713 HD11 HD22 ' A' ' 66' ' ' LEU . 25.2 mt -70.87 -37.61 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 -18.71 39.85 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -97.25 -43.57 7.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.633 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 83.1 mtp -132.09 52.02 2.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.7 t30 -63.91 -40.2 95.94 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.5 mt-10 -141.25 78.26 1.63 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.402 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.9 p -122.04 164.03 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.642 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -91.44 118.96 31.01 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.1 tp -131.12 130.87 43.67 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.053 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 t80 62.42 15.11 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.694 0.798 . . . . 0.0 112.285 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.52 60.1 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -126.08 154.48 43.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.548 0.339 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.22 133.23 35.24 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.3 pt -116.43 153.78 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.095 0.474 . . . . 0.0 112.265 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -125.83 130.63 51.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.531 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.84 137.2 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.291 0.369 . . . . 0.0 110.483 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -148.94 171.91 15.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.59 126.29 29.28 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.448 0.299 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.139 -179.839 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 . . . . . 0 CA--C 1.543 0.684 0 CA-C-O 120.586 0.232 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.86 134.29 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.364 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.898 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.87 155.49 37.96 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.655 0.597 . . . . 0.0 111.024 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 67.1 t80 -102.32 130.85 49.15 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.463 HG12 ' CG1' ' A' ' 137' ' ' VAL . 12.6 m -126.22 124.57 66.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 O-C-N 123.533 0.52 . . . . 0.0 110.074 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 154.58 22.16 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.1 20.68 10.21 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 123.888 0.405 . . . . 0.0 112.424 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -89.6 160.44 16.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 110.664 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.511 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.08 155.54 19.39 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.978 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 43.5 mt-10 -61.69 -26.21 67.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.892 0.477 . . . . 0.0 111.933 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.44 -4.34 33.06 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.1 m -90.43 142.49 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.541 0.21 . . . . 0.0 110.786 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.599 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.8 p30 -127.71 -173.84 3.03 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.744 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.18 -32.94 71.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.764 0.425 . . . . 0.0 111.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 90.8 mttt -68.9 -40.25 79.28 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.782 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.599 HG23 ' OD1' ' A' ' 76' ' ' ASP . 44.1 t -66.25 -47.91 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.191 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -67.22 -38.41 85.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.576 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 11.2 t60 -68.26 -48.7 64.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.54 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.55 -20.51 62.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.41 -34.39 23.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.934 0.397 . . . . 0.0 111.473 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.9 m-85 -100.79 -0.63 36.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.189 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.6 -31.92 2.81 Favored Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.95 -22.82 65.15 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 121.93 1.753 . . . . 0.0 113.867 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.44 -31.18 47.95 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.08 -162.69 36.43 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.656 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -82.53 134.21 35.2 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.604 0.362 . . . . 0.0 111.72 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.52 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 12.1 mt -114.67 139.73 39.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.365 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -90.36 -62.9 1.36 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -146.95 153.01 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.516 HD11 HG21 ' A' ' 90' ' ' ILE . 14.5 mm -117.94 123.3 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -120.27 121.67 39.19 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.84 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mp -127.7 116.57 20.97 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.979 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.88 124.57 16.0 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.254 1.97 . . . . 0.0 112.514 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.87 134.71 49.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.036 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.18 143.31 26.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.459 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -64.59 -34.6 78.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -71.65 -48.73 45.78 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.1 p -96.04 -28.02 14.83 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 56.27 24.67 8.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.221 0.608 . . . . 0.0 111.562 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -122.21 154.71 37.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.475 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 25.0 p80 -99.49 161.62 13.51 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.293 0.371 . . . . 0.0 110.802 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -86.01 -4.8 59.25 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.25 27.96 7.04 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.311 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -148.71 149.68 31.85 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.215 0.507 . . . . 0.0 110.887 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.66 39.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.345 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.467 ' CE1' ' HD1' ' A' ' 67' ' ' TYR . 90.2 m-85 -109.57 134.35 52.02 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 93' ' ' ILE . 9.1 p -112.01 132.93 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.327 0.392 . . . . 0.0 110.54 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.445 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.2 OUTLIER -107.14 128.8 54.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.615 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -114.14 145.11 42.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.928 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.76 -37.08 76.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.589 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.584 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.9 mp -105.38 137.68 42.79 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.058 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.07 -19.75 59.85 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.172 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -71.15 -49.98 38.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.152 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.7 p30 -69.29 -31.77 70.49 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.898 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.45 -44.73 90.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.99 0.516 . . . . 0.0 111.334 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.84 69.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.073 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.59 -35.16 75.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.962 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.53 -38.73 81.09 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.718 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.706 HD11 HD22 ' A' ' 66' ' ' LEU . 72.5 mt -69.78 -33.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 123.096 0.247 . . . . 0.0 111.195 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.33 -35.71 73.8 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -102.53 -36.01 8.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.465 1.284 . . . . 0.0 114.465 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.492 ' O ' HG13 ' A' ' 137' ' ' VAL . 90.9 mmm -90.74 0.43 57.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.653 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.9 t-20 -56.68 -37.01 70.26 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.747 0.248 . . . . 0.0 111.602 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -140.78 71.89 1.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.371 0.605 . . . . 0.0 109.516 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m -121.13 154.03 36.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.295 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -92.01 119.17 31.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.427 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -127.9 127.42 43.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.925 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 61.89 15.91 7.57 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.736 0.814 . . . . 0.0 112.399 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.45 -9.09 62.57 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.01 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -113.45 149.52 34.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.811 0.444 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.46 138.45 36.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.671 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.11 156.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.843 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 10.2 ptp180 -128.32 134.06 48.82 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.181 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.12 143.64 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.384 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -141.8 171.1 14.52 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.976 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tt -81.51 125.55 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.14 -179.764 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 120.622 0.249 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 111' ' ' GLU . 5.8 t -103.21 134.72 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.429 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.854 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -123.35 155.46 37.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.866 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 76.8 t80 -93.56 137.46 32.81 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.417 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.64 123.42 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 123.598 0.561 . . . . 0.0 110.226 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.98 151.57 20.48 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.135 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.79 15.71 12.81 Favored Glycine 0 C--N 1.334 0.423 0 O-C-N 123.996 0.468 . . . . 0.0 112.57 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -88.48 164.64 15.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.766 0.317 . . . . 0.0 110.637 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.47 154.36 20.09 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.57 -30.34 69.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.556 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.53 1.8 13.29 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.978 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.9 m -88.95 137.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.598 0.237 . . . . 0.0 110.769 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.4 p30 -117.49 -175.77 2.88 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -61.98 -31.16 71.49 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.693 0.397 . . . . 0.0 112.042 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -35.62 76.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.879 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.581 HG23 ' OD1' ' A' ' 76' ' ' ASP . 61.8 t -69.75 -49.03 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -66.96 -38.64 86.47 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.74 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 31.2 t-80 -68.62 -47.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.742 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.27 -20.89 63.02 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.3 -33.98 23.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.009 0.433 . . . . 0.0 111.178 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 70.0 m-85 -100.39 0.04 39.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.254 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.0 tp -69.36 -31.89 2.9 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 44.8 Cg_exo -59.27 -22.93 67.48 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.879 1.719 . . . . 0.0 113.822 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.63 -31.63 36.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.92 35.49 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.798 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -83.18 137.49 34.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.718 0.407 . . . . 0.0 112.027 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 93' ' ' ILE . 6.8 mt -117.53 138.21 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.519 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.48 -62.1 1.51 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -145.09 153.13 41.09 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 90' ' ' ILE . 18.1 mm -119.58 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.529 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 5.8 tp60 -114.38 135.06 54.5 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.263 0.352 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mm -121.81 101.09 42.88 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.91 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.69 124.41 14.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.214 1.943 . . . . 0.0 112.382 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.54 132.12 53.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.961 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.93 141.73 28.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -64.74 -33.56 76.26 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.97 -48.8 51.29 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.1 p -100.59 -28.62 12.77 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 53.08 29.99 8.93 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.253 0.621 . . . . 0.0 111.673 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 101' ' ' THR . 34.1 mttt -121.18 156.89 31.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.193 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -89.42 139.22 30.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.69 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -99.01 3.31 46.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 93.84 21.77 27.54 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 114.741 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -146.05 150.82 36.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.655 0.728 . . . . 0.0 111.13 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -162.33 -179.83 7.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.875 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.463 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 85.3 m-85 -119.51 151.8 37.99 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.1 p -122.71 132.97 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 123.325 0.391 . . . . 0.0 110.495 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.497 ' HG3' HG22 ' A' ' 65' ' ' VAL . 21.1 tt0 -106.04 130.18 54.0 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.287 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.02 147.39 42.38 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.46 -37.94 71.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.456 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.6 mp -106.7 137.3 44.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.024 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.19 -19.62 60.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.253 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -70.8 -50.03 40.04 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.235 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.604 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 13.3 p30 -68.99 -31.71 70.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -63.7 -44.46 93.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.298 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -30.34 70.3 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.08 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.32 -34.72 75.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.845 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.25 -38.14 81.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.6 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.675 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 74.6 mt -68.79 -35.56 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.129 0.268 . . . . 0.0 111.124 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.17 -37.15 78.04 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -101.14 -35.44 9.31 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.496 ' O ' HG13 ' A' ' 137' ' ' VAL . 92.6 mmm -91.95 1.17 57.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.675 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.8 t-20 -57.16 -37.48 72.13 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -140.04 70.28 1.36 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.398 0.618 . . . . 0.0 109.523 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -122.24 157.42 31.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.217 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.88 122.32 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.04 129.46 42.03 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.879 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 62.25 15.43 7.55 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.675 0.79 . . . . 0.0 112.393 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 5.28 59.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.273 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -126.91 154.17 44.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 122.446 0.298 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.25 134.78 35.3 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.88 158.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 O-C-N 123.4 0.438 . . . . 0.0 111.92 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 4.0 ptp180 -128.24 134.31 48.96 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.401 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.578 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.28 143.57 40.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 123.198 0.311 . . . . 0.0 111.128 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -141.75 171.25 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.152 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.14 124.42 28.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.716 0.293 . . . . 0.0 110.532 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.216 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 74.8 mtt85 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.79 129.18 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.915 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -123.32 156.87 34.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.811 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.785 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 38.8 t80 -92.91 131.48 37.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.791 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.436 HG21 HD21 ' A' ' 80' ' ' LEU . 1.5 m -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.643 0.589 . . . . 0.0 109.565 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -137.24 162.06 25.3 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.595 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.0 32.92 6.85 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.759 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.3 mp -91.08 164.86 13.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.051 0.54 . . . . 0.0 111.501 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.69 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -84.73 163.3 19.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.643 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.94 -36.35 77.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.803 0.441 . . . . 0.0 112.093 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.66 -10.77 59.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.205 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -74.31 140.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.703 0.287 . . . . 0.0 111.632 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.611 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -126.78 179.09 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.314 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 2.1 t70 -62.5 -35.72 80.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 112.675 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -65.26 -35.32 80.66 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.106 0.479 . . . . 0.0 111.013 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.611 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -66.69 -39.65 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.707 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.436 HD21 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -67.84 -37.49 81.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.283 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.556 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 17.4 t60 -68.36 -49.65 58.73 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.342 0.401 . . . . 0.0 111.492 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.76 -20.93 62.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.05 -34.44 22.28 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.909 0.385 . . . . 0.0 111.351 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.434 ' C ' HD11 ' A' ' 90' ' ' ILE . 70.9 m-85 -98.61 -1.38 41.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.163 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.04 -31.89 3.05 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.0 Cg_exo -59.48 -23.86 72.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.953 1.769 . . . . 0.0 113.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -78.28 -31.39 48.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.5 -162.45 36.22 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.501 0.501 . . . . 0.0 112.761 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -81.77 136.91 35.41 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.684 0.393 . . . . 0.0 111.723 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.522 HG21 HD11 ' A' ' 93' ' ' ILE . 11.1 mt -115.79 139.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.703 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -92.94 -60.76 1.73 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.462 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -145.96 153.1 40.42 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.578 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 16.6 mm -120.01 119.33 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -118.57 129.28 55.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -127.92 114.61 20.51 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.729 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.78 116.49 3.29 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.216 1.944 . . . . 0.0 112.449 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.03 135.82 51.35 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.487 ' HB2' ' OG1' ' A' ' 101' ' ' THR . 9.9 m-20 -92.91 146.41 23.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.298 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.51 -36.24 83.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -77.03 -49.06 16.23 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.932 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.5 p -88.95 -28.58 20.17 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 49.81 25.3 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.607 0.763 . . . . 0.0 112.242 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 101' ' ' THR . 65.4 mttt -103.8 146.08 29.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.734 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -87.89 -15.84 35.59 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.407 0.442 . . . . 0.0 112.104 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 70.42 -6.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.251 1.02 . . . . 0.0 112.991 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.434 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.13 20.28 28.39 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-O 119.138 -0.812 . . . . 0.0 114.98 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.44 150.02 36.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.044 0.922 . . . . 0.0 111.68 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 95' ' ' ILE . . . -156.53 174.0 16.09 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.793 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.0 151.12 41.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.7 p -121.57 134.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 111.188 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 90' ' ' ILE . 21.8 tt0 -108.5 131.0 55.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.937 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 62.8 m-85 -116.59 149.16 40.13 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.417 0.448 . . . . 0.0 111.441 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.58 -38.05 70.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.562 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.7 mp -104.58 139.27 39.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.179 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.05 59.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.527 0.68 . . . . 0.0 109.186 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.94 -50.02 39.15 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.63 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.581 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -68.76 -31.96 71.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.999 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.915 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.32 -45.41 88.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.755 0.422 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.34 70.03 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.48 68.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.015 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -38.75 84.62 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.85 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.756 HD11 HD22 ' A' ' 66' ' ' LEU . 9.6 mt -70.27 -40.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.242 0.339 . . . . 0.0 111.692 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.41 -44.57 11.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.7 mtp -129.27 50.02 2.19 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 8.8 t-20 -64.36 -37.86 89.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.736 0.303 . . . . 0.0 110.887 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.1 77.63 1.59 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.712 0.767 . . . . 0.0 109.705 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.3 m -122.81 162.73 21.57 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.211 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -89.68 118.33 29.21 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.979 0.418 . . . . 0.0 110.74 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -122.14 128.44 51.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.897 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 56.81 20.51 5.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.073 0.949 . . . . 0.0 112.754 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.03 4.78 58.58 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.875 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -127.75 154.0 45.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.77 0.285 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.96 132.14 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.8 pt -119.55 153.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 68.8 mtt180 -124.08 134.82 53.3 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.24 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -129.1 135.56 61.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.191 0.52 . . . . 0.0 110.96 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -149.72 174.59 12.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 130.39 40.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.631 0.253 . . . . 0.0 111.245 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.042 -179.541 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.62 HG22 ' HG2' ' A' ' 111' ' ' GLU . 9.4 t -103.59 125.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.8 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.29 158.42 32.59 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.078 -179.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.89 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 36.7 t80 -96.66 123.75 40.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.88 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.562 HG12 HG12 ' A' ' 137' ' ' VAL . 2.4 m -124.47 114.56 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -133.78 160.19 23.96 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.556 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.3 33.5 6.22 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.742 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -92.13 165.78 12.98 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 124.016 0.48 . . . . 0.0 111.374 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -87.9 161.16 17.63 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.06 -33.11 73.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 0.0 111.949 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.78 4.45 25.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.804 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.742 HG11 ' HB3' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -86.16 139.26 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.859 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -124.68 174.28 7.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.26 -33.19 73.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.234 0.613 . . . . 0.0 112.23 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -66.0 -39.5 90.33 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.84 -42.28 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.729 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.1 tt -67.98 -37.38 81.45 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.665 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 7.0 t60 -68.6 -47.86 65.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.476 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.527 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.49 -21.36 62.77 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.08 22.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.147 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 62.3 m-85 -98.14 -1.03 43.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.135 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.16 -31.78 2.5 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.3 Cg_exo -59.56 -24.11 73.8 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.942 1.761 . . . . 0.0 113.785 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.516 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 52.1 m-85 -79.05 -31.24 44.46 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.244 0.34 . . . . 0.0 111.902 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.29 -164.83 38.33 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.455 0.472 . . . . 0.0 112.764 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -82.38 136.09 35.04 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.671 0.388 . . . . 0.0 111.638 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.526 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 4.8 mt -116.1 141.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.558 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 4.9 p -88.85 -64.15 1.19 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 123.521 0.513 . . . . 0.0 112.11 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -149.48 157.4 43.26 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.458 ' CD1' HG23 ' A' ' 110' ' ' VAL . 11.8 mm -116.56 122.85 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.74 132.14 54.89 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.3 mp -128.13 118.09 20.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.456 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.05 117.13 4.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.938 1.759 . . . . 0.0 112.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.7 mt -117.39 147.29 42.79 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.545 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -86.69 143.81 27.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.523 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -64.82 -32.0 73.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.1 -44.57 68.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.8 p -112.83 -26.47 8.54 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 56.5 21.99 6.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.648 0.779 . . . . 0.0 112.253 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -108.22 147.73 30.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.392 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -86.9 152.38 22.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 66.9 mtt-85 -89.32 2.32 54.53 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.791 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.423 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 99.39 21.45 14.93 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.466 -0.63 . . . . 0.0 114.165 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.47 ' O ' HG23 ' A' ' 95' ' ' ILE . 44.7 p90 -143.11 149.3 37.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.454 0.627 . . . . 0.0 111.481 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.42 172.09 18.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.65 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -120.01 149.08 42.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.1 p -122.74 135.5 62.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.224 0.328 . . . . 0.0 111.216 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.62 ' HG2' HG22 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -109.42 130.79 55.48 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.438 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 64.9 m-85 -112.26 142.37 44.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.77 -37.78 85.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.677 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.584 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.1 mp -103.58 136.02 44.09 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.597 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.4 -23.63 61.91 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.3 0.571 . . . . 0.0 110.399 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.07 -49.58 49.59 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.283 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.4 p30 -68.35 -32.64 72.88 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.8 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -44.88 79.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.521 0.328 . . . . 0.0 111.199 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.5 -30.19 71.35 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.821 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.559 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -70.44 -32.83 70.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.623 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.41 -38.69 88.03 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.376 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.645 HD11 HD22 ' A' ' 66' ' ' LEU . 41.3 mt -70.74 -36.6 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.354 0.409 . . . . 0.0 111.749 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.3 p30 -82.82 -16.08 49.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -98.27 -45.23 6.26 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.516 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 88.9 mtp -130.6 51.87 2.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 16.7 p30 -67.03 -36.14 81.43 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.502 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.93 80.16 1.7 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.777 0.799 . . . . 0.0 109.468 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.0 p -126.4 165.61 18.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.398 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.33 120.62 33.04 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -125.82 128.97 48.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 55.84 21.69 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.06 0.944 . . . . 0.0 112.813 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.66 4.45 59.2 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 116.186 -0.461 . . . . 0.0 114.059 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -128.63 154.7 45.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.885 0.343 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.5 m -79.33 132.08 36.32 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -118.4 153.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.433 0.458 . . . . 0.0 112.132 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 86.7 mtt180 -125.47 134.25 52.13 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.493 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.89 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -127.42 133.36 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 110.361 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -147.38 172.75 13.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 tt -67.85 125.52 26.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.693 0.397 . . . . 0.0 110.476 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.114 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 45.9 t -99.38 135.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.82 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -124.08 151.25 44.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 110.909 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 66.0 t80 -94.45 129.46 41.2 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.519 HG12 HG12 ' A' ' 137' ' ' VAL . 5.0 m -126.21 121.46 59.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 123.468 0.48 . . . . 0.0 110.202 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.35 153.0 20.59 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.645 0.591 . . . . 0.0 112.961 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.8 10.38 Favored Glycine 0 C--N 1.334 0.441 0 O-C-N 124.015 0.479 . . . . 0.0 112.442 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.74 161.44 17.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.798 0.333 . . . . 0.0 110.672 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.5 158.22 17.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.228 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.61 ' HA ' ' HE2' ' A' ' 104' ' ' HIS . 44.6 mt-10 -64.32 -27.76 69.25 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.648 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.92 -2.54 34.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.887 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.7 m -86.11 138.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 120.689 0.28 . . . . 0.0 110.738 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.484 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.3 m-20 -117.94 178.56 4.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.598 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.89 -28.82 69.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.566 0.346 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.82 -40.71 79.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.49 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 5.2 t -65.88 -45.81 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.087 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -65.91 -39.21 90.38 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.571 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 26.9 t-80 -68.31 -48.49 64.78 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.763 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.28 62.99 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.42 -35.41 23.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 82.2 m-85 -100.25 -0.43 38.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.159 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.8 tp -68.07 -32.59 4.17 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.69 -22.87 69.34 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.773 1.649 . . . . 0.0 113.89 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -81.18 -31.46 34.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.35 -167.86 40.05 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.098 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.06 131.79 34.77 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.684 0.394 . . . . 0.0 111.183 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.513 HG21 HD11 ' A' ' 93' ' ' ILE . 9.2 mt -112.98 135.88 51.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.388 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -91.3 -58.73 2.35 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.544 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -146.57 152.97 39.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.513 HD11 HG21 ' A' ' 90' ' ' ILE . 19.4 mm -118.23 115.14 47.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -114.53 122.77 47.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.035 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -127.43 123.23 23.11 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.602 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.15 127.6 18.73 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.226 1.951 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.64 135.6 47.06 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -94.01 146.33 24.02 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -64.6 -36.03 82.91 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.55 -49.2 19.35 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.5 p -92.57 -28.58 16.66 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 52.46 22.99 2.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.265 0.626 . . . . 0.0 111.885 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 101' ' ' THR . 66.2 mttt -107.44 148.48 29.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.67 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 21.8 p80 -93.0 -9.39 39.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.016 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 71.61 -18.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.359 1.063 . . . . 0.0 113.063 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.495 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.9 26.07 4.56 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 119.507 -0.607 . . . . 0.0 114.551 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -147.5 145.58 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.604 0.702 . . . . 0.0 111.213 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.403 ' HB2' HG23 ' A' ' 95' ' ' ILE . . . -152.58 168.26 26.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.949 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -113.29 140.93 47.58 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 93' ' ' ILE . 7.8 p -116.22 135.22 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 90' ' ' ILE . 19.0 tt0 -104.79 125.59 51.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.261 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -111.52 138.38 48.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.088 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -66.35 -37.0 84.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.65 134.19 52.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.94 63.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.45 -49.54 63.2 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.08 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -68.67 -32.47 72.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.82 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.94 -44.09 97.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.534 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.07 68.82 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.252 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.94 73.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.243 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.82 -37.95 87.62 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.717 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.734 HD11 HD22 ' A' ' 66' ' ' LEU . 64.8 mt -69.99 -33.89 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.022 0.201 . . . . 0.0 111.125 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.44 -35.9 80.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -102.58 -35.03 8.87 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.503 ' O ' HG13 ' A' ' 137' ' ' VAL . 95.6 mmm -92.07 0.57 57.47 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.4 t-20 -56.49 -37.37 70.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.827 0.285 . . . . 0.0 111.728 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -141.9 73.49 1.41 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.345 0.593 . . . . 0.0 109.504 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.2 p -125.41 157.2 37.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.25 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -94.99 120.05 34.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.612 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.11 129.83 44.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.985 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.9 t80 62.64 15.1 7.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.747 0.819 . . . . 0.0 112.366 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.62 4.61 58.04 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.402 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -127.58 154.11 45.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.741 0.271 . . . . 0.0 110.999 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -83.0 134.62 35.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 pt -119.8 156.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 123.421 0.451 . . . . 0.0 112.113 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 31.7 ptt180 -126.06 132.94 51.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.211 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -128.98 140.19 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.062 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -144.31 170.26 16.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 119.81 15.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.153 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.086 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 76.1 mtt85 . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 111' ' ' GLU . 6.0 t -106.5 131.3 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.636 HD22 HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -123.45 156.95 34.55 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.459 0.475 . . . . 0.0 110.837 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.865 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 48.0 t80 -98.71 134.8 41.12 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.704 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 137' ' ' VAL . 2.6 m -134.11 114.82 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.9 150.52 19.37 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.656 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.62 36.77 3.67 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.784 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.3 mp -94.4 164.73 12.89 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.004 0.431 . . . . 0.0 111.227 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.77 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -88.7 164.44 15.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.499 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.38 -32.79 72.04 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.14 5.73 21.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.24 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.784 HG11 ' HB3' ' A' ' 71' ' ' LEU . 3.9 p -86.41 136.07 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 120.648 0.261 . . . . 0.0 110.854 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -122.35 174.58 6.92 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.467 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.434 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.0 m-20 -61.65 -32.53 72.69 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.146 0.578 . . . . 0.0 112.045 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -67.37 -40.25 85.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.684 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.2 -43.08 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.967 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -68.46 -36.47 79.05 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.809 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 6.4 t60 -68.56 -49.51 58.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.595 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.522 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -71.0 -20.91 62.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.64 -34.35 23.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.209 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 64.9 m-85 -98.14 -2.46 39.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.102 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.4 tp -67.13 -32.35 4.66 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.5 -23.54 71.21 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 121.782 1.655 . . . . 0.0 113.795 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 45.0 m-85 -80.3 -31.62 38.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.23 -168.05 40.94 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 123.467 0.48 . . . . 0.0 112.738 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -84.88 133.19 34.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.566 0.347 . . . . 0.0 111.148 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 5.3 mt -114.08 138.9 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.643 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.1 p -89.89 -60.31 1.97 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.951 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -149.06 159.22 44.43 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.441 ' CD1' HG23 ' A' ' 110' ' ' VAL . 17.7 mm -117.93 126.98 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -121.01 126.96 51.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -128.13 115.88 20.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.698 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.45 126.87 22.67 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.284 1.989 . . . . 0.0 112.623 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -127.53 135.09 49.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.173 -179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -91.32 144.17 25.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -34.9 79.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -71.21 -48.63 50.33 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 p -98.7 -27.69 13.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' HD11 ' A' ' 97' ' ' LEU . 51.4 mt-10 57.18 22.84 7.96 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.29 0.636 . . . . 0.0 111.674 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -121.32 155.44 34.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.292 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -101.32 160.85 14.07 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.236 0.335 . . . . 0.0 110.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 77.9 mtt180 -88.55 2.95 52.03 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.197 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 96.34 27.13 10.23 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.326 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.4 p90 -143.6 148.98 36.68 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.372 0.586 . . . . 0.0 111.127 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.54 169.5 22.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -117.3 144.08 45.25 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.441 HG23 ' CD1' ' A' ' 93' ' ' ILE . 10.6 p -120.99 134.53 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.211 0.319 . . . . 0.0 111.01 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.5 OUTLIER -106.53 128.49 54.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.32 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.505 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 13.6 m-85 -109.25 137.16 47.55 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.04 -35.82 82.39 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.54 134.26 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.82 -26.42 65.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.31 -44.1 84.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.873 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -68.49 -33.06 73.5 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.58 -46.16 91.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.28 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.29 -28.79 66.59 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.314 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.88 72.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.507 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.01 88.78 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.223 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.781 HD13 HD22 ' A' ' 139' ' ' LEU . 12.8 mt -70.73 -33.65 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 123.252 0.345 . . . . 0.0 111.875 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.13 -17.31 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -101.22 -43.03 6.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.506 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 84.7 mtp -126.24 47.41 2.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 19.0 p-10 -66.29 -33.92 76.83 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.328 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.1 mt-10 -143.06 77.47 1.57 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.733 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.6 m -123.56 162.57 22.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.179 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.32 119.7 30.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.87 0.367 . . . . 0.0 110.77 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.8 129.63 48.7 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.003 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 57.22 20.59 5.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 112.693 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.99 3.99 60.3 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.893 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -127.66 155.08 44.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.686 0.243 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.0 131.25 35.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -116.83 151.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 74.6 mtt180 -122.72 134.3 54.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -128.16 133.78 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.459 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -147.13 172.67 13.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.665 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.781 HD22 HD13 ' A' ' 122' ' ' ILE . 1.9 mm? -67.9 127.42 32.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.704 0.402 . . . . 0.0 110.66 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.128 -179.651 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 72.5 mtt85 . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.663 0.268 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 111' ' ' GLU . 22.0 t -104.95 136.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.632 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.98 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.88 155.97 37.11 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.554 0.533 . . . . 0.0 111.386 -178.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.769 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.0 t80 -92.71 134.79 34.69 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.437 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.545 HG12 HG12 ' A' ' 137' ' ' VAL . 2.6 m -134.64 115.18 19.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 O-C-N 123.654 0.596 . . . . 0.0 109.663 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.22 152.31 20.35 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.989 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.89 8.03 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.99 0.465 . . . . 0.0 112.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -92.01 164.76 13.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.573 0.349 . . . . 0.0 110.592 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -91.09 155.52 18.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.739 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.08 -26.16 68.7 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.67 0.388 . . . . 0.0 111.749 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.79 -3.03 32.72 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.689 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -86.3 135.51 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.907 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -109.49 174.86 5.68 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.547 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -60.52 -29.63 69.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.567 0.347 . . . . 0.0 111.57 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -68.81 -35.39 76.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.42 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.79 -47.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.792 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 68' ' ' VAL . 1.5 tt -67.62 -38.88 84.56 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.614 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.543 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 7.7 t60 -67.67 -48.94 65.2 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.446 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.59 -20.36 62.78 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.84 -34.04 24.73 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 111.456 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' C ' HD11 ' A' ' 90' ' ' ILE . 77.5 m-85 -102.34 0.2 33.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.433 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -68.83 -32.81 3.75 Favored Pre-proline 0 CA--C 1.565 1.525 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 15.1 Cg_endo -58.61 -23.42 65.22 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 121.94 1.76 . . . . 0.0 113.941 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -78.34 -31.39 48.64 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.87 -161.94 34.81 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.998 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.71 134.79 34.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.689 0.396 . . . . 0.0 111.833 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.514 HG21 HD11 ' A' ' 93' ' ' ILE . 15.2 mt -116.63 138.67 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -94.21 -60.8 1.65 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 111' ' ' GLU . 75.4 m-20 -143.86 153.19 42.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.514 HD11 HG21 ' A' ' 90' ' ' ILE . 20.8 mm -119.46 124.64 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.59 127.56 54.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.71 114.37 20.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.935 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.28 130.88 37.99 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.399 2.066 . . . . 0.0 112.734 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.09 132.53 50.61 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.131 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -94.25 142.76 27.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.355 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -64.69 -34.28 77.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.8 -42.58 81.35 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 19.1 p -112.65 -26.71 8.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 60.82 19.61 9.81 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.347 0.659 . . . . 0.0 111.397 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -122.43 155.34 36.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.343 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -107.03 157.88 17.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.645 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -82.75 -1.39 51.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.326 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.57 41.64 2.49 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-O 119.807 -0.44 . . . . 0.0 113.836 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -147.28 147.47 30.43 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.85 0.357 . . . . 0.0 110.961 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.27 172.76 17.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -115.57 142.33 46.87 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.7 p -114.05 134.51 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 123.213 0.321 . . . . 0.0 110.599 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HG3' HG22 ' A' ' 65' ' ' VAL . 17.0 tt0 -108.26 125.64 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.618 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 30.0 m-85 -112.42 137.61 50.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.56 -36.71 84.58 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.58 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.6 mp -105.74 140.23 39.1 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.38 -22.51 57.44 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.924 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -72.8 -49.55 29.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.58 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 21.3 p30 -67.03 -32.3 73.41 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.653 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.98 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.6 -42.73 91.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.01 0.524 . . . . 0.0 111.036 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.1 69.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.209 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.18 -37.31 78.11 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.934 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.05 -38.08 87.47 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.454 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.764 HD11 HD22 ' A' ' 66' ' ' LEU . 44.2 mt -70.16 -33.0 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 123.234 0.334 . . . . 0.0 111.281 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.83 -36.18 77.87 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -105.56 -33.04 8.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.485 ' O ' HG13 ' A' ' 137' ' ' VAL . 98.0 mmm -95.85 3.98 53.21 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.647 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.6 t-20 -56.57 -37.52 70.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.845 0.293 . . . . 0.0 111.764 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.06 72.85 1.4 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.695 0.76 . . . . 0.0 109.94 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.1 t -124.71 157.33 35.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -93.8 120.85 34.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.6 tp -128.48 128.21 43.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.806 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.98 7.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.658 0.783 . . . . 0.0 112.437 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.92 58.25 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.447 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -127.51 153.81 45.89 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.428 0.291 . . . . 0.0 110.778 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -82.08 134.17 35.32 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.27 154.36 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 73.7 mtt180 -122.26 134.3 54.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.359 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -130.95 138.38 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.896 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -151.67 172.18 16.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' HG ' HD13 ' A' ' 122' ' ' ILE . 19.7 mt -70.29 129.9 40.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.553 0.216 . . . . 0.0 111.118 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.459 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 139' ' ' LEU . 67.0 ttt180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.614 0.245 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 111' ' ' GLU . 18.9 t -106.63 136.38 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.976 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.0 157.58 34.08 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.457 0.473 . . . . 0.0 111.709 -178.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.824 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 42.8 t80 -96.38 136.16 37.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.302 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.446 HG12 HG12 ' A' ' 137' ' ' VAL . 4.1 m -134.39 115.09 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 109.718 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.04 142.52 13.75 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.821 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.8 29.52 2.61 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.946 0.439 . . . . 0.0 112.616 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER -97.11 163.31 12.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.929 0.395 . . . . 0.0 110.549 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -84.61 155.79 21.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.13 -27.64 68.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.64 0.376 . . . . 0.0 111.608 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.61 -0.28 29.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.951 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -84.7 140.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.127 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.81 178.71 4.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -59.31 -31.22 68.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.742 0.417 . . . . 0.0 111.482 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.42 -39.97 81.39 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.07 -47.51 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.894 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD22 HD12 ' A' ' 93' ' ' ILE . 1.7 tt -67.62 -38.96 84.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.553 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 24.0 t-80 -68.69 -47.64 65.93 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.657 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.33 -20.69 62.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -32.96 23.65 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 74.9 m-85 -102.32 1.16 35.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.319 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.22 -31.64 2.41 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.362 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.6 Cg_exo -59.21 -24.01 72.06 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 121.967 1.778 . . . . 0.0 113.861 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.551 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 55.2 m-85 -79.91 -31.45 40.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.18 -161.51 35.11 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.95 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.16 136.56 33.93 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.793 0.437 . . . . 0.0 111.864 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.553 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 5.8 mt -116.66 139.24 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.595 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -93.71 -61.27 1.58 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.656 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -143.26 153.51 42.86 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.554 HD12 HD22 ' A' ' 80' ' ' LEU . 18.3 mm -119.84 125.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.81 125.99 50.81 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.23 0.331 . . . . 0.0 111.721 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.35 110.81 21.22 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.04 128.44 27.81 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.43 2.087 . . . . 0.0 112.565 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 102' ' ' GLU . 1.1 tp -124.01 134.24 53.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.165 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.23 139.64 30.41 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.504 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -64.76 -31.98 73.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.09 -41.89 94.59 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 p -117.28 -22.84 8.09 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' O ' HD11 ' A' ' 97' ' ' LEU . 46.7 mt-10 59.99 22.66 11.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.231 0.613 . . . . 0.0 111.444 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -124.84 154.5 40.92 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.348 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -110.21 154.93 22.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -79.57 -11.1 59.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.025 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.77 41.47 1.11 Allowed Glycine 0 C--N 1.341 0.847 0 C-N-CA 121.095 -0.574 . . . . 0.0 114.019 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -145.12 145.13 31.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.195 0.497 . . . . 0.0 111.103 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.99 173.09 17.05 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.966 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.94 144.5 43.98 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.453 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.2 p -116.17 131.03 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 110.692 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.496 ' HG3' HG22 ' A' ' 65' ' ' VAL . 20.3 tt0 -106.37 126.89 52.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.259 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 47.7 m-85 -111.51 141.94 44.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -64.05 -36.89 85.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -115.63 125.1 52.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.758 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.68 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.405 ' HB2' HD23 ' A' ' 114' ' ' LEU . 70.3 mm-40 -68.25 -47.87 66.61 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.586 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 112' ' ' PHE . 8.0 p30 -69.03 -32.43 71.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.378 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.976 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.58 -42.2 87.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.685 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.17 71.29 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.699 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.665 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -68.48 -33.66 74.54 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.692 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.83 82.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.602 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.74 HD11 HD22 ' A' ' 66' ' ' LEU . 48.0 mt -70.33 -37.76 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.7 p30 -82.94 -16.72 46.27 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -93.89 -47.86 6.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.551 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 62.7 mtt -130.87 53.49 1.97 Allowed 'General case' 0 C--N 1.346 0.434 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.1 t-20 -64.73 -37.71 88.53 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.9 mt-10 -143.18 77.22 1.56 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.728 0.775 . . . . 0.0 109.834 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.0 m -119.77 160.72 22.05 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.31 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -90.28 118.25 29.64 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.955 0.407 . . . . 0.0 110.679 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.3 tp -129.17 130.55 46.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.911 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.3 t80 62.86 15.07 7.94 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.727 0.811 . . . . 0.0 112.232 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.19 4.69 59.74 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.209 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -126.93 155.48 43.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.572 0.349 . . . . 0.0 110.817 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.15 133.32 35.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.2 pt -118.05 151.77 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 57.7 mtt180 -122.81 134.71 54.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.424 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.824 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.73 134.99 61.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.89 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -154.2 172.13 18.09 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.494 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.603 HD12 ' NH2' ' A' ' 64' ' ' ARG . 5.4 tt -69.21 129.69 40.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.578 0.228 . . . . 0.0 110.628 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.136 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 133.13 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.93 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.11 156.99 33.87 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.535 0.522 . . . . 0.0 111.411 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.0 t80 -101.04 134.61 43.78 Favored 'General case' 0 N--CA 1.458 -0.042 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.455 HG12 ' CG1' ' A' ' 137' ' ' VAL . 4.0 m -128.98 116.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 O-C-N 123.548 0.53 . . . . 0.0 109.769 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.2 152.96 18.88 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.762 -0.733 . . . . 0.0 113.384 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.02 23.72 7.6 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.985 0.462 . . . . 0.0 112.588 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -92.0 163.09 14.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -90.61 157.86 17.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.869 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.6 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 38.8 mt-10 -64.71 -26.67 68.47 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.722 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -77.41 -1.53 30.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.766 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -86.53 139.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 120.572 0.225 . . . . 0.0 110.66 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.504 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.1 m-20 -121.71 179.02 4.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.803 0.441 . . . . 0.0 111.54 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.54 -40.77 80.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.702 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.504 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.3 t -67.06 -46.98 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.212 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -67.04 -39.42 86.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.644 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.569 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 9.1 t60 -68.07 -48.68 64.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.023 0.529 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.41 -20.62 62.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.43 -34.03 23.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 111.402 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.8 m-85 -101.54 0.21 36.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.285 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -70.25 -31.85 2.49 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.5 Cg_exo -59.01 -23.4 68.42 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.007 1.805 . . . . 0.0 113.882 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -78.02 -31.29 50.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.43 -162.67 36.26 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.827 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.88 134.0 35.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.72 0.408 . . . . 0.0 111.769 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.507 HG21 HD11 ' A' ' 93' ' ' ILE . 12.7 mt -114.41 139.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.267 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -62.63 1.42 Allowed 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.668 0.605 . . . . 0.0 112.303 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.9 154.91 41.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 90' ' ' ILE . 17.5 mm -117.2 125.51 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.07 128.22 52.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -127.73 116.72 20.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.706 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.37 121.74 10.39 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.209 1.939 . . . . 0.0 112.413 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 134.57 49.74 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.175 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.81 143.07 26.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.73 -33.47 76.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.66 -48.57 54.22 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.2 p -100.46 -27.85 13.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.82 23.88 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.235 0.614 . . . . 0.0 111.569 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -121.37 156.83 31.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.522 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 9.5 p80 -110.18 159.36 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.928 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 85.5 mtt-85 -87.77 3.6 47.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.015 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 94.51 35.02 6.07 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.594 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 1.3 p90 -143.73 147.12 33.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.65 0.262 . . . . 0.0 110.941 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.0 169.52 23.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.639 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -116.19 144.42 44.21 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.0 p -118.84 133.15 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.425 0.453 . . . . 0.0 110.434 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.05 127.33 53.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 32.2 m-85 -113.8 141.69 46.99 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.271 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -67.47 -37.23 82.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.606 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -102.77 138.95 38.99 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -19.54 59.37 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.483 0.658 . . . . 0.0 109.267 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.19 -50.99 23.29 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.754 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 24.0 p30 -69.33 -31.86 70.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.93 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.15 -45.02 86.71 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.931 0.492 . . . . 0.0 111.423 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.66 -30.51 71.22 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.6 77.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.101 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -67.29 -39.52 85.98 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.8 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 52.7 mt -69.16 -33.82 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.862 -0.154 . . . . 0.0 111.32 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -68.72 -36.4 78.37 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.36 -34.46 8.28 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.482 ' O ' HG13 ' A' ' 137' ' ' VAL . 94.0 mmm -91.68 0.54 57.49 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 10.1 t-20 -56.64 -36.95 70.09 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.847 0.294 . . . . 0.0 111.678 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.74 70.96 1.36 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.619 0.723 . . . . 0.0 110.061 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 55.0 m -121.81 154.7 36.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.336 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.7 119.4 32.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.471 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tp -129.94 130.18 44.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.013 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 61.99 15.68 7.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.658 0.783 . . . . 0.0 112.443 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 4.92 59.22 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.298 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -127.0 154.39 44.68 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.514 0.326 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.53 134.35 34.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.02 154.79 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.024 0.44 . . . . 0.0 112.135 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 22.8 ttp-105 -124.24 131.78 53.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.785 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.27 139.49 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.316 0.385 . . . . 0.0 110.738 179.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -145.25 171.94 13.85 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 122' ' ' ILE . 9.2 mt -68.95 133.33 48.05 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.24 0.216 . . . . 0.0 110.921 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.34 -179.438 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.2 mtt85 . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 ' HG3' ' A' ' 111' ' ' GLU . 10.2 t -107.54 128.94 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.796 HD22 HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -123.33 155.64 36.88 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.678 -179.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 52.5 t80 -92.29 136.02 33.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.834 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 136' ' ' ARG . 2.9 m -134.54 115.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.43 142.23 13.5 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.563 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.26 24.9 4.3 Favored Glycine 0 C--N 1.332 0.315 0 O-C-N 123.954 0.444 . . . . 0.0 112.429 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -95.53 164.6 12.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.264 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -79.58 151.79 30.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.72 -30.42 71.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.652 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -83.88 13.61 4.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.883 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 72' ' ' ALA . 5.6 m -88.8 133.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.707 0.289 . . . . 0.0 110.856 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 2.6 t70 -102.42 173.52 6.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.457 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -59.34 -30.1 68.14 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.697 0.399 . . . . 0.0 111.248 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.44 -38.36 81.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.431 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 43.2 t -63.81 -48.32 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.017 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 HD12 ' A' ' 93' ' ' ILE . 1.8 tt -68.74 -37.25 79.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.494 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.3 t60 -68.52 -49.32 60.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.634 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.492 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.28 -20.75 63.02 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.62 -32.53 23.66 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 73.1 m-85 -103.0 2.5 35.03 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.465 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.5 tp -71.31 -31.46 1.93 Allowed Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.206 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.9 Cg_exo -59.7 -23.54 72.08 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.901 1.734 . . . . 0.0 114.033 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.67 -31.43 46.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.52 -158.41 30.71 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.49 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -85.73 139.66 31.15 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.672 0.389 . . . . 0.0 111.426 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.563 HG21 HD11 ' A' ' 93' ' ' ILE . 8.3 mt -117.09 140.54 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 p -93.86 -62.49 1.34 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.308 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.4 ' O ' HD13 ' A' ' 93' ' ' ILE . 75.8 m-20 -144.89 152.52 40.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.563 HD11 HG21 ' A' ' 90' ' ' ILE . 17.4 mm -121.04 130.59 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.617 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.482 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 86.4 mm-40 -120.51 137.1 54.55 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.222 0.326 . . . . 0.0 111.583 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.73 100.39 28.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.787 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.52 128.09 23.71 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.543 2.162 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -128.07 133.76 49.09 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.774 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.24 138.51 31.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.422 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -64.53 -33.69 76.48 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.17 -44.68 75.42 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.979 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.55 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.5 p -102.42 -29.04 11.86 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 52.86 32.56 12.64 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.19 0.596 . . . . 0.0 110.785 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 101' ' ' THR . 58.4 mttt -124.33 154.22 40.63 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.062 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -94.77 134.8 36.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.63 4.65 53.62 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.04 25.91 23.21 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.43 -0.891 . . . . 0.0 114.695 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -143.7 148.3 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 117.668 0.734 . . . . 0.0 111.378 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.09 176.34 12.39 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.539 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.05 150.45 39.96 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.471 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.0 p -121.63 134.56 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.989 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.411 ' HG3' HG22 ' A' ' 65' ' ' VAL . 20.1 tt0 -111.03 133.15 53.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.093 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 80.7 m-85 -117.19 150.62 38.43 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.42 0.45 . . . . 0.0 111.261 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -69.07 -39.04 79.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.038 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mp -111.27 141.13 45.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -21.21 62.67 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.613 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.18 -42.99 99.79 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.131 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.89 -32.05 68.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.051 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.603 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -57.64 -46.88 83.6 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.374 0.421 . . . . 0.0 111.057 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.51 63.29 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.383 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.28 63.25 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.582 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.72 91.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.796 HD11 HD22 ' A' ' 66' ' ' LEU . 16.2 mt -70.83 -43.42 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.28 -32.49 68.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -79.42 -49.6 12.1 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 64.0 mtt -135.17 63.69 1.61 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.098 0.475 . . . . 0.0 112.227 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 17.6 p30 -69.82 -35.17 74.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.044 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.7 mt-10 -142.99 78.65 1.62 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.698 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.9 m -120.58 161.23 21.68 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.282 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -90.36 117.19 28.89 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.019 0.437 . . . . 0.0 110.752 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -129.06 131.78 47.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.88 14.49 8.39 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.765 0.826 . . . . 0.0 112.189 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.16 60.28 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.237 -0.438 . . . . 0.0 113.085 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -127.66 157.19 40.94 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.612 0.365 . . . . 0.0 110.721 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.55 133.89 34.85 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.6 pt -118.19 152.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 58.6 mtt-85 -122.81 134.55 54.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.259 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.81 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.46 133.31 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 110.766 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -151.01 172.31 15.91 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.986 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.28 131.29 42.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.662 0.268 . . . . 0.0 111.369 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.158 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.112 -179.69 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 84.4 mtt180 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 20.5 t -102.44 129.29 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -123.79 158.85 30.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.304 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 31.3 t80 -93.84 132.88 37.82 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.013 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -132.51 115.49 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.91 156.45 21.73 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.355 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.14 20.82 9.39 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.146 -0.527 . . . . 0.0 112.448 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -89.32 163.11 15.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.71 156.62 18.42 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.946 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.03 -26.66 68.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.654 0.382 . . . . 0.0 111.678 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -76.95 -2.2 32.54 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.676 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -87.41 139.57 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 120.577 0.227 . . . . 0.0 110.747 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 79' ' ' VAL . 4.3 p30 -120.64 -176.64 3.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.5 -31.11 71.09 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.879 0.472 . . . . 0.0 111.788 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 91.5 mttt -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.714 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 76' ' ' ASP . 91.5 t -65.42 -47.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.056 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.433 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.4 tt -67.38 -39.14 85.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.411 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.8 t60 -68.15 -47.85 66.94 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.572 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.82 -20.22 62.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.86 -34.81 24.53 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-O 120.845 0.355 . . . . 0.0 111.38 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' C ' HD11 ' A' ' 90' ' ' ILE . 76.3 m-85 -99.87 -2.05 35.85 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.391 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 4.9 tp -68.51 -32.48 3.78 Favored Pre-proline 0 CA--C 1.566 1.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 11.4 Cg_endo -56.66 -24.81 56.47 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.035 1.823 . . . . 0.0 113.874 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -79.43 -31.32 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.287 0.367 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.9 -169.71 42.85 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.308 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -86.03 130.77 34.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.314 0.246 . . . . 0.0 110.748 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.552 HG21 HD11 ' A' ' 93' ' ' ILE . 5.5 mt -105.89 141.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.919 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 p -88.37 -60.5 1.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.757 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -146.29 153.21 40.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.552 HD11 HG21 ' A' ' 90' ' ' ILE . 18.0 mm -120.53 122.26 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.9 125.85 48.52 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.522 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mp -127.15 117.37 21.83 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.811 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.89 121.86 8.94 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.994 1.796 . . . . 0.0 112.521 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.93 136.56 54.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.076 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -86.87 139.42 30.67 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.614 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 87.4 m-85 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.06 -42.72 89.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -108.58 -27.02 10.11 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.614 ' OE2' ' HA ' ' A' ' 99' ' ' TYR . 73.2 mm-40 57.7 24.84 11.07 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.231 0.612 . . . . 0.0 111.474 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -124.48 154.88 39.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.269 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -115.34 148.71 38.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.344 0.402 . . . . 0.0 110.81 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.293 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 110.71 39.19 1.47 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.918 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.09 149.23 36.26 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 117.084 0.442 . . . . 0.0 110.823 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.58 170.96 21.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.092 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -118.02 145.55 44.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 10.4 p -118.69 137.87 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.068 0.461 . . . . 0.0 111.43 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 90' ' ' ILE . 23.1 tt0 -107.23 128.99 54.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.23 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 45.4 m-85 -116.87 146.0 43.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -70.75 -37.4 73.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.862 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.606 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -107.37 143.19 36.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -25.87 58.85 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.745 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.13 -47.24 59.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.7 p30 -67.23 -32.02 72.78 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.962 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.04 -45.18 82.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.079 0.552 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.68 70.52 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.23 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.632 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -69.67 -33.92 73.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.59 78.67 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.723 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 66' ' ' LEU . 74.3 mt -66.65 -47.68 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.632 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 4.3 p30 -67.47 -34.31 76.91 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -88.36 -35.04 17.39 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 137' ' ' VAL . 83.6 mtp -110.73 14.39 22.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.5 t-20 -57.47 -37.26 72.6 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.813 0.278 . . . . 0.0 111.572 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -142.71 77.14 1.56 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.624 0.726 . . . . 0.0 109.908 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.5 t -127.17 157.0 40.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.118 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -93.21 118.99 31.89 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.6 tp -131.0 130.41 43.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.982 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.6 15.52 8.03 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.573 0.749 . . . . 0.0 112.361 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.39 60.08 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.301 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -126.55 153.96 44.5 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.502 0.321 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.97 133.36 34.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 pt -116.1 152.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.657 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 5.0 tpt180 -124.66 128.45 48.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.599 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.43 139.18 51.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.38 0.425 . . . . 0.0 110.764 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 28.5 p30 -145.27 173.76 11.68 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.496 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.0 tt -69.79 123.67 22.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.321 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.4 p . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.339 0.114 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.1 mtt -101.74 136.93 40.74 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.349 0.406 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.3 mtp -101.21 141.74 33.65 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.703 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -117.5 153.45 33.14 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.121 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.0 t -122.62 143.87 49.48 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.744 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.77 -65.15 1.19 Allowed Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.936 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -93.72 134.76 35.71 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.364 0.265 . . . . 0.0 111.03 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 t -130.47 121.55 26.02 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.621 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -70.85 -38.36 73.17 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.559 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -126.73 154.32 44.31 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.348 0.405 . . . . 0.0 111.241 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -96.82 134.4 40.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.71 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.6 m -86.17 -39.9 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.386 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -64.97 -43.54 92.31 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 t -66.32 -39.13 89.08 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -69.74 -39.93 76.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.907 0.483 . . . . 0.0 111.88 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -76.71 -42.91 39.6 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.67 140.72 49.09 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.23 0.331 . . . . 0.0 111.298 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -139.73 156.79 46.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.055 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.9 tp -108.06 147.4 31.23 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.262 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 t -68.05 149.23 49.94 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.722 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -63.12 -35.33 79.92 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.805 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -65.6 -47.32 76.1 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.297 0.373 . . . . 0.0 111.599 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.476 ' O ' HD12 ' A' ' 27' ' ' LEU . 91.7 mmm -70.19 -37.98 75.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -66.72 -41.88 87.2 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.072 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 44.5 mt-10 -70.06 -40.83 74.84 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.536 HG21 ' HB1' ' A' ' 140' ' ' ALA . 38.7 mt -70.57 -47.34 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 9.0 mt -69.62 -41.42 75.71 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 m -77.88 -38.06 46.75 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 85.5 m-20 -93.74 10.03 34.64 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 2.2 pp -73.27 146.08 86.34 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-N 118.487 0.585 . . . . 0.0 111.865 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.3 129.84 14.43 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.732 2.288 . . . . 0.0 112.003 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -51.66 -33.23 32.77 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 81.7 p -84.32 -39.31 19.31 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.13 -28.69 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.167 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB2' HD13 ' A' ' 30' ' ' LEU . . . -63.55 -29.05 70.37 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.931 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -154.8 126.01 7.27 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.328 0.393 . . . . 0.0 110.87 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 m -123.3 135.44 54.21 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.491 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 89.8 m -98.76 -38.66 8.99 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.49 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -113.86 139.34 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 123.372 0.42 . . . . 0.0 110.065 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -95.02 133.76 38.45 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.488 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.2 t -111.47 139.02 47.23 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.919 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.1 p -78.24 -16.54 57.72 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.436 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.33 -36.8 79.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.79 0.436 . . . . 0.0 112.165 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -69.14 -40.03 78.48 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.755 0.422 . . . . 0.0 112.073 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -133.12 128.24 35.67 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.479 0.487 . . . . 0.0 110.299 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.79 142.32 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.782 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -87.72 136.84 32.78 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.132 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.02 -122.74 1.65 Allowed Glycine 0 C--N 1.336 0.566 0 O-C-N 123.628 0.58 . . . . 0.0 112.542 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.75 -175.97 46.93 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.616 -0.326 . . . . 0.0 112.977 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.0 p -69.95 -26.17 63.99 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.76 -177.79 46.56 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.448 0.468 . . . . 0.0 113.03 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 158.77 -77.18 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.434 -0.413 . . . . 0.0 112.437 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.0 m -63.82 -35.33 80.27 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.18 -169.88 33.77 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 116.178 -0.464 . . . . 0.0 112.999 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.81 -38.56 89.53 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 113.801 0.28 . . . . 0.0 113.801 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.4 p -123.75 151.79 42.86 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.571 0.225 . . . . 0.0 111.201 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.33 -167.43 35.72 Favored Glycine 0 C--N 1.34 0.761 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.001 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.9 -56.5 1.31 Allowed Glycine 0 C--N 1.338 0.655 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.652 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.0 m -122.25 146.93 46.81 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.667 0.275 . . . . 0.0 110.976 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 139' ' ' LEU . . . -105.51 143.07 34.19 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.085 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.0 t -115.74 -1.13 12.73 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.7 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.8 p -76.81 -24.37 52.78 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.08 134.45 39.11 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.345 0.403 . . . . 0.0 110.987 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 81.3 mtm-85 -105.98 1.9 26.95 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.322 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 23' ' ' MET . 8.5 t -104.02 134.94 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.854 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.65 154.36 39.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.19 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.816 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.4 t80 -94.48 134.44 37.01 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.652 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.435 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -134.27 114.75 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.614 0.571 . . . . 0.0 109.687 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.83 146.98 18.75 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.556 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.18 23.34 6.12 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 123.881 0.4 . . . . 0.0 112.425 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.621 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -93.42 165.12 12.92 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.548 0.339 . . . . 0.0 110.262 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -81.09 151.75 28.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.044 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.58 -29.97 70.98 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.714 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.77 9.13 6.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 72' ' ' ALA . 3.5 m -90.55 136.93 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-O 120.635 0.255 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -107.79 174.72 5.75 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.626 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -61.42 -28.05 68.98 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.619 0.368 . . . . 0.0 111.617 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.5 -39.03 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.0 -47.81 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.086 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.4 -38.27 84.4 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.354 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 9.8 t60 -68.09 -49.07 63.56 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.566 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.44 -20.49 62.89 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.26 -33.62 24.0 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 120.944 0.402 . . . . 0.0 111.271 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -103.33 1.88 33.35 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.113 -0.948 . . . . 0.0 112.437 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -69.75 -31.97 2.77 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.25 -0.881 . . . . 0.0 113.339 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.6 Cg_exo -59.8 -23.3 71.6 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.861 1.707 . . . . 0.0 113.955 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.527 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 47.8 m-85 -80.04 -31.27 39.52 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.89 -168.56 41.44 Favored Glycine 0 C--N 1.339 0.696 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.804 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.18 134.06 34.99 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.468 0.307 . . . . 0.0 110.97 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.562 HG21 HD11 ' A' ' 93' ' ' ILE . 9.6 mt -113.54 140.86 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.851 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.71 -64.99 1.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.226 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -145.34 153.84 41.68 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.562 HD11 HG21 ' A' ' 90' ' ' ILE . 21.2 mm -117.84 128.73 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.438 HE22 ' HB3' ' A' ' 23' ' ' MET . 63.7 mt-30 -115.52 133.87 55.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.06 0.457 . . . . 0.0 111.875 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.62 104.19 24.35 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.584 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -58.06 96.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.471 2.114 . . . . 0.0 112.387 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tp -111.56 133.63 53.69 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -85.03 141.71 30.1 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -64.67 -34.55 78.56 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -73.05 -49.12 30.49 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.546 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 31.3 p -93.89 -28.79 15.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 49.71 30.81 3.91 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.394 0.678 . . . . 0.0 111.823 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 101' ' ' THR . 42.8 mttt -112.24 153.41 27.17 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.346 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -101.21 143.78 30.88 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.617 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -99.12 1.62 45.24 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 92.28 20.82 34.26 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 120.336 -0.935 . . . . 0.0 114.904 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.82 146.73 31.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.863 0.832 . . . . 0.0 111.458 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.66 173.02 16.72 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.66 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.448 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 76.7 m-85 -118.08 150.64 39.0 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 93' ' ' ILE . 11.0 p -119.41 136.17 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 123.47 0.481 . . . . 0.0 111.027 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 90' ' ' ILE . 0.6 OUTLIER -106.46 121.17 43.74 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.213 179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 9.1 m-85 -105.84 133.07 51.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.076 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.66 -34.73 78.89 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.794 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.81 135.9 49.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.807 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.54 -27.92 61.6 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.642 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -69.93 -40.95 75.21 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -68.59 -31.75 71.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.425 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -62.44 -45.66 92.08 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.267 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.62 -28.98 67.39 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.267 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.527 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.27 -40.25 71.07 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.27 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.9 -38.1 89.84 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.653 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.82 HD11 HD22 ' A' ' 66' ' ' LEU . 11.4 mt -71.21 -34.21 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.9 p30 -83.01 -16.77 45.84 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -100.02 -42.05 6.91 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.527 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 86.5 mtp -128.82 45.05 2.85 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.8 t-20 -63.72 -38.54 91.48 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.676 0.274 . . . . 0.0 111.238 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 39.3 mt-10 -142.09 78.13 1.61 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.729 0.776 . . . . 0.0 109.656 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.0 p -125.13 162.68 24.08 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.454 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -91.99 118.73 31.05 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.035 0.445 . . . . 0.0 110.717 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -128.29 130.78 48.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.675 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.36 15.02 8.36 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.25 5.28 59.4 Favored Glycine 0 C--N 1.343 0.942 0 CA-C-N 116.164 -0.471 . . . . 0.0 113.344 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.5 mtp85 -127.86 156.87 41.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.56 0.344 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.94 134.1 35.08 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.0 pt -120.23 154.85 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 123.37 0.419 . . . . 0.0 112.075 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.616 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 52.9 mtt180 -125.83 134.68 51.58 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.466 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.816 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.8 134.02 62.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.044 0.45 . . . . 0.0 110.834 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 13.4 p-10 -151.14 171.47 17.32 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.498 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 60' ' ' ALA . 14.3 mt -71.06 130.72 42.25 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.533 0.206 . . . . 0.0 111.168 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.536 ' HB1' HG21 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.159 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 111.305 0.113 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.0 mtp -99.09 122.7 42.67 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.343 0.402 . . . . 0.0 110.833 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 97.4 mmm -90.72 -40.33 11.91 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.595 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -124.56 153.48 42.07 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.487 0.492 . . . . 0.0 111.025 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.9 t -126.34 131.44 51.81 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.656 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.77 -108.11 0.72 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.636 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -93.78 149.0 21.6 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 122.467 0.307 . . . . 0.0 111.19 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -124.46 131.46 53.5 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.648 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -87.01 133.12 33.61 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.525 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.4 mtt-85 -125.88 151.28 47.1 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.579 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -94.12 111.44 23.16 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.435 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.9 t -129.74 145.66 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.562 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -57.15 -38.1 73.05 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 m -64.63 -37.2 86.77 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -64.3 -29.9 70.97 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.2 m -58.4 -39.06 78.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -108.87 123.69 49.46 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -133.26 124.74 27.89 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.068 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.7 tp -109.71 140.54 43.46 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.88 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 m -62.81 153.54 32.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.735 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -61.57 -38.16 86.47 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.72 -42.51 70.49 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.494 ' O ' HD12 ' A' ' 27' ' ' LEU . 78.1 mmm -64.69 -38.45 91.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -68.82 -46.52 68.4 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.948 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -71.64 -43.77 65.54 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.8 mt -66.84 -45.83 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 23' ' ' MET . 10.6 mt -69.3 -40.46 77.67 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.4 m -74.46 -36.29 63.34 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.661 0.267 . . . . 0.0 111.186 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -115.0 90.65 3.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.436 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 mt -104.18 113.8 64.91 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.651 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.31 126.16 12.03 Favored 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.737 2.292 . . . . 0.0 111.391 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -45.29 -35.3 3.36 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.006 0.922 . . . . 0.0 113.449 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.1 m -85.62 -43.7 13.23 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.01 -32.94 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 122.363 0.265 . . . . 0.0 111.349 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.94 -30.27 70.36 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -159.73 143.68 14.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.761 0.315 . . . . 0.0 111.494 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.7 p -115.19 34.06 5.08 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 86.8 m -78.11 167.88 20.74 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.761 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -122.18 151.86 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.694 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -57.4 -32.02 66.42 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 43' ' ' GLU . 35.1 t -89.63 123.9 34.1 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.279 0.362 . . . . 0.0 111.418 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.7 p -96.66 2.83 52.55 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.662 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.407 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 45.7 mt-10 -65.94 -30.3 70.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.045 0.538 . . . . 0.0 112.429 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -105.23 134.48 48.27 Favored 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.402 0.439 . . . . 0.0 110.847 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -98.31 -6.94 29.91 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.823 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.3 t -106.93 134.55 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -98.86 152.8 19.34 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.28 -130.45 3.9 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.784 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.12 -179.47 47.08 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.577 -0.345 . . . . 0.0 113.144 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.2 p -126.63 154.62 43.76 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.325 0.25 . . . . 0.0 111.07 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.37 -177.23 47.24 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.978 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -126.82 -115.06 1.93 Allowed Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.525 -0.369 . . . . 0.0 112.486 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.7 p -116.94 151.14 37.3 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.279 0.232 . . . . 0.0 111.038 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -109.67 -126.75 5.26 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.486 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.37 -35.42 91.43 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 113.784 0.274 . . . . 0.0 113.784 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.5 p -119.19 151.92 37.5 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 122.365 0.266 . . . . 0.0 111.017 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.46 -174.35 41.97 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.746 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.03 -177.15 40.7 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.467 -0.396 . . . . 0.0 112.716 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.8 p -126.94 153.56 45.66 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.624 0.249 . . . . 0.0 111.157 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.61 145.02 30.66 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.969 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.94 -49.35 7.43 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.299 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.9 p -125.72 156.51 39.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 115' ' ' ALA . 89.2 mttt -110.09 112.28 24.17 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.768 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -141.18 -27.98 0.68 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.1 t -106.4 128.67 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.539 0.209 . . . . 0.0 110.575 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.747 HD22 HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -124.14 159.73 29.38 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.66 179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.755 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.7 OUTLIER -112.66 117.4 32.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.952 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -108.71 115.32 49.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.804 178.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -127.86 148.8 17.83 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.027 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.8 41.27 3.15 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.706 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -91.33 159.82 15.81 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.118 0.485 . . . . 0.0 111.106 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.617 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -82.16 174.54 11.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.358 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -69.03 -32.51 72.07 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 122.841 0.456 . . . . 0.0 111.519 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -98.83 63.26 1.38 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.405 0.621 . . . . 0.0 111.527 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 71' ' ' LEU . 12.2 p -139.05 137.59 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.705 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.841 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.0 m-20 -140.94 -175.9 4.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.486 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -64.76 -37.06 86.32 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.85 0.46 . . . . 0.0 112.203 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -66.25 -43.52 86.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 122.982 0.513 . . . . 0.0 112.186 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.841 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 16.8 m -73.34 -39.53 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 123.322 0.389 . . . . 0.0 111.769 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.67 -35.75 82.04 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.533 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 6.8 t60 -68.31 -46.2 70.91 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.123 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.517 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.12 -20.73 63.16 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.91 -35.12 22.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.899 0.38 . . . . 0.0 111.233 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' C ' HD11 ' A' ' 90' ' ' ILE . 56.7 m-85 -97.38 -0.9 45.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.021 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.519 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.1 tp -70.39 -31.67 2.35 Favored Pre-proline 0 CA--C 1.565 1.548 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 40.4 Cg_exo -59.73 -24.14 74.52 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 121.917 1.744 . . . . 0.0 113.798 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -78.05 -31.28 50.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.89 -159.14 32.13 Favored Glycine 0 C--N 1.341 0.858 0 O-C-N 123.458 0.474 . . . . 0.0 112.612 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -85.94 137.91 32.39 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 122.636 0.374 . . . . 0.0 111.456 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 5.4 mt -118.4 144.33 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.809 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 1.4 p -91.2 -67.33 0.86 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.896 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -148.63 158.04 43.87 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' HG23 ' A' ' 110' ' ' VAL . 10.8 mm -116.94 129.4 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -126.61 127.02 44.57 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.2 mp -127.83 118.1 20.99 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.795 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.54 126.11 20.35 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.304 2.003 . . . . 0.0 112.642 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -128.02 134.67 49.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.086 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -89.55 143.38 26.86 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.278 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -64.58 -34.65 78.75 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.11 -48.71 41.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.8 p -94.72 -28.33 15.36 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 55.35 24.7 6.81 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.21 0.604 . . . . 0.0 111.513 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -120.31 156.83 30.48 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.1 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -92.77 158.58 15.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.973 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -88.52 0.54 56.21 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.017 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.451 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.85 19.46 29.05 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-O 119.453 -0.637 . . . . 0.0 114.305 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 55.1 p90 -144.55 151.15 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.464 0.632 . . . . 0.0 111.191 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -151.44 164.73 36.1 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.954 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -115.31 138.64 50.75 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.436 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.2 p -118.32 133.78 64.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.93 0.395 . . . . 0.0 111.393 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.436 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 1.1 mm-40 -109.0 137.62 46.64 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.9 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.417 ' CE2' HG12 ' A' ' 90' ' ' ILE . 82.6 m-85 -117.65 147.32 43.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.21 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -65.87 -39.52 90.78 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.07 141.74 39.31 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.705 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -69.23 -22.13 63.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.071 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.76 -42.17 95.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.177 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.96 -33.05 71.59 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.586 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -61.73 -45.74 92.65 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.207 0.317 . . . . 0.0 111.028 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.51 -28.9 64.22 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.12 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.63 -45.24 59.98 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.426 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.26 90.17 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.747 HD11 HD22 ' A' ' 66' ' ' LEU . 46.8 mt -70.65 -39.98 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -74.67 -28.3 60.79 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.8 -49.7 10.09 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 85.4 mtp -135.24 61.33 1.67 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.091 0.472 . . . . 0.0 111.993 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 11.3 t-20 -69.21 -41.68 76.77 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.482 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.6 mt-10 -140.61 79.18 1.69 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.678 0.751 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 p -126.68 164.57 21.0 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.366 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -87.15 116.14 25.03 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.02 0.438 . . . . 0.0 110.513 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.8 tp -133.31 130.49 38.97 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.136 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 64.92 17.05 10.87 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.089 0.955 . . . . 0.0 112.168 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.55 -0.19 61.24 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.735 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -128.97 156.8 43.2 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.353 0.261 . . . . 0.0 111.099 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -77.97 128.69 34.29 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 3.0 pt -112.58 148.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.172 0.511 . . . . 0.0 112.158 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.579 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 13.0 ttp180 -121.77 128.95 52.29 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.541 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -127.74 133.18 68.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 110.342 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -157.16 170.87 21.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.828 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.3 tt -71.87 130.88 42.1 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.696 0.284 . . . . 0.0 111.073 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.165 -179.758 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.611 0.243 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.2 mtp -101.15 137.18 39.85 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.801 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.1 mtt -95.93 129.4 43.19 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.036 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -69.51 -35.5 75.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.919 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.8 t -111.5 139.24 47.09 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.167 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.52 120.87 3.36 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.332 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -97.76 129.9 44.75 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.27 0.228 . . . . 0.0 110.924 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.6 t -133.67 131.13 39.15 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.84 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -93.55 129.42 39.8 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.924 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -67.88 -37.67 82.06 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.187 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -116.67 151.35 36.5 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.506 0.504 . . . . 0.0 111.079 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 m -123.87 153.32 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.293 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -64.99 -31.59 72.91 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 m -65.27 -38.34 90.0 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -69.97 -43.29 71.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -84.4 -42.15 15.98 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -108.15 151.81 25.4 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.338 0.399 . . . . 0.0 111.108 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -104.63 140.44 38.01 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.932 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 tp -97.53 148.59 23.09 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.355 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.5 p -67.32 157.28 34.34 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.005 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -64.97 -36.16 83.51 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.42 ' OE2' HG23 ' A' ' 65' ' ' VAL . 29.6 tt0 -67.81 -47.38 69.21 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.548 0.339 . . . . 0.0 111.539 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.472 ' O ' HD12 ' A' ' 27' ' ' LEU . 90.8 mmm -68.71 -36.94 79.09 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -66.95 -44.18 81.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.006 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -69.01 -39.31 79.37 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 38.3 mt -70.01 -47.66 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.208 0.203 . . . . 0.0 111.269 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 23' ' ' MET . 6.9 mt -69.77 -37.23 76.32 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.3 p -76.22 -27.48 56.82 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -111.44 80.61 1.33 Allowed 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.325 0.584 . . . . 0.0 110.117 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 5.4 mt -95.71 158.95 33.53 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.397 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.583 ' O ' HG13 ' A' ' 34' ' ' VAL . 6.3 Cg_exo -79.92 162.18 23.76 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.892 2.395 . . . . 0.0 113.264 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.47 -25.04 66.98 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.033 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.2 p -84.14 24.2 0.97 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.066 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -56.01 -12.21 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.65 -43.92 71.62 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 54.42 24.98 5.62 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.908 0.883 . . . . 0.0 112.913 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.7 t -126.59 33.05 5.05 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 120.942 0.401 . . . . 0.0 111.548 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.9 p -127.19 151.96 48.0 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.98 142.16 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.719 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -68.85 -37.86 79.39 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.045 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.517 ' SG ' ' HB ' ' A' ' 46' ' ' VAL . 35.9 t -126.99 131.15 51.1 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 123.363 0.415 . . . . 0.0 111.044 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.8 p -92.61 -10.17 38.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.277 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -110.82 140.18 45.48 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.163 0.289 . . . . 0.0 111.223 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 mtp-105 -72.68 -32.83 66.1 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.211 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -72.86 -20.89 61.03 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.517 ' HB ' ' SG ' ' A' ' 41' ' ' CYS . 12.0 t -103.61 131.48 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -98.36 144.92 27.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.078 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -142.93 166.84 26.51 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.46 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.93 48.0 5.97 Favored Glycine 0 C--N 1.342 0.88 0 C-N-CA 121.611 -0.328 . . . . 0.0 113.083 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.6 m -115.45 149.86 37.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 122.343 0.257 . . . . 0.0 111.138 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.17 38.32 7.34 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.822 -0.627 . . . . 0.0 113.262 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.54 175.13 43.8 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 121.473 -0.394 . . . . 0.0 113.039 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.1 t -135.21 149.15 49.84 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.328 0.251 . . . . 0.0 110.923 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.57 67.22 0.85 Allowed Glycine 0 C--N 1.337 0.621 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.922 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.26 -55.4 2.49 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.536 -0.364 . . . . 0.0 112.398 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.4 t -70.43 -35.47 73.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.867 0.467 . . . . 0.0 111.683 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.01 -173.62 40.25 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.454 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -135.13 -149.59 5.88 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.43 -0.415 . . . . 0.0 112.421 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.6 p -66.65 -25.29 66.51 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.74 138.89 37.19 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.64 -61.24 1.54 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.8 p -145.91 119.55 9.16 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.983 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mttt -130.88 137.5 49.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.14 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 62.8 mtt180 -71.92 -24.48 61.64 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.576 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.42 HG23 ' OE2' ' A' ' 22' ' ' GLU . 4.5 t -95.66 129.31 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.769 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.02 154.52 39.75 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.524 0.515 . . . . 0.0 110.818 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.741 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.5 t80 -98.97 122.45 42.25 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.929 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.698 HG12 HG12 ' A' ' 137' ' ' VAL . 2.9 m -117.54 116.9 53.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.965 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.54 151.09 18.8 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.876 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.45 32.26 5.24 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.739 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -91.56 165.45 13.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.996 0.427 . . . . 0.0 111.173 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.715 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -88.59 161.84 16.69 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.412 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.15 -31.45 70.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -81.59 3.02 26.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.036 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 71' ' ' LEU . 2.3 p -86.42 138.23 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 120.542 0.211 . . . . 0.0 110.923 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -124.83 176.38 6.65 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.354 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -61.36 -31.87 71.76 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.196 0.598 . . . . 0.0 112.079 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -67.74 -40.91 84.1 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.57 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -68.33 -42.3 84.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.024 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.4 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.2 tt -68.41 -37.79 80.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.396 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.2 t60 -68.48 -48.59 64.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.329 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.506 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.7 -20.52 62.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -35.38 23.06 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.851 0.358 . . . . 0.0 111.298 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.437 ' C ' HD11 ' A' ' 90' ' ' ILE . 71.2 m-85 -97.83 -2.26 41.31 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -68.28 -31.11 2.95 Favored Pre-proline 0 CA--C 1.567 1.599 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.57 -24.12 60.32 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 121.922 1.748 . . . . 0.0 113.691 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.69 -31.2 46.48 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.367 0.417 . . . . 0.0 111.692 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.96 33.8 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.262 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.23 134.23 34.74 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.545 0.212 . . . . 0.0 111.052 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 93' ' ' ILE . 5.4 mt -109.87 141.99 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.855 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -89.21 -64.29 1.16 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.673 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -145.75 153.44 40.95 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 90' ' ' ILE . 14.2 mm -119.42 123.69 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -123.46 129.34 51.1 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 107' ' ' PHE . 0.9 OUTLIER -128.0 124.1 23.0 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.724 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.7 119.95 7.46 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.111 1.874 . . . . 0.0 112.191 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.57 135.66 50.62 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.362 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.18 144.31 25.9 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.312 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -64.81 -34.32 78.08 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.54 -46.82 62.86 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.2 p -101.43 -27.66 13.01 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 56.07 25.45 8.93 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.25 0.62 . . . . 0.0 111.709 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -121.87 154.99 36.35 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.648 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -106.78 164.39 12.14 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.415 0.447 . . . . 0.0 110.915 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -88.02 -1.49 58.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 100.3 25.87 8.59 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-O 119.479 -0.623 . . . . 0.0 114.57 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 95' ' ' ILE . 28.9 p90 -145.07 147.11 32.2 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.445 0.622 . . . . 0.0 111.108 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -149.91 167.31 27.0 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.264 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.473 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 75.9 m-85 -111.65 137.49 49.47 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.476 HG23 ' CD1' ' A' ' 93' ' ' ILE . 7.1 p -112.55 132.09 62.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 O-C-N 123.243 0.34 . . . . 0.0 110.573 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 90' ' ' ILE . 2.9 tt0 -103.81 130.73 51.39 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.762 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 52.3 m-85 -117.12 146.99 42.81 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.139 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -73.66 -36.07 65.32 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.04 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.577 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -105.72 141.05 37.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.503 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.55 -19.99 58.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.559 0.695 . . . . 0.0 109.162 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -71.92 -49.96 33.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.431 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.577 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.7 p30 -69.49 -32.32 71.13 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.769 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.1 -45.52 84.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.795 0.438 . . . . 0.0 111.135 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.02 -29.39 69.74 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.049 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.61 -34.4 72.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.143 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.18 -39.03 82.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.743 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.695 HD11 HD22 ' A' ' 66' ' ' LEU . 14.2 mt -70.48 -34.12 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.271 0.357 . . . . 0.0 111.473 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.96 -16.84 49.07 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -101.52 -43.71 5.82 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 61.8 mtt -124.79 44.48 2.76 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.3 t30 -63.22 -37.95 89.24 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.618 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.3 mt-10 -142.85 77.57 1.58 Allowed 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.667 0.746 . . . . 0.0 109.809 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.6 p -123.09 165.03 17.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.301 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -91.99 120.38 32.58 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.624 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -125.54 129.13 49.11 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.098 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 56.56 20.45 4.91 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.905 0.882 . . . . 0.0 112.814 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.67 3.85 59.39 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.848 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -126.9 153.2 46.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.86 0.33 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.2 m -78.57 132.28 37.09 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -119.54 156.46 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 14.1 ptt-85 -129.39 136.13 49.58 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.001 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -127.17 140.73 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.898 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 14.9 p-10 -150.78 171.63 16.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.805 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.4 mt -69.34 133.2 47.55 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.529 0.332 . . . . 0.0 111.146 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.137 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.095 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 111.319 0.118 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.5 mtp -99.21 132.0 44.83 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.365 0.416 . . . . 0.0 110.837 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.8 mtp -68.8 -37.27 79.15 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.253 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -118.59 148.43 42.69 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.395 0.435 . . . . 0.0 111.164 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.2 t -130.31 133.53 46.52 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.498 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.28 -112.16 0.45 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.948 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -92.73 152.42 19.51 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 122.57 0.348 . . . . 0.0 111.316 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.4 t -122.25 131.04 53.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.61 150.08 20.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.21 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -119.51 141.2 49.41 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.646 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -70.47 -38.63 74.46 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -100.86 86.61 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.16 0.505 . . . . 0.0 111.454 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -66.35 -40.66 89.95 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.662 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 m -63.56 -38.68 92.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -69.03 -35.99 77.24 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.476 0.546 . . . . 0.0 112.476 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.2 m -85.7 -40.29 16.29 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -100.45 146.21 27.32 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.278 0.361 . . . . 0.0 111.186 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -110.17 150.57 28.44 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.922 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 tp -95.31 142.81 27.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.4 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.3 p -70.69 159.28 34.74 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.779 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -62.73 -35.05 78.49 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -68.12 -46.48 70.78 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.324 0.39 . . . . 0.0 111.824 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.534 ' O ' HD12 ' A' ' 27' ' ' LEU . 91.1 mmm -67.39 -39.13 85.58 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -63.67 -42.05 98.1 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.69 0.396 . . . . 0.0 111.772 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -70.44 -38.66 74.57 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.3 mt -68.2 -45.78 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 122.162 0.185 . . . . 0.0 111.169 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 23' ' ' MET . 5.4 mt -69.45 -40.96 76.87 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.0 p -76.58 -29.98 56.81 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.268 0.355 . . . . 0.0 111.812 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -123.33 88.88 3.0 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.472 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.687 HD13 ' HB2' ' A' ' 35' ' ' ALA . 2.0 pp -123.12 152.76 64.06 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.109 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.39 125.8 9.9 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.495 2.13 . . . . 0.0 111.824 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -50.93 -32.91 22.23 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.596 ' O ' ' HB ' ' A' ' 37' ' ' THR . 80.9 p -82.61 -41.73 19.13 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.314 0.384 . . . . 0.0 111.89 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.94 -27.0 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.595 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' HD13 ' A' ' 30' ' ' LEU . . . -67.28 -31.43 71.74 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.753 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -166.32 -47.13 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.596 ' HB ' ' O ' ' A' ' 33' ' ' SER . 10.9 t 47.73 24.23 0.53 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.49 1.116 . . . . 0.0 113.704 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.5 m -96.18 -42.14 8.35 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.573 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.25 133.28 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 123.374 0.421 . . . . 0.0 110.099 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -113.58 130.21 56.41 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.135 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 36.5 t -120.73 116.45 25.29 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.013 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 p -97.17 -18.17 19.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.626 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -68.67 -33.08 73.38 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.933 0.493 . . . . 0.0 112.207 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -119.0 138.15 53.02 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.764 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -130.52 152.01 50.37 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.79 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -128.9 139.66 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.77 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -96.22 131.28 42.86 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.599 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.87 8.56 55.5 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.4 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -88.41 1.62 84.33 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 121.592 -0.337 . . . . 0.0 113.318 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -122.16 142.01 50.85 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.45 0.3 . . . . 0.0 110.675 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.1 -173.74 42.02 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.568 0.543 . . . . 0.0 112.767 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.58 129.39 6.65 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.588 -0.339 . . . . 0.0 112.431 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -64.21 -36.73 85.01 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.56 3.96 64.28 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.509 0.505 . . . . 0.0 113.342 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.94 -40.81 62.72 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 113.687 0.235 . . . . 0.0 113.687 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.6 p -126.13 152.58 45.73 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.574 0.226 . . . . 0.0 111.21 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.54 -172.87 45.53 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.676 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.64 -93.32 1.04 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.459 -0.401 . . . . 0.0 112.727 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.5 t -115.71 145.37 42.82 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.598 0.237 . . . . 0.0 111.071 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' O ' HD13 ' A' ' 139' ' ' LEU . . . -101.96 146.24 28.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.002 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.1 p -124.54 157.66 34.82 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.463 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p 48.06 38.57 9.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.284 1.034 . . . . 0.0 113.202 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HG3' ' HB1' ' A' ' 60' ' ' ALA . 70.5 mmtt -101.78 137.23 40.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.999 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 50.9 mtm180 -104.75 -2.47 24.84 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.632 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 t -109.9 132.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.15 152.56 41.05 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.578 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.3 t80 -100.68 116.33 32.34 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.583 178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 m -114.33 117.7 56.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.976 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.05 153.08 19.91 Favored Glycine 0 C--N 1.336 0.571 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.074 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.91 26.06 5.94 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.9 0.412 . . . . 0.0 112.502 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -94.27 163.47 13.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.955 0.407 . . . . 0.0 110.54 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -91.0 157.35 17.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.902 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.558 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 45.7 mt-10 -63.66 -26.9 68.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.64 0.376 . . . . 0.0 111.744 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -74.7 -4.05 35.06 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.801 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.0 m -86.71 141.1 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.671 0.272 . . . . 0.0 110.855 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.519 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -122.08 179.1 4.64 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.622 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -59.87 -30.44 68.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.845 0.458 . . . . 0.0 111.669 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.57 -40.91 80.37 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.721 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.519 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.1 t -66.66 -46.74 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.292 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD22 HD12 ' A' ' 93' ' ' ILE . 2.2 tt -67.02 -39.38 87.04 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.594 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.521 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 25.6 t-80 -68.01 -48.42 65.77 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.78 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.485 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.6 62.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.16 -32.7 24.48 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.98 0.419 . . . . 0.0 111.268 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.453 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -103.78 1.76 32.03 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.416 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -70.23 -33.12 3.14 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 19.8 Cg_endo -59.7 -23.5 71.93 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.867 1.711 . . . . 0.0 114.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -80.76 -31.26 35.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.84 -170.28 43.18 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.773 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -84.01 133.55 34.67 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.53 0.332 . . . . 0.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.505 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 6.9 mt -113.0 139.4 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.854 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -90.19 -62.59 1.43 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.174 -179.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.5 155.21 42.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.491 HD12 HD22 ' A' ' 80' ' ' LEU . 20.6 mm -116.64 124.98 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -120.13 126.23 50.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.88 117.45 20.8 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.961 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.68 126.64 21.85 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.313 2.009 . . . . 0.0 112.519 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -125.36 134.36 52.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.143 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.13 142.25 27.9 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.22 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -64.64 -33.46 75.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -71.05 -48.28 53.69 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.7 p -98.69 -27.75 13.84 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.445 ' O ' HD11 ' A' ' 97' ' ' LEU . 47.0 mt-10 57.92 22.59 8.89 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.178 0.591 . . . . 0.0 111.506 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -123.07 156.34 35.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.212 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.558 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 13.5 p80 -99.89 160.15 14.53 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.431 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 24.2 mtp180 -88.5 0.08 56.67 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 98.95 29.3 7.32 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.15 -0.548 . . . . 0.0 114.269 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 36.5 p90 -145.09 145.47 31.44 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.155 0.477 . . . . 0.0 111.028 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.14 165.91 34.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.105 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -111.96 143.5 42.85 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 93' ' ' ILE . 13.0 p -116.78 135.94 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.821 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.1 OUTLIER -107.62 125.77 51.75 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.86 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 28.4 m-85 -111.12 136.08 50.7 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -64.66 -36.58 84.73 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.664 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.26 132.51 52.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.58 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.68 -24.54 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.206 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.74 -44.57 81.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.808 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -68.89 -32.7 72.53 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.397 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.41 -48.51 81.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.375 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.56 69.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.207 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.564 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -71.66 -37.41 70.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.299 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.86 -38.39 88.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.828 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.69 HD11 HD22 ' A' ' 66' ' ' LEU . 14.3 mt -70.4 -38.91 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.564 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.6 p30 -76.34 -25.88 55.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -82.36 -50.05 9.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 63.5 mtt -132.73 58.97 1.74 Allowed 'General case' 0 C--N 1.347 0.482 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.633 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.6 t30 -67.36 -37.82 83.81 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 33.9 mt-10 -140.7 79.48 1.7 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.915 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.2 t -122.15 160.97 24.01 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.187 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -90.77 118.24 30.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.615 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -129.35 129.78 45.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.993 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 62.54 15.31 7.79 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.671 0.788 . . . . 0.0 112.389 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.83 3.95 59.13 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.222 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -126.02 154.22 43.27 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.533 0.333 . . . . 0.0 110.826 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.15 133.74 35.02 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -117.81 152.91 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 1.8 tpt180 -125.54 131.43 52.77 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.237 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -126.95 135.68 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 O-C-N 123.196 0.31 . . . . 0.0 110.319 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -147.24 171.75 14.9 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.368 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HG ' HD13 ' A' ' 122' ' ' ILE . 8.5 mt -72.61 129.67 38.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.227 0.211 . . . . 0.0 110.894 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.282 -179.605 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.442 0.163 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 86.0 mtp -104.38 137.15 42.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.83 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.4 mtt -120.99 156.34 32.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -103.18 152.28 21.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.1 t -119.9 134.16 55.33 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.92 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.65 -30.07 12.46 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.855 -0.612 . . . . 0.0 113.468 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -94.32 134.93 36.29 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.603 0.239 . . . . 0.0 111.212 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -133.37 134.24 43.48 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.69 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -91.33 117.96 30.1 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -71.87 -41.74 67.69 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -125.72 137.11 53.81 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.188 0.305 . . . . 0.0 111.804 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.5 t -126.97 131.72 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.336 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -65.84 -41.64 91.51 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 m -65.25 -38.61 90.89 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.3 -35.34 80.13 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.9 m -75.89 -41.85 50.89 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.62 -39.07 70.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -131.93 151.98 51.37 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.316 0.385 . . . . 0.0 111.252 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -93.21 161.62 14.34 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.701 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.652 ' H ' HD23 ' A' ' 19' ' ' LEU . 99.9 p -65.19 158.93 24.75 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.87 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.04 -33.7 76.34 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.09 -46.06 75.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.576 ' HB2' HD22 ' A' ' 19' ' ' LEU . 23.8 mtt -73.66 -38.12 65.05 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -68.31 -45.66 72.38 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -71.31 -42.7 68.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.511 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 56.7 mt -70.34 -48.57 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 23' ' ' MET . 9.5 mt -68.95 -41.49 77.97 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 m -73.1 -34.88 66.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.551 0.215 . . . . 0.0 111.256 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -116.26 91.42 3.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.79 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 7.2 mt -109.55 107.14 59.25 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.752 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.74 129.62 19.05 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 123.022 2.481 . . . . 0.0 111.336 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -44.36 -33.55 1.68 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m -93.56 -40.62 10.2 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.64 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 54.4 t -68.15 -30.12 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.84 71.9 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.53 125.32 11.19 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.232 0.332 . . . . 0.0 110.819 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 54.65 100.54 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.946 0.898 . . . . 0.0 112.198 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.64 ' SG ' ' HA ' ' A' ' 34' ' ' VAL . 83.6 m -105.84 -49.05 3.48 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.344 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.9 t -124.9 136.22 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 123.44 0.462 . . . . 0.0 110.175 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -118.36 137.88 52.8 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.964 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.1 t -129.5 130.73 46.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.954 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.8 p -79.46 -27.57 41.59 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.987 -0.552 . . . . 0.0 112.409 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -111.74 153.22 26.81 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.297 0.373 . . . . 0.0 111.078 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -120.48 149.11 42.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.771 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -111.28 137.28 49.21 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.904 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -129.68 143.52 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.586 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -87.05 121.28 29.3 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.684 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.79 -114.42 2.77 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.503 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.25 48.22 1.57 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.563 -0.351 . . . . 0.0 112.874 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 m -63.48 -36.64 84.43 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.64 -23.34 36.36 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 123.498 0.499 . . . . 0.0 113.232 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 160.48 -134.75 3.74 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.618 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.7 m -117.42 150.48 38.82 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.438 0.295 . . . . 0.0 110.899 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.94 -169.97 46.6 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.773 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.32 -32.23 67.61 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 113.664 0.226 . . . . 0.0 113.664 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.3 p -115.32 150.64 35.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.401 0.281 . . . . 0.0 110.74 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.8 172.99 24.23 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.768 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -119.52 105.41 1.13 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.417 -0.421 . . . . 0.0 112.65 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.6 m -123.08 144.06 49.56 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.306 0.242 . . . . 0.0 110.793 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.42 140.13 44.96 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.237 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.0 p -130.65 158.23 40.6 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.563 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.6 p 56.46 -0.71 0.05 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -102.66 122.75 45.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.71 0.291 . . . . 0.0 110.945 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.0 mtt85 -122.36 -1.02 9.2 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.359 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.69 HG22 ' HG2' ' A' ' 111' ' ' GLU . 14.4 t -103.49 129.42 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.973 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.92 157.81 33.42 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.501 0.501 . . . . 0.0 111.324 -179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.795 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 37.0 t80 -99.6 136.21 39.87 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.321 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -134.42 115.33 19.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 O-C-N 123.546 0.529 . . . . 0.0 109.927 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.95 149.28 19.12 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.631 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.83 19.22 9.29 Favored Glycine 0 C--N 1.331 0.298 0 O-C-N 123.914 0.42 . . . . 0.0 112.271 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.62 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -90.94 166.24 13.15 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 122.604 0.361 . . . . 0.0 110.438 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.482 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -90.7 156.97 17.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -65.44 -27.52 68.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.36 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.1 -4.75 40.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.849 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.3 m -82.52 138.12 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 120.606 0.241 . . . . 0.0 110.664 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 77.3 m-20 -119.01 178.9 4.32 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.802 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 22.9 m-20 -59.19 -30.93 68.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.904 0.482 . . . . 0.0 111.64 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -68.56 -40.51 80.57 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.764 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.513 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.2 t -67.32 -47.33 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.522 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.477 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.5 tt -68.14 -39.74 82.61 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.714 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.547 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 21.3 t-80 -68.32 -47.76 66.68 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.608 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.46 -20.62 62.87 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.11 -33.19 24.39 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.912 0.387 . . . . 0.0 111.156 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.477 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 78.6 m-85 -102.31 0.79 34.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.381 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.6 tp -69.95 -32.75 3.08 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 14.9 Cg_endo -58.48 -23.23 63.21 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 121.941 1.761 . . . . 0.0 113.931 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -78.85 -31.17 45.57 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 123.345 0.403 . . . . 0.0 112.085 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.75 -163.74 37.45 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.898 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -82.9 135.27 34.97 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.775 0.43 . . . . 0.0 111.823 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.547 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 7.2 mt -116.85 140.34 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.389 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 9.1 p -88.47 -64.23 1.18 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.85 157.04 43.55 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.473 ' CD1' HG23 ' A' ' 110' ' ' VAL . 12.7 mm -119.38 128.75 75.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.428 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.458 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 65.4 mt-30 -114.96 131.81 56.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.692 0.282 . . . . 0.0 111.683 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.431 HG23 ' CD2' ' A' ' 104' ' ' HIS . 4.1 mp -126.6 102.75 25.55 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.824 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.36 121.42 9.87 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.533 2.156 . . . . 0.0 112.546 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 tp -129.52 134.9 48.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.939 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -87.74 140.83 29.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -64.42 -34.31 77.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.14 -48.75 32.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.892 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.559 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.4 p -93.03 -29.22 15.93 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 50.65 32.27 6.69 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.247 0.619 . . . . 0.0 111.018 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 101' ' ' THR . 51.6 mttt -118.03 154.82 31.38 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.359 -178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.431 ' CD2' HG23 ' A' ' 95' ' ' ILE . 12.3 t-80 -97.32 142.45 29.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.594 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -93.95 -1.68 54.28 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.46 20.42 38.01 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 120.393 -0.908 . . . . 0.0 114.669 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -145.6 148.1 32.76 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.708 0.754 . . . . 0.0 111.192 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -157.49 172.78 17.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.857 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -117.94 149.32 41.1 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.3 p -125.89 136.46 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 123.257 0.348 . . . . 0.0 111.214 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.69 ' HG2' HG22 ' A' ' 65' ' ' VAL . 1.1 tm-20 -109.9 130.0 55.58 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.082 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 15.9 m-85 -109.42 143.2 39.31 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.974 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.26 -37.07 82.88 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.376 0.422 . . . . 0.0 110.624 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.575 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -105.7 141.44 37.15 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.898 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.01 56.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.763 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -72.25 -48.61 41.4 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.347 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 23.2 p30 -66.58 -32.36 73.66 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.974 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.973 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.88 -43.48 83.38 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.49 0.494 . . . . 0.0 111.131 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.96 -28.89 69.83 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.352 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.85 -36.43 75.53 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.13 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.98 86.35 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.781 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.712 HD11 HD22 ' A' ' 66' ' ' LEU . 35.4 mt -70.71 -33.49 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.63 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 -32.75 69.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -104.32 -35.68 7.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.488 ' O ' HG13 ' A' ' 137' ' ' VAL . 77.8 mtp -103.37 14.83 30.61 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.619 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.1 t-20 -57.2 -36.69 71.15 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.691 0.281 . . . . 0.0 111.253 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.9 74.25 1.44 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.742 0.782 . . . . 0.0 109.765 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.3 p -124.09 161.25 25.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.333 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -94.31 120.59 34.78 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -128.35 128.8 45.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.808 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.22 15.82 7.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.728 0.811 . . . . 0.0 112.364 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.06 5.27 58.37 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 116.263 -0.426 . . . . 0.0 113.475 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.5 mtp85 -127.22 154.81 44.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.427 0.291 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -81.12 132.97 35.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.1 pt -119.41 154.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 55.5 mtt85 -123.04 133.58 54.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.186 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.99 136.08 59.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.531 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -149.82 171.86 16.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.74 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.459 ' HG ' HD13 ' A' ' 122' ' ' ILE . 11.6 mt -71.98 128.85 37.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.606 0.241 . . . . 0.0 110.898 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.421 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.309 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 111.286 0.106 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 86.8 mtp -106.42 136.97 45.25 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.43 0.456 . . . . 0.0 110.71 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.9 mtt -111.8 142.56 44.02 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.57 -34.12 77.2 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.4 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.5 t -108.35 131.94 54.24 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.384 0.427 . . . . 0.0 111.062 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.55 -41.27 2.76 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 123.735 0.647 . . . . 0.0 112.953 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -92.62 151.02 20.35 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 122.458 0.303 . . . . 0.0 111.198 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.0 t -101.78 141.41 34.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.932 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -89.67 7.7 35.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.172 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -118.87 141.3 48.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.618 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -131.26 -1.88 3.97 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.992 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.07 141.56 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -65.62 -28.44 69.12 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.979 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 m -58.1 -37.01 73.72 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.61 -36.9 83.71 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.0 m -86.5 -44.03 12.28 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.301 0.375 . . . . 0.0 112.005 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -115.01 142.36 46.74 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.395 0.435 . . . . 0.0 110.7 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -79.34 -44.05 22.33 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.149 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 tp -133.37 150.45 51.83 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.328 0.393 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.2 p -80.6 160.55 25.07 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.249 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.93 -39.45 92.12 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.11 -40.87 78.07 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.588 ' SD ' ' HG3' ' A' ' 111' ' ' GLU . 10.1 mtt -67.68 -39.04 84.5 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -65.33 -42.01 93.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.612 0.365 . . . . 0.0 111.687 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.81 -47.72 57.98 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 24.3 mt -67.59 -45.4 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 23' ' ' MET . 6.7 mt -68.88 -33.86 74.48 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.0 p -69.35 -35.9 76.33 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -131.65 101.45 5.49 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 123.363 0.414 . . . . 0.0 111.026 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 4.6 mt -114.69 124.75 30.03 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.149 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.04 128.51 17.78 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.427 2.084 . . . . 0.0 111.561 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -46.14 -34.4 4.23 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.9 p -89.24 -41.11 12.39 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.4 t -68.35 -32.62 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.248 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.09 69.5 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -156.92 130.34 8.03 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.208 0.318 . . . . 0.0 111.348 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.0 p -128.44 157.64 40.53 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.8 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 94.2 m -92.76 -50.9 5.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.308 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.45 133.27 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -116.24 -50.72 2.64 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.189 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.6 t -136.29 128.74 30.33 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.325 0.39 . . . . 0.0 110.949 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.8 p -85.23 -24.76 27.69 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.115 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -110.27 152.68 25.85 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 123.395 0.435 . . . . 0.0 110.425 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -110.73 142.58 42.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.65 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -91.66 -20.32 21.73 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.808 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.6 t -72.7 -42.24 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.708 0.403 . . . . 0.0 111.343 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -84.99 131.31 34.49 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.44 0.462 . . . . 0.0 111.294 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.11 -31.15 7.62 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.844 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.12 -166.36 39.46 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 121.766 -0.254 . . . . 0.0 112.773 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.7 p -107.72 151.4 25.74 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.595 0.236 . . . . 0.0 111.037 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.97 -172.0 46.05 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.074 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.43 172.31 33.62 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 121.601 -0.333 . . . . 0.0 112.822 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 m -64.75 -33.97 77.23 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.37 175.62 34.34 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.691 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.43 -50.73 3.71 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.715 -0.279 . . . . 0.0 113.284 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.8 m -121.9 149.36 43.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.607 0.242 . . . . 0.0 111.47 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -161.66 178.21 37.63 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.374 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.65 157.0 27.11 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.952 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 78.0 p -133.92 153.63 51.63 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 122.52 0.328 . . . . 0.0 110.89 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.36 131.01 49.26 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -108.53 -12.65 14.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.963 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.2 p -84.78 -29.32 25.54 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -118.65 126.19 51.39 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.223 0.327 . . . . 0.0 111.311 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -115.39 1.83 13.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.183 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 111' ' ' GLU . 14.6 t -104.74 135.88 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.982 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.21 155.31 37.37 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.358 0.411 . . . . 0.0 111.473 -179.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.784 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.3 t80 -96.32 135.1 38.62 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.171 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.9 m -134.37 115.65 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.333 0.396 . . . . 0.0 110.006 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -132.42 154.41 21.04 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.94 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.87 26.49 6.71 Favored Glycine 0 C--N 1.332 0.352 0 O-C-N 123.935 0.432 . . . . 0.0 112.309 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -92.9 159.88 15.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.955 0.407 . . . . 0.0 110.652 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -83.62 154.08 23.94 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.027 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 24.1 tp10 -60.03 -30.89 69.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.678 0.391 . . . . 0.0 111.454 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -72.17 -18.7 61.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 71' ' ' LEU . 1.5 m -68.58 139.03 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.686 0.279 . . . . 0.0 111.487 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.402 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.8 m-20 -117.63 179.03 4.18 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.31 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -61.96 -28.95 69.91 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 120.972 0.415 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -69.05 -40.53 78.49 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 36.6 t -64.86 -46.48 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.084 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.7 tt -65.77 -39.57 91.13 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.908 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.616 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 23.7 t-80 -68.49 -47.97 65.65 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.944 0.498 . . . . 0.0 111.82 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.31 -20.59 63.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.42 23.53 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.04 0.448 . . . . 0.0 111.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 75.0 m-85 -102.38 1.39 35.37 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.239 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 82' ' ' ALA . 4.0 tp -70.79 -31.62 2.16 Favored Pre-proline 0 CA--C 1.565 1.553 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.3 Cg_exo -59.5 -23.9 72.68 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 121.954 1.769 . . . . 0.0 113.859 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.567 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 60.1 m-85 -78.89 -31.31 45.36 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.95 -163.28 36.69 Favored Glycine 0 C--N 1.34 0.75 0 C-N-CA 121.31 -0.471 . . . . 0.0 113.032 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -83.85 134.34 34.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.868 0.467 . . . . 0.0 111.97 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.616 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 6.2 mt -116.67 139.81 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.426 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 6.4 p -86.97 -61.23 1.77 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.817 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -152.53 159.67 43.28 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.948 0.404 . . . . 0.0 111.949 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.445 ' CD1' HG23 ' A' ' 110' ' ' VAL . 18.7 mm -115.23 124.58 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -117.76 127.45 53.92 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.233 0.333 . . . . 0.0 111.818 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.62 121.12 22.1 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.665 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -65.77 96.69 0.31 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 121.937 1.758 . . . . 0.0 112.082 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.7 tp -107.33 135.87 48.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.234 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -87.37 141.18 28.83 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -64.67 -34.18 77.69 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -70.85 -48.8 52.01 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.442 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 29.9 p -95.85 -28.31 14.78 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 54.36 24.76 5.38 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.256 0.622 . . . . 0.0 111.672 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 101' ' ' THR . 61.5 mttt -117.13 152.27 35.08 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.178 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.54 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.4 p80 -103.76 157.64 16.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.227 0.329 . . . . 0.0 110.692 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.9 mtt85 -88.05 0.81 55.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.186 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.51 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 96.22 24.73 13.86 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-O 119.636 -0.535 . . . . 0.0 114.199 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.66 150.38 34.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 117.216 0.508 . . . . 0.0 111.037 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.36 171.09 18.56 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.615 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -115.73 140.2 49.43 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.3 p -116.09 134.17 60.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.155 0.284 . . . . 0.0 111.192 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.588 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 0.5 OUTLIER -106.45 126.83 52.74 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.413 ' HB3' ' OD1' ' A' ' 117' ' ' ASP . 21.8 m-85 -111.07 139.35 46.51 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.755 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -64.48 -37.92 89.23 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.78 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.585 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.3 mp -103.87 136.47 43.48 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.958 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.09 -19.45 60.6 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.441 0.639 . . . . 0.0 109.374 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.4 -50.45 31.84 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.371 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 19.2 p30 -69.72 -32.13 70.52 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.878 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.982 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.18 -44.48 91.87 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.44 -28.96 69.01 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.943 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.45 74.69 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.114 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.69 -40.51 84.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.93 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.692 HD11 HD22 ' A' ' 66' ' ' LEU . 21.2 mt -70.56 -34.38 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 123.301 0.375 . . . . 0.0 111.944 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.76 -17.07 45.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -99.48 -44.48 6.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.567 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 61.4 mtt -130.18 50.55 2.18 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.6 t-20 -64.08 -37.1 86.22 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.962 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 27.8 tt0 -143.77 76.65 1.52 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.068 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.8 t -119.4 162.73 18.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.207 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.85 118.15 29.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.015 0.436 . . . . 0.0 110.796 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.35 131.77 42.24 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.929 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 t80 62.93 14.66 7.68 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.771 0.828 . . . . 0.0 112.307 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.9 2.31 59.59 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.339 -0.391 . . . . 0.0 113.204 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -126.96 156.39 41.61 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.559 0.344 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.22 133.71 35.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.589 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.0 pt -115.66 154.44 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 O-C-N 123.425 0.453 . . . . 0.0 112.046 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 6.0 tpt180 -124.42 132.23 53.51 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.03 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.784 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -131.39 133.62 61.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 120.885 0.374 . . . . 0.0 110.421 178.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -147.38 171.44 15.47 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.406 ' HG ' HD13 ' A' ' 122' ' ' ILE . 13.2 mt -71.21 129.78 39.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.517 0.199 . . . . 0.0 111.123 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.204 -179.518 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.531 0.205 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 87.0 mtp -101.1 137.1 39.91 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.859 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.5 mtt -102.08 144.5 30.58 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -65.31 -35.85 82.25 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.529 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.1 t -127.72 135.44 50.17 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.387 0.429 . . . . 0.0 111.196 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.55 132.01 3.67 Favored Glycine 0 C--N 1.337 0.612 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.244 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -98.85 139.75 34.06 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.613 0.244 . . . . 0.0 111.069 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 76.3 m -85.83 -37.1 19.57 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.753 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -81.21 136.84 35.88 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.444 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -98.01 0.01 45.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.704 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -100.46 140.8 34.2 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.09 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.09 -30.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.584 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -63.63 -30.81 71.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.103 0.561 . . . . 0.0 112.402 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.9 m -60.84 -36.3 78.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.075 0.55 . . . . 0.0 112.467 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -60.38 -38.1 82.84 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.034 0.533 . . . . 0.0 111.768 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.3 m -72.69 -34.64 67.31 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.136 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.93 -26.95 67.1 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.16 0.584 . . . . 0.0 112.424 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.86 160.36 29.3 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.761 0.424 . . . . 0.0 111.729 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -82.14 165.49 20.5 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.082 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.78 ' H ' HD23 ' A' ' 19' ' ' LEU . 98.9 p -62.93 159.7 16.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 122.953 0.501 . . . . 0.0 112.014 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.46 -31.0 72.03 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -64.65 -49.31 71.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.618 ' HB2' HD22 ' A' ' 19' ' ' LEU . 74.2 mmm -73.19 -39.08 65.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -69.04 -44.99 71.56 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.66 -41.21 72.38 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 53.8 mt -70.14 -47.32 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.532 HD12 ' O ' ' A' ' 23' ' ' MET . 8.7 mt -69.56 -41.72 75.52 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.6 m -74.43 -35.31 63.37 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -111.3 84.28 1.91 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.214 0.53 . . . . 0.0 110.266 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 4.1 mt -90.81 133.67 31.92 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.972 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 2.8 Cg_exo -76.03 29.99 0.39 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.664 2.243 . . . . 0.0 113.342 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 50.64 -80.4 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.77 1.228 . . . . 0.0 113.869 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 m -62.25 -40.08 95.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.86 -34.42 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-O 120.472 0.177 . . . . 0.0 111.071 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.63 -32.58 71.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -151.88 144.58 24.3 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.674 0.273 . . . . 0.0 111.701 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.2 p -87.84 1.96 52.61 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.249 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.0 m -64.77 -27.45 68.9 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.0 p -123.59 150.81 27.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 123.365 0.416 . . . . 0.0 110.618 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -97.44 160.98 14.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.234 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.0 t -94.67 127.86 40.94 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.84 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.6 p -76.96 -26.38 53.9 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -104.19 130.36 51.95 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.345 0.403 . . . . 0.0 110.901 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -77.26 -37.09 53.71 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.169 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -119.87 142.53 48.58 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.418 0.448 . . . . 0.0 111.169 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.8 m -130.04 156.8 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.239 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -89.33 129.37 35.88 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.386 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 179.1 -128.74 1.28 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.31 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.02 -179.75 45.65 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.531 -0.366 . . . . 0.0 112.857 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.4 p -126.5 150.79 48.54 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.578 0.228 . . . . 0.0 111.235 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.49 174.61 19.67 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.689 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.34 175.09 37.42 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.86 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.0 m -67.83 -37.43 81.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.23 -178.75 41.47 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.982 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.28 -43.3 6.29 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 121.684 -0.293 . . . . 0.0 113.043 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 t -118.67 145.29 45.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 122.308 0.243 . . . . 0.0 110.772 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.41 55.87 0.11 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.567 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.46 9.08 59.29 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.539 -0.362 . . . . 0.0 113.444 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 m -64.06 -37.41 87.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.7 148.31 41.18 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.457 0.473 . . . . 0.0 111.125 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.45 155.25 16.84 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.439 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.0 p -74.47 112.71 10.91 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.443 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -131.37 143.06 50.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.884 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 52.9 mtm180 -93.09 -0.47 57.05 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.603 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 t -107.49 126.63 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.789 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.56 156.16 36.26 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.363 0.414 . . . . 0.0 111.008 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.833 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 50.9 t80 -95.22 133.64 38.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.706 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 80' ' ' LEU . 4.5 m -134.77 115.27 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 O-C-N 123.378 0.424 . . . . 0.0 109.974 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -134.73 153.01 20.89 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.891 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.06 32.78 4.86 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 106' ' ' GLY . 1.1 mp -94.0 164.0 13.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 110.872 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.446 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -80.59 153.0 28.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.977 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -61.84 -26.6 68.22 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.842 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -87.69 9.05 22.77 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.7 m -90.63 142.24 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.383 -0.198 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.6 p30 -126.01 -175.8 3.46 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.685 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.507 ' OD1' ' HB ' ' A' ' 93' ' ' ILE . 17.3 m-20 -58.87 -33.34 70.38 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.725 0.41 . . . . 0.0 111.786 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -69.4 -36.27 76.59 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.914 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.581 HG23 ' OD1' ' A' ' 76' ' ' ASP . 55.9 t -69.48 -48.57 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.797 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 68' ' ' VAL . 1.9 tt -66.55 -38.82 87.92 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.625 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 27.0 t-80 -68.38 -47.96 65.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.79 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.72 62.96 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.21 -33.07 24.21 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 111.126 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.53 1.24 34.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.37 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.04 -32.02 2.67 Favored Pre-proline 0 CA--C 1.565 1.519 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 32.4 Cg_exo -60.39 -23.9 76.11 Favored 'Trans proline' 0 C--N 1.385 2.46 0 C-N-CA 121.982 1.788 . . . . 0.0 113.922 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.499 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 44.1 m-85 -81.46 -31.53 32.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.69 -170.0 42.62 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.89 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -84.9 134.67 34.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.598 0.359 . . . . 0.0 110.894 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.513 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 5.7 mt -115.6 140.12 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.005 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 3.8 p -89.15 -62.47 1.47 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.892 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -148.09 158.42 44.06 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.038 0.447 . . . . 0.0 112.11 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.507 ' HB ' ' OD1' ' A' ' 77' ' ' ASP . 18.6 mm -118.02 125.59 74.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.438 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -116.11 121.98 43.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.916 0.388 . . . . 0.0 111.543 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -127.65 118.83 21.34 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.822 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.36 114.88 2.17 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.24 1.96 . . . . 0.0 112.222 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp -126.19 135.5 51.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.193 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -89.61 144.2 26.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.415 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.64 -35.07 79.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.22 -49.06 29.96 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 30.8 p -93.72 -28.54 15.88 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 53.55 24.64 4.24 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.355 0.662 . . . . 0.0 111.615 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 101' ' ' THR . 79.1 mttt -114.15 156.12 24.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.371 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -106.47 158.34 16.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.718 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -88.57 -0.13 56.94 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.295 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.21 25.55 13.99 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-O 119.56 -0.578 . . . . 0.0 114.488 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.449 ' O ' HG23 ' A' ' 95' ' ' ILE . 53.1 p90 -146.51 150.0 34.71 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 117.337 0.569 . . . . 0.0 111.034 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.47 169.48 24.54 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.994 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.39 143.72 45.2 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.1 p -118.48 134.95 60.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.717 0.294 . . . . 0.0 111.415 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.478 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.6 OUTLIER -108.08 125.51 51.67 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.958 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 16.3 m-85 -106.49 138.86 41.91 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.981 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.94 -36.65 85.07 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.82 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.73 132.96 53.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.742 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.47 -24.9 64.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.365 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.87 -42.99 84.68 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.756 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.27 -32.82 72.25 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.251 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.789 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.89 -46.53 90.26 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.304 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.89 -28.94 67.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.141 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.85 70.5 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.344 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.24 92.34 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.086 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.672 HD11 HD22 ' A' ' 66' ' ' LEU . 17.6 mt -70.94 -34.24 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 O-C-N 123.278 0.361 . . . . 0.0 111.74 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.87 -17.12 44.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -94.7 -48.68 5.96 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.499 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 64.3 mtt -133.51 59.03 1.75 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.035 0.445 . . . . 0.0 112.156 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.576 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 15.8 p30 -69.4 -36.73 77.05 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.432 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.34 79.62 1.67 Allowed 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.652 0.739 . . . . 0.0 109.728 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 79.9 p -124.96 163.25 22.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.438 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.46 119.44 32.54 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.975 0.417 . . . . 0.0 110.619 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -128.53 130.1 46.96 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.903 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 t80 62.57 15.23 7.74 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.68 0.792 . . . . 0.0 112.418 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.04 4.34 58.72 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 116.261 -0.427 . . . . 0.0 113.22 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.9 mtp180 -126.34 155.07 42.61 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.455 0.302 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.05 131.98 35.14 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.4 pt -117.17 149.52 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 123.359 0.412 . . . . 0.0 111.873 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 76.9 mtt180 -123.2 133.74 54.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.593 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.6 OUTLIER -130.12 134.02 63.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 120.874 0.368 . . . . 0.0 110.421 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -150.15 172.78 14.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.668 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mt -68.95 129.66 40.58 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.953 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.113 -179.518 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.506 0.193 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.8 mtt -104.37 136.52 43.79 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.5 mtp -71.82 -36.99 70.41 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.247 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.47 -36.91 85.28 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.0 t -127.74 131.62 49.67 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.352 0.407 . . . . 0.0 111.232 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.35 -179.93 38.1 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.734 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -105.36 150.88 24.83 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.388 0.275 . . . . 0.0 110.914 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -123.24 128.01 49.39 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -95.54 3.39 54.18 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.757 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -115.49 132.73 56.53 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.462 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.5 m-90 -115.41 136.88 52.63 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.803 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 m -85.78 -36.74 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.21 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.554 ' HA ' ' SG ' ' A' ' 16' ' ' CYS . 90.2 m-70 -64.93 -40.02 94.4 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.0 m -65.38 -39.92 92.85 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -68.69 -36.31 78.31 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' A' ' 13' ' ' HIS . 26.0 p -82.79 -31.95 27.98 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.433 0.458 . . . . 0.0 112.181 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -92.19 140.74 29.32 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.278 0.361 . . . . 0.0 111.053 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -89.85 -45.47 9.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.207 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 tp -112.19 144.17 42.03 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.36 0.412 . . . . 0.0 110.307 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -75.42 152.95 37.91 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.465 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -60.54 -35.71 76.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.387 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -66.0 -41.88 90.47 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.455 0.472 . . . . 0.0 111.399 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 74.0 mmm -71.93 -39.88 69.13 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.916 0.486 . . . . 0.0 112.075 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -68.23 -41.27 81.48 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.068 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -70.18 -49.5 49.74 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.4 mt -65.13 -47.2 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.45 -31.79 70.33 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.9 p -66.19 -38.8 88.87 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.473 0.178 . . . . 0.0 111.351 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -117.64 98.62 6.47 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.447 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.61 79.08 55.5 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.324 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.01 133.12 39.72 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.007 2.471 . . . . 0.0 111.867 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -47.17 -36.16 8.26 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.869 0.868 . . . . 0.0 113.286 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 m -84.57 -41.38 16.51 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.51 -19.89 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.134 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.88 69.6 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.912 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -141.98 130.56 22.63 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.38 0.425 . . . . 0.0 111.16 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.8 t -138.96 158.49 44.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.068 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.2 m -72.96 -40.79 65.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.985 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.58 145.18 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 123.424 0.452 . . . . 0.0 110.847 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -108.64 128.24 54.67 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.934 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 t -123.09 119.32 29.95 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.497 0.498 . . . . 0.0 111.179 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.6 p -139.76 -6.71 1.29 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.485 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -68.19 -31.77 71.52 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.0 mtm105 -92.46 142.74 27.09 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.308 0.38 . . . . 0.0 111.121 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -122.74 140.76 52.54 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.856 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.52 -42.65 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.399 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -88.3 152.49 21.91 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.324 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.55 -160.95 23.76 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.928 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.64 -32.87 7.08 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.596 -0.335 . . . . 0.0 112.824 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.2 m -67.52 -35.39 79.02 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.816 0.446 . . . . 0.0 112.178 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.3 147.84 4.78 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.366 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.89 64.31 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 121.5 -0.381 . . . . 0.0 113.369 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.0 t -119.85 143.64 47.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.253 0.221 . . . . 0.0 110.762 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.11 45.66 6.18 Favored Glycine 0 C--N 1.34 0.789 0 O-C-N 123.656 0.598 . . . . 0.0 113.077 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.02 -54.39 2.76 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 121.619 -0.324 . . . . 0.0 113.179 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.7 t -126.4 140.52 52.42 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.584 0.23 . . . . 0.0 111.143 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.38 -168.33 37.16 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.738 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.25 54.03 0.98 Allowed Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.77 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.9 p -71.79 -24.14 61.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.56 -30.64 69.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.2 p -79.63 -8.28 59.1 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.455 0.472 . . . . 0.0 112.223 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.49 -42.7 15.3 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.642 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -96.15 134.64 38.98 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.37 0.419 . . . . 0.0 111.446 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -110.33 2.42 19.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.16 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.541 HG22 ' HG2' ' A' ' 111' ' ' GLU . 26.0 t -101.86 134.97 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.686 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -124.06 147.23 48.02 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.381 0.426 . . . . 0.0 110.582 179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.733 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 65.1 t80 -99.93 125.13 45.89 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.924 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.673 HG12 HG12 ' A' ' 137' ' ' VAL . 2.8 m -118.71 118.92 59.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 O-C-N 123.547 0.529 . . . . 0.0 110.028 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -128.49 149.08 18.19 Favored Glycine 0 C--N 1.337 0.592 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.544 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.39 23.93 7.75 Favored Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.1 mp -90.02 168.61 11.87 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 122.968 0.507 . . . . 0.0 110.824 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -96.4 161.82 13.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.337 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.62 -32.2 71.91 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.657 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -75.7 -7.65 54.86 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.917 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 72' ' ' ALA . 1.7 p -78.44 131.08 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 120.66 0.267 . . . . 0.0 110.577 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -114.84 175.47 5.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.952 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.497 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.3 m-20 -60.69 -33.65 73.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.459 0.704 . . . . 0.0 112.131 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -67.19 -40.32 86.53 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.584 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.56 -45.09 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.959 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 tt -69.55 -37.66 77.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.428 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.562 ' CE1' ' HB ' ' A' ' 90' ' ' ILE . 30.3 t60 -68.14 -48.78 64.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.502 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.75 -21.25 62.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.45 -34.32 23.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.914 0.388 . . . . 0.0 111.266 -178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.443 ' C ' HD11 ' A' ' 90' ' ' ILE . 61.7 m-85 -98.09 -2.36 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.1 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.7 tp -69.44 -31.31 2.54 Favored Pre-proline 0 CA--C 1.566 1.596 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -58.97 -24.18 71.87 Favored 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 121.93 1.753 . . . . 0.0 113.637 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -79.64 -31.22 41.53 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.563 0.345 . . . . 0.0 111.693 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.03 37.0 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.247 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.23 132.61 36.0 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.594 0.235 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.562 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 4.4 mt -109.34 142.04 22.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.956 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.2 p -85.73 -61.59 1.72 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.901 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -151.48 158.04 43.11 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.497 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 15.1 mm -117.73 129.8 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.57 127.89 55.57 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -124.75 100.66 33.96 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.12 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.25 119.8 6.87 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.042 1.828 . . . . 0.0 112.904 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tp -125.23 132.59 52.95 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.598 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -83.37 140.88 32.15 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.429 0.455 . . . . 0.0 110.676 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.62 -34.09 77.47 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -72.66 -48.83 35.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.068 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.543 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.7 p -95.16 -28.94 14.81 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 50.3 32.02 5.84 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.391 0.676 . . . . 0.0 111.76 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 101' ' ' THR . 85.1 mttt -115.23 150.64 35.83 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.437 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -101.53 138.31 38.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.64 1.8 57.07 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 90.04 22.62 35.0 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 120.363 -0.923 . . . . 0.0 115.175 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -142.83 151.13 40.81 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.111 0.956 . . . . 0.0 111.326 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -158.67 166.92 30.89 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.194 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.472 ' CE2' ' HD2' ' A' ' 67' ' ' TYR . 72.8 m-85 -111.33 139.55 46.64 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.463 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.6 p -118.84 132.38 68.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 123.307 0.379 . . . . 0.0 110.334 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.541 ' HG2' HG22 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -105.74 133.1 51.03 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.184 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 20.4 m-85 -115.32 140.14 49.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.315 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.31 -37.03 85.85 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.327 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.569 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.7 mp -106.2 141.17 37.99 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.47 -19.68 59.27 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.949 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -73.92 -49.94 22.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.263 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.3 p30 -68.95 -32.43 72.02 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.88 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.9 -43.57 83.02 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.471 0.482 . . . . 0.0 111.016 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.58 -28.77 69.38 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.051 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.72 -34.94 74.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.154 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.24 -40.25 82.07 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.803 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 66' ' ' LEU . 15.3 mt -69.59 -33.53 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 O-C-N 123.357 0.41 . . . . 0.0 111.596 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -16.71 46.61 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -100.62 -44.17 5.93 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 62.1 mtt -126.26 45.51 2.63 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.635 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.4 t-20 -63.13 -36.61 84.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.611 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 40.8 mt-10 -141.78 79.47 1.68 Allowed 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.659 0.742 . . . . 0.0 109.625 178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 82.0 p -125.07 166.11 16.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.274 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -91.84 120.17 32.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -127.57 129.53 47.49 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.809 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 t80 59.23 18.85 6.93 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.921 0.888 . . . . 0.0 112.31 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.51 -9.63 64.67 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 113.433 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 -114.98 152.68 31.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.66 0.384 . . . . 0.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -76.88 137.32 39.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.7 pt -121.21 156.8 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.52 0.513 . . . . 0.0 112.299 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 12.8 ptt85 -129.17 132.38 47.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.567 178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -125.83 136.49 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.102 0.477 . . . . 0.0 111.212 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -148.41 171.15 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.993 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.455 ' HG ' HD13 ' A' ' 122' ' ' ILE . 12.0 mt -74.29 131.04 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.507 0.194 . . . . 0.0 111.171 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.531 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.154 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.601 0.238 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 85.7 mtp -100.79 137.29 39.37 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.868 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mtt -99.42 149.75 22.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.937 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -110.96 150.99 28.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.7 t -126.18 133.93 51.41 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.742 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.26 -40.18 96.48 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.993 -0.549 . . . . 0.0 113.819 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -109.61 132.9 53.71 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.514 0.197 . . . . 0.0 110.823 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.9 t -132.59 127.91 36.03 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.949 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.96 -32.84 73.54 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.875 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -84.93 158.54 20.53 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.345 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -71.47 149.04 46.24 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.47 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.46 157.29 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.664 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -65.18 -28.21 69.24 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.53 -0.759 . . . . 0.0 113.011 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.2 p -59.52 -36.7 76.61 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -67.46 -30.58 70.33 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 87.8 m -76.7 -6.25 51.38 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.34 -29.9 70.68 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -93.62 125.97 38.52 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.254 0.346 . . . . 0.0 111.044 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tp -107.76 150.77 26.57 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.696 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -71.52 159.29 34.73 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.749 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.29 -34.5 78.27 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.32 -46.89 59.56 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.538 ' O ' HD12 ' A' ' 27' ' ' LEU . 58.5 mmm -67.31 -37.21 82.99 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.606 0.362 . . . . 0.0 111.875 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.68 -42.38 95.4 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.792 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -70.08 -40.73 74.84 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 31.8 mt -66.74 -49.89 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 123.163 0.29 . . . . 0.0 111.778 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 23' ' ' MET . 2.2 mt -69.4 -36.31 76.64 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.3 p -74.99 -25.3 58.73 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -103.06 8.86 38.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.379 0.609 . . . . 0.0 110.231 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 0.6 OUTLIER -83.63 120.22 74.95 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.583 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.14 126.25 13.49 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.692 2.262 . . . . 0.0 112.737 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -49.42 -34.29 16.1 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.312 1.045 . . . . 0.0 113.242 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 81.7 p -85.82 -39.1 17.43 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.66 -32.42 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.43 0.157 . . . . 0.0 111.391 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.77 -29.0 65.09 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -159.69 152.59 21.69 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.7 p -98.61 163.13 12.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.371 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 93.7 m -68.73 -32.47 72.28 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 41' ' ' CYS . 4.5 t -101.62 132.72 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 123.306 0.379 . . . . 0.0 110.054 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -90.92 3.55 54.29 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.992 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.624 ' H ' HG12 ' A' ' 39' ' ' VAL . 35.9 t -99.69 126.46 45.73 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.946 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.1 t -119.42 -1.51 10.72 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.912 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -70.94 -38.05 72.88 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -71.3 -37.77 71.81 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -115.94 127.13 54.73 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.339 0.399 . . . . 0.0 110.963 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -46.22 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.194 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -100.68 145.66 28.15 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.766 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.95 -73.48 1.21 Allowed Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.496 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.17 170.89 30.73 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.466 -0.397 . . . . 0.0 112.792 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.1 m -66.96 -35.01 79.01 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.922 0.489 . . . . 0.0 112.217 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.92 3.8 60.47 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.128 -0.487 . . . . 0.0 113.269 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.04 175.61 42.4 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 121.666 -0.302 . . . . 0.0 112.934 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.6 p -128.64 154.46 46.23 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.357 0.263 . . . . 0.0 110.994 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.16 164.74 24.79 Favored Glycine 0 C--N 1.338 0.675 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.702 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.56 -54.7 2.6 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.607 -0.33 . . . . 0.0 112.946 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.8 p -123.0 152.07 41.26 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.3 0.24 . . . . 0.0 111.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 178.41 -170.88 43.11 Favored Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.65 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -128.31 158.79 21.74 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.532 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.8 m -123.11 148.48 45.63 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 122.249 0.22 . . . . 0.0 110.995 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.68 140.49 35.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.944 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.33 -63.05 1.2 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.827 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.7 p -146.06 123.24 11.51 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 123.271 0.357 . . . . 0.0 111.094 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.84 143.36 50.12 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.846 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 79.0 mtt180 -79.47 -9.37 59.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.402 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 19.3 t -101.63 129.43 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.921 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.83 155.34 38.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.015 -178.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 49.0 t80 -92.67 130.39 38.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.89 116.6 34.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.345 0.403 . . . . 0.0 110.146 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.76 157.9 22.59 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.769 -0.651 . . . . 0.0 113.026 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.69 26.72 7.9 Favored Glycine 0 C--N 1.333 0.361 0 O-C-N 123.943 0.437 . . . . 0.0 112.158 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 75' ' ' VAL . 1.6 mp -89.83 160.88 16.27 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.991 0.424 . . . . 0.0 110.729 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -80.66 157.49 25.92 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.078 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.517 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 44.3 mt-10 -65.94 -27.54 68.25 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -84.27 7.91 17.69 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 71' ' ' LEU . 2.4 m -90.39 142.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -128.21 -176.24 3.74 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.344 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.04 -31.55 68.95 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.912 0.387 . . . . 0.0 111.523 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -68.46 -40.99 80.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.58 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.8 -47.39 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.911 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.474 HD22 HD12 ' A' ' 93' ' ' ILE . 1.9 tt -66.55 -38.19 86.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.683 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.541 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 5.8 t60 -68.17 -49.22 62.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.648 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.39 -20.33 62.95 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -33.86 23.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.972 0.415 . . . . 0.0 111.342 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.451 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 83.6 m-85 -102.56 1.36 34.81 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.389 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.541 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.3 tp -69.5 -31.73 2.75 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.8 Cg_exo -59.03 -23.46 68.79 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.979 1.786 . . . . 0.0 113.907 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.633 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 64.8 m-85 -77.34 -31.5 54.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.53 -160.27 33.71 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.696 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.58 134.63 34.8 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.71 0.404 . . . . 0.0 111.81 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.47 HG21 HD11 ' A' ' 93' ' ' ILE . 13.0 mt -115.76 137.23 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.389 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 p -92.38 -59.35 2.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.285 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -146.42 154.69 41.9 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.474 HD12 HD22 ' A' ' 80' ' ' LEU . 17.2 mm -116.85 120.13 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -112.21 125.24 53.94 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.262 0.351 . . . . 0.0 111.354 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.2 mp -127.32 109.42 21.26 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.573 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.34 126.23 18.05 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.274 1.983 . . . . 0.0 112.147 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.22 136.69 53.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.255 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -91.68 143.33 26.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.349 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -64.66 -34.96 79.53 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.14 -48.79 32.52 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.0 p -93.84 -28.48 15.84 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 52.21 24.38 2.78 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.386 0.675 . . . . 0.0 111.9 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 101' ' ' THR . 70.1 mttt -109.15 149.44 29.34 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.461 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.517 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 11.9 p80 -84.94 -14.36 47.86 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 67.75 -7.55 0.58 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.266 1.026 . . . . 0.0 113.502 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.502 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 99.25 23.73 11.01 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 119.29 -0.728 . . . . 0.0 114.755 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -144.03 152.25 40.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.794 0.797 . . . . 0.0 111.44 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -159.62 170.75 20.94 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.894 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -113.51 145.22 41.56 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.448 HG23 ' CD1' ' A' ' 93' ' ' ILE . 15.0 p -117.56 131.47 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -104.11 125.02 50.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.771 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 21.0 m-85 -112.27 143.07 43.97 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.053 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -69.38 -36.79 77.16 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.923 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.565 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.8 mp -105.62 139.95 39.44 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.057 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.34 -22.28 57.71 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.361 0.601 . . . . 0.0 109.896 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -70.02 -49.35 52.25 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.602 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.565 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -67.3 -31.92 72.54 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.868 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.921 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.28 -44.73 90.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.85 -28.72 69.18 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.025 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.1 -35.81 71.95 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.355 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.52 -40.6 85.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.062 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.713 HD11 HD22 ' A' ' 66' ' ' LEU . 25.2 mt -70.87 -37.61 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 -18.71 39.85 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -97.25 -43.57 7.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.633 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 83.1 mtp -132.09 52.02 2.1 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 2.7 t30 -63.91 -40.2 95.94 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 45.5 mt-10 -141.25 78.26 1.63 Allowed 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.402 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 51.9 p -122.04 164.03 18.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.642 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -91.44 118.96 31.01 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.713 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.1 tp -131.12 130.87 43.67 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.053 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.4 t80 62.42 15.11 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.694 0.798 . . . . 0.0 112.285 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.52 60.1 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.119 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 32.7 mtp85 -126.08 154.48 43.0 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.548 0.339 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.22 133.23 35.24 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 2.3 pt -116.43 153.78 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.095 0.474 . . . . 0.0 112.265 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -125.83 130.63 51.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.531 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.84 137.2 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.291 0.369 . . . . 0.0 110.483 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -148.94 171.91 15.58 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.59 126.29 29.28 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.448 0.299 . . . . 0.0 110.752 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.139 -179.839 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.555 ' HB3' ' O ' ' A' ' 4' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.492 0.186 . . . . 0.0 110.918 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.9 mtt -104.99 137.2 43.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.82 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.8 mtm 70.85 -46.62 0.64 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.395 1.078 . . . . 0.0 112.612 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 1' ' ' SER . 87.2 mm-40 -108.55 144.83 35.7 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.206 0.316 . . . . 0.0 110.895 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.2 t -133.24 149.82 51.97 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.09 165.17 19.51 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.954 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -125.28 141.68 51.94 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.5 0.32 . . . . 0.0 110.146 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.4 t -127.26 126.71 43.17 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.502 0.502 . . . . 0.0 111.223 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -106.76 155.33 19.82 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.802 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -113.06 131.23 55.88 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.978 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -131.44 152.89 50.28 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.893 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.5 133.52 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.826 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -65.01 -36.74 85.38 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.233 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.7 m -62.27 -36.29 81.62 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.134 0.573 . . . . 0.0 112.373 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -61.45 -36.26 79.92 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.012 0.525 . . . . 0.0 111.957 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.9 m -70.68 -45.83 64.3 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 66.01 -56.91 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.339 1.056 . . . . 0.0 113.143 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -96.46 155.72 16.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.757 0.313 . . . . 0.0 111.63 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 tp -90.35 151.26 21.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.445 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -68.64 150.58 47.8 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.498 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -61.53 -34.76 76.08 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.78 -46.76 77.52 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 123.293 0.37 . . . . 0.0 111.574 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.561 ' SD ' ' HG3' ' A' ' 111' ' ' GLU . 94.9 mmm -69.08 -38.36 78.97 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -67.07 -43.44 82.63 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.122 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.15 -39.53 75.31 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 43.7 mt -69.91 -47.56 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 123.022 0.201 . . . . 0.0 111.53 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 23' ' ' MET . 12.3 mt -69.73 -41.32 75.44 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.9 m -72.96 -35.24 66.91 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -112.3 86.49 2.36 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.611 0.569 . . . . 0.0 110.128 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.32 117.15 59.98 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.398 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.81 129.06 17.88 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.564 2.176 . . . . 0.0 111.786 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -44.49 -35.77 2.64 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.285 1.034 . . . . 0.0 113.682 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -89.67 -40.71 12.38 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t -67.57 -32.55 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.29 -29.89 70.96 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -159.19 127.25 5.02 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.717 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 p -126.38 153.56 44.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.1 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.1 m -97.43 -43.2 7.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.428 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.44 137.06 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 O-C-N 123.445 0.465 . . . . 0.0 109.971 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -100.86 126.62 47.47 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.315 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 35.2 t -98.99 125.96 44.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.3 p -89.45 -9.7 49.16 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.292 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.72 -35.38 77.08 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.759 0.424 . . . . 0.0 111.716 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -65.52 -34.24 77.8 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -109.21 136.68 48.29 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.368 0.417 . . . . 0.0 111.249 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.94 142.03 43.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.581 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -89.12 137.73 32.06 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.377 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.17 -177.15 47.23 Favored Glycine 0 C--N 1.337 0.617 0 O-C-N 123.776 0.673 . . . . 0.0 112.71 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.42 159.0 25.73 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.458 -0.401 . . . . 0.0 112.604 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.1 m -65.92 -37.17 85.36 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -142.61 -63.8 0.03 OUTLIER Glycine 0 C--N 1.339 0.715 0 O-C-N 123.457 0.473 . . . . 0.0 112.863 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.79 -176.19 48.14 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.667 -0.301 . . . . 0.0 113.288 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 m -63.72 -34.78 78.64 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.24 51.65 0.11 Allowed Glycine 0 C--N 1.339 0.747 0 O-C-N 123.427 0.454 . . . . 0.0 112.692 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.91 -48.2 4.75 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 121.646 -0.312 . . . . 0.0 112.849 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 m -65.18 -35.48 81.21 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.948 0.499 . . . . 0.0 112.193 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.62 -168.63 33.35 Favored Glycine 0 C--N 1.341 0.817 0 O-C-N 123.542 0.527 . . . . 0.0 112.978 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.28 -116.16 0.76 Allowed Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.576 -0.345 . . . . 0.0 112.29 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.7 m -68.8 -29.11 67.39 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.28 -12.91 61.7 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.1 p -70.18 -20.91 63.1 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.7 p -74.2 -25.08 59.47 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -98.2 127.11 43.97 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.407 0.442 . . . . 0.0 110.708 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.9 mtt85 -114.27 8.96 16.91 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.524 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.86 134.29 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.364 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.898 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -123.87 155.49 37.96 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.655 0.597 . . . . 0.0 111.024 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 67.1 t80 -102.32 130.85 49.15 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.463 HG12 ' CG1' ' A' ' 137' ' ' VAL . 12.6 m -126.22 124.57 66.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 O-C-N 123.533 0.52 . . . . 0.0 110.074 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.57 154.58 22.16 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.1 20.68 10.21 Favored Glycine 0 C--N 1.334 0.44 0 O-C-N 123.888 0.405 . . . . 0.0 112.424 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -89.6 160.44 16.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.815 0.341 . . . . 0.0 110.664 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.511 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.08 155.54 19.39 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.978 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 43.5 mt-10 -61.69 -26.21 67.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.892 0.477 . . . . 0.0 111.933 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.44 -4.34 33.06 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.801 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.1 m -90.43 142.49 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.541 0.21 . . . . 0.0 110.786 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.599 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.8 p30 -127.71 -173.84 3.03 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.744 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.18 -32.94 71.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.764 0.425 . . . . 0.0 111.993 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 90.8 mttt -68.9 -40.25 79.28 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.782 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.599 HG23 ' OD1' ' A' ' 76' ' ' ASP . 44.1 t -66.25 -47.91 82.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.191 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -67.22 -38.41 85.22 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.885 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.576 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 11.2 t60 -68.26 -48.7 64.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.54 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.55 -20.51 62.8 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.41 -34.39 23.54 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.934 0.397 . . . . 0.0 111.473 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.9 m-85 -100.79 -0.63 36.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.189 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.6 -31.92 2.81 Favored Pre-proline 0 CA--C 1.565 1.55 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.95 -22.82 65.15 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 121.93 1.753 . . . . 0.0 113.867 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -78.44 -31.18 47.95 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.08 -162.69 36.43 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.656 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -82.53 134.21 35.2 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.604 0.362 . . . . 0.0 111.72 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.52 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 12.1 mt -114.67 139.73 39.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.365 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -90.36 -62.9 1.36 Allowed 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -146.95 153.01 39.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.516 HD11 HG21 ' A' ' 90' ' ' ILE . 14.5 mm -117.94 123.3 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -120.27 121.67 39.19 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.84 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mp -127.7 116.57 20.97 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.979 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.88 124.57 16.0 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.254 1.97 . . . . 0.0 112.514 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tp -127.87 134.71 49.4 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.036 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -89.18 143.31 26.93 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.459 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -64.59 -34.6 78.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -71.65 -48.73 45.78 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.1 p -96.04 -28.02 14.83 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 56.27 24.67 8.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.221 0.608 . . . . 0.0 111.562 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -122.21 154.71 37.13 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.381 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.475 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 25.0 p80 -99.49 161.62 13.51 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.293 0.371 . . . . 0.0 110.802 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -86.01 -4.8 59.25 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.25 27.96 7.04 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 121.032 -0.604 . . . . 0.0 114.311 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -148.71 149.68 31.85 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.215 0.507 . . . . 0.0 110.887 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.35 163.66 39.79 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.345 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.467 ' CE1' ' HD1' ' A' ' 67' ' ' TYR . 90.2 m-85 -109.57 134.35 52.02 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.477 HG23 ' CD1' ' A' ' 93' ' ' ILE . 9.1 p -112.01 132.93 59.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.327 0.392 . . . . 0.0 110.54 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.561 ' HG3' ' SD ' ' A' ' 23' ' ' MET . 0.2 OUTLIER -107.14 128.8 54.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.615 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -114.14 145.11 42.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.928 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -69.76 -37.08 76.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.589 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.584 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.9 mp -105.38 137.68 42.79 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.058 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.07 -19.75 59.85 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.172 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -71.15 -49.98 38.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.152 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.7 p30 -69.29 -31.77 70.49 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.568 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.898 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.45 -44.73 90.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.99 0.516 . . . . 0.0 111.334 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.96 -29.84 69.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.073 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.59 -35.16 75.08 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.962 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.53 -38.73 81.09 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.718 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.706 HD11 HD22 ' A' ' 66' ' ' LEU . 72.5 mt -69.78 -33.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 123.096 0.247 . . . . 0.0 111.195 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.33 -35.71 73.8 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -102.53 -36.01 8.53 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.465 1.284 . . . . 0.0 114.465 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.492 ' O ' HG13 ' A' ' 137' ' ' VAL . 90.9 mmm -90.74 0.43 57.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.653 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.9 t-20 -56.68 -37.01 70.26 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.747 0.248 . . . . 0.0 111.602 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -140.78 71.89 1.38 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.371 0.605 . . . . 0.0 109.516 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.7 m -121.13 154.03 36.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.295 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -92.01 119.17 31.48 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.427 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -127.9 127.42 43.34 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.925 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 61.89 15.91 7.57 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.736 0.814 . . . . 0.0 112.399 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.45 -9.09 62.57 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.01 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -113.45 149.52 34.12 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.811 0.444 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.46 138.45 36.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.671 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.11 156.98 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.843 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 10.2 ptp180 -128.32 134.06 48.82 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.181 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.12 143.64 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.906 0.384 . . . . 0.0 111.384 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -141.8 171.1 14.52 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.976 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 tt -81.51 125.55 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.677 0.275 . . . . 0.0 110.615 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.14 -179.764 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.7 p . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.363 0.125 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 99.3 mmm -100.65 136.77 39.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.695 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.8 mtt -125.06 151.92 44.99 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.021 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -116.87 150.17 38.86 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.762 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.6 p -123.89 123.59 40.76 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.808 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.56 -41.66 0.06 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.801 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -63.17 -36.4 83.51 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.7 m -74.55 -38.51 62.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.178 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -89.01 149.47 23.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.364 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -117.98 149.63 40.62 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -102.44 147.65 26.47 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.068 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 t -109.23 139.0 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.64 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -61.53 -41.54 97.49 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.052 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.0 p -68.84 -37.22 78.99 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -69.84 -37.24 76.1 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.82 0.448 . . . . 0.0 111.504 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.9 m -65.93 -33.22 75.33 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 64.32 150.1 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.876 0.87 . . . . 0.0 112.039 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -93.62 127.97 39.55 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.486 HD11 ' OE1' ' A' ' 94' ' ' GLN . 11.4 tp -97.24 147.34 24.21 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.509 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.7 m -62.13 152.69 32.25 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.949 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -63.83 -36.78 85.05 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -68.3 -47.22 68.2 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.294 0.371 . . . . 0.0 111.722 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.549 ' O ' HD12 ' A' ' 27' ' ' LEU . 89.6 mmm -67.39 -39.29 85.6 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.643 0.377 . . . . 0.0 111.912 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -64.86 -41.24 95.84 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.89 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.14 -39.75 78.66 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.7 mt -70.45 -48.31 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 122.41 0.284 . . . . 0.0 111.661 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 23' ' ' MET . 4.8 mt -69.94 -40.21 75.63 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.6 m -77.27 -33.87 55.78 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.67 6.53 43.54 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 35' ' ' ALA . 2.1 pp -82.01 143.53 49.67 Favored Pre-proline 0 N--CA 1.474 0.737 0 CA-C-N 118.534 0.606 . . . . 0.0 111.482 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.5 129.55 15.93 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.863 2.376 . . . . 0.0 111.918 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -46.27 -33.1 3.49 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 m -92.14 -40.48 11.0 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -71.75 -20.56 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.232 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.654 ' HB2' HD13 ' A' ' 30' ' ' LEU . . . -61.5 -28.35 69.24 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.224 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -146.63 160.12 42.59 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.259 0.35 . . . . 0.0 111.692 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.4 t -133.36 166.91 21.42 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.285 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 m -77.83 138.13 38.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.283 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.6 m -75.62 -36.86 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.661 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -118.03 124.15 47.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.043 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 44' ' ' ARG . 1.4 m -127.36 132.09 50.25 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.4 p -77.88 -41.2 37.54 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -140.09 -22.51 0.85 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.649 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 82.7 mtt180 -56.53 -36.26 69.02 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -135.08 150.03 50.17 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.215 0.322 . . . . 0.0 111.577 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.2 m -131.16 153.41 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.038 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -97.06 146.42 25.03 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.164 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -179.92 -177.9 48.23 Favored Glycine 0 C--N 1.337 0.602 0 O-C-N 123.763 0.664 . . . . 0.0 112.788 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.57 46.38 0.71 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 121.59 -0.338 . . . . 0.0 112.618 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.6 p -71.9 -26.71 62.43 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -171.97 -170.13 35.55 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.007 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -137.6 -176.3 14.36 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.654 -0.308 . . . . 0.0 112.72 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.9 m -118.47 151.59 37.53 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.317 0.247 . . . . 0.0 111.156 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.08 41.53 4.9 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.202 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.15 -38.75 39.02 Favored Glycine 0 C--N 1.342 0.912 0 O-C-N 123.576 0.221 . . . . 0.0 113.443 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.3 m -64.01 -35.88 82.16 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.965 0.506 . . . . 0.0 112.357 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.7 36.1 10.85 Favored Glycine 0 C--N 1.342 0.861 0 O-C-N 123.522 0.514 . . . . 0.0 113.306 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.82 125.14 8.29 Favored Glycine 0 C--N 1.339 0.727 0 C-N-CA 121.494 -0.384 . . . . 0.0 112.62 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.8 m -122.68 148.17 45.6 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.679 0.282 . . . . 0.0 110.949 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.55 137.87 39.31 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.149 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.3 p -109.5 4.06 21.92 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.859 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.14 -48.73 7.5 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.658 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -101.68 131.98 47.63 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.328 0.393 . . . . 0.0 111.352 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -112.73 7.75 18.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.145 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 111' ' ' GLU . 5.8 t -103.21 134.72 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.429 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.854 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -123.35 155.46 37.27 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.866 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 76.8 t80 -93.56 137.46 32.81 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.417 178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.64 123.42 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 O-C-N 123.598 0.561 . . . . 0.0 110.226 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.98 151.57 20.48 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.135 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.79 15.71 12.81 Favored Glycine 0 C--N 1.334 0.423 0 O-C-N 123.996 0.468 . . . . 0.0 112.57 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.627 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -88.48 164.64 15.36 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.766 0.317 . . . . 0.0 110.637 -179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.47 154.36 20.09 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.57 -30.34 69.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.556 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.53 1.8 13.29 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.978 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.9 m -88.95 137.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.598 0.237 . . . . 0.0 110.769 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 79' ' ' VAL . 3.4 p30 -117.49 -175.77 2.88 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -61.98 -31.16 71.49 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.693 0.397 . . . . 0.0 112.042 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -35.62 76.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.879 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.581 HG23 ' OD1' ' A' ' 76' ' ' ASP . 61.8 t -69.75 -49.03 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.042 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.1 tt -66.96 -38.64 86.47 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.74 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.525 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 31.2 t-80 -68.62 -47.42 66.68 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.742 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.27 -20.89 63.02 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.3 -33.98 23.85 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.009 0.433 . . . . 0.0 111.178 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.435 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 70.0 m-85 -100.39 0.04 39.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.01 -0.996 . . . . 0.0 112.254 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.0 tp -69.36 -31.89 2.9 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 44.8 Cg_exo -59.27 -22.93 67.48 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 121.879 1.719 . . . . 0.0 113.822 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -80.63 -31.63 36.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.92 35.49 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.798 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -83.18 137.49 34.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.718 0.407 . . . . 0.0 112.027 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 93' ' ' ILE . 6.8 mt -117.53 138.21 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.519 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.48 -62.1 1.51 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -145.09 153.13 41.09 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 90' ' ' ILE . 18.1 mm -119.58 128.97 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.529 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 5.8 tp60 -114.38 135.06 54.5 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.263 0.352 . . . . 0.0 111.383 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 mm -121.81 101.09 42.88 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.91 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.69 124.41 14.97 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.214 1.943 . . . . 0.0 112.382 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.54 132.12 53.47 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.961 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.93 141.73 28.51 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.815 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -64.74 -33.56 76.26 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -70.97 -48.8 51.29 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.1 p -100.59 -28.62 12.77 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 53.08 29.99 8.93 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.253 0.621 . . . . 0.0 111.673 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 101' ' ' THR . 34.1 mttt -121.18 156.89 31.4 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.193 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -89.42 139.22 30.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.69 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -99.01 3.31 46.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 93.84 21.77 27.54 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 114.741 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -146.05 150.82 36.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 117.655 0.728 . . . . 0.0 111.13 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -162.33 -179.83 7.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.875 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.463 ' CE2' ' HD1' ' A' ' 67' ' ' TYR . 85.3 m-85 -119.51 151.8 37.99 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.1 p -122.71 132.97 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 123.325 0.391 . . . . 0.0 110.495 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.497 ' HG3' HG22 ' A' ' 65' ' ' VAL . 21.1 tt0 -106.04 130.18 54.0 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.287 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.02 147.39 42.38 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.46 -37.94 71.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.456 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.6 mp -106.7 137.3 44.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.024 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.19 -19.62 60.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.253 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -70.8 -50.03 40.04 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.869 -1.059 . . . . 0.0 111.235 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.604 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 13.3 p30 -68.99 -31.71 70.76 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.854 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -63.7 -44.46 93.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.298 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -30.34 70.3 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.08 178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.32 -34.72 75.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.845 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -68.25 -38.14 81.5 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.6 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.675 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 74.6 mt -68.79 -35.56 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 123.129 0.268 . . . . 0.0 111.124 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.17 -37.15 78.04 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -101.14 -35.44 9.31 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.496 ' O ' HG13 ' A' ' 137' ' ' VAL . 92.6 mmm -91.95 1.17 57.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.675 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.8 t-20 -57.16 -37.48 72.13 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -140.04 70.28 1.36 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.398 0.618 . . . . 0.0 109.523 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -122.24 157.42 31.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.217 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -93.88 122.32 36.25 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.756 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.04 129.46 42.03 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.879 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 62.25 15.43 7.55 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.675 0.79 . . . . 0.0 112.393 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 5.28 59.07 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 116.304 -0.407 . . . . 0.0 113.273 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -126.91 154.17 44.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 122.446 0.298 . . . . 0.0 110.774 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.25 134.78 35.3 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.88 158.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 O-C-N 123.4 0.438 . . . . 0.0 111.92 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.635 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 4.0 ptp180 -128.24 134.31 48.96 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.401 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.578 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.8 OUTLIER -129.28 143.57 40.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 123.198 0.311 . . . . 0.0 111.128 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -141.75 171.25 14.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.152 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.8 tt -78.14 124.42 28.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.716 0.293 . . . . 0.0 110.532 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.216 -179.514 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.514 0.197 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.3 mtt -104.67 137.02 43.13 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.703 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.1 mtp -115.62 142.17 47.08 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.55 0.531 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -67.26 -33.54 75.54 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.492 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.9 t -117.92 136.94 53.15 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.313 0.383 . . . . 0.0 111.147 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.16 -136.3 4.9 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.498 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -96.69 149.6 21.62 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.645 0.26 . . . . 0.0 111.087 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 p -92.74 -38.88 11.56 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.715 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -89.02 124.38 34.22 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.355 0.409 . . . . 0.0 110.759 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -64.54 -33.41 75.84 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.673 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -98.68 143.47 29.02 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.376 0.423 . . . . 0.0 111.114 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.61 -33.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.053 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -61.39 -35.4 77.4 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -61.94 -36.83 82.53 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.86 -36.97 85.04 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 90.7 m -89.12 -18.18 27.72 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.921 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -65.81 -23.0 66.6 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.258 0.623 . . . . 0.0 112.111 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -57.74 -37.85 74.32 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 tp -108.81 140.61 42.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.701 0.286 . . . . 0.0 110.64 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 m -69.97 157.62 37.14 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.741 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 p30 -64.69 -30.58 71.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -72.18 -44.4 63.08 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.465 ' O ' HD12 ' A' ' 27' ' ' LEU . 9.2 mtt -69.92 -37.56 75.97 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -65.13 -41.28 94.97 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.801 0.44 . . . . 0.0 111.655 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -70.25 -44.9 67.54 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 30.4 mt -70.05 -46.82 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 23' ' ' MET . 4.5 mt -68.76 -37.71 79.57 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.1 m -67.7 -39.57 84.38 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -133.36 105.38 6.92 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.416 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 1.1 mp -107.29 140.99 22.01 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.072 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.46 133.38 45.64 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.225 1.95 . . . . 0.0 111.783 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -42.27 -34.39 0.77 Allowed 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.0 -39.58 9.28 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.1 t -68.87 -26.32 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.04 -28.49 69.52 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -153.35 162.35 41.37 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 31.8 p -111.17 159.65 17.67 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.437 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 56.3 m -129.01 163.49 25.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.76 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -121.67 152.12 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.985 0.422 . . . . 0.0 111.916 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -103.38 151.93 22.18 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.605 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 37.4 t -93.67 138.41 31.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.873 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.3 m -63.79 -38.99 93.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.118 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -66.62 -40.47 88.81 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.314 0.384 . . . . 0.0 111.624 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -72.36 -31.22 65.43 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.426 0.454 . . . . 0.0 112.098 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -60.97 -37.58 82.93 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.198 0.599 . . . . 0.0 112.385 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.27 -44.15 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 122.799 0.439 . . . . 0.0 111.781 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -93.19 124.15 36.97 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 123.282 0.364 . . . . 0.0 111.426 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.15 -164.64 38.76 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.246 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.15 104.44 0.24 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.6 p -70.44 -27.57 64.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.72 -160.92 30.47 Favored Glycine 0 C--N 1.34 0.797 0 O-C-N 123.371 0.419 . . . . 0.0 112.919 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 117.48 44.17 0.56 Allowed Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.511 -0.376 . . . . 0.0 112.831 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.7 m -65.38 -33.04 75.02 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.16 43.01 4.8 Favored Glycine 0 C--N 1.341 0.853 0 O-C-N 123.438 0.461 . . . . 0.0 112.801 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.3 -28.63 72.59 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 114.061 0.384 . . . . 0.0 114.061 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 p -105.21 152.87 22.32 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.63 0.252 . . . . 0.0 111.353 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.23 -174.59 35.78 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.57 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.51 -173.11 40.2 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.374 -0.441 . . . . 0.0 112.847 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.2 m -118.77 145.9 45.22 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.294 0.238 . . . . 0.0 110.883 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.56 151.76 29.66 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.377 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.1 p -88.04 163.28 16.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.906 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.9 p -72.21 117.47 13.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.814 0.34 . . . . 0.0 111.703 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -132.02 143.49 50.1 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.679 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 74.8 mtt85 -87.35 -3.38 59.03 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.032 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.79 129.18 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.915 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.4 OUTLIER -123.32 156.87 34.47 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.811 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.785 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 38.8 t80 -92.91 131.48 37.89 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.791 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.436 HG21 HD21 ' A' ' 80' ' ' LEU . 1.5 m -134.24 114.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 123.643 0.589 . . . . 0.0 109.565 177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -137.24 162.06 25.3 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.595 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.0 32.92 6.85 Favored Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.759 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.3 mp -91.08 164.86 13.79 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.051 0.54 . . . . 0.0 111.501 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.69 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -84.73 163.3 19.25 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.643 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.94 -36.35 77.85 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.803 0.441 . . . . 0.0 112.093 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -74.66 -10.77 59.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.205 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -74.31 140.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-O 120.703 0.287 . . . . 0.0 111.632 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.611 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 76.1 m-20 -126.78 179.09 5.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.314 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 2.1 t70 -62.5 -35.72 80.28 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.552 0.741 . . . . 0.0 112.675 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -65.26 -35.32 80.66 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.106 0.479 . . . . 0.0 111.013 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.611 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -66.69 -39.65 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.707 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.436 HD21 HG21 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -67.84 -37.49 81.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.283 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.556 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 17.4 t60 -68.36 -49.65 58.73 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 123.342 0.401 . . . . 0.0 111.492 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.76 -20.93 62.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.05 -34.44 22.28 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.909 0.385 . . . . 0.0 111.351 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.434 ' C ' HD11 ' A' ' 90' ' ' ILE . 70.9 m-85 -98.61 -1.38 41.05 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.163 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.556 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -69.04 -31.89 3.05 Favored Pre-proline 0 CA--C 1.565 1.543 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 42.0 Cg_exo -59.48 -23.86 72.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 121.953 1.769 . . . . 0.0 113.893 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -78.28 -31.39 48.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.5 -162.45 36.22 Favored Glycine 0 C--N 1.339 0.737 0 O-C-N 123.501 0.501 . . . . 0.0 112.761 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -81.77 136.91 35.41 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.684 0.393 . . . . 0.0 111.723 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.522 HG21 HD11 ' A' ' 93' ' ' ILE . 11.1 mt -115.79 139.51 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.703 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -92.94 -60.76 1.73 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.462 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -145.96 153.1 40.42 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.578 ' HB ' ' OD2' ' A' ' 77' ' ' ASP . 16.6 mm -120.01 119.33 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -118.57 129.28 55.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 108' ' ' ALA . 1.0 OUTLIER -127.92 114.61 20.51 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.729 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.78 116.49 3.29 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.216 1.944 . . . . 0.0 112.449 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.03 135.82 51.35 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.071 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.487 ' HB2' ' OG1' ' A' ' 101' ' ' THR . 9.9 m-20 -92.91 146.41 23.65 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.298 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -64.51 -36.24 83.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -77.03 -49.06 16.23 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.932 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.506 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 33.5 p -88.95 -28.58 20.17 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 49.81 25.3 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.607 0.763 . . . . 0.0 112.242 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 101' ' ' THR . 65.4 mttt -103.8 146.08 29.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.734 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -87.89 -15.84 35.59 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.407 0.442 . . . . 0.0 112.104 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 70.42 -6.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.251 1.02 . . . . 0.0 112.991 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.434 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 95.13 20.28 28.39 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-O 119.138 -0.812 . . . . 0.0 114.98 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.44 150.02 36.97 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.044 0.922 . . . . 0.0 111.68 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 95' ' ' ILE . . . -156.53 174.0 16.09 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.793 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.0 151.12 41.15 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 93' ' ' ILE . 8.7 p -121.57 134.4 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.977 0.418 . . . . 0.0 111.188 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 90' ' ' ILE . 21.8 tt0 -108.5 131.0 55.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.937 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 62.8 m-85 -116.59 149.16 40.13 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 123.417 0.448 . . . . 0.0 111.441 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -71.58 -38.05 70.95 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.562 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.7 mp -104.58 139.27 39.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.179 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.05 59.39 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.527 0.68 . . . . 0.0 109.186 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.94 -50.02 39.15 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.63 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.581 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 17.4 p30 -68.76 -31.96 71.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.999 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.915 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -64.32 -45.41 88.01 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.755 0.422 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -29.34 70.03 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.948 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.48 68.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.015 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.55 -38.75 84.62 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.85 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.756 HD11 HD22 ' A' ' 66' ' ' LEU . 9.6 mt -70.27 -40.84 78.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 123.242 0.339 . . . . 0.0 111.692 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.6 -29.9 66.43 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.41 -44.57 11.25 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 87.7 mtp -129.27 50.02 2.19 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.585 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 8.8 t-20 -64.36 -37.86 89.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.736 0.303 . . . . 0.0 110.887 178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.9 mt-10 -142.1 77.63 1.59 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.712 0.767 . . . . 0.0 109.705 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.3 m -122.81 162.73 21.57 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.211 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -89.68 118.33 29.21 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.979 0.418 . . . . 0.0 110.74 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -122.14 128.44 51.26 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.897 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 56.81 20.51 5.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.073 0.949 . . . . 0.0 112.754 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.03 4.78 58.58 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 116.277 -0.42 . . . . 0.0 113.875 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -127.75 154.0 45.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.77 0.285 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.96 132.14 35.97 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.8 pt -119.55 153.7 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 68.8 mtt180 -124.08 134.82 53.3 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.24 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -129.1 135.56 61.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.191 0.52 . . . . 0.0 110.96 179.334 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -149.72 174.59 12.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.5 130.39 40.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.631 0.253 . . . . 0.0 111.245 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.198 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.042 -179.541 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.55 0.214 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 74.5 mtm -101.9 136.88 40.99 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.807 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.3 mmm -108.79 138.03 45.77 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.484 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -122.56 148.81 44.77 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.488 0.493 . . . . 0.0 111.157 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 73.5 m -89.81 -39.01 13.37 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.38 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.64 -178.09 39.51 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.525 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -107.51 131.39 54.38 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.56 0.219 . . . . 0.0 111.027 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.1 m -128.5 -21.83 3.43 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.516 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -63.48 -35.33 80.08 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.23 0.612 . . . . 0.0 112.579 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -114.24 136.12 53.31 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.363 0.414 . . . . 0.0 110.979 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -116.43 142.54 46.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.771 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -133.6 -37.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.607 0.567 . . . . 0.0 111.746 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -63.37 -33.34 75.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.5 m -61.25 -38.79 87.93 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -67.48 -37.17 82.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.901 0.48 . . . . 0.0 112.163 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.5 m -79.01 -32.04 44.94 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -78.01 132.09 37.65 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -79.45 -30.37 42.17 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.149 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -85.57 156.97 20.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.487 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.542 ' H ' HD23 ' A' ' 19' ' ' LEU . 99.3 p -73.06 158.21 35.84 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.909 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -66.37 -30.76 71.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.89 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -62.41 -49.43 75.5 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.662 0.385 . . . . 0.0 111.893 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.595 ' SD ' ' HG3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -70.75 -38.89 73.52 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -68.08 -41.79 81.36 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.002 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.15 -39.9 75.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 51.9 mt -67.25 -45.51 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.016 0.198 . . . . 0.0 111.183 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 23' ' ' MET . 12.1 mt -69.41 -38.6 78.0 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.9 p -76.5 -28.65 56.52 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -112.76 77.83 1.08 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.213 0.53 . . . . 0.0 110.944 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 14.7 mt -117.78 116.86 36.18 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.932 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.93 125.71 12.93 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.423 2.082 . . . . 0.0 111.404 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -45.13 -34.29 2.58 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.551 ' HA ' ' OG1' ' A' ' 37' ' ' THR . 32.6 m -87.88 -43.83 11.51 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.7 -25.67 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 122.26 0.224 . . . . 0.0 111.429 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.18 -31.94 73.08 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -161.87 -20.96 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 33' ' ' SER . 0.2 OUTLIER -84.09 119.74 25.33 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.917 0.389 . . . . 0.0 111.941 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 84.1 m -98.11 -39.0 9.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.278 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.7 t -119.41 141.16 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.923 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 66.85 153.29 0.08 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.959 0.904 . . . . 0.0 112.086 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.7 t -117.45 133.73 55.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.872 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.0 m -66.29 -37.54 85.66 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.911 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -92.3 137.23 32.54 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 123.359 0.412 . . . . 0.0 111.17 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -68.05 -36.35 79.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.156 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -116.08 130.24 56.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.637 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.51 -46.97 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.842 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.53 121.48 34.98 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.549 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.24 -49.54 2.03 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.558 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.45 -110.98 0.89 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 t -115.57 138.97 50.52 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.599 0.235 . . . . 0.0 110.491 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -108.4 128.26 9.01 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.778 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.75 -68.05 0.93 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.7 m -119.55 147.89 43.95 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.691 0.289 . . . . 0.0 110.63 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.92 -178.75 47.55 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 115.997 -0.547 . . . . 0.0 113.073 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.25 -51.77 3.43 Favored Glycine 0 C--N 1.339 0.744 0 C-N-CA 121.616 -0.326 . . . . 0.0 112.883 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.8 m -122.14 146.58 47.09 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 123.652 0.266 . . . . 0.0 110.892 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.82 161.74 16.72 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.624 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.9 -169.06 41.97 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 121.656 -0.306 . . . . 0.0 112.891 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 m -122.62 143.4 49.78 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 123.54 0.2 . . . . 0.0 110.804 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.74 133.42 52.16 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.2 p -84.68 -33.84 23.12 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.988 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -126.88 157.21 39.96 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.52 0.513 . . . . 0.0 111.315 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.555 ' NZ ' HD12 ' A' ' 139' ' ' LEU . 23.6 mttm -121.84 120.77 35.53 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.567 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.6 mtt85 -132.63 -40.36 0.97 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.789 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.62 HG22 ' HG2' ' A' ' 111' ' ' GLU . 9.4 t -103.59 125.33 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.8 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.29 158.42 32.59 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.078 -179.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.89 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 36.7 t80 -96.66 123.75 40.44 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.88 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.562 HG12 HG12 ' A' ' 137' ' ' VAL . 2.4 m -124.47 114.56 41.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -133.78 160.19 23.96 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.556 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.3 33.5 6.22 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.742 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.7 mp -92.13 165.78 12.98 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 124.016 0.48 . . . . 0.0 111.374 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -87.9 161.16 17.63 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.06 -33.11 73.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 0.0 111.949 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.78 4.45 25.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.804 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.742 HG11 ' HB3' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -86.16 139.26 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.859 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -124.68 174.28 7.98 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.523 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.26 -33.19 73.12 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.234 0.613 . . . . 0.0 112.23 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -66.0 -39.5 90.33 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.497 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.1 t -67.84 -42.28 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.729 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 1.1 tt -67.98 -37.38 81.45 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.665 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 7.0 t60 -68.6 -47.86 65.63 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.476 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.527 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.49 -21.36 62.77 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.08 22.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.026 0.441 . . . . 0.0 111.147 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 62.3 m-85 -98.14 -1.03 43.19 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.135 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.16 -31.78 2.5 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.3 Cg_exo -59.56 -24.11 73.8 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 121.942 1.761 . . . . 0.0 113.785 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.516 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 52.1 m-85 -79.05 -31.24 44.46 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.244 0.34 . . . . 0.0 111.902 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.29 -164.83 38.33 Favored Glycine 0 C--N 1.341 0.807 0 O-C-N 123.455 0.472 . . . . 0.0 112.764 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -82.38 136.09 35.04 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.671 0.388 . . . . 0.0 111.638 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 4.8 mt -116.1 141.7 32.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.558 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 4.9 p -88.85 -64.15 1.19 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 123.521 0.513 . . . . 0.0 112.11 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -149.48 157.4 43.26 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.458 ' CD1' HG23 ' A' ' 110' ' ' VAL . 11.8 mm -116.56 122.85 70.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -120.74 132.14 54.89 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.3 mp -128.13 118.09 20.58 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.456 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -68.05 117.13 4.7 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 121.938 1.759 . . . . 0.0 112.23 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 70.7 mt -117.39 147.29 42.79 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.545 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -86.69 143.81 27.41 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.523 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -64.82 -32.0 73.49 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -70.1 -44.57 68.73 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.8 p -112.83 -26.47 8.54 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 56.5 21.99 6.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.648 0.779 . . . . 0.0 112.253 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -108.22 147.73 30.94 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.392 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -86.9 152.38 22.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.65 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 66.9 mtt-85 -89.32 2.32 54.53 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.791 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.423 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 99.39 21.45 14.93 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.466 -0.63 . . . . 0.0 114.165 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.47 ' O ' HG23 ' A' ' 95' ' ' ILE . 44.7 p90 -143.11 149.3 37.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.454 0.627 . . . . 0.0 111.481 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.42 172.09 18.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.65 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -120.01 149.08 42.73 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.1 p -122.74 135.5 62.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.224 0.328 . . . . 0.0 111.216 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.62 ' HG2' HG22 ' A' ' 65' ' ' VAL . 0.9 OUTLIER -109.42 130.79 55.48 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.438 179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 64.9 m-85 -112.26 142.37 44.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.341 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.77 -37.78 85.27 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.677 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.584 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 7.1 mp -103.58 136.02 44.09 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.597 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -71.4 -23.63 61.91 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.3 0.571 . . . . 0.0 110.399 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.07 -49.58 49.59 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.283 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 18.4 p30 -68.35 -32.64 72.88 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.8 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.96 -44.88 79.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.521 0.328 . . . . 0.0 111.199 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.5 -30.19 71.35 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.821 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.559 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -70.44 -32.83 70.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.623 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.41 -38.69 88.03 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.376 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.645 HD11 HD22 ' A' ' 66' ' ' LEU . 41.3 mt -70.74 -36.6 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.354 0.409 . . . . 0.0 111.749 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.3 p30 -82.82 -16.08 49.12 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -98.27 -45.23 6.26 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.516 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 88.9 mtp -130.6 51.87 2.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.593 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 16.7 p30 -67.03 -36.14 81.43 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.502 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -141.93 80.16 1.7 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.777 0.799 . . . . 0.0 109.468 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.0 p -126.4 165.61 18.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.398 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -92.33 120.62 33.04 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.9 tp -125.82 128.97 48.48 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.095 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 55.84 21.69 5.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.06 0.944 . . . . 0.0 112.813 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.66 4.45 59.2 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 116.186 -0.461 . . . . 0.0 114.059 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -128.63 154.7 45.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.885 0.343 . . . . 0.0 110.863 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.5 m -79.33 132.08 36.32 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -118.4 153.44 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 O-C-N 123.433 0.458 . . . . 0.0 112.132 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 86.7 mtt180 -125.47 134.25 52.13 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.493 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.89 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -127.42 133.36 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 110.361 178.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -147.38 172.75 13.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.583 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.555 HD12 ' NZ ' ' A' ' 63' ' ' LYS . 4.2 tt -67.85 125.52 26.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.693 0.397 . . . . 0.0 110.476 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.114 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.455 0.169 . . . . 0.0 110.969 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 74.2 mtm -103.37 137.04 42.02 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 99.5 mmm -118.07 151.95 36.52 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.706 0.629 . . . . 0.0 110.783 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -106.67 139.27 41.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.006 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.7 t -132.03 134.98 46.17 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.73 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.78 39.59 2.84 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.87 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.61 144.27 28.09 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.317 0.247 . . . . 0.0 111.015 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.0 m -74.86 -37.29 62.25 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.982 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 57.0 46.41 19.42 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.751 0.82 . . . . 0.0 112.077 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -123.3 140.83 52.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.015 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 48.83 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.304 1.042 . . . . 0.0 112.866 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 m -126.71 0.72 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.052 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -64.81 -43.63 92.51 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.908 0.483 . . . . 0.0 112.012 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.5 p -68.78 -36.98 78.98 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -69.11 -39.88 78.68 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.878 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.3 m -74.98 -44.4 48.48 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -130.59 137.34 49.61 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.212 0.32 . . . . 0.0 111.397 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -142.12 103.63 4.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.787 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 tp -118.72 143.61 46.77 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.661 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.7 p -73.17 160.63 31.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.706 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.78 -37.27 86.01 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -70.25 -42.47 72.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.494 ' O ' HD12 ' A' ' 27' ' ' LEU . 31.0 mmm -66.74 -38.17 86.11 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -68.67 -43.58 75.88 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -70.88 -41.92 70.7 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.0 mt -70.3 -47.32 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 23' ' ' MET . 11.3 mt -69.32 -41.37 76.79 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -70.02 -36.03 74.76 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.742 0.306 . . . . 0.0 111.187 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.569 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 74.9 m-20 -104.66 64.28 0.74 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -104.82 93.22 5.94 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.523 -178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 29' ' ' ASN . 12.2 Cg_exo -70.33 131.0 19.56 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.91 2.407 . . . . 0.0 111.612 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -51.51 -32.48 27.83 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.9 p -86.56 -38.0 17.6 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.8 t -68.15 -29.9 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.596 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.11 71.19 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -152.51 130.56 11.85 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.193 0.308 . . . . 0.0 111.192 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 p -124.8 155.19 39.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.0 m -97.7 -41.05 8.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.621 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -120.04 137.65 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 O-C-N 123.365 0.415 . . . . 0.0 110.115 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -102.61 149.04 24.82 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.76 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 t -121.55 134.88 55.04 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.977 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.4 t -97.96 -0.9 43.95 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.96 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -98.36 138.48 35.54 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.201 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -124.18 148.4 47.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.008 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -126.42 144.98 50.65 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.628 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -112.46 132.63 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.046 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -109.9 155.42 21.74 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.23 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.23 -177.45 43.3 Favored Glycine 0 C--N 1.34 0.764 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.965 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.91 -62.25 1.09 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 121.566 -0.35 . . . . 0.0 112.786 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.9 m -120.86 148.33 44.18 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.618 0.246 . . . . 0.0 111.072 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.83 -53.33 1.2 Allowed Glycine 0 C--N 1.338 0.651 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.563 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -174.26 -178.02 43.86 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.52 -0.372 . . . . 0.0 112.818 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.0 p -70.7 -29.44 65.73 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 179.01 -178.45 48.8 Favored Glycine 0 C--N 1.339 0.705 0 O-C-N 123.467 0.479 . . . . 0.0 112.652 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.64 -55.29 2.46 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.638 -0.315 . . . . 0.0 113.127 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.0 p -70.72 -30.44 66.98 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.1 -176.73 42.21 Favored Glycine 0 C--N 1.34 0.772 0 O-C-N 123.411 0.445 . . . . 0.0 113.041 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.43 37.39 10.89 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 120.095 -0.281 . . . . 0.0 113.526 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.1 p -118.23 148.37 42.48 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.631 0.253 . . . . 0.0 111.182 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.35 -21.38 49.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.609 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.6 p -74.08 -20.7 60.19 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.0 p -82.63 -8.91 59.58 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -93.25 128.32 39.18 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.117 0.26 . . . . 0.0 110.978 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -110.31 2.15 18.96 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.598 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG11 ' SD ' ' A' ' 23' ' ' MET . 45.9 t -99.38 135.07 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.82 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.3 OUTLIER -124.08 151.25 44.06 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 110.909 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 66.0 t80 -94.45 129.46 41.2 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.519 HG12 HG12 ' A' ' 137' ' ' VAL . 5.0 m -126.21 121.46 59.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 O-C-N 123.468 0.48 . . . . 0.0 110.202 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.35 153.0 20.59 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 123.645 0.591 . . . . 0.0 112.961 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.65 18.8 10.38 Favored Glycine 0 C--N 1.334 0.441 0 O-C-N 124.015 0.479 . . . . 0.0 112.442 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.576 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.74 161.44 17.61 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.798 0.333 . . . . 0.0 110.672 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.5 158.22 17.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.228 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.61 ' HA ' ' HE2' ' A' ' 104' ' ' HIS . 44.6 mt-10 -64.32 -27.76 69.25 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.648 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.92 -2.54 34.13 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.887 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.7 m -86.11 138.74 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 120.689 0.28 . . . . 0.0 110.738 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.484 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.3 m-20 -117.94 178.56 4.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.598 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.89 -28.82 69.78 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.566 0.346 . . . . 0.0 111.546 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.82 -40.71 79.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.49 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 5.2 t -65.88 -45.81 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.087 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.461 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -65.91 -39.21 90.38 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.571 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 26.9 t-80 -68.31 -48.49 64.78 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.763 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.35 -20.28 62.99 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.42 -35.41 23.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 111.377 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 82.2 m-85 -100.25 -0.43 38.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.159 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.8 tp -68.07 -32.59 4.17 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -59.69 -22.87 69.34 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.773 1.649 . . . . 0.0 113.89 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -81.18 -31.46 34.0 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.35 -167.86 40.05 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.098 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -84.06 131.79 34.77 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.684 0.394 . . . . 0.0 111.183 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.513 HG21 HD11 ' A' ' 93' ' ' ILE . 9.2 mt -112.98 135.88 51.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.388 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -91.3 -58.73 2.35 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.544 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -146.57 152.97 39.8 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.513 HD11 HG21 ' A' ' 90' ' ' ILE . 19.4 mm -118.23 115.14 47.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -114.53 122.77 47.58 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 111.035 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 108' ' ' ALA . 0.5 OUTLIER -127.43 123.23 23.11 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.602 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.15 127.6 18.73 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.226 1.951 . . . . 0.0 112.282 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.64 135.6 47.06 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.24 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -94.01 146.33 24.02 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.387 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -64.6 -36.03 82.91 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -75.55 -49.2 19.35 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 32.5 p -92.57 -28.58 16.66 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 52.46 22.99 2.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.265 0.626 . . . . 0.0 111.885 -178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 101' ' ' THR . 66.2 mttt -107.44 148.48 29.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.67 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 21.8 p80 -93.0 -9.39 39.99 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.016 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 71.61 -18.97 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.359 1.063 . . . . 0.0 113.063 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.495 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.9 26.07 4.56 Favored Glycine 0 C--N 1.34 0.778 0 CA-C-O 119.507 -0.607 . . . . 0.0 114.551 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -147.5 145.58 29.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.604 0.702 . . . . 0.0 111.213 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.403 ' HB2' HG23 ' A' ' 95' ' ' ILE . . . -152.58 168.26 26.18 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.949 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -113.29 140.93 47.58 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 93' ' ' ILE . 7.8 p -116.22 135.22 57.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 90' ' ' ILE . 19.0 tt0 -104.79 125.59 51.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.261 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -111.52 138.38 48.12 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.088 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -66.35 -37.0 84.33 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.706 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.65 134.19 52.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.863 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.94 63.0 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.981 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.45 -49.54 63.2 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.08 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -68.67 -32.47 72.32 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.82 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.94 -44.09 97.74 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.534 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.76 -31.07 68.82 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.252 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.94 73.25 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.243 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.82 -37.95 87.62 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.717 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.734 HD11 HD22 ' A' ' 66' ' ' LEU . 64.8 mt -69.99 -33.89 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.022 0.201 . . . . 0.0 111.125 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -67.44 -35.9 80.15 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -102.58 -35.03 8.87 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.503 ' O ' HG13 ' A' ' 137' ' ' VAL . 95.6 mmm -92.07 0.57 57.47 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.4 t-20 -56.49 -37.37 70.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.827 0.285 . . . . 0.0 111.728 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -141.9 73.49 1.41 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.345 0.593 . . . . 0.0 109.504 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 78.2 p -125.41 157.2 37.44 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.25 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -94.99 120.05 34.55 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.612 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.11 129.83 44.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.985 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.9 t80 62.64 15.1 7.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.747 0.819 . . . . 0.0 112.366 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.62 4.61 58.04 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 116.279 -0.419 . . . . 0.0 113.402 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -127.58 154.11 45.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.741 0.271 . . . . 0.0 110.999 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 m -83.0 134.62 35.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.0 pt -119.8 156.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 123.421 0.451 . . . . 0.0 112.113 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 31.7 ptt180 -126.06 132.94 51.84 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.211 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -128.98 140.19 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.062 179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -144.31 170.26 16.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.409 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.13 119.81 15.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.153 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.401 ' HB3' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.086 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.457 0.17 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.8 mmm -103.55 137.02 42.21 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.814 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.7 mtt -101.09 138.78 37.67 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.653 0.596 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 57.5 41.41 26.01 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.759 0.823 . . . . 0.0 111.992 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.0 t -133.07 138.44 46.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.963 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.7 42.83 7.1 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.293 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -90.9 133.64 35.09 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 122.447 0.299 . . . . 0.0 110.5 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 t -127.96 141.4 51.54 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.056 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -95.9 146.16 24.8 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.762 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 10' ' ' ARG . 51.1 mtt180 -119.0 150.09 40.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.071 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.81 -8.95 59.84 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.225 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.98 -33.56 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -63.43 -42.29 98.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 m -66.45 -37.18 84.59 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.1 tptp -64.29 -35.84 82.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.062 0.545 . . . . 0.0 111.975 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.1 m -67.65 -36.25 80.39 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.8 147.46 25.45 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.363 0.414 . . . . 0.0 111.016 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -118.93 136.08 54.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.218 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.8 tp -106.77 150.88 25.86 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.454 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -70.25 153.84 42.61 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.565 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -61.24 -37.73 84.11 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.28 -41.86 76.28 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.469 ' O ' HD12 ' A' ' 27' ' ' LEU . 8.3 mtt -70.39 -38.46 74.7 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -65.79 -43.09 89.77 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.712 0.405 . . . . 0.0 112.079 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -70.97 -46.67 61.93 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 31.1 mt -69.93 -45.48 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 23' ' ' MET . 8.2 mt -68.86 -35.52 77.02 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -69.58 -36.53 76.34 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 120.56 0.219 . . . . 0.0 111.587 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -137.73 106.54 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.244 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 26' ' ' ILE . 4.4 mt -103.05 121.7 48.07 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.403 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.72 129.37 20.88 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.533 2.155 . . . . 0.0 111.568 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -44.78 -35.33 2.67 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.6 p -89.53 -40.88 12.36 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.26 -33.63 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.295 0.238 . . . . 0.0 111.373 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.6 -28.2 68.96 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.449 0.468 . . . . 0.0 112.014 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -161.03 128.87 4.31 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.226 0.329 . . . . 0.0 110.771 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.9 p -126.93 157.55 39.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.8 m -87.09 -44.04 11.84 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.585 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.1 t -125.78 132.58 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 123.41 0.443 . . . . 0.0 109.925 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -118.08 134.81 54.65 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.876 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 33.7 t -129.61 130.6 45.84 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -132.52 -43.24 0.93 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.359 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -107.95 141.21 39.93 Favored 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.415 0.447 . . . . 0.0 110.122 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -120.31 136.39 54.7 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.037 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -76.38 -32.66 58.71 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.63 141.44 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 123.233 0.333 . . . . 0.0 110.912 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -94.79 148.41 22.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.19 48.21 0.01 OUTLIER Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.802 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.08 178.55 48.21 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.484 -0.389 . . . . 0.0 112.723 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.0 p -130.72 153.74 48.68 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.325 0.25 . . . . 0.0 111.06 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.71 179.97 43.2 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.879 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.63 29.74 31.67 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.701 -0.285 . . . . 0.0 113.444 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.5 m -64.12 -36.18 83.2 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 163.82 -118.82 0.84 Allowed Glycine 0 C--N 1.339 0.699 0 O-C-N 123.493 0.495 . . . . 0.0 112.46 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.68 -36.2 92.03 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 113.766 0.266 . . . . 0.0 113.766 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.1 m -120.24 148.22 43.97 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 122.313 0.245 . . . . 0.0 110.954 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.37 -178.13 35.98 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.636 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.16 34.67 4.48 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.357 -0.449 . . . . 0.0 113.106 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.6 p -124.87 150.16 46.76 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.508 0.194 . . . . 0.0 111.175 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.55 151.23 31.86 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.23 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.0 p -115.12 162.16 17.41 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.7 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.3 p -79.09 91.39 4.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.147 0.499 . . . . 0.0 111.348 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.21 143.23 50.43 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 76.1 mtt85 -90.54 -0.44 57.67 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.152 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 111' ' ' GLU . 6.0 t -106.5 131.3 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.636 HD22 HD11 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -123.45 156.95 34.55 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.459 0.475 . . . . 0.0 110.837 -179.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.865 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 48.0 t80 -98.71 134.8 41.12 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.704 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 137' ' ' VAL . 2.6 m -134.11 114.82 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.9 150.52 19.37 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.656 -179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 101.62 36.77 3.67 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.784 ' HB3' HG11 ' A' ' 75' ' ' VAL . 3.3 mp -94.4 164.73 12.89 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.004 0.431 . . . . 0.0 111.227 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.77 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -88.7 164.44 15.3 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.499 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -69.38 -32.79 72.04 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -83.14 5.73 21.66 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.24 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.784 HG11 ' HB3' ' A' ' 71' ' ' LEU . 3.9 p -86.41 136.07 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 120.648 0.261 . . . . 0.0 110.854 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -122.35 174.58 6.92 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.467 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.434 ' OD2' ' HB ' ' A' ' 93' ' ' ILE . 8.0 m-20 -61.65 -32.53 72.69 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.146 0.578 . . . . 0.0 112.045 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -67.37 -40.25 85.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.684 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.2 -43.08 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.967 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.423 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -68.46 -36.47 79.05 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.809 -179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 6.4 t60 -68.56 -49.51 58.89 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.595 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.522 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -71.0 -20.91 62.36 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.64 -34.35 23.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.948 0.404 . . . . 0.0 111.209 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 64.9 m-85 -98.14 -2.46 39.9 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.102 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.4 tp -67.13 -32.35 4.66 Favored Pre-proline 0 CA--C 1.566 1.577 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.5 -23.54 71.21 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 121.782 1.655 . . . . 0.0 113.795 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 45.0 m-85 -80.3 -31.62 38.17 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.23 -168.05 40.94 Favored Glycine 0 C--N 1.339 0.74 0 O-C-N 123.467 0.48 . . . . 0.0 112.738 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -84.88 133.19 34.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.566 0.347 . . . . 0.0 111.148 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.44 ' HB ' ' CE1' ' A' ' 81' ' ' HIS . 5.3 mt -114.08 138.9 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.643 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 111' ' ' GLU . 11.1 p -89.89 -60.31 1.97 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.951 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -149.06 159.22 44.43 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.441 ' CD1' HG23 ' A' ' 110' ' ' VAL . 17.7 mm -117.93 126.98 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -121.01 126.96 51.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 107' ' ' PHE . 1.1 mp -128.13 115.88 20.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.698 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.45 126.87 22.67 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.284 1.989 . . . . 0.0 112.623 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 102' ' ' GLU . 0.9 OUTLIER -127.53 135.09 49.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.173 -179.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -91.32 144.17 25.88 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.502 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -64.7 -34.9 79.4 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -71.21 -48.63 50.33 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.5 p -98.7 -27.69 13.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' HD11 ' A' ' 97' ' ' LEU . 51.4 mt-10 57.18 22.84 7.96 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.29 0.636 . . . . 0.0 111.674 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -121.32 155.44 34.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.292 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -101.32 160.85 14.07 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.236 0.335 . . . . 0.0 110.769 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 77.9 mtt180 -88.55 2.95 52.03 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.197 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 96.34 27.13 10.23 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.326 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 95' ' ' ILE . 30.4 p90 -143.6 148.98 36.68 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 117.372 0.586 . . . . 0.0 111.127 177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -152.54 169.5 22.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.915 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -117.3 144.08 45.25 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.441 HG23 ' CD1' ' A' ' 93' ' ' ILE . 10.6 p -120.99 134.53 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 123.211 0.319 . . . . 0.0 111.01 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 91' ' ' THR . 0.5 OUTLIER -106.53 128.49 54.15 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.32 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.505 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 13.6 m-85 -109.25 137.16 47.55 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.04 -35.82 82.39 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.016 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.54 134.26 50.81 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.004 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.82 -26.42 65.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.31 -44.1 84.37 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.873 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -68.49 -33.06 73.5 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.232 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.627 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -60.58 -46.16 91.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.28 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.29 -28.79 66.59 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.314 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.69 -40.88 72.63 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.507 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.01 88.78 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.223 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.781 HD13 HD22 ' A' ' 139' ' ' LEU . 12.8 mt -70.73 -33.65 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 123.252 0.345 . . . . 0.0 111.875 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.13 -17.31 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -101.22 -43.03 6.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.506 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 84.7 mtp -126.24 47.41 2.27 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 19.0 p-10 -66.29 -33.92 76.83 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.328 178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 44.1 mt-10 -143.06 77.47 1.57 Allowed 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.733 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.6 m -123.56 162.57 22.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.179 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -90.32 119.7 30.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.87 0.367 . . . . 0.0 110.77 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.8 129.63 48.7 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.003 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 57.22 20.59 5.83 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.053 0.941 . . . . 0.0 112.693 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.99 3.99 60.3 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.154 -0.476 . . . . 0.0 113.893 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -127.66 155.08 44.49 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.686 0.243 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.0 131.25 35.76 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 1.6 pt -116.83 151.99 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 74.6 mtt180 -122.72 134.3 54.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.325 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.865 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -128.16 133.78 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.459 178.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -147.13 172.67 13.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.665 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.781 HD22 HD13 ' A' ' 122' ' ' ILE . 1.9 mm? -67.9 127.42 32.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.704 0.402 . . . . 0.0 110.66 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.128 -179.651 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 N--CA 1.487 1.406 0 N-CA-C 111.274 0.101 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.5 mmm -100.98 136.87 40.14 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.447 0.467 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.3 mtp -122.39 155.16 36.62 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -106.71 149.97 26.75 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.929 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.7 m -71.38 -36.66 71.51 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.325 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.74 -169.96 31.74 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 116.201 -0.454 . . . . 0.0 113.12 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -32.12 73.63 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t -91.27 130.1 37.18 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.336 0.397 . . . . 0.0 111.461 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -85.59 142.68 28.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.411 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -93.67 1.78 56.5 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.434 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -95.36 140.48 30.18 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.218 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 m -131.3 149.39 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.111 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -65.5 -28.66 69.35 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -59.09 -37.38 77.0 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HA ' ' ND2' ' A' ' 18' ' ' ASN . 86.6 mttt -63.67 -36.15 82.88 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.3 m -72.54 -34.69 67.71 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -66.46 -26.84 67.39 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.14 0.576 . . . . 0.0 112.214 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 15' ' ' LYS . 85.7 m-20 -57.56 -36.71 72.04 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.58 152.41 20.46 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.336 0.398 . . . . 0.0 111.38 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.8 m -90.81 157.76 17.2 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.035 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -60.59 -35.65 76.62 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.85 -45.71 60.47 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.9 tpp -65.96 -37.91 87.2 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.711 0.404 . . . . 0.0 111.61 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.83 -40.96 92.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.807 0.443 . . . . 0.0 111.534 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -69.13 -38.59 78.92 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.01 -51.69 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 123.299 0.374 . . . . 0.0 111.562 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -69.9 -39.69 76.06 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.7 m -68.16 -36.1 79.1 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 120.6 0.238 . . . . 0.0 111.524 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.595 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 82.9 m-20 -105.55 54.35 0.7 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -98.89 98.29 6.08 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.691 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 29' ' ' ASN . 9.6 Cg_exo -72.0 130.27 16.42 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.823 2.349 . . . . 0.0 111.704 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -50.86 -34.0 26.25 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.5 m -82.81 -40.73 19.99 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.61 -32.04 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.489 0.316 . . . . 0.0 111.78 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.76 -31.07 71.84 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -151.83 126.54 9.56 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.207 0.317 . . . . 0.0 111.16 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.1 p -127.66 154.21 45.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.169 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.4 m -130.72 -44.63 1.08 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.174 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -121.93 143.61 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.87 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.06 151.4 23.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.172 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.425 ' SG ' ' HG3' ' A' ' 43' ' ' GLU . 17.7 t -120.75 137.05 54.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.153 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.0 p -100.89 57.07 0.87 Allowed 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.663 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 51.0 mt-10 -62.44 139.33 58.57 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.956 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -69.73 -33.88 73.08 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.465 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -105.54 137.21 43.76 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.312 0.382 . . . . 0.0 111.13 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.6 m -130.84 154.71 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -104.1 156.8 17.58 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.198 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 178.1 135.4 2.28 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.95 79.37 0.07 OUTLIER Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.432 -0.413 . . . . 0.0 112.421 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.1 m -121.93 148.0 45.31 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.599 0.235 . . . . 0.0 111.01 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.82 178.55 36.76 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.655 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 149.84 -166.18 29.79 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 121.39 -0.433 . . . . 0.0 112.638 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.6 m -63.41 -34.4 77.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.915 0.486 . . . . 0.0 112.275 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -131.63 166.13 23.1 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.612 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.21 -48.2 4.67 Favored Glycine 0 C--N 1.34 0.764 0 C-N-CA 121.572 -0.347 . . . . 0.0 113.247 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.3 p -122.05 153.54 38.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.595 0.236 . . . . 0.0 111.203 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.25 -179.16 33.89 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.674 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.29 111.06 4.13 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.596 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.8 p -78.23 -21.14 50.42 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.85 -37.16 78.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.7 p -79.52 -25.98 41.6 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.83 -44.85 10.2 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.381 0.426 . . . . 0.0 111.748 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -96.34 130.06 43.54 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.287 0.367 . . . . 0.0 111.573 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 72.5 mtt85 -113.39 6.27 17.15 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.886 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.558 HG22 ' HG3' ' A' ' 111' ' ' GLU . 22.0 t -104.95 136.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.632 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.98 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.88 155.97 37.11 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.554 0.533 . . . . 0.0 111.386 -178.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.769 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 40.0 t80 -92.71 134.79 34.69 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.437 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.545 HG12 HG12 ' A' ' 137' ' ' VAL . 2.6 m -134.64 115.18 19.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 O-C-N 123.654 0.596 . . . . 0.0 109.663 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.22 152.31 20.35 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.989 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.89 8.03 Favored Glycine 0 C--N 1.332 0.342 0 O-C-N 123.99 0.465 . . . . 0.0 112.332 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -92.01 164.76 13.5 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.573 0.349 . . . . 0.0 110.592 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -91.09 155.52 18.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.739 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.08 -26.16 68.7 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.67 0.388 . . . . 0.0 111.749 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.79 -3.03 32.72 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.689 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -86.3 135.51 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.692 0.282 . . . . 0.0 110.907 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -109.49 174.86 5.68 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.547 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -60.52 -29.63 69.23 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.567 0.347 . . . . 0.0 111.57 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -68.81 -35.39 76.94 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.42 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.79 -47.33 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.792 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 HG21 ' A' ' 68' ' ' VAL . 1.5 tt -67.62 -38.88 84.56 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.614 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.543 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 7.7 t60 -67.67 -48.94 65.2 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.446 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.59 -20.36 62.78 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.84 -34.04 24.73 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 111.456 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' C ' HD11 ' A' ' 90' ' ' ILE . 77.5 m-85 -102.34 0.2 33.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.433 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 3.8 tp -68.83 -32.81 3.75 Favored Pre-proline 0 CA--C 1.565 1.525 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 15.1 Cg_endo -58.61 -23.42 65.22 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 121.94 1.76 . . . . 0.0 113.941 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -78.34 -31.39 48.64 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.87 -161.94 34.81 Favored Glycine 0 C--N 1.34 0.752 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.998 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -83.71 134.79 34.74 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.689 0.396 . . . . 0.0 111.833 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.514 HG21 HD11 ' A' ' 93' ' ' ILE . 15.2 mt -116.63 138.67 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.176 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -94.21 -60.8 1.65 Allowed 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.433 ' H ' ' HB3' ' A' ' 111' ' ' GLU . 75.4 m-20 -143.86 153.19 42.09 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.514 HD11 HG21 ' A' ' 90' ' ' ILE . 20.8 mm -119.46 124.64 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.59 127.56 54.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.71 114.37 20.82 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.935 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.28 130.88 37.99 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.399 2.066 . . . . 0.0 112.734 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.09 132.53 50.61 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.131 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -94.25 142.76 27.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.355 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -64.69 -34.28 77.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.8 -42.58 81.35 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 19.1 p -112.65 -26.71 8.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 60.82 19.61 9.81 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.347 0.659 . . . . 0.0 111.397 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -122.43 155.34 36.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.343 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -107.03 157.88 17.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.645 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -82.75 -1.39 51.37 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.326 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 101.57 41.64 2.49 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-O 119.807 -0.44 . . . . 0.0 113.836 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -147.28 147.47 30.43 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.85 0.357 . . . . 0.0 110.961 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.27 172.76 17.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.769 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -115.57 142.33 46.87 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.7 p -114.05 134.51 56.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 123.213 0.321 . . . . 0.0 110.599 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.558 ' HG3' HG22 ' A' ' 65' ' ' VAL . 17.0 tt0 -108.26 125.64 51.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.618 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.474 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 30.0 m-85 -112.42 137.61 50.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.694 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -65.56 -36.71 84.58 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.58 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.6 mp -105.74 140.23 39.1 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.888 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.38 -22.51 57.44 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.924 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -72.8 -49.55 29.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.58 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 21.3 p30 -67.03 -32.3 73.41 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.653 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.98 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.6 -42.73 91.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.01 0.524 . . . . 0.0 111.036 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.97 -29.1 69.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.209 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.18 -37.31 78.11 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.934 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.05 -38.08 87.47 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.454 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.764 HD11 HD22 ' A' ' 66' ' ' LEU . 44.2 mt -70.16 -33.0 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 123.234 0.334 . . . . 0.0 111.281 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.83 -36.18 77.87 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -105.56 -33.04 8.22 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.485 ' O ' HG13 ' A' ' 137' ' ' VAL . 98.0 mmm -95.85 3.98 53.21 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.647 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 9.6 t-20 -56.57 -37.52 70.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.845 0.293 . . . . 0.0 111.764 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.06 72.85 1.4 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.695 0.76 . . . . 0.0 109.94 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.1 t -124.71 157.33 35.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.181 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -93.8 120.85 34.6 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.6 tp -128.48 128.21 43.95 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.806 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 62.07 15.98 7.82 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.658 0.783 . . . . 0.0 112.437 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.92 58.25 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.447 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -127.51 153.81 45.89 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 122.428 0.291 . . . . 0.0 110.778 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 m -82.08 134.17 35.32 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pt -119.27 154.36 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 73.7 mtt180 -122.26 134.3 54.68 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.359 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -130.95 138.38 53.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.896 178.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -151.67 172.18 16.49 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.556 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' HG ' HD13 ' A' ' 122' ' ' ILE . 19.7 mt -70.29 129.9 40.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.553 0.216 . . . . 0.0 111.118 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.293 -179.459 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.483 0.182 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 98.2 mmm -100.75 128.4 46.81 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.829 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.4 mtt -72.38 -36.88 68.82 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.833 -0.622 . . . . 0.0 112.386 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -108.32 143.57 37.02 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.384 0.428 . . . . 0.0 111.048 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 77.4 m -94.28 -42.14 9.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.43 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 26.64 33.3 Favored Glycine 0 C--N 1.343 0.925 0 O-C-N 123.387 0.43 . . . . 0.0 113.429 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -97.55 149.14 22.53 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.372 0.269 . . . . 0.0 111.067 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -125.91 131.51 52.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.784 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -96.31 146.28 24.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.203 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -123.93 152.33 42.57 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.827 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -98.45 142.0 30.61 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.094 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.61 136.22 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.625 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -62.34 -40.83 97.66 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 m -65.38 -40.18 93.19 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -68.98 -32.26 71.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.88 0.472 . . . . 0.0 112.261 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.68 -34.69 78.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 62.62 169.03 0.13 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.811 0.844 . . . . 0.0 112.158 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -83.68 159.65 21.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.574 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 tp -97.1 144.62 26.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.792 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.2 p -74.56 160.56 30.73 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.49 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.02 -36.98 83.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' OE2' HG23 ' A' ' 65' ' ' VAL . 29.2 tt0 -67.1 -45.62 76.67 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 123.321 0.388 . . . . 0.0 111.567 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.526 ' O ' HD12 ' A' ' 27' ' ' LEU . 26.1 mtp -69.07 -37.34 78.43 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -61.55 -43.11 99.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.79 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.55 -40.38 73.43 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.1 mt -70.1 -47.39 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 122.22 0.208 . . . . 0.0 111.388 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 23' ' ' MET . 3.3 mt -69.61 -36.46 76.21 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.3 p -76.26 -26.34 55.87 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.57 0.224 . . . . 0.0 111.409 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -113.32 82.99 1.76 Allowed 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.217 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' HB3' ' CG1' ' A' ' 34' ' ' VAL . 7.2 mt -106.66 159.84 28.43 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.594 ' O ' HG13 ' A' ' 34' ' ' VAL . 2.8 Cg_endo -81.77 164.74 18.12 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.774 2.316 . . . . 0.0 113.323 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.94 -23.48 66.39 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.971 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.5 p -82.59 21.85 0.94 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.199 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -56.64 -8.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.06 -41.94 73.5 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 53.87 105.81 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.242 1.017 . . . . 0.0 112.848 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.01 124.53 33.17 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.119 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.34 154.29 51.42 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.504 0.503 . . . . 0.0 111.485 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.01 148.64 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.123 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -96.78 111.94 23.91 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.398 0.436 . . . . 0.0 110.9 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.7 t -134.67 138.78 44.74 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.439 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 p -75.71 -31.9 59.85 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -73.11 -38.47 66.33 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -69.45 -35.75 75.95 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -111.44 135.97 51.25 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.362 0.414 . . . . 0.0 111.452 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.2 t -121.15 136.21 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.644 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.69 122.53 30.72 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.573 0.545 . . . . 0.0 110.838 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 126.42 -46.91 1.05 Allowed Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.761 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -98.75 118.15 6.07 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 121.44 -0.409 . . . . 0.0 112.631 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.7 m -65.56 -33.66 76.43 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.46 37.43 7.03 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.149 -0.478 . . . . 0.0 113.02 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.62 164.98 33.13 Favored Glycine 0 C--N 1.339 0.75 0 C-N-CA 121.628 -0.32 . . . . 0.0 112.787 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -123.59 148.92 45.92 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.327 0.251 . . . . 0.0 111.013 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.71 108.47 3.68 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.566 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.02 -41.83 6.95 Favored Glycine 0 C--N 1.339 0.72 0 O-C-N 123.679 0.282 . . . . 0.0 113.292 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 m -119.5 147.77 44.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.571 0.224 . . . . 0.0 111.07 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.02 44.75 0.06 OUTLIER Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.564 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.24 170.84 39.67 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.655 -0.307 . . . . 0.0 112.741 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.5 m -122.81 145.2 48.64 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.53 0.205 . . . . 0.0 110.955 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.67 43.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.906 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.8 p -126.26 156.08 40.88 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.309 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.2 p 51.24 -76.23 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.686 1.194 . . . . 0.0 113.488 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 113' ' ' GLU . 94.4 mttt -104.7 143.19 33.43 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 122.467 0.307 . . . . 0.0 110.721 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 139' ' ' LEU . 67.0 ttt180 -122.58 132.85 54.49 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.346 0.404 . . . . 0.0 110.988 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 111' ' ' GLU . 18.9 t -106.63 136.38 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.976 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -124.0 157.58 34.08 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.457 0.473 . . . . 0.0 111.709 -178.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.824 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 42.8 t80 -96.38 136.16 37.25 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.302 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.446 HG12 HG12 ' A' ' 137' ' ' VAL . 4.1 m -134.39 115.09 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 123.678 0.611 . . . . 0.0 109.718 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.04 142.52 13.75 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.821 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.8 29.52 2.61 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.946 0.439 . . . . 0.0 112.616 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER -97.11 163.31 12.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.929 0.395 . . . . 0.0 110.549 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -84.61 155.79 21.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.987 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.13 -27.64 68.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.64 0.376 . . . . 0.0 111.608 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -78.61 -0.28 29.24 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.951 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 72' ' ' ALA . 2.5 m -84.7 140.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 121.177 -0.209 . . . . 0.0 111.127 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.81 178.71 4.38 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.666 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -59.31 -31.22 68.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.742 0.417 . . . . 0.0 111.482 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -68.42 -39.97 81.39 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.07 -47.51 87.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.894 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD22 HD12 ' A' ' 93' ' ' ILE . 1.7 tt -67.62 -38.96 84.67 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.439 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.553 ' NE2' ' HB ' ' A' ' 90' ' ' ILE . 24.0 t-80 -68.69 -47.64 65.93 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.657 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.33 -20.69 62.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.51 -32.96 23.65 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 74.9 m-85 -102.32 1.16 35.27 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.319 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 3.9 tp -70.22 -31.64 2.41 Favored Pre-proline 0 CA--C 1.565 1.549 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.362 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.6 Cg_exo -59.21 -24.01 72.06 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 121.967 1.778 . . . . 0.0 113.861 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.551 ' HZ ' ' SD ' ' A' ' 125' ' ' MET . 55.2 m-85 -79.91 -31.45 40.18 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.18 -161.51 35.11 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.95 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -84.16 136.56 33.93 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.793 0.437 . . . . 0.0 111.864 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.553 ' HB ' ' NE2' ' A' ' 81' ' ' HIS . 5.8 mt -116.66 139.24 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.595 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 p -93.71 -61.27 1.58 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.656 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -143.26 153.51 42.86 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.554 HD12 HD22 ' A' ' 80' ' ' LEU . 18.3 mm -119.84 125.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.81 125.99 50.81 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.23 0.331 . . . . 0.0 111.721 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.35 110.81 21.22 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.941 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -59.04 128.44 27.81 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.43 2.087 . . . . 0.0 112.565 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 102' ' ' GLU . 1.1 tp -124.01 134.24 53.49 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.165 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -92.23 139.64 30.41 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.504 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -64.76 -31.98 73.45 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.09 -41.89 94.59 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.7 p -117.28 -22.84 8.09 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' O ' HD11 ' A' ' 97' ' ' LEU . 46.7 mt-10 59.99 22.66 11.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.231 0.613 . . . . 0.0 111.444 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -124.84 154.5 40.92 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.348 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -110.21 154.93 22.7 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.761 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -79.57 -11.1 59.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.025 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 111.77 41.47 1.11 Allowed Glycine 0 C--N 1.341 0.847 0 C-N-CA 121.095 -0.574 . . . . 0.0 114.019 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -145.12 145.13 31.27 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.195 0.497 . . . . 0.0 111.103 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -154.99 173.09 17.05 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.966 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -115.94 144.5 43.98 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.453 HG23 ' CD1' ' A' ' 93' ' ' ILE . 14.2 p -116.17 131.03 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 110.692 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.496 ' HG3' HG22 ' A' ' 65' ' ' VAL . 20.3 tt0 -106.37 126.89 52.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.259 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.605 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 47.7 m-85 -111.51 141.94 44.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 26.5 tt0 -64.05 -36.89 85.48 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.137 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -115.63 125.1 52.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.758 179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.55 -23.52 64.68 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.405 ' HB2' HD23 ' A' ' 114' ' ' LEU . 70.3 mm-40 -68.25 -47.87 66.61 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.586 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 112' ' ' PHE . 8.0 p30 -69.03 -32.43 71.94 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.378 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.976 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.58 -42.2 87.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.685 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.17 71.29 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.699 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.665 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -68.48 -33.66 74.54 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.692 178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.89 -37.83 82.24 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.602 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.74 HD11 HD22 ' A' ' 66' ' ' LEU . 48.0 mt -70.33 -37.76 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.665 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 3.7 p30 -82.94 -16.72 46.27 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -93.89 -47.86 6.54 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.551 ' SD ' ' HZ ' ' A' ' 87' ' ' PHE . 62.7 mtt -130.87 53.49 1.97 Allowed 'General case' 0 C--N 1.346 0.434 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.1 t-20 -64.73 -37.71 88.53 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.9 mt-10 -143.18 77.22 1.56 Allowed 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.728 0.775 . . . . 0.0 109.834 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.0 m -119.77 160.72 22.05 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.31 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -90.28 118.25 29.64 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.955 0.407 . . . . 0.0 110.679 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.3 tp -129.17 130.55 46.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.911 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.3 t80 62.86 15.07 7.94 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.727 0.811 . . . . 0.0 112.232 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.19 4.69 59.74 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.209 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -126.93 155.48 43.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.572 0.349 . . . . 0.0 110.817 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.15 133.32 35.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.2 pt -118.05 151.77 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 57.7 mtt180 -122.81 134.71 54.4 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.424 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.824 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.73 134.99 61.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.89 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -154.2 172.13 18.09 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.494 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.603 HD12 ' NH2' ' A' ' 64' ' ' ARG . 5.4 tt -69.21 129.69 40.54 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.578 0.228 . . . . 0.0 110.628 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.189 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.136 -179.91 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.473 0.177 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.32 129.96 45.57 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.909 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 72.4 mtm -69.65 -35.37 75.14 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.374 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -105.02 151.69 23.64 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.184 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m 71.26 -47.56 0.66 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.514 1.126 . . . . 0.0 112.609 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.44 39.84 8.77 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.195 0.309 . . . . 0.0 113.098 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -63.02 -31.7 72.9 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.5 t -90.56 125.52 35.64 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.43 0.456 . . . . 0.0 111.444 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -102.99 156.31 17.76 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.804 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.0 mtp-105 -104.65 136.13 44.76 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -120.89 150.35 41.21 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.8 t -110.66 128.32 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -65.67 -39.49 91.38 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.721 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.1 p -66.06 -36.49 83.37 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -65.74 -39.63 91.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.836 0.455 . . . . 0.0 111.861 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.6 m -82.27 -44.53 16.17 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -127.81 150.65 49.73 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.265 0.353 . . . . 0.0 111.355 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -111.87 131.02 55.63 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.642 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tp -100.99 150.15 23.19 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.529 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -73.0 153.69 40.81 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.58 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.24 -35.74 78.06 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -67.13 -48.39 68.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.604 0.362 . . . . 0.0 111.537 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.534 ' O ' HD12 ' A' ' 27' ' ' LEU . 92.5 mmm -68.42 -36.63 79.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -64.45 -44.28 91.61 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.187 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.88 -39.7 76.15 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.572 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 36.4 mt -66.02 -49.79 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 122.144 0.178 . . . . 0.0 111.215 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 23' ' ' MET . 3.1 mt -70.31 -38.5 74.95 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 87.3 p -72.8 -27.2 61.83 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -98.48 9.97 41.95 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.53 0.681 . . . . 0.0 110.05 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 9.5 tp -98.68 137.7 20.64 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.487 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.61 149.83 89.97 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.345 2.03 . . . . 0.0 112.077 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -57.68 -37.78 74.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 81.0 p -96.68 -15.93 21.2 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.544 0.528 . . . . 0.0 111.519 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t 53.57 9.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 124.148 0.979 . . . . 0.0 112.876 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 62.49 15.98 8.31 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.425 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 63.5 m-85 -112.27 118.28 34.84 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 110.927 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.77 114.82 6.16 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.894 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 1.7 m 56.48 -73.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.377 1.071 . . . . 0.0 113.226 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.78 149.76 33.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.678 0.275 . . . . 0.0 110.833 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -63.65 -36.89 85.31 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.9 p -119.6 122.3 41.25 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.775 0.321 . . . . 0.0 111.232 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.5 p -81.16 -27.13 35.55 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.441 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -105.98 139.87 39.86 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.283 0.364 . . . . 0.0 111.051 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -71.05 -35.53 71.97 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.178 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -114.22 138.02 51.02 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.408 0.443 . . . . 0.0 111.033 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -133.25 142.54 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.561 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -87.59 138.25 31.63 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.288 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.59 172.33 41.13 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.858 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.46 166.27 25.33 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.397 -0.43 . . . . 0.0 112.903 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 t -131.86 143.7 50.36 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 122.402 0.281 . . . . 0.0 110.62 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.11 178.5 43.45 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.083 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.03 -175.95 42.38 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 121.629 -0.319 . . . . 0.0 112.86 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 76.1 p -124.05 152.95 42.07 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.606 0.239 . . . . 0.0 111.133 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.08 43.07 7.27 Favored Glycine 0 C--N 1.341 0.821 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.35 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.03 -50.65 10.23 Favored Glycine 0 C--N 1.343 0.921 0 C-N-CA 121.801 -0.238 . . . . 0.0 113.141 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -73.75 -36.88 65.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.755 0.422 . . . . 0.0 111.99 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.88 179.69 43.09 Favored Glycine 0 C--N 1.341 0.847 0 O-C-N 123.52 0.512 . . . . 0.0 112.92 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 170.37 -176.57 43.95 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.542 -0.361 . . . . 0.0 112.829 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.6 m -121.42 143.45 49.22 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.589 0.233 . . . . 0.0 110.981 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.51 -24.73 29.25 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.351 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.2 p -77.1 -14.42 59.81 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.2 p -74.4 -28.01 60.9 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HE2' ' C ' ' A' ' 140' ' ' ALA . 29.6 tptt -114.45 133.48 55.72 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.275 0.359 . . . . 0.0 110.363 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -102.4 -3.63 26.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.764 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.49 133.13 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.93 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.2 OUTLIER -123.11 156.99 33.87 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.535 0.522 . . . . 0.0 111.411 -178.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.0 t80 -101.04 134.61 43.78 Favored 'General case' 0 N--CA 1.458 -0.042 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.455 HG12 ' CG1' ' A' ' 137' ' ' VAL . 4.0 m -128.98 116.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 O-C-N 123.548 0.53 . . . . 0.0 109.769 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -127.2 152.96 18.88 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 120.762 -0.733 . . . . 0.0 113.384 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.02 23.72 7.6 Favored Glycine 0 C--N 1.336 0.538 0 O-C-N 123.985 0.462 . . . . 0.0 112.588 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -92.0 163.09 14.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.903 0.382 . . . . 0.0 110.813 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -90.61 157.86 17.26 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.869 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.6 ' HA ' ' NE2' ' A' ' 104' ' ' HIS . 38.8 mt-10 -64.71 -26.67 68.47 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.722 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -77.41 -1.53 30.61 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.766 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -86.53 139.78 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-O 120.572 0.225 . . . . 0.0 110.66 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 75.1 m-20 -121.71 179.02 4.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.67 -30.61 68.88 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.803 0.441 . . . . 0.0 111.54 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.54 -40.77 80.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.702 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.504 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.3 t -67.06 -46.98 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.212 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.448 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 tt -67.04 -39.42 86.96 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.644 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.569 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 9.1 t60 -68.07 -48.68 64.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.023 0.529 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.41 -20.62 62.91 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.43 -34.03 23.56 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.923 0.392 . . . . 0.0 111.402 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 80' ' ' LEU . 79.8 m-85 -101.54 0.21 36.11 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.285 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.2 tp -70.25 -31.85 2.49 Favored Pre-proline 0 CA--C 1.564 1.495 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 45.5 Cg_exo -59.01 -23.4 68.42 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.007 1.805 . . . . 0.0 113.882 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -78.02 -31.29 50.41 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.43 -162.67 36.26 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.827 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.88 134.0 35.1 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.72 0.408 . . . . 0.0 111.769 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.507 HG21 HD11 ' A' ' 93' ' ' ILE . 12.7 mt -114.41 139.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.267 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.45 -62.63 1.42 Allowed 'General case' 0 C--O 1.235 0.327 0 O-C-N 123.668 0.605 . . . . 0.0 112.303 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -146.9 154.91 41.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 90' ' ' ILE . 17.5 mm -117.2 125.51 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -121.07 128.22 52.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.4 mp -127.73 116.72 20.93 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.706 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.37 121.74 10.39 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.209 1.939 . . . . 0.0 112.413 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 134.57 49.74 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.175 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.81 143.07 26.9 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.424 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -64.73 -33.47 76.05 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -70.66 -48.57 54.22 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.2 p -100.46 -27.85 13.22 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 56.82 23.88 8.56 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.235 0.614 . . . . 0.0 111.569 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -121.37 156.83 31.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.522 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 73' ' ' GLU . 9.5 p80 -110.18 159.36 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.928 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.43 ' HB2' ' CE2' ' A' ' 107' ' ' PHE . 85.5 mtt-85 -87.77 3.6 47.52 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.015 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 94.51 35.02 6.07 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.594 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 1.3 p90 -143.73 147.12 33.76 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.65 0.262 . . . . 0.0 110.941 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -155.0 169.52 23.89 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.639 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -116.19 144.42 44.21 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.0 p -118.84 133.15 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.425 0.453 . . . . 0.0 110.434 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.05 127.33 53.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.521 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . 32.2 m-85 -113.8 141.69 46.99 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.271 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -67.47 -37.23 82.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.606 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.515 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 5.1 mp -102.77 138.95 38.99 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.46 -19.54 59.37 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.483 0.658 . . . . 0.0 109.267 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -72.19 -50.99 23.29 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.754 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.515 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 24.0 p30 -69.33 -31.86 70.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.905 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.93 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -65.15 -45.02 86.71 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 122.931 0.492 . . . . 0.0 111.423 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.66 -30.51 71.22 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.017 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.65 -35.6 77.48 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.101 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 125' ' ' MET . . . -67.29 -39.52 85.98 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.8 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.637 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 52.7 mt -69.16 -33.82 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 116.862 -0.154 . . . . 0.0 111.32 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -68.72 -36.4 78.37 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.36 -34.46 8.28 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.482 ' O ' HG13 ' A' ' 137' ' ' VAL . 94.0 mmm -91.68 0.54 57.49 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 122' ' ' ILE . 10.1 t-20 -56.64 -36.95 70.09 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.847 0.294 . . . . 0.0 111.678 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.74 70.96 1.36 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.619 0.723 . . . . 0.0 110.061 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 55.0 m -121.81 154.7 36.66 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.336 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.7 119.4 32.65 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.471 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tp -129.94 130.18 44.77 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.013 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 61.99 15.68 7.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.658 0.783 . . . . 0.0 112.443 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.51 4.92 59.22 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.256 -0.429 . . . . 0.0 113.298 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -127.0 154.39 44.68 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.514 0.326 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.53 134.35 34.84 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 pt -118.02 154.79 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.024 0.44 . . . . 0.0 112.135 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 22.8 ttp-105 -124.24 131.78 53.55 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.785 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.8 OUTLIER -129.27 139.49 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.316 0.385 . . . . 0.0 110.738 179.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -145.25 171.94 13.85 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.248 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 122' ' ' ILE . 9.2 mt -68.95 133.33 48.05 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.24 0.216 . . . . 0.0 110.921 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.405 ' C ' ' HE2' ' A' ' 63' ' ' LYS . . . . . . . . 0 N--CA 1.464 0.274 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.34 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.483 0.183 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.4 mtt -101.57 137.03 40.43 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.819 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 73.5 mtm -103.49 145.8 29.48 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.879 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -111.61 141.33 45.34 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.742 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.82 -39.51 11.72 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.863 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.77 134.47 12.44 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 123.433 0.458 . . . . 0.0 112.992 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -88.55 -12.33 43.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.1 t -132.83 142.44 48.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -93.15 10.25 32.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.584 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -108.32 154.75 21.37 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -101.26 152.22 20.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.43 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 t -110.98 141.07 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.742 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -60.22 -42.98 96.33 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.273 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.9 p -69.42 -36.9 77.14 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -67.27 -39.72 86.1 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.0 p -73.36 -36.71 66.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.4 126.44 43.93 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.203 0.314 . . . . 0.0 111.074 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -147.33 159.98 43.05 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.954 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.4 tp -107.7 141.73 38.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.014 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.9 p -71.12 156.47 39.55 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.739 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.36 -35.18 80.03 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.515 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -68.24 -45.52 73.0 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.714 0.406 . . . . 0.0 111.642 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.502 ' O ' HD12 ' A' ' 27' ' ' LEU . 97.6 mmm -68.08 -38.58 82.54 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -65.57 -42.59 91.62 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.045 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.24 -39.57 74.97 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.3 mt -68.78 -47.24 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 123.007 0.192 . . . . 0.0 111.262 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 23' ' ' MET . 5.3 mt -69.52 -36.9 76.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 96.3 p -76.31 -24.52 54.35 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -114.99 80.92 1.48 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.17 0.509 . . . . 0.0 110.76 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.8 mt -108.39 122.13 41.38 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.245 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.52 138.56 65.69 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.751 2.301 . . . . 0.0 112.379 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -37.45 -35.53 0.13 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 t -118.27 -23.09 7.41 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.0 t -67.86 -25.16 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.63 -33.3 73.7 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -157.19 138.73 13.97 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.273 0.358 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.4 p -130.19 154.4 47.58 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.043 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 68.0 m -120.53 -51.42 2.17 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.153 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.67 160.89 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.689 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -94.52 122.96 37.64 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.316 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.677 ' SG ' ' HG3' ' A' ' 43' ' ' GLU . 4.4 t -128.36 151.05 49.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.092 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.9 t -90.83 23.53 3.09 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.616 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.677 ' HG3' ' SG ' ' A' ' 41' ' ' CYS . 45.4 mt-10 -65.51 -29.25 69.86 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.228 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -79.01 147.39 32.89 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.492 0.495 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -104.56 141.68 35.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.851 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -73.93 -30.59 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.583 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -90.86 127.15 36.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.379 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 55' ' ' GLY . . . -89.96 -171.26 44.53 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.872 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.38 14.69 50.03 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.407 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.0 p -68.26 -24.82 64.93 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.34 50.23 0.24 Allowed Glycine 0 C--N 1.338 0.685 0 O-C-N 123.506 0.504 . . . . 0.0 112.594 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -156.21 178.37 32.75 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 121.426 -0.416 . . . . 0.0 112.784 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.6 p -78.45 -20.08 51.75 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.15 32.98 5.33 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.37 0.419 . . . . 0.0 113.153 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.42 ' O ' ' HA3' ' A' ' 48' ' ' GLY . . . -65.16 -36.7 93.22 Favored Glycine 0 C--N 1.345 1.069 0 N-CA-C 113.849 0.3 . . . . 0.0 113.849 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 m -121.28 148.84 43.77 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 123.584 0.226 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.01 -168.75 37.35 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.668 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.41 13.01 49.78 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-O 119.89 -0.395 . . . . 0.0 113.531 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.7 m -118.0 144.77 45.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.818 0.309 . . . . 0.0 110.831 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.22 150.04 31.44 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.618 0.574 . . . . 0.0 111.431 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.449 ' OG1' ' HE2' ' A' ' 63' ' ' LYS . 27.4 p -120.69 163.24 18.37 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.659 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -74.13 99.59 3.41 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.218 0.532 . . . . 0.0 111.347 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HE2' ' OG1' ' A' ' 61' ' ' THR . 60.3 mttm -129.85 143.34 50.76 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.854 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 77.2 mtt85 -91.58 3.59 54.64 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.715 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG22 ' HG3' ' A' ' 111' ' ' GLU . 10.2 t -107.54 128.94 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.796 HD22 HD11 ' A' ' 122' ' ' ILE . 0.6 OUTLIER -123.33 155.64 36.88 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.678 -179.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 52.5 t80 -92.29 136.02 33.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.834 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 136' ' ' ARG . 2.9 m -134.54 115.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 135' ' ' ILE . . . -130.43 142.23 13.5 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.563 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 114.26 24.9 4.3 Favored Glycine 0 C--N 1.332 0.315 0 O-C-N 123.954 0.444 . . . . 0.0 112.429 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -95.53 164.6 12.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.264 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' HB3' HG13 ' A' ' 75' ' ' VAL . . . -79.58 151.79 30.44 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.134 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.72 -30.42 71.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.652 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -83.88 13.61 4.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.883 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 72' ' ' ALA . 5.6 m -88.8 133.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-O 120.707 0.289 . . . . 0.0 110.856 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' H ' ' CG2' ' A' ' 79' ' ' VAL . 2.6 t70 -102.42 173.52 6.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.457 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -59.34 -30.1 68.14 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.697 0.399 . . . . 0.0 111.248 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.44 -38.36 81.09 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.431 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 43.2 t -63.81 -48.32 86.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.017 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.455 HD22 HD12 ' A' ' 93' ' ' ILE . 1.8 tt -68.74 -37.25 79.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.04 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.494 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.3 t60 -68.52 -49.32 60.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.634 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.492 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.28 -20.75 63.02 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.62 -32.53 23.66 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HD2' ' O ' ' A' ' 80' ' ' LEU . 73.1 m-85 -103.0 2.5 35.03 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.465 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 81' ' ' HIS . 4.5 tp -71.31 -31.46 1.93 Allowed Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.205 -0.902 . . . . 0.0 113.206 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 85' ' ' ILE . 39.9 Cg_exo -59.7 -23.54 72.08 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.901 1.734 . . . . 0.0 114.033 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.67 -31.43 46.7 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.52 -158.41 30.71 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.49 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -85.73 139.66 31.15 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.672 0.389 . . . . 0.0 111.426 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.563 HG21 HD11 ' A' ' 93' ' ' ILE . 8.3 mt -117.09 140.54 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.998 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.9 p -93.86 -62.49 1.34 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.308 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.4 ' O ' HD13 ' A' ' 93' ' ' ILE . 75.8 m-20 -144.89 152.52 40.37 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.563 HD11 HG21 ' A' ' 90' ' ' ILE . 17.4 mm -121.04 130.59 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.617 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.482 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 86.4 mm-40 -120.51 137.1 54.55 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.222 0.326 . . . . 0.0 111.583 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.73 100.39 28.25 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.787 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.52 128.09 23.71 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.543 2.162 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -128.07 133.76 49.09 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.774 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.24 138.51 31.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.422 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -64.53 -33.69 76.48 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.17 -44.68 75.42 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.979 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.55 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 26.5 p -102.42 -29.04 11.86 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 52.86 32.56 12.64 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.19 0.596 . . . . 0.0 110.785 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 101' ' ' THR . 58.4 mttt -124.33 154.22 40.63 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.062 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -94.77 134.8 36.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.63 4.65 53.62 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 91.04 25.91 23.21 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.43 -0.891 . . . . 0.0 114.695 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -143.7 148.3 35.52 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 117.668 0.734 . . . . 0.0 111.378 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 94' ' ' GLN . . . -159.09 176.34 12.39 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.539 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -119.05 150.45 39.96 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.471 HG23 ' CD1' ' A' ' 93' ' ' ILE . 12.0 p -121.63 134.56 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.989 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.411 ' HG3' HG22 ' A' ' 65' ' ' VAL . 20.1 tt0 -111.03 133.15 53.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.093 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 80.7 m-85 -117.19 150.62 38.43 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.42 0.45 . . . . 0.0 111.261 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -69.07 -39.04 79.34 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.038 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mp -111.27 141.13 45.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.083 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.62 -21.21 62.67 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.613 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -62.18 -42.99 99.79 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.131 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -70.89 -32.05 68.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.051 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.603 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -57.64 -46.88 83.6 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 123.374 0.421 . . . . 0.0 111.057 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.15 -28.51 63.29 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.383 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.18 -44.28 63.25 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.582 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.72 91.94 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.796 HD11 HD22 ' A' ' 66' ' ' LEU . 16.2 mt -70.83 -43.42 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -71.28 -32.49 68.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -79.42 -49.6 12.1 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 64.0 mtt -135.17 63.69 1.61 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.098 0.475 . . . . 0.0 112.227 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 17.6 p30 -69.82 -35.17 74.57 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.044 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 135' ' ' ILE . 38.7 mt-10 -142.99 78.65 1.62 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.698 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 49.9 m -120.58 161.23 21.68 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.282 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -90.36 117.19 28.89 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.019 0.437 . . . . 0.0 110.752 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.7 tp -129.06 131.78 47.37 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.762 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.5 t80 63.88 14.49 8.39 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.765 0.826 . . . . 0.0 112.189 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.61 5.16 60.28 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.237 -0.438 . . . . 0.0 113.085 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.7 mtp180 -127.66 157.19 40.94 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.612 0.365 . . . . 0.0 110.721 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.55 133.89 34.85 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 1.6 pt -118.19 152.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 58.6 mtt-85 -122.81 134.55 54.41 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.259 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.81 ' HA ' ' O ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -130.46 133.31 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 110.766 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -151.01 172.31 15.91 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.986 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.28 131.29 42.5 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.662 0.268 . . . . 0.0 111.369 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.158 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.112 -179.69 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.337 0.113 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 97.2 mmm -99.9 128.78 45.96 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 123.353 0.408 . . . . 0.0 110.843 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.0 mtt -131.65 -51.79 0.99 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.901 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -136.9 118.09 14.48 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.399 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 t -139.77 128.74 23.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.332 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.34 178.7 48.42 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.593 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -128.11 151.79 48.78 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.853 0.384 . . . . 0.0 110.708 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.4 t -93.97 120.84 34.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -136.47 158.61 44.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.921 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -120.95 147.88 44.85 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.529 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -106.29 136.87 45.26 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.25 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 t -124.6 138.31 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.573 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' GLU . 93.0 m-70 -61.21 -39.94 92.1 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t -63.31 -39.43 94.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -65.7 -37.38 86.3 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.2 m -76.86 -33.27 57.88 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' HIS . 49.1 mt-10 -66.14 -31.93 73.08 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -88.0 -73.21 0.49 Allowed 'General case' 0 CA--C 1.538 0.514 0 O-C-N 123.129 0.268 . . . . 0.0 111.564 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.97 150.54 31.97 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.693 0.282 . . . . 0.0 111.045 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.5 m -87.6 159.2 18.66 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.47 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -58.94 -39.35 81.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -67.35 -39.98 85.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.854 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.479 ' O ' HD12 ' A' ' 27' ' ' LEU . 17.1 mtt -68.03 -38.51 82.63 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -65.46 -45.54 83.35 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.61 -45.36 62.35 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.436 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 34.0 mt -66.67 -46.37 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 23' ' ' MET . 10.5 mt -68.8 -32.18 71.72 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.5 p -68.06 -36.58 80.1 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -124.1 97.85 5.52 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.12 0.486 . . . . 0.0 111.071 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 27' ' ' LEU . 5.7 mt -121.51 125.66 26.76 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.169 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.04 119.76 6.54 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.31 2.007 . . . . 0.0 111.344 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -46.72 -34.81 5.47 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -84.05 -43.73 14.82 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t -65.49 -36.99 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.291 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.54 -27.83 63.46 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -169.81 159.63 8.11 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 120.658 0.266 . . . . 0.0 111.657 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.6 p -101.78 160.05 14.8 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.03 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 34.3 m -122.79 155.97 35.46 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.08 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t 61.87 160.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 123.836 0.855 . . . . 0.0 111.416 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -95.64 126.31 40.83 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.023 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.8 t -134.56 153.8 51.78 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.855 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.0 p -71.73 -23.48 61.62 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.289 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.25 -31.99 71.86 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.942 0.497 . . . . 0.0 112.274 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -62.37 -33.0 73.88 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -72.87 -20.67 61.06 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 t -106.62 135.01 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -79.65 143.77 34.37 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.71 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.69 172.5 37.83 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.908 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.25 42.25 8.08 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 121.68 -0.295 . . . . 0.0 113.217 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.7 m -117.98 147.91 42.72 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.242 0.217 . . . . 0.0 111.044 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.47 -175.62 46.02 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.068 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -177.84 -171.18 40.99 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 121.513 -0.375 . . . . 0.0 112.664 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.5 p -68.12 -27.03 66.1 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.61 138.24 2.6 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 123.433 0.458 . . . . 0.0 112.45 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.33 -49.71 4.1 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 121.672 -0.299 . . . . 0.0 112.924 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.6 m -65.32 -34.76 79.1 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -136.85 177.9 19.34 Favored Glycine 0 C--N 1.34 0.76 0 O-C-N 123.451 0.469 . . . . 0.0 112.893 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.7 117.7 3.23 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.623 -0.322 . . . . 0.0 112.403 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -121.61 146.83 46.58 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.288 0.235 . . . . 0.0 111.098 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.87 150.8 27.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.058 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.9 p -87.35 159.47 18.73 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.146 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.2 p -82.15 125.96 31.5 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.686 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -132.06 143.25 49.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.89 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 112' ' ' PHE . 84.4 mtt180 -78.83 -12.48 60.03 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.452 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 20.5 t -102.44 129.29 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.881 HD21 ' HB1' ' A' ' 118' ' ' ALA . 0.1 OUTLIER -123.79 158.85 30.8 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.304 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 31.3 t80 -93.84 132.88 37.82 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.013 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -132.51 115.49 25.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.91 156.45 21.73 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.355 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.14 20.82 9.39 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.146 -0.527 . . . . 0.0 112.448 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -89.32 163.11 15.48 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -89.71 156.62 18.42 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.946 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.03 -26.66 68.66 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.654 0.382 . . . . 0.0 111.678 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -76.95 -2.2 32.54 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.676 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 72' ' ' ALA . 1.9 m -87.41 139.57 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 120.577 0.227 . . . . 0.0 110.747 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 79' ' ' VAL . 4.3 p30 -120.64 -176.64 3.28 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.5 -31.11 71.09 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.879 0.472 . . . . 0.0 111.788 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB2' ' OD1' ' A' ' 76' ' ' ASP . 91.5 mttt -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.714 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 76' ' ' ASP . 91.5 t -65.42 -47.59 86.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.056 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.433 ' O ' ' HD1' ' A' ' 84' ' ' PHE . 1.4 tt -67.38 -39.14 85.63 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.411 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' A' ' 85' ' ' ILE . 4.8 t60 -68.15 -47.85 66.94 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.572 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.488 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -70.82 -20.22 62.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.86 -34.81 24.53 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-O 120.845 0.355 . . . . 0.0 111.38 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' C ' HD11 ' A' ' 90' ' ' ILE . 76.3 m-85 -99.87 -2.05 35.85 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.391 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' HD2' ' A' ' 86' ' ' PRO . 4.9 tp -68.51 -32.48 3.78 Favored Pre-proline 0 CA--C 1.566 1.578 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 85' ' ' ILE . 11.4 Cg_endo -56.66 -24.81 56.47 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.035 1.823 . . . . 0.0 113.874 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -79.43 -31.32 42.57 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.287 0.367 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.9 -169.71 42.85 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.308 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -86.03 130.77 34.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.314 0.246 . . . . 0.0 110.748 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.552 HG21 HD11 ' A' ' 93' ' ' ILE . 5.5 mt -105.89 141.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.919 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.4 p -88.37 -60.5 1.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.757 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -146.29 153.21 40.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.552 HD11 HG21 ' A' ' 90' ' ' ILE . 18.0 mm -120.53 122.26 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 -120.9 125.85 48.52 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 111.522 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mp -127.15 117.37 21.83 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.811 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.89 121.86 8.94 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.994 1.796 . . . . 0.0 112.521 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 tp -122.93 136.56 54.9 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.076 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -86.87 139.42 30.67 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.68 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.614 ' HA ' ' OE2' ' A' ' 102' ' ' GLU . 87.4 m-85 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -66.06 -42.72 89.07 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -108.58 -27.02 10.11 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.614 ' OE2' ' HA ' ' A' ' 99' ' ' TYR . 73.2 mm-40 57.7 24.84 11.07 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.231 0.612 . . . . 0.0 111.474 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -124.48 154.88 39.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.269 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -115.34 148.71 38.93 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 123.344 0.402 . . . . 0.0 110.81 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -71.58 -15.21 62.26 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.293 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 71' ' ' LEU . . . 110.71 39.19 1.47 Allowed Glycine 0 C--N 1.342 0.88 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.918 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -144.09 149.23 36.26 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 117.084 0.442 . . . . 0.0 110.823 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.58 170.96 21.18 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.092 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -118.02 145.55 44.7 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 10.4 p -118.69 137.87 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.068 0.461 . . . . 0.0 111.43 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 90' ' ' ILE . 23.1 tt0 -107.23 128.99 54.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.23 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' A' ' 64' ' ' ARG . 45.4 m-85 -116.87 146.0 43.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.898 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -70.75 -37.4 73.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.862 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.606 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 6.5 mp -107.37 143.19 36.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.1 -25.87 58.85 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.745 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -71.13 -47.24 59.1 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.297 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 114' ' ' LEU . 20.7 p30 -67.23 -32.02 72.78 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.962 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.881 ' HB1' HD21 ' A' ' 66' ' ' LEU . . . -66.04 -45.18 82.36 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.079 0.552 . . . . 0.0 111.343 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.68 70.52 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.23 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.632 ' HA ' ' OD2' ' A' ' 123' ' ' ASP . . . -69.67 -33.92 73.24 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.007 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.04 -37.59 78.67 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.723 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.667 HD11 HD22 ' A' ' 66' ' ' LEU . 74.3 mt -66.65 -47.68 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.632 ' OD2' ' HA ' ' A' ' 120' ' ' ALA . 4.3 p30 -67.47 -34.31 76.91 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -88.36 -35.04 17.39 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 137' ' ' VAL . 83.6 mtp -110.73 14.39 22.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.657 ' O ' ' HA ' ' A' ' 136' ' ' ARG . 9.5 t-20 -57.47 -37.26 72.6 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.813 0.278 . . . . 0.0 111.572 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -142.71 77.14 1.56 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.624 0.726 . . . . 0.0 109.908 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.5 t -127.17 157.0 40.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.118 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -93.21 118.99 31.89 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.6 tp -131.0 130.41 43.3 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.982 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 62.6 15.52 8.03 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.573 0.749 . . . . 0.0 112.361 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.02 4.39 60.08 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 116.194 -0.457 . . . . 0.0 113.301 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.9 mtp85 -126.55 153.96 44.5 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.502 0.321 . . . . 0.0 110.885 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.97 133.36 34.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 pt -116.1 152.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.657 ' HA ' ' O ' ' A' ' 126' ' ' ASN . 5.0 tpt180 -124.66 128.45 48.86 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.599 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 122' ' ' ILE . 0.7 OUTLIER -130.43 139.18 51.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.38 0.425 . . . . 0.0 110.764 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.498 ' OD1' ' HB3' ' A' ' 67' ' ' TYR . 28.5 p30 -145.27 173.76 11.68 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.496 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.0 tt -69.79 123.67 22.04 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.756 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.321 -179.54 . . . . . . . . 0 0 . 1 stop_ save_